
<html lang="en"     class="pb-page"  data-request-id="2b161f4e-cecb-4ebf-ada5-e64bc72c83c3"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-20;website:website:acspubs;article:article:10.1021/jm3011146;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification and Characterization of Carprofen as a Multitarget Fatty Acid Amide Hydrolase/Cyclooxygenase Inhibitor" /></meta><meta name="dc.Creator" content="Angelo D.  Favia" /></meta><meta name="dc.Creator" content="Damien  Habrant" /></meta><meta name="dc.Creator" content="Rita  Scarpelli" /></meta><meta name="dc.Creator" content="Marco  Migliore" /></meta><meta name="dc.Creator" content="Clara  Albani" /></meta><meta name="dc.Creator" content="Sine Mandrup  Bertozzi" /></meta><meta name="dc.Creator" content="Mauro  Dionisi" /></meta><meta name="dc.Creator" content="Glauco  Tarozzo" /></meta><meta name="dc.Creator" content="Daniele  Piomelli" /></meta><meta name="dc.Creator" content="Andrea  Cavalli" /></meta><meta name="dc.Creator" content="Marco  De Vivo" /></meta><meta name="dc.Description" content="Pain and inflammation are major therapeutic areas for drug discovery. Current drugs for these pathologies have limited efficacy, however, and often cause a number of unwanted side effects. In the p..." /></meta><meta name="Description" content="Pain and inflammation are major therapeutic areas for drug discovery. Current drugs for these pathologies have limited efficacy, however, and often cause a number of unwanted side effects. In the p..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 8, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3011146" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3011146" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3011146" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3011146" /></link>
        
    
    

<title>Identification and Characterization of Carprofen as a Multitarget Fatty Acid Amide Hydrolase/Cyclooxygenase Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3011146" /></meta><meta property="og:title" content="Identification and Characterization of Carprofen as a Multitarget Fatty Acid Amide Hydrolase/Cyclooxygenase Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0012.jpeg" /></meta><meta property="og:description" content="Pain and inflammation are major therapeutic areas for drug discovery. Current drugs for these pathologies have limited efficacy, however, and often cause a number of unwanted side effects. In the present study, we identify the nonsteroidal anti-inflammatory drug carprofen as a multitarget-directed ligand that simultaneously inhibits cyclooxygenase-1 (COX-1), COX-2, and fatty acid amide hydrolase (FAAH). Additionally, we synthesized and tested several derivatives of carprofen, sharing this multitarget activity. This may result in improved analgesic efficacy and reduced side effects (Naidu et al. J. Pharmacol. Exp. Ther.2009, 329, 48–56; Fowler, C. J.; et al. J. Enzyme Inhib. Med. Chem.2012, in press; Sasso et al. Pharmacol. Res.2012, 65, 553). The new compounds are among the most potent multitarget FAAH/COX inhibitors reported so far in the literature and thus may represent promising starting points for the discovery of new analgesic and anti-inflammatory drugs." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3011146"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3011146">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3011146&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3011146&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3011146&amp;href=/doi/10.1021/jm3011146" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8807-8826</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301103y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301119s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification and Characterization of Carprofen as a Multitarget Fatty Acid Amide Hydrolase/Cyclooxygenase Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angelo+D.++Favia">Angelo D. Favia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Damien++Habrant">Damien Habrant</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rita++Scarpelli">Rita Scarpelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Migliore">Marco Migliore</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Clara++Albani">Clara Albani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sine+Mandrup++Bertozzi">Sine Mandrup Bertozzi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mauro++Dionisi">Mauro Dionisi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Glauco++Tarozzo">Glauco Tarozzo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniele++Piomelli">Daniele Piomelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Cavalli">Andrea Cavalli</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++De+Vivo">Marco De Vivo</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Drug Discovery and Development, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Anatomy and Neurobiology, University of California, Irvine, California 92697, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Pharmaceutical Sciences, University of Bologna, via Belmeloro 6, 40126 Bologna, Italy</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#6904081b0a06470d0c1f001f062900001d47001d"><span class="__cf_email__" data-cfemail="64090516070b4a0001120d120b240d0d104a0d10">[email protected]</span></a> (M.D.V.); <a href="/cdn-cgi/l/email-protection#65040b011700044b0604130409090c250c0c114b0c11"><span class="__cf_email__" data-cfemail="d6b7b8b2a4b3b7f8b5b7a0b7bababf96bfbfa2f8bfa2">[email protected]</span></a> (A.C.). Phone: +39 010 71781577 (M.D.V.); +39 010 71781530/+39 051 2099735 (A.C.).</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3011146&amp;href=/doi/10.1021%2Fjm3011146" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8807–8826</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 8, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 July 2012</li><li><span class="item_label"><b>Published</b> online</span>8 October 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 October 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3011146" title="DOI URL">https://doi.org/10.1021/jm3011146</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8807%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAngelo%2BD.%2BFavia%252C%2BDamien%2BHabrant%252C%2BRita%2BScarpelli%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D20%26contentID%3Djm3011146%26title%3DIdentification%2Band%2BCharacterization%2Bof%2BCarprofen%2Bas%2Ba%2BMultitarget%2BFatty%2BAcid%2BAmide%2BHydrolase%252FCyclooxygenase%2BInhibitor%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8826%26publicationDate%3DOctober%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3011146"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1944</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">51</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3011146" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification and Characterization of Carprofen as a Multitarget Fatty Acid Amide Hydrolase/Cyclooxygenase Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Angelo&quot;,&quot;last_name&quot;:&quot;D. Favia&quot;},{&quot;first_name&quot;:&quot;Damien&quot;,&quot;last_name&quot;:&quot;Habrant&quot;},{&quot;first_name&quot;:&quot;Rita&quot;,&quot;last_name&quot;:&quot;Scarpelli&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Migliore&quot;},{&quot;first_name&quot;:&quot;Clara&quot;,&quot;last_name&quot;:&quot;Albani&quot;},{&quot;first_name&quot;:&quot;Sine&quot;,&quot;last_name&quot;:&quot;Mandrup Bertozzi&quot;},{&quot;first_name&quot;:&quot;Mauro&quot;,&quot;last_name&quot;:&quot;Dionisi&quot;},{&quot;first_name&quot;:&quot;Glauco&quot;,&quot;last_name&quot;:&quot;Tarozzo&quot;},{&quot;first_name&quot;:&quot;Daniele&quot;,&quot;last_name&quot;:&quot;Piomelli&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Cavalli&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;De Vivo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;08&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;8807-8826&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3011146&quot;},&quot;abstract&quot;:&quot;Pain and inflammation are major therapeutic areas for drug discovery. Current drugs for these pathologies have limited efficacy, however, and often cause a number of unwanted side effects. In the present study, we identify the nonsteroidal anti-inflammatory drug carprofen as a multitarget-directed ligand that simultaneously inhibits cyclooxygenase-1 (COX-1), COX-2, and fatty acid amide hydrolase (FAAH). Additionally, we synthesized and tested several derivatives of carprofen, sharing this multitarget activity. This may result in improved analgesic efficacy and reduced side effects (Naidu et al. J. Pharmacol. Exp. Ther.2009, 329, 48–56; Fowler, C. J.; et al. J. Enzyme Inhib. Med. Chem.2012, in press; Sasso et al. Pharmacol. Res.2012, 65, 553). The new compounds are among the most potent multitarget FAAH/COX inhibitors reported so far in the literature and thus may represent promising starting points for the discovery of new analgesic and anti-inflammatory drugs.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3011146&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3011146" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3011146&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3011146" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3011146&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3011146" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3011146&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3011146&amp;href=/doi/10.1021/jm3011146" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3011146" /></input><a href="/doi/pdf/10.1021/jm3011146" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3011146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3011146%26sid%3Dliteratum%253Aachs%26pmid%3D23043222%26genre%3Darticle%26aulast%3DFavia%26date%3D2012%26atitle%3DIdentification%2Band%2BCharacterization%2Bof%2BCarprofen%2Bas%2Ba%2BMultitarget%2BFatty%2BAcid%2BAmide%2BHydrolase%252FCyclooxygenase%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D20%26spage%3D8807%26epage%3D8826%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jmcmar.2012.55.issue-20/production/jmcmar.2012.55.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Pain and inflammation are major therapeutic areas for drug discovery. Current drugs for these pathologies have limited efficacy, however, and often cause a number of unwanted side effects. In the present study, we identify the nonsteroidal anti-inflammatory drug carprofen as a multitarget-directed ligand that simultaneously inhibits cyclooxygenase-1 (COX-1), COX-2, and fatty acid amide hydrolase (FAAH). Additionally, we synthesized and tested several derivatives of carprofen, sharing this multitarget activity. This may result in improved analgesic efficacy and reduced side effects (Naidu et al. <i>J. Pharmacol. Exp. Ther.</i><b>2009</b>, <i>329</i>, 48–56; Fowler, C. J.; et al. <i>J. Enzyme Inhib. Med. Chem.</i><b>2012</b>, in press; Sasso et al. <i>Pharmacol. Res.</i><b>2012</b>, <i>65</i>, 553). The new compounds are among the most potent multitarget FAAH/COX inhibitors reported so far in the literature and thus may represent promising starting points for the discovery of new analgesic and anti-inflammatory drugs.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>∥</span> Author Contributions</h4><p class="last">These authors contributed equally to this work.</p></div><div class="extra-info-sec articleNote"><h4><span>⊥</span> Author Present Address</h4><p class="last">In-Cell-Art, IRT-UN INSERM 1087, Nantes, France.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Pain and inflammation remain areas of substantial unmet patient need.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6 ref7">(1-7)</a> Current drugs used to treat these conditions have, however, moderate efficacy and can produce a variety of untoward side effects, such as gastrointestinal bleeding and ulceration, renal dysfunction, nausea, and vomiting. Therefore, the search for novel and more effective analgesics able to overcome these limitations is the subject of intense efforts in both academia and industry.</div><div class="NLM_p">Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to treat acute and chronic pain. NSAIDs produce their beneficial action by inhibiting the two isoforms of the cyclooxygenase (COX) enzyme, COX-1 and COX-2.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> These enzymes convert arachidonic acid into prostaglandins and thromboxane, which are important physiological and pathological effectors. Different tissues express varying levels of COX-1 and COX-2. COX-1 is a constitutive enzyme found in most mammalian cells. COX-2, on the other hand, is an inducible enzyme whose expression can be strongly stimulated by pro-inflammatory stimuli in macrophages and other cells.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> There are several well-known classes of NSAIDs, which are either nonselective for COX-1 and COX-2 or selective for COX-2.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Both classes exert, however, a number of potentially serious side effects.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In the gastrointestinal tract, COX-1 inhibition blocks the synthesis of tissue-protecting prostaglandins such as PGE<sub>2</sub>, facilitating the development of peptic ulceration and dyspepsia. Selective COX-2 inhibitors have raised major concerns because of increased cardiovascular risk. A notable example is rofecoxib, which was withdrawn from the market in 2004 because of such—still debated—concerns.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a></div><div class="NLM_p">Fatty acid amide hydrolase (FAAH) has been proposed as a promising target for the discovery of new drugs to treat pain, inflammation, and other pathologies.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18 ref19">(15-19)</a> FAAH is an intracellular serine hydrolase responsible for the deactivating hydrolysis of a family of naturally occurring fatty acid ethanolamides, such as its main substrate anandamide, which acts as an endogenous cannabinoid agonist.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20-22)</a> Interestingly, it has been suggested that drugs currently marketed as analgesics may derive some of their efficacy from inhibition of FAAH, which further highlights the potential of this target for drug discovery.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> Several classes of FAAH inhibitors have been discovered during the past decade—including α-ketoheterocycles and carbamate, piperidine and piperazine urea-based molecules—some of which are undergoing preclinical and clinical studies.<a onclick="showRef(event, 'ref25 ref26 ref27 ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28 ref29 ref30 ref31">(25-31)</a></div><div class="NLM_p">Several in vivo studies suggest that the simultaneous inhibition of COX and FAAH activities produces superadditive pharmacological effects and lowered toxicity in animal models. Naidu et al. showed that the FAAH inhibitor URB597<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and the nonselective COX inhibitor diclofenac act synergistically to reduce visceral pain in mice.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Similar results were obtained by Sasso et al. using the peripherally restricted FAAH inhibitor URB937 and the NSAID indomethacin.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Importantly, both studies showed that FAAH blockade lowers the ulcerogenic activity of COX inhibitors.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> These findings suggest that multitarget-directed ligands<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> able to simultaneously inhibit FAAH and COX activities might offer certain advantages over traditional single-target drugs and/or drug combinations. These include (i) improved efficacy, due to the synergistic interaction between FAAH and COX blockade, (ii) improved safety, due to the lowering of COX-mediated side effects produced by FAAH inhibition, and (iii) reduced uncertainty in clinical development with respect to drug cocktails or multicomponent drugs, due to the avoided risk of drug–drug interactions.<a onclick="showRef(event, 'ref35 ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37 ref38">(35-38)</a> It is worth remembering that some very successful drugs act via multiple-target mechanisms (e.g., quetiapine, imatinib).</div><div class="NLM_p">Here, we report on the discovery of new multitarget inhibitors that show improved potency compared to previously reported mixed FAAH/COX compounds.<a onclick="showRef(event, 'ref23 ref24 ref39'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref39">(23, 24, 39)</a> We used docking calculations to identify putative FAAH/COX inhibitors starting from known COX-targeting drugs. In vitro pharmacological tests identified carprofen (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) as a multitarget FAAH/COX hit. On the basis of this finding, we designed several carprofen derivatives that showed significant multitarget inhibitory activity, highlighting the potential of the carprofen scaffold as a source for new effective and safe analgesics.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Circular tree based on pairwise Tanimoto distances between Daylight fingerprints of 382 diverse known COX inhibitors. To help in the interpretation, only selected molecules, belonging to different clusters, are depicted in proximity of their positions in the tree to highlight the structural diversity of the set. Carprofen is shown in the upper left corner.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Identification of Carprofen as a Multitarget FAAH/COX Inhibitor</h3><div class="NLM_p">We selected 382 COX inhibitors retrieved from DrugBank<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and DUD<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and docked them into the structure of FAAH (see the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a>). Several clinically approved drugs were found among the top-ranking molecules. The entire assembled set was clustered according to pairwise Tanimoto distances, using a description based on the Daylight fingerprints (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). A clustering threshold of 0.4 resulted in 84 clusters, which highlighted the structural diversity within the set. The top 100 scored molecules were visually inspected. Among them, indomethacin was ranked no. 4, flurbiprofen no. 10, and celecoxib no. 16 (the putative binding mode of these three COX inhibitors at the active site of FAAH is reported in Figure S2, <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information">Supporting Information</a>). On the basis of their commercial availability, we purchased 25 compounds for testing (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). These molecules were also clustered according to their topological distance and physicochemical similarity, as highlighted in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. According to the reported tree, a clustering threshold of 0.3 originated 19 clusters, underlining the absence of trivially similar compounds. This unanticipated chemotype richness enabled us to probe FAAH binding thoroughly and maximize the chance to find a multitarget FAAH/COX inhibitor among the 25 selected compounds. The in vitro results identified carprofen (<b>1</b>) as the best multitarget FAAH/COX inhibitor in the set of compounds tested. Carprofen inhibited FAAH with a median effective concentration (IC<sub>50</sub>) of 79 μM, COX-1 with an IC<sub>50</sub> = 22 μM, and COX-2 with an IC<sub>50</sub> = 4 μM. As the profile against the three targets turned out to be rather balanced, compound <b>1</b> emerged as a promising starting point for multitarget FAAH/COX lead discovery.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Tree based on the pairwise Tanimoto fingerprint distances between the 25 COX inhibitors tested in the present study. The heat map highlights the distances calculated in the first 5 principal components space (variance explained >90%) originating from 10 physicochemical descriptors (i.e., net charge, MW, log <i>P</i>, log <i>S</i>, number of hydrogen bond donors, number of hydrogen bond acceptors, polar surface area, number of atoms, number of rings, and number of rotatable bonds).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p">Several possible chemical variations of <b>1</b> were considered (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). The preparation of the corresponding deschlorinated derivative (<b>2</b>) was performed by hydrogenation of <b>1</b>, using a flow hydrogenator apparatus (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Planned Chemical Variations of Carprofen, <b>1</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Deschlorinated Compound <b>2,</b> Ester <b>3</b>, and Amides <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H-Cube, H<sub>2</sub>, 10% Pd/C, EtOH, EtOAc, 60 °C, 40%; (b) MeOH, H<sub>2</sub>SO<sub>4</sub>, rt, 12 h, quantitative; (c) CDI, pyridine, 60 °C, 12 h, 85–86%.</p></p></figure><div class="NLM_p">Syntheses of the ester and amide derivatives of <b>1</b> were achieved using standard reaction conditions (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, for representative examples). The esterification of <b>1</b> in acidic methanol gave the corresponding methyl ester <b>3</b> in quantitative yield. The amides <b>4a</b> and <b>4b</b> were efficiently prepared by the reaction of <b>1</b> in pyridine in the presence of CDI with ethanolamine and aniline, respectively.</div><div class="NLM_p">The functionalization of the nitrogen atom of <b>1</b> was achieved using ester <b>3</b> as a common intermediate (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The preparation of different <i>N</i>-alkyl derivatives was performed using the appropriate alkyl halides in the presence of Cs<sub>2</sub>CO<sub>3</sub> in MeCN to provide compounds <b>5</b> in moderate to good yields. Saponification of the ester with LiOH, followed by acidic treatment, gave the corresponding carboxylic acids <b>6</b> in good yields.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>6</b>, <b>8</b>, <b>10</b>, and <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>X, Cs<sub>2</sub>CO<sub>3</sub>, MeCN, reflux, 12 h, 32–99%; (b) R<sub>2</sub>SO<sub>2</sub>Cl, Et<sub>3</sub>N, DMAP, THF, reflux, 5 h, or 100 °C, 3 h, microwave, 35–78%; (c) R<sub>3</sub>NCO, Et<sub>3</sub>N, DMAP, THF, 100 °C, microwave, 10 h, 51–81%; (d) LiOH, MeOH, THF, H<sub>2</sub>O, 12 h, 21–85%; (e) 6 M HCl, THF, rt, 5 days, 80%; (f) hexyl chloroformate, Et<sub>3</sub>N, DMAP, THF, 100 °C, 3 h, microwave, 85%; (g) 6 M HCl, THF, rt, 3 days, 55%.</p></p></figure><div class="NLM_p">Preparation of the sulfonamide derivatives <b>7</b> was achieved by reaction of <b>3</b> with the appropriate sulfonyl chlorides in THF, in the presence of DMAP and Et<sub>3</sub>N, under thermal heating or microwave irradiation. In a similar manner, as described before, saponification of the ester group produced the corresponding acid <b>8</b> in good yields.</div><div class="NLM_p">Reaction of compound <b>3</b> with the appropriate isocyanates in THF, in the presence of DMAP and Et<sub>3</sub>N, under microwave conditions, afforded the urea derivatives <b>9</b>. Compounds <b>9</b> were then hydrolyzed under basic conditions to give the corresponding acid derivatives <b>10</b> in moderate to good yields. In the case of <b>9d</b>, bearing a <i>p</i>-chlorophenyl moiety, the methyl ester hydrolysis was performed in acidic medium (due to the observed cleavage of the urea bond of <b>9d</b> under basic conditions) to provide <b>10d</b> in a good 80% yield.</div><div class="NLM_p">The carbamate derivative <b>12</b> was prepared under standard conditions (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Compound <b>3</b> was reacted in THF with hexyl chloroformate, in the presence of Et<sub>3</sub>N and DMAP, to give intermediate <b>11</b>, which was further hydrolyzed under acidic conditions to provide <b>12</b>.</div><div class="NLM_p">The preparation of the acyl derivatives was performed using a different protecting group on the carboxylic functionality (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). In our initial experiments, it was indeed observed that <i>N</i>-acetylated derivatives were not stable under basic and acidic conditions, typically used for the hydrolysis of the methyl ester. The use of <i>tert</i>-butyl ester was also exploited without any synthetic success.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> We therefore decided to protect <b>1</b> as an <i>O</i>-benzyl ester, using standard reaction conditions (BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The acylation reactions of the benzyl ester <b>13</b> proceeded well in MeCN in the presence of DMAP and Et<sub>3</sub>N, with various acyl chlorides, to afford esters <b>14</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 3 h, 84%; (b) acyl chloride, DMAP, Et<sub>3</sub>N, MeCN, rt, 2 h, 76–97% ; (c) H-Cube, H<sub>2</sub>, 1% or 5% Pd/C, rt, THF, 15–42%.</p></p></figure><div class="NLM_p last">The last debenzylation step to obtain the corresponding acids <b>15</b> was performed using the H-Cube apparatus, under optimized conditions to reduce the formation of the undesired deschloro derivatives <b>16</b>. In this context, the influence of the solvent (EtOH/EtOAc (1:1) and THF), the temperature of the reaction (from room temperature to 60 °C), the catalyst loading (1%, 5%, and 10% Pd/C cartridge), and the hydrogenation conditions were evaluated. After several trials, two different conditions appeared to be satisfactory and were applied for the preparation of our targeted compounds. The first method relied on passing a solution of <b>14</b> in THF through a 5% Pd/C cartridge, at room temperature and 1 bar of H<sub>2</sub> pressure (H-Cube “full H<sub>2</sub> mode”). In this case, complete conversion of the benzyl ester <b>14</b> was observed, and the expected <b>15</b> was formed in an approximately 3:1 ratio with respect to <b>16</b>. The second method was performed using a 1% Pd/C cartridge at room temperature and 1 bar of H<sub>2</sub> pressure, in a closed-loop system with the H-Cube (where the outcoming solution was directly reinjected into the incoming solution). By carefully monitoring the advancement of the reaction by UPLC/MS analysis, it was possible, after 4–5 h of hydrogenation, to reach a stage where the conversion of <b>14</b> was satisfactory (generally around 70%) and where the formation of <b>16</b> was maintained low compared to that of <b>15</b>; the reaction was stopped when the <b>15</b>:<b>16</b> ratio reached approximately 9:1. <b>15a</b>–<b>j</b> were prepared using this procedure with the exception of <b>15k</b>. In this case, we observed that the final hydrogenation step did not proceed, probably because of the presence of the thiazole ring, which poisoned the catalyst. We therefore decided to use the methyl ester <b>3</b> as the starting material and to carry the hydrolysis in acidic medium, which led to the formation of <b>15k</b> in a low yield.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Structure–Activity Relationship (SAR) Exploration</h3><div class="NLM_p">The inhibitory activities against FAAH, COX-1, and COX-2 of the first set of derivatives of <b>1</b> are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. The IC<sub>50</sub> values were not determined for compounds showing less than 50% inhibition at concentrations of 100 μM for FAAH and COXs.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. FAAH-1, COX-1, and COX-2 Activities of Carprofen Derivatives<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0008.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0009.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0015.gif" alt="" id="GRAPHIC-d1683e796-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Values are means of ≥3 experiments performed in duplicate.</p></div></div><div></div></div><div class="NLM_p">Compound <b>1</b> inhibited FAAH, COX-1, and COX-2 with a rather balanced profile (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Although an improved potency against FAAH was observed with <b>2</b> (IC<sub>50</sub> = 5 μM), the removal of the chlorine atom was detrimental for the inhibition of both COX-1 and COX-2. Also, the pivotal role of the carboxylic function for COX inhibition was confirmed by the lack of activity of the ester derivative <b>3</b> and the amides <b>4a</b> and <b>4b</b>. On the other hand, we observed a 26-fold increase in FAAH potency for <b>4b</b> (IC<sub>50</sub> = 3 μM) compared to <b>1</b>. On the basis of these results, we decided to continue the exploration exclusively on derivatives bearing both the chlorine atom and the carboxylic function.</div><div class="NLM_p">We investigated the functionalization of the nitrogen atom of the carbazole core. The <i>N</i>-alkylated compounds <b>6a</b>–<b>g</b> and the <i>N</i>-arylsulfonylated derivatives <b>8a</b>,<b>b</b> were devoid of COX inhibitory activity. On the other hand, the compounds showed a slightly better FAAH inhibitory potency compared to <b>1</b>. The introduction of a methyl group (<b>6a</b>) led to an IC<sub>50</sub> = 15 μM against FAAH, while a benzyl group on the carbazole nitrogen gave a 3-fold improvement in FAAH inhibition compared to that of <b>1</b> (<b>6b</b>, IC<sub>50</sub> = 23 μM). We also evaluated the influence of the substitution on the phenyl ring. Also compound <b>6c</b>, which bears a CN group in the <i>para</i> position, showed a slight decrease in FAAH potency (IC<sub>50</sub> = 33 μM). Conversely, the <i>p</i>-Cl derivative <b>6d</b> and the <i>p</i>-OCH<sub>3</sub> derivative <b>6e</b> showed greater potency against FAAH, with IC<sub>50</sub> values of 10 and 8 μM, respectively. Moreover, we observed that the <i>para</i> substitution was preferential: the <i>p</i>-OCH<sub>3</sub> derivative <b>6e</b> was more potent against FAAH (IC<sub>50</sub> = 8 μM) than the <i>m</i>-OCH<sub>3</sub> derivative <b>6f</b> (IC<sub>50</sub> = 32 μM) and the <i>o</i>-OCH<sub>3</sub> derivative <b>6g</b> (which showed no activity at 30 μM). Within the series of sulfonamides, <b>8a</b> and <b>8b</b> were active against FAAH, displaying IC<sub>50</sub> values of 50 and 5 μM, respectively. It is worth mentioning that <i>N</i>-alkylated and <i>N</i>-arylsulfonylated carprofen derivatives were previously investigated for their ability to inhibit γ-secretase activity.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></div><div class="NLM_p">A number of urea derivatives were also investigated. Here, too, it was observed that inhibitory activity was generally lost on both COX isoforms, while FAAH inhibitory activity was highly dependent on the type of substituent on the urea moiety. Indeed, the best FAAH inhibitor of this series was <b>10a</b> (IC<sub>50</sub> = 3 μM), bearing a linear C<sub>6</sub> chain. Shorter linear chains, from C<sub>1</sub> to C<sub>4</sub>, showed no inhibition on FAAH, as exemplified by <b>10b</b> and <b>10c</b>. Longer chains brought less potent FAAH inhibitors, but interestingly led to an increase in COX-1 inhibition. For example, <b>10d</b> showed an IC<sub>50</sub> = 27 μM against FAAH and an IC<sub>50</sub> = 15 μM against COX-1. Compound <b>10e</b> (bearing a 4-chlorobenzyl moiety) showed weak potency against FAAH (IC<sub>50</sub> = 102 μM) and an IC<sub>50</sub> value of 41 μM against COX-1. <i>N</i>,<i>N</i>-Disubstituted derivatives or ureas bearing a cyclic moiety, such as <b>10f</b> and <b>10g</b>, were also prepared, but they all did not show any improved activities against the targets. Compound <b>12</b> showed a 10-fold weaker potency against FAAH (IC<sub>50</sub> = 32 μM) compared to its carbamate analogue <b>10a</b> (IC<sub>50</sub> = 3 μM), while it showed an IC<sub>50</sub> = 17 μM on COX-1.</div><div class="NLM_p">We then analyzed a set of acyl derivatives. The acetyl derivative <b>15a</b> did not show any inhibitory potency. Compound <b>15b</b> was active only against FAAH (IC<sub>50</sub> = 25 μM). Compound <b>15c</b>, which bears a <i>p</i>-chlorobenzoyl group, showed promising inhibitory potency on FAAH (IC<sub>50</sub> = 22 μM) and COX (COX-1 IC<sub>50</sub> = 74 μM and COX-2 IC<sub>50</sub> = 72 μM).</div><div class="NLM_p">In light of these promising results, we came to the conclusion that a carbonyl function linked to the nitrogen atom of the carbazole ring of <b>1</b> could be important to obtain a multitarget inhibition. Therefore, we decided to further expand the SAR around <b>15c</b>, obtaining a second series of molecules, whose activities are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Exploration around <b>15c</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0010.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0011.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Values are means of ≥3 experiments performed in duplicate.</p></div></div><div></div></div><div class="NLM_p">Focusing on the benzoyl core of <b>15c</b>, we prepared the <i>p</i>-fluorobenzoyl and <i>p</i>-methoxybenzoyl analogues <b>15d</b> and <b>15e</b>, which showed IC<sub>50</sub> values on FAAH of 31 and 11 μM, respectively. However, the compounds did not inhibit COX-1 or COX-2 activity. We then analyzed the influence of the position of the chlorine atom on the phenyl ring. Interestingly, as we reported before in the <i>N</i>-alkyl series, the <i>para</i> substitution was the most tolerated. The <i>m</i>-Cl derivative <b>15f</b> (FAAH IC<sub>50</sub> = 20 μM) and the <i>o</i>-Cl derivative <b>15g</b> (FAAH IC<sub>50</sub> = 60 μM) retained a similar inhibitory potency for FAAH compared to <b>15c</b>, while inhibitory activity against COX was lost. A total loss of activity for the three enzymes was observed when we tried to combine the most tolerated <i>p-</i> and <i>m</i>-Cl substitutions, as shown with <b>15h</b>.</div><div class="NLM_p">The inhibitory activity on the three enzymes was also highly dependent on the nature of the heteroaromatic ring. The 4-oxazole substitution of <b>15i</b> proved to be well tolerated, with FAAH IC<sub>50</sub> = 85 μM, COX-1 IC<sub>50</sub> = 30 μM, and COX-2 IC<sub>50</sub> = 28 μM. Compound <b>15j</b>, bearing a 4-imidazole ring, showed FAAH IC<sub>50</sub> = 6 μM and COX-1 IC<sub>50</sub> = 13 μM, but no relevant inhibition of COX-2. The introduction of a 4-thiazole ring in <b>15k</b> was detrimental for the inhibition of FAAH and COX enzymes.</div><div class="NLM_p">We finally analyzed the potency of the single enantiomers of the most active compounds of the present series, namely, <b>1</b>, <b>15c</b>, and <b>15i</b>. The racemic mixtures were submitted to enantiomeric separation by chiral HPLC. The results obtained are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. For <b>1</b>, the (<i>S</i>)-(+) enantiomer was the only one active against the three targets. For <b>15c</b> and <b>15i</b>, the (<i>S</i>)-(+) enantiomer was the only one active against COXs while the inhibitory activity against FAAH was obtained with the (<i>R</i>)-(−) enantiomer for both compounds. These findings are consistent with the known ability of the (<i>R</i>) enantiomers of flurbiprofen, indomethacin, and celecoxib to inhibit FAAH.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44, 45)</a> In addition, the inactivity of (<i>R</i>)-(−) enantiomers of <b>1</b>, <b>15c</b>, and <b>15i</b> against COXs was expected, in agreement with previous results showing a preferential COX inhibition by (<i>S</i>)-enantiomers.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. FAAH, COX-1, and COX-2 Activities of Single Enantiomers of Compounds <b>1</b>, <b>15c</b>, and <b>15i</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">IC<sub>50</sub> (μM) ± SD</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">FAAH</th><th class="colsep0 rowsep0" align="center">COX-1</th><th class="colsep0 rowsep0" align="center">COX-2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>1</b></td><td class="colsep0 rowsep0" align="left">78.6 ± 19.7</td><td class="colsep0 rowsep0" align="left">22.3 ± 6.6</td><td class="colsep0 rowsep0" align="left">3.9 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-(+)-<b>1</b></td><td class="colsep0 rowsep0" align="left">64.2 ± 3.6</td><td class="colsep0 rowsep0" align="left">5.6 ± 0.1</td><td class="colsep0 rowsep0" align="left">5.3 ± 3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-(−)-<b>1</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>15c</b></td><td class="colsep0 rowsep0" align="left">22.0 ± 4.2</td><td class="colsep0 rowsep0" align="left">74.3 ± 28.0</td><td class="colsep0 rowsep0" align="left">72.3 ± 28.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-(+)-<b>15c</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">45.0 ± 0.3</td><td class="colsep0 rowsep0" align="left">46.5 ± 4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-(−)-<b>15c</b></td><td class="colsep0 rowsep0" align="left">14.9 ± 1.6</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(±)-<b>15i</b></td><td class="colsep0 rowsep0" align="left">84.8 ± 10.6</td><td class="colsep0 rowsep0" align="left">30.0 ± 12.1</td><td class="colsep0 rowsep0" align="left">27.8 ± 9.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>S</i>)-(+)-<b>15i</b></td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">4.1 ± 2.8</td><td class="colsep0 rowsep0" align="left">2.5 ± 1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(<i>R</i>)-(−)-<b>15i</b></td><td class="colsep0 rowsep0" align="left">53.2 ± 22.6</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Values are means of ≥3 experiments performed in duplicate.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The present results identify carprofen (compound <b>1</b>) as a multitarget FAAH/COX inhibitor. SAR studies on the scaffold of the molecule show that different functionalizations at the nitrogen atom of the carbazole ring of this molecule yield additional active compounds, such as <b>15c</b> and <b>15i</b>, which inhibit FAAH/COX activities in the low micromolar range (see Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The ability of NSAIDs to inhibit anandamide hydrolysis has been previously described by Fowler and co-workers in several informative studies.<a onclick="showRef(event, 'ref39 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref39 ref47 ref48">(39, 47, 48)</a> These investigators described new molecules that simultaneously target FAAH and COX activities. In particular, the compound ibu-am5 (<i>N</i>-(3-methylpyridin-2-yl)-2-(4-isobutylphenyl)propionamide) was shown to be a promising multitarget FAAH/COX inhibitor.<a onclick="showRef(event, 'ref23 ref24 ref39 ref49'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref39 ref49">(23, 24, 39, 49)</a> This compound displayed an IC<sub>50</sub> value for FAAH of ∼0.5 μM (in EtOH) and IC<sub>50</sub> values for COX-1 of ∼60 μM and ∼240 μM in DMSO and ethanol, respectively. These data for COX inhibition were generated using an oxygen electrode assay for peroxidase (POX) activity.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Under these experimental conditions, ibu-am5 was inactive against COX-2. However, if anandamide was used as a COX-2 substrate in the assay, instead of arachidonic acid, ibu-am5 showed a COX-2 IC<sub>50</sub> ≈ 20 μM, suggesting a substrate dependency in COX-2 inhibition.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Under our present experimental conditions, ibu-am5 inhibited FAAH with an IC<sub>50</sub> of 66 μM. COX inhibition was measured with an enzyme immunoassay using a prostaglandin-specific antibody (see the <a class="ref internalNav" href="#sec5" aria-label="Methods">Methods</a>), which yielded an IC<sub>50</sub> for COX-1 of 170 μM. The potency toward COX-2 was very low, as ibu-am5 produced only 30% inhibition at 30 μM. We also tested ibuprofen as an additional reference compound, which showed IC<sub>50</sub> values of 5 and 36 μM against COX-1 and COX-2, respectively, while it was very weak against FAAH, in reasonably good agreement with previous findings.<a onclick="showRef(event, 'ref47 ref50'); return false;" href="javascript:void(0);" class="ref ref47 ref50">(47, 50)</a></div><div class="NLM_p">Therefore, carprofen and its racemic derivatives described in the present study are among the most potent multitarget FAAH/COX inhibitors reported so far. These molecules also show a well-balanced multitarget profile, implying that they may provide a starting point for the discovery of new FAAH/COX inhibitors to treat pain, inflammation, and potentially, as recently discussed, cancer.<a onclick="showRef(event, 'ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref51 ref52">(51, 52)</a> In addition, these compounds may provide a pharmacological tool to characterize the synergistic effect produced by the simultaneous inhibition of FAAH and COXs in different pathological conditions.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">Despite being evolutionary unrelated, FAAH and COXs share several structural similarities, which might help in the rationalization of the multitarget activity of carprofen and its derivatives. Such common features of the catalytic pocket of FAAH and COXs could also be anticipated in light of the similarity of their endogenous substrates. The main product of FAAH activity on anandamide is arachidonic acid, which is a substrate for COXs. In addition, it has been shown that anandamide can be metabolized by COX-2.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Because of the presence of such common structural features, useful also to discuss the basis of biological promiscuity,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> we mapped FAAH and COX-2 with two probes able to pinpoint hydrophilic and hydrophobic spots of the proteins (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The acyl chain binding channel is the most hydrophobic portion of FAAH, while, in proximity of the oxyanion hole, the hydrophilic features become preponderant due to both the presence of hydroxyl groups and the proximity of the cytosolic channel. We found a similar pattern in COX-2. In the case of this enzyme, the core of the binding site is mainly hydrophobic. In fact, this is the volume that hosts the lipophilic core of virtually all known COX inhibitors. Approaching the exit of the site, the hydrophilic character increases. The polar tails of several well-known COX inhibitors lie in this area, establishing H-bond interactions with Arg120 and Tyr355. The most important difference can be observed for the hydrophobic volume, which is greater in the case of FAAH (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hydrophilic (light blue) and hydrophobic (orange) isocontour surfaces of FAAH-1 (A) and COX-2 (B). For the sake of clarity, relevant residues are highlighted as stick models with C atoms colored in cyan. The protein is shown as a transparent cyan tube. Substrates are methyl arachidonyl fluorophosphonate in FAAH and arachidonic acid in COX-2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of our docking results, we are quite confident in the binding mode of <b>1</b> in COXs, since it is consistent with the experimentally observed binding mode of several arylpropionic acid derivatives in complex with either of the two COX isoforms.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> On the other hand, in FAAH, <b>1</b> could be accommodated into the acyl chain binding channel and establish H-bond interactions with the oxyanion hole through its carboxylic group. However, we cannot rule out alternative binding modes, in different regions of the large binding cavities of FAAH’s catalytic site (see Figure S3, <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information">Supporting Information</a>). Notably, <b>1</b> is a small molecule bearing fragmentlike physicochemical features.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p last">Finally, it is worth mentioning that the multitarget FAAH/COX activity described in this study could in principle explain why <b>1</b> is reported to have reduced ulcerogenic side effects in humans compared to other NSAIDs.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The ability of this compound to block FAAH activity might attenuate the ulcerogenic effects of COX inhibition, as shown in mice for the combination URB937 plus indomethacin.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04774" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04774" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We reported on the identification of multitarget inhibitors that simultaneously block FAAH, COX-1, and COX-2 activities. The concomitant inhibition of these enzymes has recently been shown to produce, in vivo, improved analgesic response and diminished side effects in animal models of pain. Despite their still moderate activity, the present series of compounds comprise the most active multitarget FAAH/COX inhibitors reported in the literature so far. They could serve, therefore, both as starting points for future drug discovery efforts and as tools to further characterize the synergistic effects obtained by the simultaneous inhibition of FAAH and COX activities.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45178" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45178" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> COX Inhibitor Data Set</h3><div class="NLM_p">A large collection of known COX inhibitors was retrieved, in a ready-to-dock format, from DUD<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and from DrugBank.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The grand total of unique molecules collected, after elimination of double occurrences, was 382. Some of these are currently marketed drugs mostly in use as anti-inflammatory agents, while others have been reported to inhibit at least one of the two COX isoforms, with diverse potencies. For years, COX inhibitors have been classified according to their binding preferences and mechanism of action. A clear-cut distinction between classes can be sometimes misleading and formally incorrect. In general, there can be selective, nonselective, and isoenzyme-preferring binders that can act through (i) an irreversible mechanism (e.g., aspirin), (ii) a reversible substrate competitive binding (e.g., piroxicam), (iii) a slow, time-dependent noncovalent action (e.g., indomethacin), and (iv) a slow, time-dependent COX-2 irreversible type of inhibition (e.g., rofecoxib/Vioxx, celecoxib/Celebrex). Very recently, Marnett and colleagues showed that the (<i>R</i>) enantiomers of several well-known COX inhibitors such as naproxen, flurbiprofen, and ibuprofen, considered to be COX-2 inactive, are, in fact, “substrate-selective inhibitors”.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_p">The data set reported here comprises all the classes of inhibitors mentioned above, among which we can find classic NSAIDs, such as Fenac (e.g., sulindac) and Profen derivatives (e.g., ketoprofen), oxicams (e.g., tenoxicam), and some classes of COX-2-selective binders, such as di(hetero)aryl (thio)ethers (e.g., NS-398, nimesulide), carbocycles and heterocycles with vicinal aryl substitutions (e.g., valdecoxib, celecoxib, and the recently retired from the market xib), just to mention a few. However, the collection presented here is meant to be a set of readily accessible molecules known to inhibit at least one of the two COX isoforms and to be used as starting points toward the search for dual FAAH/COX inhibitors, rather than being an exhaustive collection of COX inhibitors.</div><div class="NLM_p last">The entire assembled set was clustered according to pairwise Tanimoto distances, using a description based on the Daylight fingerprints (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). A clustering threshold of 0.4 resulted in 84 clusters, which highlighted the structural diversity within the set. The chemotype richness found among the selected COX inhibitors is convenient when looking for binders of an evolutionary unrelated target (i.e., FAAH), as in this case. To better characterize the molecular diversity in the data set, we looked at specific physicochemical features of each compound. The distribution observed for nine common physicochemical descriptors further describes the diversity found over the entire data set. Normal distributions can be observed for most of the selected descriptors. An exception was the total charge descriptor. In fact, apart from a few negatively charged molecules, the vast majority of entries were neutral. Also, most compounds showed a number of hydrogen bond donors of either 0 or 2 (see Figure S1, <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Molecular Descriptors and Fingerprint Similarity</h3><div class="NLM_p last">Molecular properties for each fragment were calculated by means of ICM3.7 (Molsoft LLC, San Diego, CA). Molecular patterns were calculated and hashed into bitmaps according to the Daylight algorithm for fingerprint generation (Daylight Chemical Information Systems Inc., Laguna Niguel, CA) as available in ICM3.7 (Molsoft LLC, San Diego, CA). Similarity between molecules was calculated as the difference between 1 and the Tanimoto coefficient, <i>T</i><sub>c</sub> = <i>c</i>/(<i>a</i> + <i>b</i> – <i>c</i>), where <i>c</i> counts the common bits <i>on</i> molecule 1 and molecule 2, <i>a</i> counts the bits <i>on</i> molecule 1, and <i>b</i> counts the bits <i>on</i> molecule 2. <i>T</i><sub>c</sub> spans from 0 to 1, with 1 indicating that two molecules share the same fingerprint.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Docking and Binding Site Mapping</h3><div class="NLM_p">Chain A of the X-ray structure of rFAAH, covalently bound to a molecule of methyl arachidonyl fluorophosphonate, as available at the Protein Data Bank (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1mt5">1mt5</a>),<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and chain A of the X-ray structure of COX-2, in complex with flurbiprofen (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pgh">3pgh</a>),<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> were used for the docking study. Missing side chains were added through SCWRL 4.0.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Then water and cocrystallized ligands were removed, and the catalytic serine (S241) was treated as negatively charged. The so-obtained structures were energy minimized with the NAMD 2.6<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> program until a 0.3 Å rmsd convergence criterion on heavy atoms was reached. The Amber force field parm99SB<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> was employed throughout. The final protein models and the selected known COX inhibitors were then converted through the Python scripts available in the ADT suite of programs<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> into a suitable format for AutoDock Vina v.1.0.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p last">AutoDock Vina v.1.0<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> was used to dock 382 known COX inhibitors at the FAAH binding site. The search volume, centered on the phosphate atom of the cocrystallized inhibitor, spanned 24 Å in the three directions. The algorithm search exhaustiveness was set to 4, and the maximum number of output poses was set to 10. Finally, the top 100 ranked molecules (approximately 25% of the distribution) were visually inspected to eliminate hits that did not directly bind in proximity of the oxyanion hole. We checked the commercial availability of each of the top 100 scored molecules and eventually purchased 25 compounds for experimental testing (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Some molecules such as acetaminophen and aspirin that exceeded the rank threshold (rank nos. 350 and 326, respectively) were considered because they were readily available. Despite their low scores, we also included molecules belonging to an under-represented chemical class, the oxicams (i.e., piroxicam, meloxicam, and tenoxicam). When a top-ranked molecule was not available, we purchased alternative molecules that were close in the Tanimoto fingerprint space, regardless of their estimated binding energies. For example, diclofenac and etodolac were purchased in place of ZINC03814788 (rank no. 61) and ketorolac (rank no. 53), respectively.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> General Methods for Synthesis</h3><div class="NLM_p">Solvents and reagents were obtained from commercial suppliers and were used without further purification. For simplicity, solvents and reagents are indicated as follows: acetyl chloride (AcCl), acetonitrile (MeCN), ammonium chloride (NH<sub>4</sub>Cl), benzyl bromide (BnBr), carbonyldiimidazole (CDI), cesium carbonate (Cs<sub>2</sub>CO<sub>3</sub>), cyclohexane (Cy), chloroform (CHCl<sub>3</sub>), dichloromethane (DCM), dimethyl sulfoxide (DMSO), diethyl ether (Et<sub>2</sub>O), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), 4-(dimethylamino)pyridine (DMAP), di-<i>tert</i>-butyl dicarbonate (Boc<sub>2</sub>O), ethanol (EtOH), ethyl acetate (EtOAc), hydrochloric acid (HCl), sulfuric acid (H<sub>2</sub>SO<sub>4</sub>), iodomethane (MeI), <i>N</i>,<i>N</i>-dimethylformamide (DMF), lithium hydroxide (LiOH), magnesium sulfate (MgSO<sub>4</sub>), methanol (MeOH), sodium bicarbonate (NaHCO<sub>3</sub>), tetrabutylammonium iodide (TBAI), tetrahydrofuran (THF), triethylamine (Et<sub>3</sub>N), trifluoroacetic acid (TFA).</div><div class="NLM_p last">Automated column chromatography purifications were done using a Teledyne ISCO apparatus (CombiFlash Rf) with prepacked silica gel columns of different sizes (from 4 to 120 g). Mixtures of increasing polarity of cyclohexane and ethyl acetate or dichloromethane and methanol were used as eluents. Preparative TLC were performed using Macherey-Nagel precoated 0.05 mm TLC plates (SIL G-50 UV<sub>254</sub>). Hydrogenation reactions were performed using H-Cube continuous hydrogenation equipment (SS-reaction line version), employing disposable catalyst cartridges (CatCart) preloaded with the required heterogeneous catalyst. Microwave heating was performed using the Explorer-48 position instrument (CEM). NMR experiments were run on a Bruker Avance III 400 system (400.13 MHz for <sup>1</sup>H and 100.62 MHz for <sup>13</sup>C), equipped with a BBI probe and <i>Z</i>-gradients. Spectra were acquired at 300 K, using deuterated dimethyl sulfoxide (DMSO-<i>d</i><sub>6</sub>) or deuterated chloroform (CDCl<sub>3</sub>) as the solvent. Chemical shifts for <sup>1</sup>H and <sup>13</sup>C spectra were recorded in parts per million using the residual nondeuterated solvent as the internal standard (for DMSO-<i>d</i><sub>6</sub>, 2.50 ppm, <sup>1</sup>H, and 39.52 ppm, <sup>13</sup>C; for CDCl<sub>3</sub>, 7.26 ppm, <sup>1</sup>H, and 77.16 ppm, <sup>13</sup>C). Data are reported as follows: chemical shift (ppm), multiplicity (indicated as br, broad signal, s, singlet, d, doublet, t, triplet, q, quartet, p, quintet, sx, sextet, and m, multiplet, and combinations thereof), coupling constant (<i>J</i>, Hz), and integrated intensity. UPLC/MS analyses were run on a Waters ACQUITY UPLC/MS system consisting of an SQD (single-quadropole detector) mass spectrometer equipped with an electrospray ionization interface and a photodiode array detector (PDA). The PDA range was 210–400 nm. Analyses were performed on an ACQUITY UPLC BEH C18 column (50 × 2.1 mm i.d., particle size 1.7 μm) with a VanGuard BEH C18 precolumn (5 × 2.1 mm i.d., particle size 1.7 μm). The mobile phases were either 10 mM NH<sub>4</sub>OAc in H<sub>2</sub>O at pH 5 adjusted with AcOH (A) and 10 mM NH<sub>4</sub>OAc in MeCN–H<sub>2</sub>O (95:5) at pH 5 (B) or 5 mM NH<sub>4</sub>OAc + 0.25% AcOH in H<sub>2</sub>O (A) and 5 mM NH<sub>4</sub>OAc + 0.25% AcOH in MeOH (B) for compounds <b>5</b>. Electrospray ionization in positive and negative modes was applied. Purifications by preparative HPLC/MS were run on a Waters Autopurification system consisting of a 3100 single-quadropole mass spectrometer equipped with an electrospray ionization interface and a 2998 photodiode array detector. The HPLC system included a 2747 sample manager, 2545 binary gradient module, system fluidic organizer, and 515 HPLC pump. The PDA range was 210–400 nm. Purifications were performed on a XBridge Prep C18 OBD column (100 × 19 mm i.d., particle size 5 μm) with an XBridge Prep C18 (10 × 19 mm i.d., particle size 5 μm) guard cartridge. The mobile phases were 10 mM NH<sub>4</sub>OAc in H<sub>2</sub>O at pH 5 adjusted with AcOH (A) and 10 mM NH<sub>4</sub>OAc in MeCN-H<sub>2</sub>O (95:5) at pH 5 (B). Electrospray ionization in positive and negative modes was used. Analyses by chiral HPLC were run on a Waters Alliance HPLC instrument consisting of an e2695 separation module and a 2998 photodiode array detector. The PDA range was 210–400 nm. Analyses were performed isocratic on a Daicel ChiralPak AD column (250 × 4.6 mm i.d., particle size 10 μm). The mobile phase was 0.1% TFA heptane/2-propanol (75:25). Separations by preparative chiral HPLC were run on a Waters Alliance HPLC instrument consisting of a 1525 binary HPLC pump, a Waters Fraction Collector III, and a 2998 photodiode array detector. UV detection was at 240 nm. Purifications were performed isocratic on a Daicel ChiralPak AD column (250 × 10 mm i.d., particle size 10 μm). The mobile phase was 0.1% TFA heptane/2-propanol (75:25). Optical rotations were measured on a Rudolf Research Analytical Autopol II automatic polarimeter using a sodium lamp (589 nm) as the light source (concentrations expressed in grams per 100 mL using EtOAc or MeOH as the solvent and a 1 dm cell. All final compounds displayed ≥95% purity as determined by NMR and UPLC/MS analysis.</div></div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-(9<i>H</i>-Carbazol-2-yl)propanoic Acid (<b>2</b>)</h3><div class="NLM_p last">A solution of carprofen (<b>1</b>, 106 mg, 0.39 mmol) in a 1:1 mixture of EtOH/EtOAc (20 mL) was hydrogenated with the ThalesNano H-Cube using a 10% Pd/C catalyst, at a 1 mL/min flow rate and room temperature and in a H<sub>2</sub> atmosphere (1 atm) (full H<sub>2</sub> mode). After three consecutive runs, the solvent was removed in vacuo, and the crude oil was purified by preparative HPLC to yield the corresponding deschlorinated compound <b>2</b> (37 mg, 40%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.45 (d, <i>J</i> = 7.1 Hz, 3H), 3.83 (q, <i>J</i> = 7.1 Hz, 1H), 7.09 (dd, <i>J</i> = 8.1, 1.3 Hz, 1H), 7.14 (m, 1H), 7.38 (m, 2H), 7.47 (d, <i>J</i> = 8.1 Hz, 1H), 8.04 (d, <i>J</i> = 8.0 Hz, 1H), 8.07 (d, <i>J</i> = 7.8 Hz, 1H), 11.18 (s, 1H), 12.25 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>15</sub>H<sub>13</sub>NO<sub>2</sub> requires 239, found 240 [M + H]<sup>+</sup>.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Methyl 2-(6-Chloro-9<i>H</i>-carbazol-2-yl)propanoate (<b>3</b>)</h3><div class="NLM_p last">To a suspension of <b>1</b> (1.055 g, 3.85 mmol) in MeOH (40 mL) was added H<sub>2</sub>SO<sub>4</sub> (0.1 mL). The mixture became homogeneous and was stirred at room temperature overnight. After evaporation of MeOH, the residue was taken up in EtOAc and washed with a saturated aqueous NaHCO<sub>3</sub> solution (3 × 20 mL) and brine (10 mL). After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo to give <b>3</b> (1.15 g, quantitative) as a pale yellow solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.59 (d, <i>J</i> = 7.2 Hz, 3H), 3.68 (s, 3H), 3.88 (q, <i>J</i> = 7.2 Hz, 1H), 7.18 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 7.37 (m, 3H), 7.95 (d, <i>J</i> = 8.1 Hz, 1H), 7.99 (m, 1H), 8.02 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>16</sub>H<sub>14</sub> ClNO<sub>2</sub> requires 287, found 286 [M – H]<sup>−</sup>.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2-(6-Chloro-9<i>H</i>-carbazol-2-yl)-<i>N</i>-(2-hydroxyethyl)propanamide (<b>4a</b>)</h3><div class="NLM_p last">To a solution of <b>1</b> (112 mg, 0.41 mmol, 1 equiv) in pyridine (2 mL) was added CDI (133 mg, 0.82 mmol, 2 equiv) portionwise. The mixture was stirred for 2 h at room temperature, before addition of ethanolamine (50 μL, 0.82 mmol, 2 equiv), and then the reaction was heated at 55 °C overnight. Pyridine was then evaporated and the residue taken up in EtOAc and washed with a saturated aqueous NH<sub>4</sub>Cl solution (5 mL). After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (DCM/MeOH) to give amide <b>4a</b> (110 mg, 85%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.41 (d, <i>J</i> = 7.0 Hz, 3H), 3.03–3.20 (m, 2H), 3.38 (dt, <i>J</i> = 9.4, 5.8 Hz, 2H), 3.78 (q, <i>J</i> = 7.0 Hz, 1H), 4.64 (t, <i>J</i> = 5.3 Hz, 1H), 7.15 (dd, <i>J</i> = 8.2, 1.3 Hz, 1H), 7.34–7.37 (m, 1H), 7.45 (s, 1H), 7.47–7.49 (m, 1H), 7.96 (t, <i>J</i> = 5.5 Hz, 1H), 8.05 (d, <i>J</i> = 8.1 Hz, 1H), 8.16 (d, <i>J</i> = 2.0 Hz, 1H), 11.33 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>17</sub>H<sub>17</sub>ClN<sub>2</sub>O<sub>2</sub> requires 316, found 317 [M + H]<sup>+</sup>.</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-(6-Chloro-9<i>H</i>-carbazol-2-yl)-<i>N</i>-phenylpropanamide (<b>4b</b>)</h3><div class="NLM_p last">To a solution of <b>1</b> (126 mg, 0.46 mmol, 1 equiv) in pyridine (2 mL) was added CDI (149 mg, 0.92 mmol, 2 equiv) portionwise. The mixture was stirred for 2 h at room temperature, before addition of aniline (84 μL, 0.92 mmol, 2 equiv), and then the reaction was heated at 55 °C overnight. Pyridine was then evaporated and the residue taken up in EtOAc and washed with a saturated aqueous NH<sub>4</sub>Cl solution (5 mL). After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (DCM/MeOH) to give amide <b>4b</b> (138 mg, 86%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.51 (d, <i>J</i> = 7.0 Hz, 3H), 4.00 (q, <i>J</i> = 6.9 Hz, 1H), 7.02 (t, <i>J</i> = 7.4 Hz, 1H), 7.23 (dd, <i>J</i> = 8.2, 1.3 Hz, 1H), 7.26–7.30 (m, 2H), 7.35–7.37 (m, 1H), 7.47–7.49 (m, 1H), 7.52 (s, 1H), 7.61 (d, <i>J</i> = 8.5 Hz, 2H), 8.10 (d, <i>J</i> = 8.1 Hz, 1H), 8.17 (d, <i>J</i> = 2.0 Hz, 1H), 10.07 (s, 1H), 11.36 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>21</sub>H<sub>17</sub>ClN<sub>2</sub>O requires 348, found 349 [M + H]<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Procedure A</h3><div class="NLM_p">To a solution of <b>3</b> in MeCN (0.05 M solution) were successively added the alkyl halide (3 to 5 equiv) and Cs<sub>2</sub>CO<sub>3</sub> (5 equiv). The mixture was heated under reflux overnight. After being cooled to room temperature, the mixture was filtered. EtOAc and H<sub>2</sub>O were added to the filtrate. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc) to provide the alkylated product <b>5</b>.</div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Methyl 2-(6-Chloro-9-methyl-9<i>H</i>-carbazol-2-yl)propanoate (<b>5a</b>)</h4><div class="NLM_p last">Following general procedure A, alkylation of <b>3</b> (113 mg, 0.39 mmol) in the presence of MeI (0.12 mL, 1.96 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (756 mg, 1.96 mol) afforded the methylated product <b>5a</b> (118 mg, quantitative) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.62 (d, <i>J</i> = 7.1 Hz, 3H), 3.69 (s, 3H), 3.83 (s, 3H), 3.93 (q, <i>J</i> = 7.1 Hz, 1H), 7.18 (d, <i>J</i> = 8.0 Hz, 1H), 7.29 (d, J = 8.8 Hz, 1H), 7.33 (s, 1H), 7.30–7.42 (m, 1H), 7.97 (d, <i>J</i> = 8.1 Hz, 1H), 8.01 (d, <i>J</i> = 2.0 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>17</sub>H<sub>16</sub>ClNO<sub>2</sub> requires 301, found 302 [M + H]<sup>+</sup>.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Methyl 2-(9-Benzyl-6-chloro-9<i>H</i>-carbazol-2-yl)propanoate (<b>5b</b>)</h4><div class="NLM_p last">Following general procedure A, alkylation of <b>3</b> (103 mg, 0.39 mmol) in the presence of BnBr (0.13 mmol, 1,08 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (692 mg, 1.79 mmol) afforded the benzylated product <b>5b</b> (55 mg, 40%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.55 (d, <i>J</i> = 7.3 Hz, 3H), 3.64 (s, 3H), 3.87 (q, <i>J</i> = 7.1 Hz, 1H), 5.49 (s, 2H), 7.11 (dd, <i>J</i> = 7.3, 2.1 Hz, 2H), 7.19–7.29 (m, 6H), 7.33–7.35 (m, 1H), 8.01 (d, <i>J</i> = 8.1 Hz, 1H), 8.04 (d, <i>J</i> = 2.1 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>23</sub>H<sub>20</sub>ClNO<sub>2</sub> requires 377, found 378 [M + H]<sup>+</sup>.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Methyl 2-(6-Chloro-9-(4-cyanobenzyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>5c</b>)</h4><div class="NLM_p last">Following general procedure A, alkylation of <b>3</b> (112 mg, 0.39 mmol) in the presence of 4-cyanobenzyl bromide (380 mg, 1.94 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (785 mg, 1.94 mmol) afforded the 4-cyanobenzylated product <b>5c</b> (149 mg, 95%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.58 (d, <i>J</i> = 7.1 Hz, 3H), 3.66 (s, 3H), 3.89 (q, <i>J</i> = 7.1 Hz, 1H), 5.55 (s, 2H), 7.17 (d, <i>J</i> = 8.7 Hz, 1H), 7.20 (d, <i>J</i> = 8.5 Hz, 2H), 7.24–7.28 (m, 2H), 7.38 (dd, <i>J</i> = 8.6, 2.1 Hz, 1H), 7.58–7.60 (m, 2H), 8.04 (dd, <i>J</i> = 7.9, 0.8 Hz, 1H), 8.07 (d, <i>J</i> = 2.0 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>24</sub>H<sub>19</sub>ClN<sub>2</sub>O<sub>2</sub> requires 402, found 401 [M – H]<sup>−</sup>.</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Methyl 2-(6-Chloro-9-(4-methoxybenzyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>5e</b>)</h4><div class="NLM_p last">Following general procedure A, alkylation of <b>3</b> (122 mg, 0.42 mmol) in the presence of 4-methoxybenzyl bromide (0.31 mL, 2.11 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (816 mg, 2.11 mmol) afforded the 4-methoxybenzylated product <b>5e</b> (99 mg, 55%) as a yellow oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.57 (d, <i>J</i> = 7.2 Hz, 3H), 3.65 (s, 3H), 3.75 (s, 3H), 3.88 (q, <i>J</i> = 7.2 Hz, 1H), 5.42 (s, 2H), 6.79–6.81 (m, 2H), 7.06 (d, <i>J</i> = 8.7 Hz, 2H), 7.20 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 7.25–7.27 (m, 1H), 7.29–7.31 (m, 1H), 7.33–7.35 (m, 1H), 8.00 (d, <i>J</i> = 8.1 Hz, 1H), 8.03 (d, <i>J</i> = 2.0 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>24</sub>H<sub>22</sub>ClNO<sub>3</sub> requires 407, found 408 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> General Procedure B</h3><div class="NLM_p">To a solution of the methyl ester in a 1:1:1 MeOH/THF/H<sub>2</sub>O (0.03 M solution) was added LiOH (4 equiv). The mixture was stirred at room temperature overnight, and then the organic solvents were evaporated. The aqueous solution was then acidified to pH 1 with 6 M HCl. The precipitate formed was either (1) filtered, washed with H<sub>2</sub>O, and dried under vacuum or (2) redissolved in EtOAc, dried over MgSO<sub>4</sub>, and concentrated.</div><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-(6-Chloro-9-methyl-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>6a</b>)</h4><div class="NLM_p last">Following general procedure B, hydrolysis of ester <b>5a</b> (86 mg, 0.28 mmol) in the presence of LiOH (27 mg, 1.13 mmol) furnished acid <b>6a</b> (69 mg, 85%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.48 (d, <i>J</i> = 7.1 Hz, 3H), 3.86 (q, <i>J</i> = 7.1 Hz), 3.87 (s, 3H), 7.16 (dd, <i>J</i> = 8.2, 1.5 Hz, 1H), 7.45 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 7.50 (d, <i>J</i> = 1.5 Hz, 1H), 7.61 (d, <i>J</i> = 8.7 Hz, 1H), 8.12 (d, <i>J</i> = 8.0 Hz, 1H), 8.21 (d, <i>J</i> = 2.1 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>16</sub>H<sub>14</sub>ClNO<sub>2</sub> requires 287, found 242 [M – H – CO<sub>2</sub>]<sup>−</sup>.</div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-(9-Benzyl-6-chloro-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>6b</b>)</h4><div class="NLM_p last">Following general procedure B, hydrolysis of ester <b>5b</b> (40 mg, 0.10 mmol) in the presence of LiOH (10 mg, 0.42 mmol) furnished acid <b>6b</b> (27 mg, 73%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.44 (d, <i>J</i> = 7.1 Hz, 3H), 3.83 (q, <i>J</i> = 7.1 Hz, 1H), 5.60–5.74 (m, 2H), 7.13–7.20 (m, 3H), 7.19–7.33 (m, 3H), 7.42 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 7.58 (s, 1H), 7.62 (d, <i>J</i> = 8.7 Hz, 1H), 8.17 (d, <i>J</i> = 8.1 Hz, 1H), 8.25 (d, <i>J</i> = 2.0 Hz, 1H), 12.31 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>18</sub>ClNO<sub>2</sub> requires 287, found 363 [M – H – CO<sub>2</sub>]<sup>−</sup>, 362 [M – H]<sup>−</sup>.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-(6-Chloro-9-(4-cyanobenzyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>6c</b>)</h4><div class="NLM_p last">Following general procedure B, hydrolysis of ester <b>5c</b> (104 mg, 0.26 mmol) in the presence of LiOH (25 mg, 1.04 mmol), followed by purification by preparative TLC (DCM/MeOH, 95:5), furnished acid <b>6c</b> (52 mg, 67%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.43 (d, <i>J</i> = 7.1 Hz, 3H), 3.82 (q, <i>J</i> = 7.0 Hz, 1H), 5.80 (s, 2H), 7.19 (dd, <i>J</i> = 8.2, 1.4 Hz, 1H), 7.26 (d, <i>J</i> = 8.1 Hz, 2H), 7.43 (dd, <i>J</i> = 8.8, 2.1 Hz, 1H), 7.55 (d, <i>J</i> = 1.4 Hz, 1H), 7.60 (d, <i>J</i> = 8.7 Hz, 1H), 7.75–7.77 (m, 2H), 8.18 (d, <i>J</i> = 8.1 Hz, 1H), 8.28 (d, <i>J</i> = 2.1 Hz, 1H), 12.28 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>23</sub>H<sub>17</sub>ClN<sub>2</sub> O<sub>2</sub> requires 388, found 343 [M – H – CO<sub>2</sub>]<sup>−</sup>.</div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-(6-Chloro-9-(4-chlorobenzyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>6d</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (144 mg, 0.5 mmol, 1 equiv) in MeCN (5 mL) were successively added 4-chlorobenzyl bromide (308 mg, 1.50 mmol, 3 equiv), Cs<sub>2</sub>CO<sub>3</sub> (814 mg, 5 mmol, 5 equiv), and TBAI (92 mg, 0.25 mmol, 0.5 equiv). The mixture was stirred at room temperature overnight. The suspension was then passed through a silica plug and washed with EtOAc. After concentration in vacuo, the residue was dissolved in a 1:1:1 MeOH/THF/H<sub>2</sub>O solution (3 mL). LiOH (24 mg, 1 mmol, 2 equiv) was added and the mixture was stirred at room temperature overnight. The solution was then acidified with 2 M HCl and extracted with EtOAc. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was crystallized in Et<sub>2</sub>O to obtain acid <b>6d</b> (64 mg, 32%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.44 (d, <i>J</i> = 7.1 Hz, 3H), 3.83 (q, <i>J</i> = 7.1 Hz, 1H), 5.67 (s, 2H), 7.15 (d, <i>J</i> = 8.4 Hz, 2H), 7.18 (dd, <i>J</i> = 8.2, 1.3 Hz, 1H), 7.34 (d, <i>J</i> = 8.4 Hz, 2H), 7.42 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 7.56 (d, <i>J</i> = 1.3 Hz, 1H), 7.61 (d, <i>J</i> = 8.7 Hz, 1H), 8.16 (d, <i>J</i> = 8.1 Hz, 1H), 8.25 (d, <i>J</i> = 2.0 Hz, 1H), 12.27 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>17</sub>Cl<sub>2</sub>NO<sub>2</sub> requires 397, found 352 [M – H – CO<sub>2</sub>]<sup>−</sup>.</div></div><div id="sec5_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-(6-Chloro-9-(4-methoxybenzyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>6e</b>)</h4><div class="NLM_p last">Following general procedure B, hydrolysis of ester <b>5e</b> (55 mg, 0.13 mmol) in the presence of LiOH (12 mg, 0.52 mmol), followed by purification by preparative HPLC, furnished acid <b>6e</b> (18 mg, 35%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.45 (d, <i>J</i> = 7.1 Hz, 3H), 3.68 (s, 3H), 3.84 (q, <i>J</i> = 7.1 Hz, 1H), 5.54–5.62 (m, 2H), 6.82–6.84 (m, 2H), 7.12–7.18 (m, 3H), 7.42 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 7.61–7.65 (m, 2H), 8.15 (d, <i>J</i> = 8.1 Hz, 1H), 8.24 (d, <i>J</i> = 2.1 Hz, 1H), 12.29 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>23</sub>H<sub>20</sub>ClNO<sub>3</sub> requires 393, found 348 [M – H – CO<sub>2</sub>]<sup>−</sup>.</div></div><div id="sec5_6_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-(6-Chloro-9-(3-methoxybenzyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>6f</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (144 mg, 0.5 mmol, 1 equiv) in MeCN (5 mL) were successively added 3-methoxybenzyl bromide (0.21, 1.50 mmol, 3 equiv), Cs<sub>2</sub>CO<sub>3</sub> (814 mg, 5 mmol, 5 equiv), and TBAI (92 mg, 0.25 mmol, 0.5 equiv). The mixture was stirred at room temperature overnight. The suspension was then passed through a silica plug and washed with EtOAc. After concentration in vacuo, the residue was dissolved in a 1:1:1 MeOH/THF/H<sub>2</sub>O solution (3 mL). LiOH (24 mg, 1 mmol, 2 equiv) was added/ and the mixture was stirred at room temperature overnight. The solution was then acidified with 2 M HCl and extracted with EtOAc. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by preparative HPLC to obtain acid <b>6f</b> (42 mg, 21%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.44 (d, <i>J</i> = 7.1 Hz, 3H), 3.66 (s, 2H), 3.84 (q, <i>J</i> = 7.0 Hz, 1H), 5.62 (m, 3H), 6.66 (d, <i>J</i> = 7.6 Hz, 1H), 6.79 (m, 2H), 7.16 (m, 2H), 7.41 (dd, <i>J</i> = 8.7, 1.9 Hz, 1H), 7.59 (s, 1H), 7.62 (d, <i>J</i> = 8.8 Hz, 1H), 8.16 (d, <i>J</i> = 8.1 Hz, 1H), 8.24 (d, <i>J</i> = 1.8 Hz, 1H), 12.28 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>23</sub>H<sub>20</sub>ClNO<sub>3</sub> requires 393, found 348 [M – H – CO<sub>2</sub>]<sup>−</sup>.</div></div><div id="sec5_6_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-(6-Chloro-9-(2-methoxybenzyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>6g</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (144 mg, 0.5 mmol, 1 equiv) in MeCN (5 mL) were successively added 2-methoxybenzyl bromide (235 mg, 1.50 mmol, 3 equiv), Cs<sub>2</sub>CO<sub>3</sub> (814 mg, 5 mmol, 5 equiv) and TBAI (92 mg, 0.25 mmol, 0.5 equiv). The mixture was stirred at room temperature overnight. The suspension was then passed through a silica plug and washed with EtOAc. After concentration in vacuo, the residue was dissolved in a 1:1:1 MeOH/THF/H<sub>2</sub>O solution (3 mL). LiOH (24 mg, 1 mmol, 2 equiv) was added and the mixture was stirred at room temperature overnight. The solution was then acidified with 2 M HCl and extracted with EtOAc. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by preparative HPLC to obtain acid <b>6g</b> (46 mg, 23%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.42 (d, <i>J</i> = 7.1 Hz, 3H), 3.83 (q, <i>J</i> = 7.2 Hz, 1H), 3.86 (s, 3H), 5.55 (s, 2H), 6.65 (dd, <i>J</i> = 7.6, 1.7 Hz, 1H), 6.75 (td, <i>J</i> = 7.4, 1.0 Hz, 1H), 7.05 (dd, <i>J</i> = 8.3, 0.9 Hz, 1H), 7.16 (dd, <i>J</i> = 8.2, 1.4 Hz, 1H), 7.23 (ddd, <i>J</i> = 8.2, 7.4, 1.8 Hz, 1H), 7.40 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 7.51 (d, <i>J</i> = 1.3 Hz, 1H), 7.56 (d, <i>J</i> = 8.7 Hz, 1H), 8.15 (d, <i>J</i> = 8.1 Hz, 1H), 8.24 (d, <i>J</i> = 2.0 Hz, 1H), 12.28 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>23</sub>H<sub>20</sub>ClNO<sub>3</sub> requires 393, found 348 [M – H – CO<sub>2</sub>]<sup>−</sup>.</div></div><div id="sec5_6_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Methyl 2-(6-Chloro-9-(hexylsulfonyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>7a</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (105 mg, 0.36 mmol, 1 equiv) in THF (5 mL) were successively added 1-hexanesulfonyl chloride (0.17 mL, 1.09 mmol, 3 equiv), DMAP (133 mg, 1.09 mmol, 3 equiv), and Et<sub>3</sub>N (0.15 mmol, 1.09 mmol, 3 equiv). The mixture was heated under reflux overnight, then filtered, and concentrated. The residue was purified by column chromatography (Cy/EtOAc) to give sulfonamide <b>7a</b> (55 mg, 35%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.81 (t, <i>J</i> = 7.0 Hz, 3H), 1.11–1.30 (m, 6H), 1.58–1.68 (m, 5H), 3.19–3.23 (m, 2H), 3.71 (s, 3H), 3.94 (q, <i>J</i> = 7.2 Hz, 1H), 7.41 (dd, <i>J</i> = 8.1, 1.3 Hz, 1H), 7.45 (dd, <i>J</i> = 8.9, 2.1 Hz, 1H), 7.93 (d, <i>J</i> = 8.1 Hz, 1H), 7.96 (d, <i>J</i> = 2.0 Hz, 1H), 8.08–8.11 (m, 2H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>26</sub>ClNO<sub>4</sub>S requires 435, found 436 [M + H<sup>+</sup>], 453 [M + NH<sub>4</sub><sup>+</sup>].</div></div><div id="sec5_6_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Methyl 2-(6-Chloro-9-((4-chlorophenyl)sulfonyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>7b</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (110 mg, 0.38 mmol, 1 equiv) in THF (5 mL) were successively added 4-chlorobenzenesulfonyl chloride (241 mg, 1.14 mmol, 3 equiv), DMAP (140 mg, 1.14 mml, 3 equiv), and Et<sub>3</sub>N (0.16 mL, 1.14 mmol, 3 equiv). The mixture was heated in the microwave at 100 °C for 3 h, then filtrated through a pad of Celite, washed with EtOAc, and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc) to furnish sulfonamide <b>7b</b> (137 mg, 78%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.65 (d, <i>J</i> = 7.2 Hz, 3H), 3.74 (s, 3H), 3.96 (q, <i>J</i> = 7.2 Hz, 1H), 7.32 (d, <i>J</i> = 8.7 Hz, 2H), 7.36 (dd, <i>J</i> = 8.1, 1.4 Hz, 1H), 7.47 (dd, <i>J</i> = 8.9, 2.1 Hz, 1H), 7.73 (d, <i>J</i> = 8.7 Hz, 2H), 7.82 (d, <i>J</i> = 8.1 Hz, 1H), 7.86 (d, <i>J</i> = 2.1 Hz, 1H), 8.24–8.27 (m, 2H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>17</sub>Cl<sub>2</sub>NO<sub>4</sub>S requires 461, found 460, 462 [M – H]<sup>−</sup>.</div></div><div id="sec5_6_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-(6-Chloro-9-(hexylsulfonyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>8a</b>)</h4><div class="NLM_p last">Following general procedure B, hydrolysis of ester <b>7a</b> (55 mg, 0.13 mmol) in the presence of LiOH (12 mg, 0.50 mmol), followed by purification by column chromatography (Cy/EtOAc) and trituration with Et<sub>2</sub>O, furnished acid <b>8a</b> (15 mg, 28%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.71 (t, <i>J</i> = 6.9 Hz, 3H), 0.99–1.08 (m, 4H), 1.15 (p, <i>J</i> = 7.3 Hz, 2H), 1.41–1.48 (m, 5H), 3.56 (t, <i>J</i> = 7.5 Hz, 2H), 3.91 (q, <i>J</i> = 7.0 Hz, 1H), 7.42 (d, <i>J</i> = 8.1 Hz, 1H), 7.58 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 8.00 (s, 1H), 8.03 (d, <i>J</i> = 8.9 Hz, 1H), 8.24 (d, <i>J</i> = 8.1 Hz, 1H), 8.37 (d, <i>J</i> = 2.1 Hz, 1H), 12.44 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>21</sub>H<sub>24</sub>ClNO<sub>4</sub>S requires 421, found 376 [M – H – CO<sub>2</sub>]<sup>−</sup>, 420 [M – H]<sup>−</sup>.</div></div><div id="sec5_6_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-(6-Chloro-9-((4-chlorophenyl)sulfonyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>8b</b>)</h4><div class="NLM_p last">Following general procedure B, hydrolysis of ester <b>7b</b> (133 mg, 0.29 mmol) in the presence of LiOH (27 mg, 1.15 mmol), followed by trituration with Et<sub>2</sub>O, furnished acid <b>8b</b> (51 mg, 40%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.49 (d, <i>J</i> = 7.0 Hz, 3H), 3.97 (q, <i>J</i> = 6.8 Hz, 1H), 7.41 (d, <i>J</i> = 8.0 Hz, 1H), 7.57–7.63 (m, 3H), 7.82 (d, <i>J</i> = 8.6 Hz, 2H), 8.14–8.17 (m, 2H), 8.25 (d, <i>J</i> = 8.9 Hz, 1H), 8.30 (s, 1H), 12.44 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>21</sub>H<sub>15</sub>Cl<sub>2</sub>NO<sub>4</sub>S requires 447, found 402, 404 [M – H – CO<sub>2</sub>]<sup>−</sup>, 446, 448 [M – H]<sup>−</sup>.</div></div><div id="sec5_6_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Methyl 2-(6-Chloro-9-(hexylcarbamoyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>9a</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (100 mg, 0.35 mmol, 1 equiv) in THF (5 mL) were successively added hexyl isocyanate (0.10 mL, 0.70 mmol, 2 equiv), DMAP (85 mg, 0.70 mmol, 2 equiv), and Et<sub>3</sub>N (0.15 mL, 1.05 mmol, 3 equiv). The mixture was heated under reflux for 60 h and then concentrated. The residue was taken up in EtOAc, and a saturated aqueous NH<sub>4</sub>Cl solution (5 mL) was added. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc) to furnish the urea <b>9a</b> (106 mg, 70%) as a yellow oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.92 (t, <i>J</i> = 6.6 Hz, 3H), 1.38 (dt, <i>J</i> = 7.6, 3.7 Hz, 4H), 1.46–1.50 (m, 2H), 1.60 (d, <i>J</i> = 7.1 Hz, 3H), 1.74 (p, <i>J</i> = 7.3 Hz, 2H), 3.56 (q, <i>J</i> = 6.7 Hz, 2H), 3.68 (s, 3H), 3.90 (q, <i>J</i> = 7.2 Hz, 1H), 5.67 (t, <i>J</i> = 5.6 Hz, 1H), 7.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.40 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 7.90–7.94 (m, 4H); MS (ES, <i>m</i>/<i>z</i>) C<sub>23</sub>H<sub>27</sub>ClN<sub>2</sub>O<sub>3</sub> requires 414, found 415 [M + H]<sup>+</sup>, 433 [M + NH<sub>4</sub>]<sup>+</sup>.</div></div><div id="sec5_6_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Methyl 2-(6-Chloro-9-(methylcarbamoyl)carbazol-2-yl)propanoate (<b>9b</b>)</h4><div class="NLM_p last">To a solution of Boc<sub>2</sub>O (0.392 mg, 1.79 mmol, 3 equiv) in MeCN (3 mL) were successively added DMAP (219 mg, 1.79 mmol, 3 equiv) and methylamine (2 M solution in THF, 0.89 mL, 1.79 mmol, 3 equiv). The mixture was stirred for 30 min at room temperature and then added to a solution of <b>3</b> (170 mg, 0.60 mmol, 1 equiv) in MeCN (2 mL). The mixture was heated in the microwave at 100 °C for 3 h. EtOAc (10 mL) and a saturated aqueous NH<sub>4</sub>Cl solution (5 mL) were then added. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc) to furnish the urea <b>9b</b> (139 mg, 68%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.48 (d, <i>J</i> = 7.1 Hz, 3H), 2.94 (d, <i>J</i> = 4.4 Hz, 3H), 3.60 (s, 3H), 3.99 (q, <i>J</i> = 7.1 Hz, 1H), 7.26 (dd, <i>J</i> = 1.3, 8.1 Hz, 1H), 7.50 (dd, <i>J</i> = 2.2, 8.8 Hz, 1H), 7.85 (s, 1H), 7.89 (d, <i>J</i> = 8.8 Hz, 1H), 8.18 (d, <i>J</i> = 8.1 Hz, 1H), 8.25 (q, <i>J</i> = 4.1 Hz, 1H), 8.28 (d, <i>J</i> = 2.1 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>18</sub>H<sub>17</sub>ClN<sub>2</sub>O<sub>3</sub> requires 344, found 345 [M + H]<sup>+</sup>.</div></div><div id="sec5_6_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Methyl 2-(9-(Butylcarbamoyl)-6-chloro-9<i>H</i>-carbazol-2-yl)propanoate (<b>9c</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (105 mg, 0.36 mmol, 1 equiv) in THF (5 mL) were successively added butyl isocyanate (0.12 mL, 1.09 mmol, 3 equiv), DMAP (133 mg, 1.09 mml, 3 equiv), and Et<sub>3</sub>N (0.15 mL, 1.09 mmol, 3 equiv). The mixture was heated in the microwave at 100 °C for 10 h. EtOAc (10 mL) and a saturated aqueous NH<sub>4</sub>Cl solution (5 mL) were then added. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc) to furnish the urea <b>9c</b> (97 mg, 80%) as a yellow oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.03 (t, <i>J</i> = 7.3 Hz, 3H), 1.51 (m, 2H), 1.60 (d, <i>J</i> = 7.2 Hz, 3H), 1.73 (m, 2H), 3.58 (td, <i>J</i> = 7.1, 5.5 Hz, 2H), 3.69 (s, 3H), 3.91 (q, <i>J</i> = 7.3 Hz, 1H), 5.66 (t, <i>J</i> = 5.7 Hz, 1H), 7.29 (m, 1H), 7.41 (dd, <i>J</i> = 8.9, 2.0 Hz, 1H), 7.93 (m, 4H); MS (ES, <i>m</i>/<i>z</i>) C<sub>21</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>3</sub> requires 386, found 387 [M + H]<sup>+</sup>, 404 [M + NH<sub>4</sub>]<sup>+</sup>.</div></div><div id="sec5_6_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Methyl 2-(6-Chloro-9-(octylcarbamoyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>9d</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (106 mg, 0.37 mmol, 1 equiv) in THF (5 mL) were successively added octyl isocyanate (0.19 mL, 1.10 mmol, 3 equiv), DMAP (135 mg, 1.10 mml, 3 equiv), and Et<sub>3</sub>N (0.15 mL, 1.10 mmol, 3 equiv). The mixture was heated in the microwave at 100 °C for 10 h. EtOAc (10 mL) and a saturated aqueous NH<sub>4</sub>Cl solution (5 mL) were then added. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc) to furnish the urea <b>9d</b> (170 mg, 70%) as a yellow oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 0.86–0.91 (m, 3H), 1.26–1.47 (m, 10H), 1.60 (d, <i>J</i> = 7.2 Hz, 3H), 1.70–1.77 (m, 2H), 3.56 (td, <i>J</i> = 7.2, 5.5 Hz, 2H), 3.68 (s, 3H), 3.90 (q, <i>J</i> = 7.2 Hz, 1H), 5.68 (t, <i>J</i> = 5.4 Hz, 1H), 7.29 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.40 (dd, <i>J</i> = 8.9, 2.1 Hz, 1H), 7.90–7.93 (m, 4H); MS (ES, <i>m</i>/<i>z</i>) C<sub>25</sub>H<sub>31</sub>ClN<sub>2</sub>O<sub>3</sub> requires 442, found 443 [M + H]<sup>+</sup>, 460 [M + NH<sub>4</sub>]<sup>+</sup>.</div></div><div id="sec5_6_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Methyl 2-(6-Chloro-9-((4-chlorophenyl)carbamoyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>9e</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (116 mg, 0.40 mmol, 1 equiv) in THF (5 mL) were successively added 4-chlorophenyl isocyanate (0.16 mL, 1.21 mmol, 3 equiv), DMAP (148 mg, 1.21 mml, 3 equiv), and Et<sub>3</sub>N (0.17 mL, 1.21 mmol, 3 equiv). The mixture was heated in the microwave at 100 °C for 10 h. EtOAc (10 mL) and a saturated aqueous NH<sub>4</sub>Cl solution (5 mL) were then added. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc) to furnish the urea <b>9e</b> (143 mg, 81%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.60 (d, <i>J</i> = 7.2 Hz, 3H), 3.69 (s, 3H), 3.91 (q, <i>J</i> = 7.2 Hz, 1H), 7.33 (dd, <i>J</i> = 8.0, 1.3 Hz, 1H), 7.40–7.44 (m, 3H), 7.54–7.59 (m, 3H), 7.92–7.98 (m, 4H); MS (ES, <i>m</i>/<i>z</i>) C<sub>23</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>3</sub> requires 440, found 441, 443 [M + H]<sup>+</sup>, 458, 460 [M + NH<sub>4</sub>]<sup>+</sup>.</div></div><div id="sec5_6_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Methyl 2-(6-Chloro-9-(hexylmethylcarbamoyl)carbazol-2-yl)propanoate (<b>9f</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (124 mg, 0.43 mmol, 1 equiv) in THF (5 mL) were successively added <i>N</i>-hexyl-<i>N</i>-methylcarbamoyl chloride (460 mg, 2.58 mmol, 6 equiv, freshly prepared from <i>N</i>-methylhexylamine (1.0 equiv) and triphosgene (0.33 equiv) in the presence of pyridine (1.0 equiv) in dry DCM), DMAP (158 mg, 1.29 mmol, 3 equiv), and Et<sub>3</sub>N (0.18 mL, 1.27 mmol, 3 equiv). The mixture was heated in the microwave at 100 °C for 3 h. EtOAc (10 mL) and a saturated aqueous NH<sub>4</sub>Cl solution (5 mL) were then added. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc) to furnish the urea <b>9f</b> (88 mg, 48%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.75 (q, <i>J</i> = 6.7 Hz, 2H), 1.04 - 1.23 (m, 6H), 1.47 (dd, <i>J</i> = 1.3, 7.1 Hz, 3H), 1.59 (p, <i>J</i> = 7.2 Hz, 2H), 3.00 (d, <i>J</i> = 5.2 Hz, 3H), 3.35 - 3.48 (m, 2H), 3.60 (d, <i>J</i> = 1.4 Hz, 3H), 4.01 (q, <i>J</i> = 7.1 Hz, 1H), 5.75 (s, 1H), 7.26 (ddd, <i>J</i> = 1.5, 2.6, 8.2 Hz, 1H), 7.39 - 7.44 (m, 1H), 7.47 - 7.54 (m, 2H), 8.19 (d, <i>J</i> = 8.1 Hz, 1H), 8.30 (dd, <i>J</i> = 0.9, 1.8 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>24</sub>H<sub>29</sub>ClN<sub>2</sub>O<sub>3</sub> requires 428, found 429 [M + H]<sup>+</sup>.</div></div><div id="sec5_6_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Methyl 2-(6-Chloro-9-(cyclohexylcarbamoyl)carbazol-2-yl)propanoate (<b>9g</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (103 mg, 0.36 mmol, 1 equiv) in THF (5 mL) were successively added cyclohexyl isocyanate (0.10 mL, 0.70 mmol, 2 equiv), DMAP (85 mg, 0.70 mmol, 2 equiv), and Et<sub>3</sub>N (0.15 mL, 1.05 mmol, 3 equiv). The mixture was heated under reflux for 60 h and then concentrated. EtOAc (10 mL) and a saturated aqueous NH<sub>4</sub>Cl solution (5 mL) were then added. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc) to furnish the urea <b>9g</b> (120 mg, 80%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.18–1.57 (m, 5H), 1.60 (d, <i>J</i> = 7.2 Hz, 3H), 1.70 (dt, <i>J</i> = 3.7, 12.8 Hz, 1H), 1.82 (dt, <i>J</i> = 3.7, 13.0 Hz, 2H), 2.18 (d, <i>J</i> = 11.6 Hz, 2H), 3.69 (s, 3H), 3.91 (q, <i>J</i> = 7.2 Hz, 1H), 4.01 (tdt, <i>J</i> = 3.9, 7.8, 11.6 Hz, 1H), 5.54 (d, <i>J</i> = 7.5 Hz, 1H), 7.29 (dd, <i>J</i> = 1.4, 8.1 Hz, 1H), 7.41 (dd, <i>J</i> = 2.2, 8.8 Hz, 1H), 7.92 (d, <i>J</i> = 4.9 Hz, 1H), 7.93–7.96 (m, 3H); MS (ES, <i>m</i>/<i>z</i>) C<sub>23</sub>H<sub>25</sub>ClN<sub>2</sub>O<sub>3</sub> requires 412, found 413 [M + H]<sup>+</sup>.</div></div><div id="sec5_6_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-(6-Chloro-9-(hexylcarbamoyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>10a</b>)</h4><div class="NLM_p last">Following general procedure B, hydrolysis of ester <b>9a</b> (74 mg, 0.25 mmol) in the presence of LiOH (24 mg, 1 mmol), followed by trituration with EtOAc at 40 °C, furnished acid <b>10a</b> (28 mg, 39%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.90 (t, <i>J</i> = 6.9 Hz, 3H), 1.33–1.36 (m, 4H), 1.37 (d, J = 7.2 Hz, 3H), 1.40–1.45 (m, 2H), 1.65 (p, <i>J</i> = 7.2 Hz, 2H), 3.34–3.40 (m, 2H), 3.37 (q, J = 7.2 Hz, 1H), 7.29 (d, <i>J</i> = 8.1 Hz, 1H), 7.45 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 7.80 (s, 1H), 7.84 (d, <i>J</i> = 8.8 Hz, 1H), 8.05 (d, <i>J</i> = 8.1 Hz, 1H), 8.21 (d, <i>J</i> = 2.2 Hz, 1H), 8.34 (t, <i>J</i> = 5.5 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>25</sub>ClN<sub>2</sub>O<sub>3</sub> requires 400, found 401 [M + H]<sup>+</sup>, 418 [M + NH<sub>4</sub>]<sup>+</sup>.</div></div><div id="sec5_6_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 2-(6-Chloro-9-(methylcarbamoyl)carbazol-2-yl)propanoic Acid (<b>10b</b>)</h4><div class="NLM_p last">To a solution of ester <b>9b</b> (60 mg, 0.17 mmol) in THF (6 mL) was added a solution of 6 M HCl (4 mL). The solution was stirred for 3 days at room temperature. EtOAc and H<sub>2</sub>O were then added. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by trituration with Et<sub>2</sub>O/pentane to furnish acid <b>10b</b> (43 mg, 75%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.45 (d, <i>J</i> = 7.1 Hz, 3H), 2.94 (d, <i>J</i> = 4.4 Hz, 3H), 3.86 (q, <i>J</i> = 7.0 Hz, 1H), 7.28 (d, <i>J</i> = 8.1 Hz, 1H), 7.49 (dd, <i>J</i> = 2.1, 8.8 Hz, 1H), 7.86 (s, 1H), 7.89 (d, <i>J</i> = 8.8 Hz, 1H), 8.17 (d, <i>J</i> = 8.1 Hz, 1H), 8.25 (q, <i>J</i> = 4.0 Hz, 2H), 8.27 (d, <i>J</i> = 2.1 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>17</sub>H<sub>15</sub>ClN<sub>2</sub>O<sub>3</sub> requires 330, found 331 [M + H]<sup>+</sup>.</div></div><div id="sec5_6_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(9-(Butylcarbamoyl)-6-chloro-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>10c</b>)</h4><div class="NLM_p last">Following general procedure B, hydrolysis of ester <b>9b</b> (80 mg, 0.20 mmol) in the presence of LiOH (24 mg, 1 mmol), followed by purification by preparative HPLC, furnished acid <b>10c</b> (45 mg, 60%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.98 (t, <i>J</i> = 7.3 Hz, 3H), 1.47 (m, 5H), 1.66 (p, <i>J</i> = 7.2 Hz, 2H), 3.39 (dd, <i>J</i> = 13.3, 6.4 Hz, 2H), 3.86 (q, <i>J</i> = 7.0 Hz, 1H), 7.29 (d, <i>J</i> = 8.1 Hz, 1H), 7.51 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 7.85–7.87 (m, 2H), 8.18 (d, <i>J</i> = 8.1 Hz, 1H), 8.28 (d, <i>J</i> = 1.9 Hz, 1H), 8.39 (t, <i>J</i> = 5.4 Hz, 1H), 12.34 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>20</sub>H<sub>21</sub>ClN<sub>2</sub>O<sub>3</sub> requires 372, found 371 [M – H]<sup>−</sup>.</div></div><div id="sec5_6_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 2-(6-Chloro-9-(octylcarbamoyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>10d</b>)</h4><div class="NLM_p last">Following general procedure B, hydrolysis of ester <b>9c</b> (120 mg, 0.27 mmol) in the presence of LiOH (26 mg, 1.08 mmol), followed by trituration with Et<sub>2</sub>O, furnished acid <b>10d</b> (62 mg, 53%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.87 (t, J = 6.7 Hz, 3H), 1.28–1.44 (m, 10H), 1.46 (d, <i>J</i> = 7.1 Hz, 3H), 1.66 (p, <i>J</i> = 7.0 Hz, 2H), 3.34–3.40 (m, 2H), 3.86 (q, <i>J</i> = 7.0 Hz, 1H), 7.29 (dd, <i>J</i> = 8.1, 1.7 Hz, 1H), 7.50 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 7.84–7.87 (m, 2H), 8.18 (d, <i>J</i> = 8.0 Hz, 1H), 8.28 (d, <i>J</i> = 2.1 Hz, 1H), 8.40 (t, <i>J</i> = 5.5 Hz, 1H), 12.31 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>24</sub>H<sub>29</sub>ClN<sub>2</sub>O<sub>3</sub> requires 428, found 429 [M + H]<sup>+</sup>, 447 [M + NH<sub>4</sub>]<sup>+</sup>.</div></div><div id="sec5_6_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 2-(6-Chloro-9-((4-chlorophenyl)carbamoyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>10e</b>)</h4><div class="NLM_p last">To a solution of ester <b>9d</b> (140 mg, 0.32 mmol) in THF (5 mL) was added a solution of 6 M HCl (5 mL). The solution was stirred for 5 days at room temperature. EtOAc (10 mL) and H<sub>2</sub>O (5 mL) were then added. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was triturated with Et<sub>2</sub>O/pentane to furnish acid <b>10e</b> (105 mg, 80%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.46 (d, <i>J</i> = 7.1 Hz, 3H), 3.90 (q, <i>J</i> = 7.0 Hz, 1H), 7.35 (dd, <i>J</i> = 8.1, 1.2 Hz, 1H), 7.50 (d, <i>J</i> = 8.9 Hz, 2H), 7.55 (m, 1H), 7.73 (d, <i>J</i> = 8.9 Hz, 2H), 7.88 (s, 1H), 7.92 (d, <i>J</i> = 8.8 Hz, 1H), 8.24 (d, <i>J</i> = 8.1 Hz, 1H), 8.34 (s, 1H), 10.74 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>3</sub> requires 426, found 427, 429 [M + H]<sup>+</sup>, 444, 446 [M + NH<sub>4</sub>]<sup>+</sup>.</div></div><div id="sec5_6_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-(6-Chloro-9-(hexylmethylcarbamoyl)carbazol-2-yl)propanoic Acid (<b>10f</b>)</h4><div class="NLM_p last">Following general procedure B, hydrolysis of ester <b>9f</b> (60 mg, 0.14 mmol) in the presence of LiOH (8 mg, 0.35 mmol), followed by trituration with DCM/MeOH, furnished acid <b>10f</b> (45 mg, 77%) as a colorless oil: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.71 - 0.79 (m, 2H), 1.16 (m, 6H), 1.44 (dd, <i>J</i> = 2.8, 7.1 Hz, 3H), 1.60 (t, <i>J</i> = 7.1 Hz, 2H), 3.00 (d, <i>J</i> = 1.7 Hz, 3H), 3.41 (h, <i>J</i> = 7.2 Hz, 2H), 3.87 (q, <i>J</i> = 7.1 Hz, 1H), 5.75 (s, 1H), 7.28 (dt, <i>J</i> = 1.6, 8.2 Hz, 1H), 7.43 (d, <i>J</i> = 1.3 Hz, 1H), 7.46 - 7.53 (m, 2H), 8.18 (d, <i>J</i> = 8.1 Hz, 1H), 8.29 (dd, <i>J</i> = 0.9, 1.8 Hz, 1H), 12.36 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>23</sub>H<sub>27</sub>ClN<sub>2</sub>O<sub>3</sub> requires 414, found 415 [M + H]<sup>+</sup>.</div></div><div id="sec5_6_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 2-(6-Chloro-9-(cyclohexylcarbamoyl)carbazol-2-yl)propanoic Acid (<b>10g</b>)</h4><div class="NLM_p last">Following general procedure B, hydrolysis of ester <b>9g</b> (60 mg, 0.14 mmol) in the presence of LiOH (8 mg, 0.35 mmol), followed by trituration with Et<sub>2</sub>O, furnished acid <b>10g</b> (51 mg, 89%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.17–1.31 (m, 2H), 1.43 (dd, <i>J</i> = 9.1, 16.1 Hz, 6H), 1.63 (d, <i>J</i> = 12.8 Hz, 1H), 1.72 - 1.84 (m, 2H), 2.02 (d, <i>J</i> = 9.6 Hz, 2H), 3.68–3.81 (m, 1H), 3.85 (q, <i>J</i> = 7.1 Hz, 1H), 7.27 (dd, <i>J</i> = 1.3, 8.1 Hz, 1H), 7.49 (dd, <i>J</i> = 2.2, 8.8 Hz, 1H), 7.79–7.87 (m, 2H), 8.16 (d, <i>J</i> = 8.1 Hz, 1H), 8.27 (d, <i>J</i> = 2.1 Hz, 1H), 8.35 (d, <i>J</i> = 7.5 Hz, 1H), 12.34 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>23</sub>ClN<sub>2</sub>O<sub>3</sub> requires 398, found 399 [M + H]<sup>+</sup>.</div></div><div id="sec5_6_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Hexyl 6-Chloro-2-(1-methoxy-1-oxoprop-2-yl)-9<i>H</i>-carbazole-9-carboxylate (<b>11</b>)</h4><div class="NLM_p last">To a solution of <b>3</b> (140 mg, 0.49 mmol, 1 equiv) in THF (5 mL) were successively added hexyl chloroformate (freshly prepared, 215 mg, 1.47 mmol, 3 equiv), DMAP (179 mg, 1.47 mml, 3 equiv), and Et<sub>3</sub>N (0.20 mL, 1.47 mmol, 3 equiv). The mixture was heated in the microwave at 100 °C for 3 h. The reaction mixture was then filtrated and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc) to furnish the carbamate <b>11</b> (173 mg, 85%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.89 (t, <i>J</i> = 6.9 Hz, 3H), 1.33–1.37 (m, 4H), 1.48–1.53 (m, 5H), 1.84–1.91 (m, 2H), 3.61 (s, 3H), 4.02 (q, <i>J</i> = 7.0 Hz, 1H), 4.52 (t, <i>J</i> = 6.5 Hz, 2H), 7.37 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.56 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 8.20–8.25 (m, 3H), 8.31 (d, <i>J</i> = 2.1 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>23</sub>H<sub>26</sub>ClNO<sub>4</sub> requires 415, found 433 [M + NH<sub>4</sub>]<sup>+</sup>.</div></div><div id="sec5_6_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-(6-Chloro-9-((hexyloxy)carbonyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>12</b>)</h4><div class="NLM_p last">To a solution of ester <b>11</b> (87 mg, 0.21 mmol) in THF (2.5 mL) was added a solution of 6 M HCl (2.5 mL). The solution was stirred for 5 days at room temperature. EtOAc (10 mL) and H<sub>2</sub>O (5 mL) were then added. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc) to furnish acid <b>12</b> (46 mg, 55%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.89 (t, <i>J</i> = 6.9 Hz, 3H), 1.31–139 (m, 4H), 1.46 (d, <i>J</i> = 7.1 Hz, 3H), 1.49–1.54 (m, 2H), 1.84–1.91 (m, 2H), 3.88 (q, <i>J</i> = 7.1 Hz, 1H), 4.52 (t, <i>J</i> = 6.5 Hz, 2H), 7.38 (dd, <i>J</i> = 8.1, 1.5 Hz, 1H), 7.55 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 8.19 (d, <i>J</i> = 8.1 Hz, 1H), 8.22–8.24 (m, 2H), 8.30 (d, <i>J</i> = 2.2 Hz, 1H), 12.38 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>24</sub>ClNO<sub>4</sub> requires 401, found 400 [M – H]<sup>−</sup>, 356 [M – H – CO<sub>2</sub>]<sup>−</sup>.</div></div><div id="sec5_6_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Benzyl 2-(6-Chloro-9<i>H</i>-carbazol-2-yl)propanoate (<b>13</b>).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a></h4><div class="NLM_p last">To a solution of <b>1</b> (773 mg, 2.82 mmol, 1 equiv) in DMF (10 mL) was added K<sub>2</sub>CO<sub>3</sub> (1.17 g, 8.47 mmol, 3 equiv). The mixture was stirred at room temperature for 30 min, and then BnBr (0.37 mL, 3.10 mmol, 1.1 equiv) was added. After 3 h at room temperature, EtOAc was added (20 mL), and the mixture was washed with a saturated aqueous NH<sub>4</sub>Cl solution (5 mL) and with H<sub>2</sub>O (5 mL). The organic phase was then dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc) to yield the corresponding benzyl ester <b>13</b> (860 mg, 84%): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.61 (d, <i>J</i> = 7.2 Hz, 3H), 3.94 (q, <i>J</i> = 7.1 Hz, 1H), 5.13 (q, <i>J</i> = 12.5 Hz, 2H), 7.19 (dd, <i>J</i> = 8.1, 1.3 Hz, 1H), 7.23–7.25 (m, 2H), 7.28–7.36 (m, 6H), 7.94 (d, <i>J</i> = 8.1 Hz, 1H), 7.99 (d, <i>J</i> = 1.8 Hz, 1H), 8.03 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>18</sub>ClNO<sub>2</sub> requires 363, found 362 [M – H]<sup>−</sup>.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> General Procedure C</h3><div class="NLM_p">To a solution of <b>13</b> (or <b>3</b> in the case of <b>14j</b>) in MeCN (5 mL) were successively added the acyl chloride (3 equiv, either obtained from a commercial source or freshly prepared from the corresponding acid), DMAP (3 equiv), and Et<sub>3</sub>N (3 equiv). The mixture was stirred at room temperature for 2 h, and then a saturated aqueous NH<sub>4</sub>Cl solution and H<sub>2</sub>O were added. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc).</div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Benzyl 2-(9-Acetyl-6-chloro-9<i>H</i>-carbazol-2-yl)propanoate (<b>14a</b>)</h4><div class="NLM_p last">Following general procedure C, acylation of <b>13</b> (185 mg, 0.51 mmol) in the presence of AcCl (0.11 mL, 1.52 mmol), DMAP (186 mg, 1.52 mmol), and Et<sub>3</sub>N (0.21 mL, 1.52 mmol) furnished the acetyl derivative <b>14a</b> (200 mg, 97%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.64 (d, <i>J</i> = 7.2 Hz, 3H), 2.82 (s, 3H), 3.98 (q, <i>J</i> = 7.2 Hz, 1H), 5.12–5.19 (m, 2H), 7.25–7.32 (m, 5H), 7.37 (dd, <i>J</i> = 8.0, 1.3 Hz, 1H), 7.44 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 7.91 (d, <i>J</i> = 8.0 Hz, 1H), 7.94 (d, <i>J</i> = 2.1 Hz, 1H), 8.08 (s, 1H), 8.24 (d, <i>J</i> = 8.9 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>24</sub>H<sub>20</sub>ClNO<sub>3</sub> requires 405, found 406 [M + H<sup>+</sup>], 423 [M + NH<sub>4</sub><sup>+</sup>].</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Benzyl 2-(9-Benzoyl-6-chloro-9<i>H</i>-carbazol-2-yl)propanoate (<b>14b</b>)</h4><div class="NLM_p last">Following general procedure C, acylation of <b>13</b> (105 mg, 0.29 mmol) in the presence of benzoyl chloride (0.10 mL, 0.87 mmol), DMAP (106 mg, 0.87 mmol), and Et<sub>3</sub>N (0.12 mL, 0.87 mmol) furnished the benzoyl derivative <b>14b</b> (123 mg, 91%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.47 (d, <i>J</i> = 7.2 Hz, 3H), 3.81 (q, <i>J</i> = 7.1 Hz, 1H), 5.06–5.14 (m, 2H), 7.23–7.26 (m, 2H), 7.29–7.34 (m, 5H), 7.38 (s, 1H), 7.50–7.54 (m, 3H), 7.65–7.70 (m, 3H), 7.91 (d, <i>J</i> = 8.0 Hz, 1H), 7.96 (d, <i>J</i> = 2.1 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>29</sub>H<sub>22</sub>ClNO<sub>3</sub> requires 467, found 468 [M + H<sup>+</sup>], 485 [M + NH<sub>4</sub><sup>+</sup>].</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Benzyl 2-(6-Chloro-9-(4-chlorobenzoyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>14c</b>)</h4><div class="NLM_p last">Following general procedure C, acylation of <b>13</b> (98 mg, 0.27 mmol) in the presence of 4-chlorobenzoyl chloride (0.10 mL, 0.80 mmol), DMAP (98 mg, 0.80 mmol), and Et<sub>3</sub>N (0.11 mL, 0.80 mmol) furnished the 4-chlorobenzoyl derivative <b>14c</b> (119 mg, 88%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.47 (d, <i>J</i> = 7.2 Hz, 3H), 3.81 (q, <i>J</i> = 7.2 Hz, 1H), 5.06–5.13 (m, 2H), 7.21–7.24 (m, 2H), 7.28–7.33 (m, 5H), 7.40 (s, 1H), 7.47 (dd, <i>J</i> = 8.6, 5.6 Hz, 3H), 7.62 (d, <i>J</i> = 8.5 Hz, 2H), 7.89 (d, <i>J</i> = 8.1 Hz, 1H), 7.94 (d, <i>J</i> = 2.1 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>29</sub>H<sub>21</sub>Cl<sub>2</sub>NO<sub>3</sub> requires 501, found 502 [M + H<sup>+</sup>], 519 [M + NH<sub>4</sub><sup>+</sup>].</div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Benzyl 2-(6-Chloro-9-(4-fluorobenzoyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>14d</b>)</h4><div class="NLM_p last">Following general procedure C, acylation of <b>13</b> (98 mg, 0.27 mmol) in the presence of 4-fluorobenzoyl chloride (0.10 mL, 0.80 mmol), DMAP (98 mg, 0.80 mmol), and Et<sub>3</sub>N (0.11 mL, 0.80 mmol) furnished the 4-fluorobenzoyl derivative <b>14d</b> (104 mg, 88%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.49 (d, <i>J</i> = 7.2 Hz, 3H), 3.83 (q, <i>J</i> = 7.1 Hz, 1H), 5.07–5.14 (m, 2H), 7.18 (t, <i>J</i> = 8.6 Hz, 2H), 7.23–7.25 (m, 2H), 7.31–7.35 (m, 5H), 7.40 (s, 1H), 7.52 (d, <i>J</i> = 8.9 Hz, 1H), 7.72 (dd, <i>J</i> = 8.8, 5.3 Hz, 1H), 7.92 (d, <i>J</i> = 8.1 Hz, 2H), 7.97 (d, <i>J</i> = 1.9 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>29</sub>H<sub>21</sub>ClFNO<sub>3</sub> requires 485, found 486 [M + H<sup>+</sup>].</div></div><div id="sec5_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> Benzyl 2-(6-Chloro-9-(4-methoxybenzoyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>14e</b>)</h4><div class="NLM_p last">Following general procedure C, acylation of <b>13</b> (137 mg, 0.37 mmol) in the presence of 4-methoxybenzoyl chloride (0.15 mL, 1.12 mmol), DMAP (138 mg, 1.12 mmol), and Et<sub>3</sub>N (0.16 mL, 1.12 mmol) furnished the 4-methoxybenzoyl derivative <b>14e</b> (156 mg, 85%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.49 (d, <i>J</i> = 7.2 Hz, 3H), 3.83 (q, <i>J</i> = 7.1 Hz, 1H), 3.90 (s, 3H), 5.05–5.13 (m, 2H), 6.96 (d, <i>J</i> = 8.8 Hz, 2H), 7.21–7.23 (m, 2H), 7.26–7.31 (m, 5H), 7.46–7.49 (m, 2H), 7.67 (d, <i>J</i> = 4.9 Hz, 2H), 7.90 (d, <i>J</i> = 8.1 Hz, 1H), 7.94 (d, <i>J</i> = 2.0 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>30</sub>H<sub>24</sub>ClNO<sub>4</sub> requires 497, found 498 [M + H]<sup>+</sup>.</div></div><div id="sec5_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> Benzyl 2-(6-Chloro-9-(3-chlorobenzoyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>14f</b>)</h4><div class="NLM_p last">Following general procedure C, acylation of <b>13</b> (112 mg, 0.32 mmol) in the presence of 3-chlorobenzoyl chloride (0.12 mL, 0.96 mmol), DMAP (117 mg, 0.96 mmol), and Et<sub>3</sub>N (0.13 mL, 0.96 mmol) furnished the 3-chlorobenzoyl derivative <b>14f</b> (124 mg, 77%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.46 (d, <i>J</i> = 7.2 Hz, 3H), 3.80 (q, <i>J</i> = 7.1 Hz, 1H), 5.04–5.13 (m, 2H), 7.21–7.23 (m, 2H), 7.28–7.34 (m, 6H), 7.42 (m, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 2H), 7.61–7.63 (m, 1H), 7.67 (t, <i>J</i> = 1.7 Hz, 1H), 7.89 (d, <i>J</i> = 8.0 Hz, 1H), 7.94 (d, <i>J</i> = 2.1 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>29</sub>H<sub>21</sub>Cl<sub>2</sub>NO<sub>3</sub> requires 501, found 502 [M + H<sup>+</sup>], 519 [M + NH<sub>4</sub><sup>+</sup>].</div></div><div id="sec5_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Benzyl 2-(6-Chloro-9-(2-chlorobenzoyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>14g</b>)</h4><div class="NLM_p last">Following general procedure C, acylation of <b>13</b> (105 mg, 0.29 mmol) in the presence of 2-chlorobenzoyl chloride (0.11 mL, 0.86 mmol), DMAP (105 mg, 0.86 mmol), and Et<sub>3</sub>N (0.12 mL, 0.86 mmol) furnished the 2-chlorobenzoyl derivative <b>14g</b> (129 mg, 88%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.42 (d, <i>J</i> = 7.0 Hz, 3H), 3.77 (q, <i>J</i> = 7.1 Hz, 1H), 5.04–5.12 (m, 2H), 7.22–7.33 (m, 8H), 7.43–7.57 (m, 5H), 7.86 (d, <i>J</i> = 8.1 Hz, 1H), 7.92 (d, <i>J</i> = 2.1 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>29</sub>H<sub>21</sub>Cl<sub>2</sub>NO<sub>3</sub> requires 501, found 502 [M + H<sup>+</sup>], 519 [M + NH<sub>4</sub><sup>+</sup>].</div></div><div id="sec5_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Benzyl 2-(6-Chloro-9-(3,4-dichlorobenzoyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>14h</b>)</h4><div class="NLM_p last">Following general procedure C, acylation of <b>13</b> (120 mg, 0.33 mmol) with 3,4-dichlorobenzoyl chloride (freshly prepared from 3,4-dichlorobenzoic acid, 1 mmol), DMAP (122 mg, 1 mmol), and Et<sub>3</sub>N (0.14 mL, 1 mmol) furnished the 3,4-dichlorobenzoyl derivative <b>14h</b> (157 mg, 89%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.48 (d, <i>J</i> = 7.2 Hz, 3H), 3.83 (q, <i>J</i> = 7.1 Hz, 1H), 5.05–5.14 (m, 2H), 7.22–7.25 (m, 2H), 7.29–7.34 (m, 5H), 7.40 (s, 1H), 7.46–7.50 (m, 2H), 7.54–7.56 (m, 1H), 7.79 (d, <i>J</i> = 1.9 Hz, 1H), 7.88 (d, <i>J</i> = 8.0 Hz, 1H), 7.92 (d, <i>J</i> = 2.0 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>29</sub>H<sub>20</sub>Cl<sub>3</sub>NO<sub>3</sub> requires 535, found 536, 538 [M + H<sup>+</sup>], 553, 555 [M + NH<sub>4</sub><sup>+</sup>].</div></div><div id="sec5_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Benzyl 2-(6-Chloro-9-(oxazol-4-ylcarbonyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>14i</b>)</h4><div class="NLM_p last">Following general procedure C, acylation of <b>13</b> (144 mg, 0.39 mmol) with oxazol-4-ylcarbonyl chloride (freshly prepared from oxazole-4-carboxylic acid, 1.20 mmol), DMAP (145 mg, 1.20 mmol), and Et<sub>3</sub>N (0.16 mL, 1.20 mmol) furnished the oxazol-4-ylcarbonyl derivative <b>14i</b> (135 mg, 76%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.53 (d, <i>J</i> = 7.2 Hz, 3H), 3.86 (q, <i>J</i> = 7.1 Hz, 1H), 5.06–5.14 (m, 2H), 7.23–7.25 (m, 2H), 7.28–7.35 (m, 5H), 7.58 (d, <i>J</i> = 0.9 Hz, 1H), 7.69 (d, <i>J</i> = 8.9 Hz, 1H), 7.87 (d, <i>J</i> = 8.0 Hz, 1H), 7.93 (m, 2H), 8.33 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>26</sub>H<sub>19</sub>ClN<sub>2</sub>O<sub>4</sub> requires 458, found 459 [M + H<sup>+</sup>], 476 [M + NH<sub>4</sub><sup>+</sup>].</div></div><div id="sec5_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>tert</i>-Butyl 4-(2-(1-(Benzyloxy)-1-oxoprop-2-yl)-6-chloro-9<i>H</i>-carbazol-9-ylcarbonyl)-1<i>H</i>-imidazole-1-carboxylate (<b>14j</b>)</h4><div class="NLM_p last">To a suspension of imidazole-4-carboxylic acid (143 mg, 1.28 mmol, 1 equiv) in DMF (1.5 mL) were successively added Et<sub>3</sub>N (0.35 mL, 2.56 mmol, 2 equiv) and a solution of Boc<sub>2</sub>O (307 mg, 1.08 mmol, 1.1 equiv) in DMF (1.5 mL). After 4 h at room temperature, the solution was concentrated. The residue was taken up in EtOAc and washed with H<sub>2</sub>O. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was suspended in DCM (5 mL), and oxalyl chloride (0.26 mL, 3.07 mmol, 2.4 equiv) followed by DMF (0.05 mL) was added. The solution was stirred for 2 h at room temperature and then concentrated in vacuo to provide the crude (1-((<i>tert</i>-butyloxy)carbonyl)imidazol-4-yl)carbonyl chloride as a yellow oil. To a solution of <b>13</b> (120 mg, 0.33 mmol, 1 equiv) in MeCN (3 mL) were successively added the crude acyl chloride described previously (1.28 mmol, 3.9 equiv) in MeCN (2 mL), DMAP (156 mg, 1.28 mmol, 3.9 equiv), and Et<sub>3</sub>N (0.18 mL, 1.28 mmol, 3.9 equiv). The mixture was stirred at room temperature for 2 h,and then a saturated aqueous NH<sub>4</sub>Cl solution and H<sub>2</sub>O were added. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography (Cy/EtOAc) to give the <i>N</i>-((<i>tert</i>-butyloxy)carbonyl)carbonylimidazole compound <b>14j</b> (46 mg, 25%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.56 (d, <i>J</i> = 7.2 Hz, 3H), 1.70 (s, 9H), 3.89 (q, <i>J</i> = 7.1 Hz, 1H), 5.06–5.17 (m, 2H), 7.24–7.34 (m, 7H), 7.65 (d, <i>J</i> = 8.8 Hz, 1H), 7.68 (s, 1H), 7.89 (d, <i>J</i> = 8.0 Hz, 1H), 7.94 (d, <i>J</i> = 1.9 Hz, 1H), 8.13 (d, <i>J</i> = 1.2 Hz, 1H), 8.17 (d, <i>J</i> = 1.2 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>31</sub>H<sub>28</sub>ClN<sub>3</sub>O<sub>5</sub> requires 557, found 558 [M + H]<sup>+</sup>.</div></div><div id="sec5_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Methyl 2-(6-Chloro-9-(thiazol-4-ylcarbonyl)-9<i>H</i>-carbazol-2-yl)propanoate (<b>14k</b>)</h4><div class="NLM_p last">Following general procedure C, acylation of <b>3</b> (117 mg, 0.41 mmol) with thiazol-4-ylcarbonyl chloride (freshly prepared from thiazole-4-carboxylic acid, 1.22 mmol), DMAP (149 mg, 1.22 mmol), and Et<sub>3</sub>N (0.17 mL, 1.22 mmol) furnished the thiazol-4-ylcarbonyl derivative <b>14k</b> (115 mg, 71%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.49 (d, <i>J</i> = 7.2 Hz, 3H), 3.67 (s, 3H), 3.80 (q, <i>J</i> = 7.1 Hz, 1H), 7.27 – 7.35 (m, 3H), 7.48 (d, <i>J</i> = 8.8 Hz, 1H), 7.90 (d, <i>J</i> = 8.0 Hz, 1H), 7.93 (d, <i>J</i> = 2.1 Hz, 1H), 8.27 (d, <i>J</i> = 2.0 Hz, 1H), 8.94 (d, <i>J</i> = 2.0 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>20</sub>H<sub>15</sub>ClN<sub>2</sub>O<sub>3</sub>S requires 398, found 399 [M + H]<sup>+</sup>.</div></div><div id="sec5_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-(9-Acetyl-6-chloro-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>15a</b>)</h4><div class="NLM_p last">A solution of benzyl ester <b>14a</b> (100 mg, 0.25 mmol) in THF (30 mL) was hydrogenated with the ThalesNano H-Cube using a 1% Pd/C catalyst, at a 1 mL/min flow rate and room temperature and in a H<sub>2</sub> atmosphere (1 atm) (full H<sub>2</sub> mode), in a closed system for 5 h. The solvent was then removed in vacuo, and the product was crystallized from DCM/pentane to give acid <b>15a</b> (15 mg, 19%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.46 (d, <i>J</i> = 7.1 Hz, 3H), 2.88 (s, 3H), 3.91 (q, <i>J</i> = 7.1 Hz, 1H), 7.37–7.39 (m, 1H), 7.53 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 8.20–8.25 (m, 3H), 8.31 (d, <i>J</i> = 2.2 Hz, 1H), 12.39 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>17</sub>H<sub>14</sub>ClNO<sub>3</sub> requires 315, found 314 [M – H] <sup>–</sup>, 270 [M – H – CO<sub>2</sub>]<sup>−</sup>.</div></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> General Procedure D</h3><div class="NLM_p">A solution of benzyl ester <b>14</b> in THF (5 mM solution) was hydrogenated with the ThalesNano H-Cube using a 1% or 5% Pd/C catalyst, at a 1 mL/min flow rate and room temperature and in a H<sub>2</sub> atmosphere (1 atm) (full H<sub>2</sub> mode). The solvent was then removed in vacuo, and the crude oil was purified by preparative HPLC to yield the corresponding acid <b>15</b>.</div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 2-(9-Benzoyl-6-chloro-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>15b</b>)</h4><div class="NLM_p last">Following general procedure D (5% Pd/C catalyst), ester <b>14b</b> (120 mg, 0.25 mmol) was hydrogenated to yield acid <b>15b</b> (29 mg, 31%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.29 (d, <i>J</i> = 7.1 Hz, 3H), 3.72 (q, <i>J</i> = 7.1 Hz, 1H), 7.34–7.37 (m, 3H), 7.39–7.42 (m, 1H), 7.60–7.64 (m, 2H), 7.72–7.78 (m, 3H), 8.22 (d, <i>J</i> = 8.4 Hz, 1H), 8.34 (d, <i>J</i> = 2.0 Hz, 1H), 12.31 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>16</sub>ClNO<sub>3</sub> requires 377, found 378 [M + H<sup>+</sup>], 395 [M + NH<sub>4</sub><sup>+</sup>].</div></div><div id="sec5_8_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 2-(6-Chloro-9-(4-chlorobenzoyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>15c</b>)</h4><div class="NLM_p last">Following general procedure D (5% Pd/C catalyst), ester <b>14c</b> (119 mg, 0.23 mmol) was hydrogenated to yield acid <b>15c</b> (40 mg, 42%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (d, <i>J</i> = 7.1 Hz, 3H), 3.76 (q, <i>J</i> = 7.0 Hz, 1H), 7.33–7.40 (m, 2H), 7.39–7.47 (m, 2H), 7.69 (d, <i>J</i> = 8.4 Hz, 2H), 7.78 (d, <i>J</i> = 8.5 Hz, 2H), 8.22 (d, <i>J</i> = 8.0 Hz, 1H), 8.34 (d, <i>J</i> = 2.1 Hz, 1H), 12.35 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>15</sub>ClNO<sub>3</sub> requires 411, found 366 [M – H – CO<sub>2</sub>]<sup>−</sup>.</div></div><div id="sec5_8_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 2-(6-Chloro-9-(4-fluorobenzoyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>15d</b>)</h4><div class="NLM_p last">Following general procedure D (5% Pd/C catalyst), ester <b>14d</b> (104 mg, 0.21 mmol) was hydrogenated to yield acid <b>15d</b> (35 mg, 42%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (d, <i>J</i> = 7.1 Hz, 3H), 3.75 (q, <i>J</i> = 7.0 Hz, 1H), 7.35–7.39 (m, 3H), 7.42–7.47 (m, 3H), 7.83 (dd, <i>J</i> = 8.6, 5.4 Hz, 2H), 8.22 (d, <i>J</i> = 8.6 Hz, 1H), 8.34 (d, <i>J</i> = 2.0 Hz, 1H), 12.33 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>15</sub>ClFNO<sub>3</sub> requires 395, found 396 [M + H<sup>+</sup>], 413 [M + NH<sub>4</sub><sup>+</sup>].</div></div><div id="sec5_8_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 2-(6-Chloro-9-(4-methoxybenzoyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>15e</b>)</h4><div class="NLM_p last">Following general procedure D (1% Pd/C catalyst), ester <b>14e</b> (0.156 g, 0.31 mmol) was hydrogenated to yield acid <b>15e</b> (28 mg, 22%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.33 (d, <i>J</i> = 7.1 Hz, 3H), 3.76 (q, <i>J</i> = 7.0 Hz, 1H), 3.90 (s, 3H), 7.13 (d, <i>J</i> = 8.8 Hz, 2H), 7.33 (t, <i>J</i> = 8.9 Hz, 2H), 7.39–7.42 (m, 1H), 7.47 (s, 1H), 7.71 (d, <i>J</i> = 8.8 Hz, 2H), 8.21 (d, <i>J</i> = 8.0 Hz, 1H), 8.33 (d, <i>J</i> = 2.1 Hz, 1H), 12.32 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>23</sub>H<sub>18</sub>ClNO<sub>4</sub> requires 407, found 408 [M + H]<sup>+</sup>.</div></div><div id="sec5_8_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 2-(6-Chloro-9-(3-chlorobenzoyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>15f</b>)</h4><div class="NLM_p last">Following general procedure D (1% Pd/C catalyst), ester <b>14f</b> (197 mg, 0.39 mmol) was hydrogenated to yield acid <b>15f</b> (25 mg, 15%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.30 (d, <i>J</i> = 7.1 Hz, 3H), 3.74 (q, <i>J</i> = 7.1 Hz, 1H), 7.33–7.37 (m, 2H), 7.40–7.45 (m, 2H), 7.62–7.66 (m, 1H), 7.68–7.70 (m, 1H), 7.81–7.85 (m, 2H), 8.21 (d, <i>J</i> = 8.0 Hz, 1H), 8.34 (s, 1H), 12.33 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>15</sub>Cl<sub>2</sub>NO<sub>3</sub>requires 411, found 412 [M + H<sup>+</sup>], 434 [M + Na<sup>+</sup>].</div></div><div id="sec5_8_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 2-(6-Chloro-9-(2-chlorobenzoyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>15g</b>)</h4><div class="NLM_p last">Following general procedure D (1% Pd/C catalyst), ester <b>14g</b> (125 mg, 0.25 mmol) was hydrogenated to yield acid <b>15g</b> (22 mg, 21%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.26 (d, <i>J</i> = 7.1 Hz, 3H), 3.71 (q, <i>J</i> = 6.9 Hz, 1H), 7.23–7.25 (m, 1H), 7.38 (d, <i>J</i> = 7.7 Hz, 1H), 7.44 (d, <i>J</i> = 6.6 Hz, 2H), 7.63–7.67 (m, 1H), 7.71–7.77 (m, 2H), 7.84 (d, <i>J</i> = 7.2 Hz, 1H), 8.21 (d, <i>J</i> = 8.0 Hz, 1H), 8.35 (s, 1H), 12.34 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>15</sub>Cl<sub>2</sub>NO<sub>3</sub> requires 411, found 412 [M + H<sup>+</sup>], 429 [M + NH<sub>4</sub>]<sup>+</sup>.</div></div><div id="sec5_8_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 2-(6-Chloro-9-(3,4-dichlorobenzoyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>15h</b>)</h4><div class="NLM_p last">Following general procedure D (5% Pd/C catalyst), ester <b>14h</b> (157 mg, 0.29 mmol) was hydrogenated to yield acid <b>15h</b> (35 mg, 28%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (d, <i>J</i> = 7.1 Hz, 3H), 3.78 (q, <i>J</i> = 7.0 Hz, 1H), 7.37 - 7.44 (m, 4H), 7.74 (dd, <i>J</i> = 8.3, 2.0 Hz, 1H), 7.89 (d, <i>J</i> = 8.3 Hz, 1H), 8.08 (d, <i>J</i> = 1.9 Hz, 1H), 8.22 (d, <i>J</i> = 8.0 Hz, 1H), 8.34 (d, <i>J</i> = 1.7 Hz, 1H), 12.35 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>14</sub>Cl<sub>3</sub>NO<sub>3</sub> requires 445, found 400, 402 [M – H – CO<sub>2</sub>]<sup>−</sup>.</div></div><div id="sec5_8_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 2-(6-Chloro-9-(oxazol-4-ylcarbonyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>15i</b>)</h4><div class="NLM_p last">Following general procedure D (1% Pd/C catalyst), ester <b>14i</b> (130 mg, 0.28 mmol) was hydrogenated to yield acid <b>15i</b> (21 mg, 20%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.38 (d, <i>J</i> = 7.1 Hz, 3H), 3.82 (q, <i>J</i> = 7.0 Hz, 1H), 7.37 (dd, <i>J</i> = 8.1, 1.1 Hz, 1H), 7.44 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 7.58 - 7.63 (m, 2H), 8.21 (d, <i>J</i> = 8.0 Hz, 1H), 8.33 (d, <i>J</i> = 2.1 Hz, 1H), 8.69 (s, 1H), 9.06 (s, 1H), 12.38 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>19</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>4</sub> requires 368, found 323 [M – H – CO<sub>2</sub>]<sup>−</sup>.</div></div><div id="sec5_8_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 2-(6-Chloro-9-(1<i>H</i>-imidazol-4-ylcarbonyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid Hydrochloride (<b>15j</b>)</h4><div class="NLM_p last">To a solution of <b>14j</b> (84 mg, 0.15 mmol) in acetone (2 mL) was added 2 M HCl (2 mL). The mixture was stirred at room temperature overnight. After evaporation of the solvents, the residue was then dissolved in THF (40 mL), and the solution was hydrogenated using the ThalesNano H-Cube using a 5% Pd/C catalyst, at a 1 mL/min flow rate and room temperature and in a H<sub>2</sub> atmosphere (1 atm) (full H<sub>2</sub> mode). The solvent was then removed in vacuo, and the crude oil was purified by preparative HPLC. After evaporation of the solvents, the residue was dissolved in a 1:1 mixture of MeCN/H<sub>2</sub>O and 0.5 mL of concentrated HCl. The solution was lyophilized overnight to afford the acid <b>15j</b> (11 mg, 18%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.39 (d, <i>J</i> = 7.1 Hz, 3H), 3.81 (q, <i>J</i> = 7.0 Hz, 1H), 7.35 (d, <i>J</i> = 8.1 Hz, 1H), 7.42 (dd, <i>J</i> = 8.9, 2.0 Hz, 1H), 7.55 (d, <i>J</i> = 8.9 Hz, 1H), 7.60 (s, 1H), 8.16 (s, 1H), 8.20 (d, <i>J</i> = 8.1 Hz, 1H), 8.27 (s, 1H), 8.30 (d, <i>J</i> = 1.9 Hz, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>19</sub>H<sub>14</sub>ClN<sub>3</sub>O<sub>3</sub> requires 367, found 322 [M – H – CO<sub>2</sub>]<sup>−</sup>, 366 [M – H]<sup>−</sup>.</div></div><div id="sec5_8_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 2-(6-Chloro-9-(thiazol-4-ylcarbonyl)-9<i>H</i>-carbazol-2-yl)propanoic Acid (<b>15k</b>)</h4><div class="NLM_p last">To a solution of ester <b>14k</b> (115 mg, 0.29 mmol) in THF (5 mL) was added a solution of 6 M HCl (5 mL). The solution was stirred for 5 days at room temperature. EtOAc and H<sub>2</sub>O were then added. After separation, the organic phase was dried over MgSO<sub>4</sub> and concentrated in vacuo. The residue was purified by preparative HPLC to furnish acid <b>15k</b> (18 mg, 16%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.34 (d, <i>J</i> = 7.1 Hz, 3H), 3.76 (q, <i>J</i> = 7.1 Hz, 1H), 7.20 (s, 1H), 7.34 - 7.41 (m, 2H), 7.45 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 8.21 (d, <i>J</i> = 8.0 Hz, 1H), 8.34 (s, 1H), 8.74 (s, 1H), 9.29 (s, 1H), 12.35 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>19</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>3</sub>S requires 384, found 339 [M – H – CO<sub>2</sub>]<sup>−</sup>.</div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Separation of Enantiomers</h3><div class="NLM_p">Compounds <b>1</b>, <b>15c</b>, and <b>15i</b> were subjected to enantiomeric separation by chiral HPLC. For <b>1</b>, the absolute configuration of each enantiomer was assigned by measuring the optical rotation and comparing the values to the data described in the literature.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The absolute configuration of each enantiomer of compounds <b>15c</b> and <b>15i</b> was assigned by chemical correlation. To this purpose, each enantiomer of <b>15c</b> and <b>15i</b> was separately hydrolyzed with 6 M HCl in THF for 3 days at 40 °C to give (<i>S</i>)- and (<i>R</i>)-<b>1</b>. The absolute configuration of each enantiomer was assigned by comparison of the chiral HPLC chromatogram with that of samples of (+)-(<i>S</i>)- and (-)-(<i>R</i>)-<b>1</b>. The results were consistent with the formation of a single enantiomer of <b>1</b> in each experiment.</div><div id="sec5_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> Data for (2<i>S</i>)-2-(6-chloro-9<i>H</i>-carbazol-2-yl)propanoic acid [(+)-<b>1</b>]:</h4><div class="NLM_p last">[α]<sub>D</sub> = +58.32 (<i>c</i> = 0.1, MeOH); ee > 99.5% (detector UV 240 nm); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.45 (d, <i>J</i> = 7.1 Hz, 3H), 3.84 (q, <i>J</i> = 7.0 Hz, 1H), 7.12 (dd, <i>J</i> = 8.1, 1.3 Hz, 1H), 7.37 (dd, <i>J</i> = 8.6, 2.1 Hz, 1H), 7.41 (s, 1H), 7.49 (d, <i>J</i> = 8.6 Hz, 1H), 8.09 (d, <i>J</i> = 8.1 Hz, 1H), 8.18 (d, <i>J</i> = 2.0 Hz, 1H), 11.36 (s, 1H), 12.32 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>15</sub>H<sub>12</sub>ClNO<sub>2</sub> requires 273, found 272 [M – H]<sup>−</sup>; retention time on analytical chiral HPLC, 8.295 min.</div></div><div id="sec5_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> Data for (2<i>R</i>)-2-(6-chloro-9<i>H</i>-carbazol-2-yl)propanoic acid [(−)-<b>1</b>]:</h4><div class="NLM_p last">[α]<sub>D</sub> = −58.25 (<i>c</i> = 0.1, MeOH); ee > 99.5% (detector UV 240 nm); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.45 (d, <i>J</i> = 7.1 Hz, 3H), 3.84 (q, <i>J</i> = 7.0 Hz, 1H), 7.12 (dd, <i>J</i> = 8.1, 1.3 Hz, 1H), 7.37 (dd, <i>J</i> = 8.6, 2.1 Hz, 1H), 7.41 (s, 1H), 7.49 (d, <i>J</i> = 8.6 Hz, 1H), 8.09 (d, <i>J</i> = 8.1 Hz, 1H), 8.18 (d, <i>J</i> = 2.0 Hz, 1H), 11.36 (s, 1H), 12.29 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>15</sub>H<sub>12</sub>ClNO<sub>2</sub> requires 273, found 272 [M – H]<sup>−</sup>; retention time on analytical chiral HPLC, 10.173 min.</div></div><div id="sec5_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> Data for (2<i>S</i>)-(6-chloro-9-(4-chlorobenzoyl)-9<i>H</i>-carbazol-2-yl)propanoic acid [(+)-<b>15c</b>]:</h4><div class="NLM_p last">[α]<sub>D</sub> = +28.42 (<i>c</i> = 0.1, EtOAc); ee > 99.5% (detector UV 240 nm); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (d, <i>J</i> = 7.1 Hz, 3H), 3.76 (q, <i>J</i> = 7.0 Hz, 1H), 7.33–7.40 (m, 2H), 7.39–7.47 (m, 2H), 7.69 (d, <i>J</i> = 8.4 Hz, 2H), 7.78 (d, <i>J</i> = 8.5 Hz, 2H), 8.22 (d, <i>J</i> = 8.0 Hz, 1H), 8.34 (d, <i>J</i> = 2.1 Hz, 1H), 12.35 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>15</sub>Cl<sub>2</sub>NO<sub>3</sub> requires 411, found 366 [M – H – CO<sub>2</sub>]<sup>−</sup>; retention time on analytical chiral HPLC, 16.834 min.</div></div><div id="sec5_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> Data for (2<i>R</i>)-(6-chloro-9-(4-chlorobenzoyl)-9<i>H</i>-carbazol-2-yl)propanoic acid [(−)-<b>15c</b>]:</h4><div class="NLM_p last">[α]<sub>D</sub> = −28.72 (<i>c</i> = 0.1, EtOAc), ee >99.5% (detector UV 240 nm); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.32 (d, <i>J</i> = 7.1 Hz, 3H), 3.76 (q, <i>J</i> = 7.0 Hz, 1H), 7.33–7.40 (m, 2H), 7.39–7.47 (m, 2H), 7.69 (d, <i>J</i> = 8.4 Hz, 2H), 7.78 (d, <i>J</i> = 8.5 Hz, 2H), 8.22 (d, <i>J</i> = 8.0 Hz, 1H), 8.34 (d, <i>J</i> = 2.1 Hz, 1H), 12.35 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>22</sub>H<sub>15</sub>Cl<sub>2</sub>NO<sub>3</sub> requires 411, found 366 [M – H – CO<sub>2</sub>]<sup>−</sup>; retention time on analytical chiral HPLC, 23.442 min.</div></div><div id="sec5_9_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Data for (2<i>S</i>)-(6-chloro-9-(oxazol-4-ylcarbonyl)-9<i>H</i>-carbazol-2-yl)propanoic acid [(+)-<b>15i</b>]:</h4><div class="NLM_p last">[α]<sub>D</sub> = +39.85 (<i>c</i> = 0.1, EtOAc); ee > 99.5% (detector UV 240 nm) ; <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.38 (d, <i>J</i> = 7.1 Hz, 3H), 3.82 (q, <i>J</i> = 7.0 Hz, 1H), 7.37 (dd, <i>J</i> = 8.1, 1.1 Hz, 1H), 7.44 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 7.58–7.63 (m, 2H), 8.21 (d, <i>J</i> = 8.0 Hz, 1H), 8.33 (d, <i>J</i> = 2.1 Hz, 1H), 8.69 (s, 1H), 9.06 (s, 1H), 12.38 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>19</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>3</sub>S requires 384, found 323 [M – H – CO<sub>2</sub>]<sup>−</sup>; retention time on analytical chiral HPLC, 24.425 min.</div></div><div id="sec5_9_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Data for (2<i>R</i>)-(6-chloro-9-(oxazol-4-ylcarbonyl)-9<i>H</i>-carbazol-2-yl)propanoic acid [(−)-<b>15i</b>]:</h4><div class="NLM_p last">[α]<sub>D</sub> = −39.38 (<i>c</i> = 0.1, EtOAc); ee > 99.5% (detector UV 240 nm); <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.38 (d, <i>J</i> = 7.1 Hz, 3H), 3.82 (q, <i>J</i> = 7.0 Hz, 1H), 7.37 (dd, <i>J</i> = 8.1, 1.1 Hz, 1H), 7.44 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 7.58–7.63 (m, 2H), 8.21 (d, <i>J</i> = 8.0 Hz, 1H), 8.33 (d, <i>J</i> = 2.1 Hz, 1H), 8.69 (s, 1H), 9.06 (s, 1H), 12.38 (s, 1H); MS (ES, <i>m</i>/<i>z</i>) C<sub>19</sub>H<sub>13</sub>ClN<sub>2</sub>O<sub>3</sub>S requires 384, found 323 [M – H – CO<sub>2</sub>]<sup>−</sup>; retention time on analytical chiral HPLC, 37.257 min.</div></div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> In Vitro Assays</h3><div class="NLM_p">FAAH activity was measured by incubation of [<sup>3</sup>H]anandamide (1 μM cold AEA and 0.6 nM (1 mCi/mL) [<sup>3</sup>H]AEA (arachidonyl[1-<sup>3</sup>H]ethanolamine), specific activity 60 Ci/mmol; American Radiolabeled Chemicals, Inc., St. Louis, MO) for 30 min at 37 °C in the presence of 50 μg of protein per sample of total rat brain homogenates in assay buffer (50 mM Tris, pH 7.4, 0.05% fatty acid free BSA). The reaction was stopped with cold 1:1 CHCl<sub>3</sub>/MeOH. The aqueous phase was counted by liquid scintillation (Microbeta2 Lumijet, Perkin-Elmer Inc., Waltham, MA; adapted from Kathuria et al., 2003). Inhibitors were preincubated with the enzyme preparation at the appropriate concentration for 10 min prior to substrate addition.</div><div class="NLM_p last">COX activity was measured using a commercial enzyme immunoassay kit (Cayman Chemical Co., Ann Arbor, MI). The manufacturer protocol was followed except for the substrate concentration. Briefly, inhibitors were preincubated with either ovine COX-1 or human COX-2 for 10 min at 37 °C, and the reaction was carried out in the presence of 5 μM arachidonic acid for 2 min at 37 °C. The reaction was stopped with hydrochloric acid, and COX-derived PGH<sub>2</sub> was then converted to PGF2α with SnCl<sub>2</sub>. The PGF2α product was then quantified via enzyme immunoassay (EIA) using a PG-specific antibody and competing with a PG–acetylcholinesterase conjugate. Absorbance was measured at 412 nM with a Tecan Infinite M200 plate reader (Tecan Group Ltd., Männedorf, Switzerland), and data were processed according to the manufacturer’s instructions.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92"><a href="/doi/suppl/10.1021/jm3011146">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64631" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64631" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Percentage distribution of some molecular properties of the 382 COX inhibitors and putative binding mode to FAAH of some known COX inhibitors, including carprofen and some of its derivatives. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3011146/suppl_file/jm3011146_si_001.pdf">jm3011146_si_001.pdf (1.1 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3011146" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50538" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50538" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Cavalli</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery
and Development, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical Sciences, University of Bologna, via Belmeloro 6, 40126 Bologna,
Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#deb3bfacbdb1f0babba8b7a8b19eb7b7aaf0b7aafebfb0baacbbbff0bdbfa8bfb2b2b79eb7b7aaf0b7aa"><span class="__cf_email__" data-cfemail="44292536272b6a2021322d322b042d2d306a2d30">[email protected]</span> <span class="__cf_email__" data-cfemail="b2d3dcd6c0d7d39cd1d3c4d3dededbf2dbdbc69cdbc6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco De Vivo</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery
and Development, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#89e4e8fbeae6a7edecffe0ffe6c9e0e0fda7e0fda9e8e7edfbece8a7eae8ffe8e5e5e0c9e0e0fda7e0fd"><span class="__cf_email__" data-cfemail="711c1003121e5f15140718071e311818055f1805">[email protected]</span> <span class="__cf_email__" data-cfemail="b9d8d7ddcbdcd897dad8cfd8d5d5d0f9d0d0cd97d0cd">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angelo D. Favia</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery
and Development, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Damien Habrant</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery
and Development, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rita Scarpelli</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery
and Development, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Migliore</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery
and Development, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clara Albani</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery
and Development, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sine Mandrup Bertozzi</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery
and Development, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mauro Dionisi</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery
and Development, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Glauco Tarozzo</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery
and Development, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniele Piomelli</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Discovery
and Development, Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Anatomy and Neurobiology, University of
California, Irvine, California 92697,
United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d1683e6741-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20575" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20575" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Silvia Venzano, Luca Goldoni, Paola Bisignano, and Marino Convertino for their technical support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i94" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i94"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i95" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i95"> Abbreviations Used</h2><tr><td class="NLM_term">FAAH</td><td class="NLM_def"><p class="first last">fatty acid amide hydrolase</p></td></tr><tr><td class="NLM_term">PGE2</td><td class="NLM_def"><p class="first last">prostaglandin E2</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-(dimethylamino)pyridine</p></td></tr><tr><td class="NLM_term">POX</td><td class="NLM_def"><p class="first last">peroxidase</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i96">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84280" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84280" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 63 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Wilson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Eon, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikail, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emery, P. C.</span><span> </span><span class="NLM_article-title">Major depression and insomnia in chronic pain</span> <span class="citation_source-journal">Clin. J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1097%2F00002508-200203000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=11882770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADC%252BD387ltVSjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=77-83&author=K.+G.+Wilsonauthor=M.+Y.+Erikssonauthor=J.+L.+D%E2%80%99Eonauthor=S.+F.+Mikailauthor=P.+C.+Emery&title=Major+depression+and+insomnia+in+chronic+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Major depression and insomnia in chronic pain</span></div><div class="casAuthors">Wilson Keith G; Eriksson Mariane Y; D'Eon Joyce L; Mikail Samuel F; Emery Patricia C</div><div class="citationInfo"><span class="NLM_cas:title">The Clinical journal of pain</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-83</span>
        ISSN:<span class="NLM_cas:issn">0749-8047</span>.
    </div><div class="casAbstract">OBJECTIVES:  Insomnia and depression are common problems for people with chronic pain, and previous research has found that each is correlated with measures of pain and disability.  The goal of this study was to examine the combined impact of major depression and insomnia on individuals with chronic pain.  METHODS:  The participants were patients with chronic musculoskeletal pain who underwent evaluation at an interdisciplinary treatment center.  On the basis of semistructured interviews, participants were classified in three groups depending on whether they: (1) met criteria for major depression with insomnia (n = 38); (2) had insomnia without major depression (n = 58); or (3) had neither insomnia nor major depression (n = 47).  The groups were then compared on self-report measures that included the McGill Pain Questionnaire, the Beck Depression Inventory, and the Multidimensional Pain Inventory.  RESULTS:  Participants with major depression and insomnia reported the most difficulty on measures of affective distress, life control, interference, and pain severity, although the insomniac patients without major depression also had elevated scores on some measures.  In regression analyses, insomnia severity ratings did not contribute uniquely to the prediction of psychosocial problems when depression was controlled, but they did contribute to the prediction of pain severity.  CONCLUSIONS:  These results suggest that patients with chronic pain and concurrent major depression and insomnia report the highest levels of pain-related impairment, but insomnia in the absence of major depression is also associated with increased pain and distress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4HhFGdCqV6oMcDoIzZtNkfW6udTcc2eYKUkBwiRdxsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ltVSjtQ%253D%253D&md5=6a1d8b301e9d78ff65ebaa791febff2d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1097%2F00002508-200203000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002508-200203000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DK.%2BG.%26aulast%3DEriksson%26aufirst%3DM.%2BY.%26aulast%3DD%25E2%2580%2599Eon%26aufirst%3DJ.%2BL.%26aulast%3DMikail%26aufirst%3DS.%2BF.%26aulast%3DEmery%26aufirst%3DP.%2BC.%26atitle%3DMajor%2520depression%2520and%2520insomnia%2520in%2520chronic%2520pain%26jtitle%3DClin.%2520J.%2520Pain%26date%3D2002%26volume%3D18%26spage%3D77%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Morin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, J.</span><span> </span><span class="NLM_article-title">Self-reported sleep and mood disturbance in chronic pain patients</span> <span class="citation_source-journal">Clin. J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1097%2F00002508-199812000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=9874009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADyaK1M%252FovFCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1998&pages=311-314&author=C.+M.+Morinauthor=D.+Gibsonauthor=J.+Wade&title=Self-reported+sleep+and+mood+disturbance+in+chronic+pain+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Self-reported sleep and mood disturbance in chronic pain patients</span></div><div class="casAuthors">Morin C M; Gibson D; Wade J</div><div class="citationInfo"><span class="NLM_cas:title">The Clinical journal of pain</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-4</span>
        ISSN:<span class="NLM_cas:issn">0749-8047</span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the prevalence of self-reported sleep disturbance and its relationship to mood disturbance in chronic pain patients.  DESIGN AND SETTING:  Survey of patients referred to a multidisciplinary outpatient pain clinic.  PATIENTS:  The sample consisted of 105 consecutive patients (59 men and 46 women), with an average age of 41.5 (SD +/-13.4) years.  MEASURES:  Self-report measures of sleep disturbance and visual analog scales of mood disturbance (anxiety and depression) and pain experience (intensity and unpleasantness).  RESULTS:  Patients were grouped according to whether they considered themselves "poor" (n = 68) or "good" (n = 37) sleepers.  Poor sleepers reported more difficulties initiating and maintaining sleep and greater pain intensity and pain unpleasantness than did good sleepers.  The two groups did not differ on measures of depressive or anxious mood.  CONCLUSION:  The results suggest that sleep disturbance is a prevalent complaint in chronic pain patients, but it is not always associated with an underlying mood disturbance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTul9RQ18hrcj0SWnHPWbmmfW6udTcc2eZ9bFt-ggq_k7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252FovFCjtw%253D%253D&md5=ad5ca8e28454004a077a2df8a021ca1a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1097%2F00002508-199812000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002508-199812000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DMorin%26aufirst%3DC.%2BM.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DWade%26aufirst%3DJ.%26atitle%3DSelf-reported%2520sleep%2520and%2520mood%2520disturbance%2520in%2520chronic%2520pain%2520patients%26jtitle%3DClin.%2520J.%2520Pain%26date%3D1998%26volume%3D14%26spage%3D311%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Menefee, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doghramji, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picarello, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Schwartz, L.</span><span> </span><span class="NLM_article-title">Self-reported sleep quality and quality of life for individuals with chronic pain conditions</span> <span class="citation_source-journal">Clin. J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1097%2F00002508-200012000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=11153783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADC%252BD3M7jvVKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2000&pages=290-297&author=L.+A.+Menefeeauthor=E.+D.+Frankauthor=K.+Doghramjiauthor=K.+Picarelloauthor=J.+J.+Parkauthor=S.+Jalaliauthor=L.+Perez-Schwartz&title=Self-reported+sleep+quality+and+quality+of+life+for+individuals+with+chronic+pain+conditions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Self-reported sleep quality and quality of life for individuals with chronic pain conditions</span></div><div class="casAuthors">Menefee L A; Frank E D; Doghramji K; Picarello K; Park J J; Jalali S; Perez-Schwartz L</div><div class="citationInfo"><span class="NLM_cas:title">The Clinical journal of pain</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">290-7</span>
        ISSN:<span class="NLM_cas:issn">0749-8047</span>.
    </div><div class="casAbstract">OBJECTIVE:  To determine the sleep quality and quality of life for individuals with degenerative spinal disease or failed back surgery syndrome.  DESIGN:  Cross-sectional survey design utilizing standardized instruments.  Data were analyzed with use of hierarchical stepwise multiple regression analyses.  PATIENTS:  One hundred sixty-seven individuals with degenerative spinal disease or postlaminectomy syndrome who presented to a tertiary care outpatient patient pain center.  OUTCOME MEASURES:  The Center for Epidemiological Studies Depression Index measured depressive symptomatology.  A modified Pittsburgh Sleep Quality Index (PSQI) measured sleep quality.  The arithmetic average of least and usual VAS ratings of pain measured everyday pain.  A visual analog scale rating of highest pain during the past 2 weeks measured highest pain.  The Epworth Sleepiness Scale measured daytime sleepiness.  The Medical Outcome Study-Short Form-Health Survey (SF-36) measured the mental health and general health components of quality of life.  RESULTS:  Higher overall sleep quality and lower sleep latency primarily were related to higher ratings of physical functioning and shorter duration of pain.  Ratings of the highest pain, but not everyday pain, were independent predictors of overall sleep quality and sleep latency.  Daytime sleepiness was associated with younger age and depressed mood.  Pain was not associated independently with daytime sleepiness.  The quality of life related to mental functioning was associated positively with depressed mood and with the interaction of pain and depressed mood.  None of the variables in the model (i.e., pain intensity, sleep quality, depression, and demographic variables) predicted quality of life related to overall general health.  CONCLUSIONS:  These data suggest that physical functioning, duration of pain, and age may be more important than pain intensity and depressed mood in contributing to decreased overall sleep quality and sleep latency.  The contribution of physical functioning was particularly strong and should be included in subsequent studies of sleep, pain, and mood.  The SF-36 should be compared to pain-specific quality-of-life measures to further evaluate the usefulness of this instrument with outpatients with chronic nonmalignant pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5pi1zkEdpnVw2ofyr07jXfW6udTcc2eZ9bFt-ggq_k7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7jvVKhuw%253D%253D&md5=7dc0ba7c02b2e4bb3686e3757c57dfa7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2F00002508-200012000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002508-200012000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DMenefee%26aufirst%3DL.%2BA.%26aulast%3DFrank%26aufirst%3DE.%2BD.%26aulast%3DDoghramji%26aufirst%3DK.%26aulast%3DPicarello%26aufirst%3DK.%26aulast%3DPark%26aufirst%3DJ.%2BJ.%26aulast%3DJalali%26aufirst%3DS.%26aulast%3DPerez-Schwartz%26aufirst%3DL.%26atitle%3DSelf-reported%2520sleep%2520quality%2520and%2520quality%2520of%2520life%2520for%2520individuals%2520with%2520chronic%2520pain%2520conditions%26jtitle%3DClin.%2520J.%2520Pain%26date%3D2000%26volume%3D16%26spage%3D290%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Stahl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briley, M.</span><span> </span><span class="NLM_article-title">Understanding pain in depression</span> <span class="citation_source-journal">Hum. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S9</span><span class="NLM_x">–</span> <span class="NLM_lpage">S13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=S9-S13&issue=Suppl.+1&author=S.+Stahlauthor=M.+Briley&title=Understanding+pain+in+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStahl%26aufirst%3DS.%26aulast%3DBriley%26aufirst%3DM.%26atitle%3DUnderstanding%2520pain%2520in%2520depression%26jtitle%3DHum.%2520Psychopharmacol.%26date%3D2004%26volume%3D19%26issue%3DSuppl.%25201%26spage%3DS9%26epage%3DS13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Linton, S. J.</span><span> </span><span class="NLM_article-title">A review of psychological risk factors in back and neck pain</span> <span class="citation_source-journal">Spine (Philadelphia)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1148</span><span class="NLM_x">–</span> <span class="NLM_lpage">1156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1097%2F00007632-200005010-00017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=10788861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADC%252BD3c3ltFansw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=1148-1156&author=S.+J.+Linton&title=A+review+of+psychological+risk+factors+in+back+and+neck+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A review of psychological risk factors in back and neck pain</span></div><div class="casAuthors">Linton S J</div><div class="citationInfo"><span class="NLM_cas:title">Spine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1148-56</span>
        ISSN:<span class="NLM_cas:issn">0362-2436</span>.
    </div><div class="casAbstract">STUDY DESIGN:  The literature on psychological factors in neck and back pain was systematically searched and reviewed.  OBJECTIVES:  To summarize current knowledge concerning the role of psychological variables in the etiology and development of neck and back pain.  SUMMARY OF BACKGROUND DATA:  Recent conceptions of spinal pain, especially chronic back pain, have highlighted the role of psychological factors.  Numerous studies subsequently have examined the effects of various psychological factors in neck and back pain.  There is a need to review this material to ascertain what conclusions may be drawn.  METHODS:  Medical and psychological databases and cross-referencing were used to locate 913 potentially relevant articles.  A table of 37 studies was constructed, consisting only of studies with prospective designs to ensure quality.  Each study was reviewed for the population studied, the psychological predictor variables, and the outcome.  RESULTS:  The available literature indicated a clear link between psychological variables and neck and back pain.  The prospective studies indicated that psychological variables were related to the onset of pain, and to acute, subacute, and chronic pain.  Stress, distress, or anxiety as well as mood and emotions, cognitive functioning, and pain behavior all were found to be significant factors.  Personality factors produced mixed results.  Although the level of evidence was low, abuse also was found to be a potentially significant factor.  CONCLUSIONS:  Psychological factors play a significant role not only in chronic pain, but also in the etiology of acute pain, particularly in the transition to chronic problems.  Specific types of psychological variables emerge and may be important in distinct developmental time frames, also implying that assessment and intervention need to reflect these variables.  Still, psychological factors account for only a portion of the variance, thereby highlighting the multidimensional view.  Because the methodologic quality of the studies varied considerably, future research should focus on improving quality and addressing new questions such as the mechanism, the developmental time factor, and the relevance that these risk factors have for intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJFerIqvxa370AGQpJZWpJfW6udTcc2eZ9bFt-ggq_k7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3ltFansw%253D%253D&md5=95777065afec0e30d1737f6c9bf4076f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1097%2F00007632-200005010-00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007632-200005010-00017%26sid%3Dliteratum%253Aachs%26aulast%3DLinton%26aufirst%3DS.%2BJ.%26atitle%3DA%2520review%2520of%2520psychological%2520risk%2520factors%2520in%2520back%2520and%2520neck%2520pain%26jtitle%3DSpine%2520%2528Philadelphia%2529%26date%3D2000%26volume%3D25%26spage%3D1148%26epage%3D1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Fishbain, D. A.</span><span> </span><span class="NLM_article-title">The association of chronic pain and suicide</span> <span class="citation_source-journal">Semin. Clin. Neuropsychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=10498789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADyaK1Mvjt1Cgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=221-227&author=D.+A.+Fishbain&title=The+association+of+chronic+pain+and+suicide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The association of chronic pain and suicide</span></div><div class="casAuthors">Fishbain D A</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in clinical neuropsychiatry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-7</span>
        ISSN:<span class="NLM_cas:issn">1084-3612</span>.
    </div><div class="casAbstract">Chronic pain patients (CPPs) are at greater risk for depression than the general population.  As such, one would expect suicidal ideation, suicide attempts, and suicide completions to be commonly found within chronic pain (CP) populations.  To explore these issues, 18 studies relating to the association of CP and suicide were subjected to a structured review.  These studies indicated that suicide ideation, suicide attempts, and suicide completions are commonly found in CPP populations.  In addition, a number of controlled studies and suicide completion rate studies indicated that CP may be a suicide risk factor.  Finally, a review of known suicide risk factors from other populations indicated that CP populations commonly exhibit other suicide risk factors.  Psychiatric examiners should consider CP to be a potential suicide risk factor.  In addition, in all CPPs exhibiting suicidal behavior, a careful search for associated comorbid suicide risk factors should be initiated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfx2FlAHQi55ggzHGM8X5CfW6udTcc2eaQQmxBBiVre7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1Mvjt1Cgsg%253D%253D&md5=1012d3f6872f4a396211712a8484c9ad</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFishbain%26aufirst%3DD.%2BA.%26atitle%3DThe%2520association%2520of%2520chronic%2520pain%2520and%2520suicide%26jtitle%3DSemin.%2520Clin.%2520Neuropsychiatry%26date%3D1999%26volume%3D4%26spage%3D221%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Tang, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, C.</span><span> </span><span class="NLM_article-title">Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links</span> <span class="citation_source-journal">Psychol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1017%2FS0033291705006859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=16420727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADC%252BD283gtlantg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=575-586&author=N.+K.+Tangauthor=C.+Crane&title=Suicidality+in+chronic+pain%3A+a+review+of+the+prevalence%2C+risk+factors+and+psychological+links"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links</span></div><div class="casAuthors">Tang Nicole K Y; Crane Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Psychological medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">575-86</span>
        ISSN:<span class="NLM_cas:issn">0033-2917</span>.
    </div><div class="casAbstract">BACKGROUND:  This paper reviews and integrates the growing literature concerning the prevalence of and risk factors for suicidality in chronic pain.  METHOD:  A series of systematic searches in MEDLINE and PsychINFO identified 12 relevant articles examining suicide, suicide attempts, and suicidal ideation in chronic pain.  A selection of theoretical and empirical work identifying psychological processes that have been implicated in both the pain and suicide literature and which may be related to increased suicidality was also reviewed.  RESULTS:  Relative to controls, risk of death by suicide appeared to be at least doubled in chronic pain patients.  The lifetime prevalence of suicide attempts was between 5% and 14% in individuals with chronic pain, with the prevalence of suicidal ideation being approximately 20%.  Eight risk factors for suicidality in chronic pain were identified, including the type, intensity and duration of pain and sleep-onset insomnia co-occurring with pain, which appeared to be pain-specific.  Helplessness and hopelessness about pain, the desire for escape from pain, pain catastrophizing and avoidance, and problem-solving deficits were highlighted as psychological processes relevant to the understanding of suicidality in chronic pain.  CONCLUSIONS:  Programmatic research is urgently required to investigate the role of both general and pain-specific risk factors for suicidality, to examine how the psychological processes mentioned above mediate or exacerbate suicidality, and to develop enhanced interventions for pain patients at risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJ66IkVJUyeDToTC3aBaesfW6udTcc2eaQQmxBBiVre7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283gtlantg%253D%253D&md5=8068a07781b5368d4969209643da13be</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1017%2FS0033291705006859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0033291705006859%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DN.%2BK.%26aulast%3DCrane%26aufirst%3DC.%26atitle%3DSuicidality%2520in%2520chronic%2520pain%253A%2520a%2520review%2520of%2520the%2520prevalence%252C%2520risk%2520factors%2520and%2520psychological%2520links%26jtitle%3DPsychol.%2520Med.%26date%3D2006%26volume%3D36%26spage%3D575%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Cyclooxygenase enzymes: catalysis and inhibition</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1016%2FS0959-440X%2801%2900277-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=11751058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1aqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=752-760&author=R.+G.+Kurumbailauthor=J.+R.+Kieferauthor=L.+J.+Marnett&title=Cyclooxygenase+enzymes%3A+catalysis+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclooxygenase enzymes: catalysis and inhibition</span></div><div class="casAuthors">Kurumbail, Ravi G.; Kiefer, James R.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">752-760</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review and discussion with 54 refs.  Scientists working in the field of cyclooxygenases have witnessed several major advances in the past 2 yr.  Crystal structures of fatty acid substrate and prostaglandin product complexes have been elucidated.  Elegant site-directed mutagenesis studies have pinpointed the roles of key amino acids within the active site.  Together, these results have provided key insights into the overall reaction mechanism.  Detailed kinetic, spectroscopic, and crystallog. studies have shed new light on the complex mechanism of inhibition of these fascinating enzymes.  Finally, novel substrates of cyclooxygenase-2 have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4ySdndSyBLVg90H21EOLACvtfcHk0lgv1UGKIq7adA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1aqsLs%253D&md5=5224cfc047b710642e6a1c1de5c5affe</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0959-440X%2801%2900277-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-440X%252801%252900277-9%26sid%3Dliteratum%253Aachs%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DCyclooxygenase%2520enzymes%253A%2520catalysis%2520and%2520inhibition%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D11%26spage%3D752%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Structural and functional basis of cyclooxygenase inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1425</span><span class="NLM_x">–</span> <span class="NLM_lpage">1441</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0613166" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFeisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1425-1441&author=A.+L.+Blobaumauthor=L.+J.+Marnett&title=Structural+and+functional+basis+of+cyclooxygenase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Functional Basis of Cyclooxygenase Inhibition</span></div><div class="casAuthors">Blobaum, Anna L.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1425-1441</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review will focus on the structural and functional basis of the inhibition of cyclooxygenase (COX) enzymes by nonselective and COX-2 selective inhibitors.  It will integrate kinetic, mechanistic, and structural information to illustrate not only the range of mols. with COX inhibitory activity but also the diversity of mechanisms by which they act.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8SMg_SRasDLVg90H21EOLACvtfcHk0lgv1UGKIq7adA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFeisL8%253D&md5=b9de2eafa7d2b510c866245b09fba546</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm0613166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0613166%26sid%3Dliteratum%253Aachs%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DStructural%2520and%2520functional%2520basis%2520of%2520cyclooxygenase%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1425%26epage%3D1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Rouzer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Cyclooxygenases: structural and functional insights</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S29</span><span class="NLM_x">–</span> <span class="NLM_lpage">S34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=S29-S34&issue=Suppl.&author=C.+A.+Rouzerauthor=L.+J.+Marnett&title=Cyclooxygenases%3A+structural+and+functional+insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRouzer%26aufirst%3DC.%2BA.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DCyclooxygenases%253A%2520structural%2520and%2520functional%2520insights%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2009%26volume%3D50%26issue%3DSuppl%26spage%3DS29%26epage%3DS34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">The COXIB experience: a look in the rearview mirror</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1146%2Fannurev.pharmtox.011008.145638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=18851701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisV2jsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=265-290&author=L.+J.+Marnett&title=The+COXIB+experience%3A+a+look+in+the+rearview+mirror"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The COXIB experience: a look in the rearview mirror</span></div><div class="casAuthors">Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-290</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used prescription and nonprescription drugs in the world.  The discovery of cyclooxygenase (COX) as the target of NSAIDs, the subsequent identification of two isoforms of COX (COX-1 and COX-2), and studies of their regulation and sites of expression led to the hypothesis that COX-2 is the mol. target for the anti-inflammatory and analgesic effects of NSAIDs.  A corollary was that COX-2-selective inhibitors (COXIBs) would retain the desirable effects of NSAIDs without some of their liabilities (e.g., gastrointestinal toxicity, which was ascribed to COX-1 inhibition).  The first marketed COXIBs exhibited reduced gastrointestinal side effects relative to traditional NSAIDs and were enormous com. successes.  However, clin. trials testing the hypothesis that COXIBs prevent recurrence of premalignant colon polyps uncovered adverse cardiovascular effects that are mechanism based.  This review provides an overview of the discovery, development, and difficulties of the COXIBs, a perspective on what has been learned, and speculation on the way forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJBE0T9Iu_7Vg90H21EOLACvtfcHk0lgGxLSCwIqa8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisV2jsb4%253D&md5=5147f02bf6314c86f1f707609a9d2fa5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.011008.145638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.011008.145638%26sid%3Dliteratum%253Aachs%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520COXIB%2520experience%253A%2520a%2520look%2520in%2520the%2520rearview%2520mirror%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2009%26volume%3D49%26spage%3D265%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Naesdal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K.</span><span> </span><span class="NLM_article-title">NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options</span> <span class="citation_source-journal">Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.2165%2F00002018-200629020-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=16454539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtlWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=119-132&author=J.+Naesdalauthor=K.+Brown&title=NSAID-associated+adverse+effects+and+acid+control+aids+to+prevent+them%3A+a+review+of+current+treatment+options"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options</span></div><div class="casAuthors">Naesdal, Joergen; Brown, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-132</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  NSAIDs are central to the clin. management of a wide range of conditions.  However, NSAIDs in combination with gastric acid, which has been shown to play a central role in upper gastrointestinal (GI) events, can damage the gastroduodenal mucosa and result in dyspeptic symptoms and peptic lesions such as ulceration.  NSAID-assocd. GI mucosal injury is an important clin. problem.  Gastroduodenal ulcers or ulcer complications occur in up to 25% of patients receiving NSAIDs.  However, these toxicities are often not preceded by indicative symptoms.  Data obtained from the Arthritis, Rheumatism, and Aging Medical Information System have shown that 50-60% of NSAID-assocd. peptic ulcer cases can remain clin. silent and do not present until complications occur.  Therefore, prophylactic treatment to prevent GI complications may be necessary in a substantial proportion of NSAID users, esp. those in groups assocd. with a high risk of developing these complications.  Use of cyclooxygenase (COX)-2 selective NSAIDs, also known as 'coxibs', substantially reduces the incidence of upper GI toxicities seen with non-selective NSAIDs.  However, there are concerns regarding the cardiovascular safety of coxibs.  For this reason, the US FDA recommends minimal use of coxibs and only when strictly necessary.  Addnl., rofecoxib has been removed from the US market and sales of valdecoxib have been suspended.  Furthermore, upper GI toxicities still occur in patients receiving coxibs.  Therefore, cotherapies are required to prevent and/or heal upper GI effects assocd. with NSAID use.  Effective prophylactic and treatment strategies include misoprostol, histamine H2 receptor antagonists and proton pump inhibitors (PPIs).  The key role that gastric acid plays in upper GI adverse events among NSAID users suggests that it is important to choose the most effective agent for acid control to alleviate symptoms, heal mucosal erosions and improve the reduced quality of life in this patient population.  PPIs provide effective acid suppression, which is essential to avoid GI mucosal injury, and they are, therefore, capable of dramatically decreasing the morbidity and mortality assocd. with this disorder.  Since many serious GI complications are not heralded by any previous symptoms, physicians need to be aware of risk factor profiles that predispose patients to serious GI problems.  Physicians also need to initiate the appropriate preventative acid suppressive therapy to minimize the burden of NSAID-assocd. GI adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLBdsUZ85VTbVg90H21EOLACvtfcHk0lgGxLSCwIqa8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtlWrsLc%253D&md5=d2c625dceeb0ce084a129a554dc77e7c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2165%2F00002018-200629020-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-200629020-00002%26sid%3Dliteratum%253Aachs%26aulast%3DNaesdal%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DK.%26atitle%3DNSAID-associated%2520adverse%2520effects%2520and%2520acid%2520control%2520aids%2520to%2520prevent%2520them%253A%2520a%2520review%2520of%2520current%2520treatment%2520options%26jtitle%3DDrug%2520Saf.%26date%3D2006%26volume%3D29%26spage%3D119%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Topol, E. J.</span><span> </span><span class="NLM_article-title">Failing the public health—rofecoxib, Merck, and the FDA</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">1707</span><span class="NLM_x">–</span> <span class="NLM_lpage">1709</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1056%2FNEJMp048286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=15470193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovFSks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=1707-1709&author=E.+J.+Topol&title=Failing+the+public+health%E2%80%94rofecoxib%2C+Merck%2C+and+the+FDA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Failing the public health - Rofecoxib, Merck, and the FDA</span></div><div class="casAuthors">Topol, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1707-1709</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvqA9LswLQxrVg90H21EOLACvtfcHk0lgGxLSCwIqa8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovFSks7g%253D&md5=2e9bc3805e6c50dcce0eaf737d6309c5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1056%2FNEJMp048286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp048286%26sid%3Dliteratum%253Aachs%26aulast%3DTopol%26aufirst%3DE.%2BJ.%26atitle%3DFailing%2520the%2520public%2520health%25E2%2580%2594rofecoxib%252C%2520Merck%252C%2520and%2520the%2520FDA%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26spage%3D1707%26epage%3D1709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brideau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charleson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Hutchinson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gresser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodger, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thérien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupniak, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visco, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D.</span><span> </span><span class="NLM_article-title">The discovery of rofecoxib, [MK 966, Vioxx, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1773</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1773-1778&author=P.+Prasitauthor=Z.+Wangauthor=C.+Brideauauthor=C.-C.+Chanauthor=S.+Charlesonauthor=W.+Cromlishauthor=D.+Ethierauthor=J.+F.+Evansauthor=A.+W.+Ford-Hutchinsonauthor=J.+Y.+Gauthierauthor=R.+Gordonauthor=J.+Guayauthor=M.+Gresserauthor=S.+Kargmanauthor=B.+Kennedyauthor=Y.+Leblancauthor=S.+L%C3%A9gerauthor=J.+Manciniauthor=G.+P.+O%E2%80%99Neillauthor=M.+Ouelletauthor=M.+D.+Percivalauthor=H.+Perrierauthor=D.+Riendeauauthor=I.+Rodgerauthor=P.+Tagariauthor=M.+Th%C3%A9rienauthor=P.+Vickersauthor=E.+Wongauthor=L.-J.+Xuauthor=R.+N.+Youngauthor=R.+Zamboniauthor=S.+Boyceauthor=N.+Rupniakauthor=M.+Forrestauthor=D.+Viscoauthor=D.+Patrick&title=The+discovery+of+rofecoxib%2C+%5BMK+966%2C+Vioxx%2C+4-%284%E2%80%B2-methylsulfonylphenyl%29-3-phenyl-2%285H%29-furanone%5D%2C+an+orally+active+cyclooxygenase-2-inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBrideau%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DC.-C.%26aulast%3DCharleson%26aufirst%3DS.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DEthier%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DGuay%26aufirst%3DJ.%26aulast%3DGresser%26aufirst%3DM.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DL%25C3%25A9ger%26aufirst%3DS.%26aulast%3DMancini%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DG.%2BP.%26aulast%3DOuellet%26aufirst%3DM.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DPerrier%26aufirst%3DH.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRodger%26aufirst%3DI.%26aulast%3DTagari%26aufirst%3DP.%26aulast%3DTh%25C3%25A9rien%26aufirst%3DM.%26aulast%3DVickers%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DE.%26aulast%3DXu%26aufirst%3DL.-J.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DRupniak%26aufirst%3DN.%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DVisco%26aufirst%3DD.%26aulast%3DPatrick%26aufirst%3DD.%26atitle%3DThe%2520discovery%2520of%2520rofecoxib%252C%2520%255BMK%2520966%252C%2520Vioxx%252C%25204-%25284%25E2%2580%25B2-methylsulfonylphenyl%2529-3-phenyl-2%25285H%2529-furanone%255D%252C%2520an%2520orally%2520active%2520cyclooxygenase-2-inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D1773%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">The endocannabinoid system: a drug discovery perspective</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs (BioMed Cent.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=16044662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2MXms1ejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=672-679&author=D.+Piomelli&title=The+endocannabinoid+system%3A+a+drug+discovery+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid system: A drug discovery perspective</span></div><div class="casAuthors">Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">672-679</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The endocannabinoids are lipid messengers that engage the same cell surface receptors targeted by Δ9-tetrahydrocannabinol, the active component of marijuana.  They are produced by cells in the brain and other tissues and combine with two subtypes of G protein-coupled cannabinoid receptors, CB1 and CB2.  Their ability to modulate a variety of pathophysiol. processes, including appetite, pain and mood, provides unique opportunities for drug discovery.  Three such opportunities are discussed here: redn. of body wt. through blockade of CB1 receptors, alleviation of pain through activation of extracerebral cannabinoid receptors, and modulation of pain and anxiety through inhibition of endocannabinoid degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonb_fUBDB5xLVg90H21EOLACvtfcHk0ljRLT2YX9qKKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXms1ejsL8%253D&md5=dc723ac3c3739a94b7f9858c8affac94</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520endocannabinoid%2520system%253A%2520a%2520drug%2520discovery%2520perspective%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%2520%2528BioMed%2520Cent.%2529%26date%3D2005%26volume%3D6%26spage%3D672%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Gaetani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dipasquale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Righetti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuomo, V.</span><span> </span><span class="NLM_article-title">The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs</span> <span class="citation_source-journal">Int. Rev. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1016%2FS0074-7742%2809%2985005-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=19607961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Wis7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2009&pages=57-72&author=S.+Gaetaniauthor=P.+Dipasqualeauthor=A.+Romanoauthor=L.+Righettiauthor=T.+Cassanoauthor=D.+Piomelliauthor=V.+Cuomo&title=The+endocannabinoid+system+as+a+target+for+novel+anxiolytic+and+antidepressant+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs</span></div><div class="casAuthors">Gaetani, Silvana; Dipasquale, Pasqua; Romano, Adele; Righetti, Laura; Cassano, Tommaso; Piomelli, Daniele; Cuomo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">Advances in Neuropharmacology</span>),
    <span class="NLM_cas:pages">57-72</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Observational studies in humans suggest that exposure to marijuana and other cannabis-derived drugs produces a wide range of subjective effects on mood tone and emotionality.  These observations have their counterpart in animal studies, showing that cannabinoid agonists strongly affect emotional reactivity in directions that vary depending on dose and context.  Based on these evidence, the activation of central CB1 receptor has emerged as potential target for the development of antianxiety and antidepressant therapies.  However, the variable effects of exogenous cannabinoid agonists have gradually shifted the interest to the alternative approach of amplifying the effects of endogenous cannabinoids (EC), namely anandamide (AEA) and 2-arachidonoylglycerol (2-AG), by preventing their deactivation.  The enzyme fatty acid amide hydrolase (FAAH) has been the target of intense research efforts aimed at developing potent and selective inhibitors that might prolong AEA actions in vivo.  Among the inhibitors developed, the compd. URB597 was found to potently inhibit FAAH activity in vivo and cause brain AEA levels to increase.  Interestingly, the enhanced AEA tone produced by URB597 does not result in the behavioral effects typical of a direct-acting cannabinoid agonist.  Though URB597 does not elicit a full-fledged cannabinoid profile of behavioral responses, it does elicit marked anxiolytic-like and antidepressant-like effects in rats and mice.  Such effects involve the downstream activation of CB1 receptors, since they are attenuated by the CB1 antagonist SR141716 (rimonabant).  Parallel to FAAH inhibition, similar results can also be obsd. by pharmacol. blocking the AEA transport system, which is responsible of the intracellular uptake of AEA from the synaptic cleft.  The reason why FAAH inhibition approach produces a smaller set of cannabimimetic effects might depend on the mechanism of EC synthesis and release upon neuronal activation and on the target selectivity of the drug.  The mechanism of EC release is commonly referred to as "on request", since they are not synthesized and stored in synaptic vesicles, such as classical neurotransmitters, but are synthesized from membrane precursors and immediately released in the synaptic cleft following neuronal activation.  The neural stimulation in specific brain areas, for example, those involved in the regulation of mood tone and/or emotional reactivity, would result in an increased EC tone in these same areas, but not necessarily in others.  Therefore, inhibition of AEA metab. activity could amplify CB1 activation mainly where AEA release is higher.  Furthermore, the inhibition of FAAH causes an accumulation of AEA but not 2-AG, which, being 200-fold more abundant than AEA in the brain, might differently modulate CB1-mediated behavioral responses.  The evidence outlined above supports the hypothesis that the EC system plays an important role in anxiety and mood disorders and suggests that modulation of FAAH activity might be a pharmacol. target for novel anxiolytic and antidepressant therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoikIKJ9JJfGLVg90H21EOLACvtfcHk0ljRLT2YX9qKKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Wis7rL&md5=159980712c246a32cd127e61a98df686</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2809%2985005-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252809%252985005-8%26sid%3Dliteratum%253Aachs%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DDipasquale%26aufirst%3DP.%26aulast%3DRomano%26aufirst%3DA.%26aulast%3DRighetti%26aufirst%3DL.%26aulast%3DCassano%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DCuomo%26aufirst%3DV.%26atitle%3DThe%2520endocannabinoid%2520system%2520as%2520a%2520target%2520for%2520novel%2520anxiolytic%2520and%2520antidepressant%2520drugs%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2009%26volume%3D85%26spage%3D57%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Gobbi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bambico, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangieri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campolongo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solinas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgese, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debonnel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trezza, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuomo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">18620</span><span class="NLM_x">–</span> <span class="NLM_lpage">18625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=18620-18625&author=G.+Gobbiauthor=F.+R.+Bambicoauthor=R.+Mangieriauthor=M.+Bortolatoauthor=P.+Campolongoauthor=M.+Solinasauthor=T.+Cassanoauthor=M.+G.+Morgeseauthor=G.+Debonnelauthor=A.+Durantiauthor=A.+Tontiniauthor=G.+Tarziaauthor=M.+Morauthor=V.+Trezzaauthor=S.+R.+Goldbergauthor=V.+Cuomoauthor=D.+Piomelli&title=Antidepressant-like+activity+and+modulation+of+brain+monoaminergic+transmission+by+blockade+of+anandamide+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGobbi%26aufirst%3DG.%26aulast%3DBambico%26aufirst%3DF.%2BR.%26aulast%3DMangieri%26aufirst%3DR.%26aulast%3DBortolato%26aufirst%3DM.%26aulast%3DCampolongo%26aufirst%3DP.%26aulast%3DSolinas%26aufirst%3DM.%26aulast%3DCassano%26aufirst%3DT.%26aulast%3DMorgese%26aufirst%3DM.%2BG.%26aulast%3DDebonnel%26aufirst%3DG.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTrezza%26aufirst%3DV.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DCuomo%26aufirst%3DV.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAntidepressant-like%2520activity%2520and%2520modulation%2520of%2520brain%2520monoaminergic%2520transmission%2520by%2520blockade%2520of%2520anandamide%2520hydrolysis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D18620%26epage%3D18625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciolino, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spradley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2Fnn.2632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=20852626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1265-1270&author=J.+R.+Clapperauthor=G.+Moreno-Sanzauthor=R.+Russoauthor=A.+Guijarroauthor=F.+Vacondioauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Sanchiniauthor=N.+R.+Sciolinoauthor=J.+M.+Spradleyauthor=A.+G.+Hohmannauthor=A.+Calignanoauthor=M.+Morauthor=G.+Tarziaauthor=D.+Piomelli&title=Anandamide+suppresses+pain+initiation+through+a+peripheral+endocannabinoid+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism</span></div><div class="casAuthors">Clapper, Jason R.; Moreno-Sanz, Guillermo; Russo, Roberto; Guijarro, Ana; Vacondio, Federica; Duranti, Andrea; Tontini, Andrea; Sanchini, Silvano; Sciolino, Natale R.; Spradley, Jessica M.; Hohmann, Andrea G.; Calignano, Antonio; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1265-1270</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Peripheral cannabinoid receptors exert a powerful inhibitory control over pain initiation, but the endocannabinoid signal that normally engages this intrinsic analgesic mechanism is unknown.  To address this question, we developed a peripherally restricted inhibitor (URB937) of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degrdn. of the endocannabinoid anandamide.  URB937 suppressed FAAH activity and increased anandamide levels outside the rodent CNS.  Despite its inability to access brain and spinal cord, URB937 attenuated behavioral responses indicative of persistent pain in rodent models of peripheral nerve injury and inflammation and prevented noxious stimulus-evoked neuronal activation in spinal cord regions implicated in nociceptive processing.  CB1 cannabinoid receptor blockade prevented these effects.  These results suggest that anandamide-mediated signaling at peripheral CB1 receptors controls the access of pain-related inputs to the CNS.  Brain-impenetrant FAAH inhibitors, which strengthen this gating mechanism, might offer a new approach to pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2AxNb5bVlE7Vg90H21EOLACvtfcHk0lipENLVKsC2jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73O&md5=f75c13a37e3524ab4130b2ebd67d6348</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnn.2632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2632%26sid%3Dliteratum%253Aachs%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DGuijarro%26aufirst%3DA.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DSciolino%26aufirst%3DN.%2BR.%26aulast%3DSpradley%26aufirst%3DJ.%2BM.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAnandamide%2520suppresses%2520pain%2520initiation%2520through%2520a%2520peripheral%2520endocannabinoid%2520mechanism%26jtitle%3DNat.%2520Neurosci.%26date%3D2010%26volume%3D13%26spage%3D1265%26epage%3D1270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kathuria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaetani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fegley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giustino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tattoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmery, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuomo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Modulation of anxiety through blockade of anandamide hydrolysis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2Fnm803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=12461523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivF2l" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=76-81&author=S.+Kathuriaauthor=S.+Gaetaniauthor=D.+Fegleyauthor=F.+Valinoauthor=A.+Durantiauthor=A.+Tontiniauthor=M.+Morauthor=G.+Tarziaauthor=G.+La+Ranaauthor=A.+Calignanoauthor=A.+Giustinoauthor=M.+Tattoliauthor=M.+Palmeryauthor=V.+Cuomoauthor=D.+Piomelli&title=Modulation+of+anxiety+through+blockade+of+anandamide+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of anxiety through blockade of anandamide hydrolysis</span></div><div class="casAuthors">Kathuria, Satish; Gaetani, Silvana; Fegley, Darren; Valino, Fernando; Duranti, Andrea; Tontini, Andrea; Mor, Marco; Tarzia, Giorgio; La Rana, Giovanna; Calignano, Antonio; Giustino, Arcangela; Tattoli, Maria; Palmery, Maura; Cuomo, Vincenzo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-81</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The psychoactive constituent of cannabis, Δ9-tetrahydrocannabinol, produces in humans subjective responses mediated by CB1 cannabinoid receptors, indicating that endogenous cannabinoids may contribute to the control of emotion.  But the variable effects of Δ9-tetrahydrocannabinol obscure the interpretation of these results and limit the therapeutic potential of direct cannabinoid agonists.  An alternative approach may be to develop drugs that amplify the effects of endogenous cannabinoids by preventing their inactivation.  Here, the authors describe a class of potent, selective, and systemically active inhibitors of fatty acid amide hydrolase, the enzyme responsible for the degrdn. of the endogenous cannabinoid anandamide.  Like clin. used anti-anxiety drugs, in rats the inhibitors exhibit benzodiazepine-like properties in the elevated zero-maze test and suppress isolation-induced vocalizations.  These effects are accompanied by augmented brain levels of anandamide and are prevented by CB1 receptor blockade.  Apparently, anandamide participates in the modulation of emotional states and fatty acid amide hydrolase inhibition is an innovative approach to anti-anxiety therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbjKypjqxPcrVg90H21EOLACvtfcHk0lipENLVKsC2jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivF2l&md5=350c8a5af97b6ea4e41e9f0c821231e4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnm803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm803%26sid%3Dliteratum%253Aachs%26aulast%3DKathuria%26aufirst%3DS.%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DFegley%26aufirst%3DD.%26aulast%3DValino%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DGiustino%26aufirst%3DA.%26aulast%3DTattoli%26aufirst%3DM.%26aulast%3DPalmery%26aufirst%3DM.%26aulast%3DCuomo%26aufirst%3DV.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DModulation%2520of%2520anxiety%2520through%2520blockade%2520of%2520anandamide%2520hydrolysis%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D76%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Devane, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelbaum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span> </span><span class="NLM_article-title">Isolation and structure of a brain constituent that binds to the cannabinoid receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">1946</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1126%2Fscience.1470919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=1470919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADyaK3sXpvVKntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1946-1949&author=W.+A.+Devaneauthor=L.+Hanusauthor=A.+Breuerauthor=R.+G.+Pertweeauthor=L.+A.+Stevensonauthor=G.+Griffinauthor=D.+Gibsonauthor=A.+Mandelbaumauthor=A.+Etingerauthor=R.+Mechoulam&title=Isolation+and+structure+of+a+brain+constituent+that+binds+to+the+cannabinoid+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of a brain constituent that binds to the cannabinoid receptor</span></div><div class="casAuthors">Devane, William A.; Hanus, Lumir; Breuer, Aviva; Pertwee, Roger G.; Stevenson, Lesley A.; Griffin, Graeme; Gibson, Dan; Mandelbaum, Asher; Etinger, Alexander; Mechoulam, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5090</span>),
    <span class="NLM_cas:pages">1946-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Arachidonylethanolamide, an arachidonic acid deriv. in the porcine brain, was identified as an endogenous ligand for the cannabinoid receptor.  The structure of this compd., anandamide, was detd. by mass spectrometry and NMR spectroscopy and was confirmed by synthesis.  Anandamide inhibited the specific binding of a radiolabeled cannabinoid probe to synaptosomal membranes in a manner typical of competitive ligands and produced a concn.-dependent inhibition of the elec. evoked twitch responses of the mouse vas deferens, a characteristic effect of psychotropic cannabinoids.  Anandamide may function as a natural ligand for the cannabinoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXqh5E4vHczbVg90H21EOLACvtfcHk0li0i8i3K6hPXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXpvVKntg%253D%253D&md5=13c7aa7316cd687240779f7f192d086b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1126%2Fscience.1470919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1470919%26sid%3Dliteratum%253Aachs%26aulast%3DDevane%26aufirst%3DW.%2BA.%26aulast%3DHanus%26aufirst%3DL.%26aulast%3DBreuer%26aufirst%3DA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DMandelbaum%26aufirst%3DA.%26aulast%3DEtinger%26aufirst%3DA.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DIsolation%2520and%2520structure%2520of%2520a%2520brain%2520constituent%2520that%2520binds%2520to%2520the%2520cannabinoid%2520receptor%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1946%26epage%3D1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">The molecular logic of endocannabinoid signalling</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2Fnrn1247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=14595399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosFOktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=873-884&author=D.+Piomelli&title=The+molecular+logic+of+endocannabinoid+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular logic of endocannabinoid signalling</span></div><div class="casAuthors">Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">873-884</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The endocannabinoids are a family of lipid messengers that engage the cell surface receptors that are targeted by Δ9-tetrahydrocannabinol, the active principle in marijuana (Cannabis).  They are made on demand through cleavage of membrane precursors and are involved in various short-range signaling processes.  In the brain, they combine with CB1 cannabinoid receptors on axon terminals to regulate ion channel activity and neurotransmitter release.  Their ability to modulate synaptic efficacy has a wide range of functional consequences and provides unique therapeutic possibilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUrtdaKTjDoLVg90H21EOLACvtfcHk0li0i8i3K6hPXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosFOktrY%253D&md5=d4af135f5309e6551bdb1f8ade45b565</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrn1247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1247%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520molecular%2520logic%2520of%2520endocannabinoid%2520signalling%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D4%26spage%3D873%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">A thickening network of lipids</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2012&pages=3-4&author=D.+Piomelli&title=A+thickening+network+of+lipids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520thickening%2520network%2520of%2520lipids%26jtitle%3DPain%26date%3D2012%26volume%3D153%26spage%3D3%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span> </span><span class="NLM_article-title">NSAIDs: eNdocannabinoid stimulating anti-inflammatory drugs?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">468</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=468-473&issue=9&author=C.+J.+Fowler&title=NSAIDs%3A+eNdocannabinoid+stimulating+anti-inflammatory+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DNSAIDs%253A%2520eNdocannabinoid%2520stimulating%2520anti-inflammatory%2520drugs%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26issue%3D9%26spage%3D468%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Fowler, C. J.; Bjorklund, E.; Lichtman, A. H.; Naidu, P. S.; Congiu, C.; Onnis, V.</span><span> </span><span class="NLM_article-title">Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide</span>. J. Enzyme Inhib. Med. Chem.<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>in press. </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=22225576" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+J.+Fowler&author=E.+Bjorklund&author=A.+H.+Lichtman&author=P.+S.+Naidu&author=C.+Congiu&author=V.+Onnis&title=Inhibitory+properties+of+ibuprofen+and+its+amide+analogues+towards+the+hydrolysis+and+cyclooxygenation+of+the+endocannabinoid+anandamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DInhibitory%2520properties%2520of%2520ibuprofen%2520and%2520its%2520amide%2520analogues%2520towards%2520the%2520hydrolysis%2520and%2520cyclooxygenation%2520of%2520the%2520endocannabinoid%2520anandamide%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7327</span><span class="NLM_x">–</span> <span class="NLM_lpage">7343</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800311k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7327-7343&author=M.+Seierstadauthor=J.+G.+Breitenbucher&title=Discovery+and+development+of+fatty+acid+amide+hydrolase+%28FAAH%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm800311k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800311k%26sid%3Dliteratum%253Aachs%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DDiscovery%2520and%2520development%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7327%26epage%3D7343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Otrubova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezzili, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4674</span><span class="NLM_x">–</span> <span class="NLM_lpage">4685</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4674-4685&author=K.+Otrubovaauthor=C.+Ezziliauthor=D.+L.+Boger&title=The+discovery+and+development+of+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtrubova%26aufirst%3DK.%26aulast%3DEzzili%26aufirst%3DC.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DThe%2520discovery%2520and%2520development%2520of%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4674%26epage%3D4685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Palermo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branduardi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vivo, M.</span><span> </span><span class="NLM_article-title">Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6612</span><span class="NLM_x">–</span> <span class="NLM_lpage">6623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2004283" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCgsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6612-6623&author=G.+Palermoauthor=D.+Branduardiauthor=M.+Masettiauthor=A.+Lodolaauthor=M.+Morauthor=D.+Piomelliauthor=A.+Cavalliauthor=M.+De+Vivo&title=Covalent+inhibitors+of+fatty+acid+amide+hydrolase%3A+a+rationale+for+the+activity+of+piperidine+and+piperazine+aryl+ureas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Inhibitors of Fatty Acid Amide Hydrolase: A Rationale for the Activity of Piperidine and Piperazine Aryl Ureas</span></div><div class="casAuthors">Palermo, Giulia; Branduardi, Davide; Masetti, Matteo; Lodola, Alessio; Mor, Marco; Piomelli, Daniele; Cavalli, Andrea; De Vivo, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6612-6623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, covalent drugs have attracted great interest in the drug discovery community, with successful examples that have demonstrated their therapeutic effects.  Here, we focus on the covalent inhibition of the fatty acid amide hydrolase (FAAH), which is a promising strategy in the treatment of pain and inflammation.  Among the most recent and potent FAAH inhibitors (FAAHi), there are the cyclic piperidine and piperazine aryl ureas.  FAAH hydrolyzes efficiently the amide bond of these compds., forming a covalent enzyme-inhibitor adduct.  To rationalize this exptl. evidence, we performed an extensive computational anal. centered on piperidine-based PF750 (1) and piperazine-based JNJ1661010 (2), two potent lead compds. used to generate covalent inhibitors as clin. candidates.  We found that FAAH induces a distortion of the amide bond of the piperidine and piperazine aryl ureas.  Quantum mechanics/mol. mechanics ΔELUMO-HOMO energies indicate that the obsd. enzyme-induced distortion of the amide bond favors the formation of a covalent FAAH-inhibitor adduct.  These findings could help in the rational structure-based design of novel covalent FAAHi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXM0Vnrifb87Vg90H21EOLACvtfcHk0lhJDqGeCSAanw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCgsb3O&md5=3130e9ef929a52cc0900ad77b38a7453</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm2004283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2004283%26sid%3Dliteratum%253Aachs%26aulast%3DPalermo%26aufirst%3DG.%26aulast%3DBranduardi%26aufirst%3DD.%26aulast%3DMasetti%26aufirst%3DM.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26atitle%3DCovalent%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520a%2520rationale%2520for%2520the%2520activity%2520of%2520piperidine%2520and%2520piperazine%2520aryl%2520ureas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6612%26epage%3D6623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyauchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardouin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fecik, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedrick, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acevedo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimaraes, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Discovery of a potent, selective, and efficacious class of reversible α-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1849</span><span class="NLM_x">–</span> <span class="NLM_lpage">1856</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049614v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1849-1856&author=D.+L.+Bogerauthor=H.+Miyauchiauthor=W.+Duauthor=C.+Hardouinauthor=R.+A.+Fecikauthor=H.+Chengauthor=I.+Hwangauthor=M.+P.+Hedrickauthor=D.+Leungauthor=O.+Acevedoauthor=C.+R.+Guimaraesauthor=W.+L.+Jorgensenauthor=B.+F.+Cravatt&title=Discovery+of+a+potent%2C+selective%2C+and+efficacious+class+of+reversible+%CE%B1-ketoheterocycle+inhibitors+of+fatty+acid+amide+hydrolase+effective+as+analgesics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm049614v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049614v%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DMiyauchi%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DFecik%26aufirst%3DR.%2BA.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DAcevedo%26aufirst%3DO.%26aulast%3DGuimaraes%26aufirst%3DC.%2BR.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520class%2520of%2520reversible%2520%25CE%25B1-ketoheterocycle%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520effective%2520as%2520analgesics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1849%26epage%3D1856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivo</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1505</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1505-1513&author=J.+R.+Clapperauthor=F.+Vacondioauthor=A.+R.+Kingauthor=A.+Durantiauthor=A.+Tontiniauthor=C.+Silvaauthor=S.+Sanchiniauthor=G.+Tarziaauthor=M.+Morauthor=D.+Piomelli&title=A+second+generation+of+carbamate-based+fatty+acid+amide+hydrolase+inhibitors+with+improved+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DKing%26aufirst%3DA.%2BR.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520second%2520generation%2520of%2520carbamate-based%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520with%2520improved%2520activity%2520in%2520vivo%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1505%26epage%3D1513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span> </span><span class="NLM_article-title">Structure-property relationships of a class of carbamate-based fatty acid amide hydrolase (FAAH) inhibitors: chemical and biological stability</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1495</span><span class="NLM_x">–</span> <span class="NLM_lpage">1504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1495-1504&author=F.+Vacondioauthor=C.+Silvaauthor=A.+Lodolaauthor=A.+Fioniauthor=S.+Rivaraauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Sanchiniauthor=J.+R.+Clapperauthor=D.+Piomelliauthor=M.+Morauthor=G.+Tarzia&title=Structure-property+relationships+of+a+class+of+carbamate-based+fatty+acid+amide+hydrolase+%28FAAH%29+inhibitors%3A+chemical+and+biological+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DFioni%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26atitle%3DStructure-property%2520relationships%2520of%2520a%2520class%2520of%2520carbamate-based%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520inhibitors%253A%2520chemical%2520and%2520biological%2520stability%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1495%26epage%3D1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazerwith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadagopan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattachar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span> </span><span class="NLM_article-title">Discovery of PF-04457845: a highly potent, orally bioavailable, and selective urea FAAH inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100190t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=91-96&author=D.+S.+Johnsonauthor=C.+Stiffauthor=S.+E.+Lazerwithauthor=S.+R.+Kestenauthor=L.+K.+Fayauthor=M.+Morrisauthor=D.+Beidlerauthor=M.+B.+Liimattaauthor=S.+E.+Smithauthor=D.+T.+Dudleyauthor=N.+Sadagopanauthor=S.+N.+Bhattacharauthor=S.+J.+Kestenauthor=T.+K.+Nomanbhoyauthor=B.+F.+Cravattauthor=K.+Ahn&title=Discovery+of+PF-04457845%3A+a+highly+potent%2C+orally+bioavailable%2C+and+selective+urea+FAAH+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor</span></div><div class="casAuthors">Johnson, Douglas S.; Stiff, Cory; Lazerwith, Scott E.; Kesten, Suzanne R.; Fay, Lorraine K.; Morris, Mark; Beidler, David; Liimatta, Marya B.; Smith, Sarah E.; Dudley, David T.; Sadagopan, Nalini; Bhattachar, Shobha N.; Kesten, Stephen J.; Nomanbhoy, Tyzoon K.; Cravatt, Benjamin F.; Ahn, Kay</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-96</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an integral membrane serine hydrolase that degrades the fatty acid amide family of signaling lipids, including the endocannabinoid anandamide.  Genetic or pharmacol. inactivation of FAAH leads to analgesic and anti-inflammatory phenotypes in rodents without showing the undesirable side effects obsd. with direct cannabinoid receptor agonists, indicating that FAAH may represent an attractive therapeutic target for the treatment of inflammatory pain and other nervous system disorders.  Herein, the discovery and characterization of a highly efficacious and selective FAAH inhibitor PF-04457845, N-(3-pyridazinyl)-4-(3-[5-trifluoromethyl-2-pyridinyloxy]benzylidene)piperidine-1-carboxamide (I), are reported.  This compd. inhibited FAAH by a covalent, irreversible mechanism involving carbamylation of the active-site serine nucleophile of FAAH with high in vitro potency (kinact/Ki and IC50 values of 40300 M-1 s-1 and 7.2 nM, resp., for human FAAH).  The compd. I had exquisite selectivity for FAAH relative to other members of the serine hydrolase superfamily as demonstrated by competitive activity-based protein profiling.  Oral administration of I at 0.1 mg/kg results in efficacy comparable to that of naproxen at 10 mg/kg in a rat model of inflammatory pain.  Compd. I is being evaluated in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoINP05KK-SNLVg90H21EOLACvtfcHk0ljBa3JqA3ok9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO&md5=c7ba2900e3abeda46f885d23bf1f76b8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fml100190t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100190t%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DLazerwith%26aufirst%3DS.%2BE.%26aulast%3DKesten%26aufirst%3DS.%2BR.%26aulast%3DFay%26aufirst%3DL.%2BK.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLiimatta%26aufirst%3DM.%2BB.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DBhattachar%26aufirst%3DS.%2BN.%26aulast%3DKesten%26aufirst%3DS.%2BJ.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520PF-04457845%253A%2520a%2520highly%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520urea%2520FAAH%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D91%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plazzi, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piersanti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kathuria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4998</span><span class="NLM_x">–</span> <span class="NLM_lpage">5008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031140x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4998-5008&author=M.+Morauthor=S.+Rivaraauthor=A.+Lodolaauthor=P.+V.+Plazziauthor=G.+Tarziaauthor=A.+Durantiauthor=A.+Tontiniauthor=G.+Piersantiauthor=S.+Kathuriaauthor=D.+Piomelli&title=Cyclohexylcarbamic+acid+3%E2%80%B2-+or+4%E2%80%B2-substituted+biphenyl-3-yl+esters+as+fatty+acid+amide+hydrolase+inhibitors%3A+synthesis%2C+quantitative+structure-activity+relationships%2C+and+molecular+modeling+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm031140x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031140x%26sid%3Dliteratum%253Aachs%26aulast%3DMor%26aufirst%3DM.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DPlazzi%26aufirst%3DP.%2BV.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DPiersanti%26aufirst%3DG.%26aulast%3DKathuria%26aufirst%3DS.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DCyclohexylcarbamic%2520acid%25203%25E2%2580%25B2-%2520or%25204%25E2%2580%25B2-substituted%2520biphenyl-3-yl%2520esters%2520as%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%253A%2520synthesis%252C%2520quantitative%2520structure-activity%2520relationships%252C%2520and%2520molecular%2520modeling%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4998%26epage%3D5008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Naidu, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span> </span><span class="NLM_article-title">Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1124%2Fjpet.108.143487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=19118134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVKntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=48-56&author=P.+S.+Naiduauthor=L.+Bookerauthor=B.+F.+Cravattauthor=A.+H.+Lichtman&title=Synergy+between+enzyme+inhibitors+of+fatty+acid+amide+hydrolase+and+cyclooxygenase+in+visceral+nociception"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception</span></div><div class="casAuthors">Naidu, Pattipati S.; Booker, Lamont; Cravatt, Benjamin F.; Lichtman, Aron H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-56</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present study investigated whether inhibition of fatty acid amide hydrolase (FAAH), the enzyme responsible for anandamide catabolism, produces antinociception in the acetic acid-induced abdominal stretching model of visceral nociception.  Genetic deletion or pharmacol. inhibition of FAAH reduced acetic acid-induced abdominal stretching.  Transgenic mice that express FAAH exclusively in the nervous system displayed the antinociceptive phenotype, indicating the involvement of peripheral fatty acid amides.  The cannabinoid receptor 1 (CB1) receptor antagonist, rimonabant, but not the cannabinoid receptor 2 (CB2) receptor antagonist, SR144528, blocked the antinociceptive phenotype of FAAH(-/-) mice and the analgesic effects of URB597 (3'-carbamoyl-biphenyl-3-yl-cyclohexylcarbamate) or OL-135 (1-oxo-1[5-(2-pyridyl)-2-yl]-7-Ph heptane), resp. irreversible and reversible FAAH inhibitors, administered to C57BL/6 mice.  The opioid receptor antagonist, naltrexone, did not block the analgesic effects of either FAAH inhibitor.  URB597, ED50 [95% confidence interval (CI) = 2.1 (1.5-2.9) mg/kg], and the non-selective cyclooxygenase inhibitor, diclofenac sodium [ED50 (95% CI) = 9.8 (8.2-11.7) mg/kg], dose-dependently inhibited acetic acid-induced abdominal stretching.  Combinations of URB597 and diclofenac yielded synergistic analgesic interactions according to isobolog. anal.  It is important that FAAH(-/-) mice and URB597-treated mice displayed significant redns. in the severity of gastric irritation caused by diclofenac.  URB597 lost its gastroprotective effects in CB1(-/-) mice, whereas it maintained its efficacy in CB2(-/-) mice, indicating a CB1 mechanism of action.  Taken together, the results of the present study suggest that FAAH represents a promising target for the treatment of visceral pain, and a combination of FAAH inhibitors and NSAIDs may have great utility to treat visceral pain, with reduced gastric toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg5twrLEI_mbVg90H21EOLACvtfcHk0ljBa3JqA3ok9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVKntb0%253D&md5=8efa156c1a389d8510fb62af14d2cd8b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.143487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.143487%26sid%3Dliteratum%253Aachs%26aulast%3DNaidu%26aufirst%3DP.%2BS.%26aulast%3DBooker%26aufirst%3DL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26atitle%3DSynergy%2520between%2520enzyme%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520and%2520cyclooxygenase%2520in%2520visceral%2520nociception%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26spage%3D48%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Sasso, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1016%2Fj.phrs.2012.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=22420940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFGhsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2012&pages=553-563&author=O.+Sassoauthor=R.+Bertorelliauthor=T.+Bandieraauthor=R.+Scarpelliauthor=G.+Colombanoauthor=A.+Armirottiauthor=G.+Moreno-Sanzauthor=A.+Reggianiauthor=D.+Piomelli&title=Peripheral+FAAH+inhibition+causes+profound+antinociception+and+protects+against+indomethacin-induced+gastric+lesions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions</span></div><div class="casAuthors">Sasso, Oscar; Bertorelli, Rosalia; Bandiera, Tiziano; Scarpelli, Rita; Colombano, Giampiero; Armirotti, Andrea; Moreno-Sanz, Guillermo; Reggiani, Angelo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">553-563</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Fatty-acid amide hydrolase (FAAH) catalyzes the intracellular hydrolysis of the endocannabinoid anandamide and other bioactive lipid amides.  In the present study, we conducted a comparative characterization of the effects of the newly identified brain-impermeant FAAH inhibitor, URB937 ([3-(3-carbamoylphenyl)-4-hydroxy-phenyl] N-cyclohexylcarbamate), in various rodent models of acute and persistent pain.  When administered by the oral route in mice, URB937 was highly active (median ED, ED50, to inhibit liver FAAH activity: 0.3 mg kg-1) and had a bioavailability of 5.3%.  The antinociceptive effects of oral URB937 were investigated in mouse models of acute inflammation (carrageenan), peripheral nerve injury (chronic sciatic nerve ligation) and arthritis (complete Freund's adjuvant).  In all models, URB937 was as effective or more effective than std. analgesic and anti-inflammatory drugs (indomethacin, gabapentin, dexamethasone) and reversed pain-related responses (mech. hyperalgesia, thermal hyperalgesia, and mech. allodynia) in a dose-dependent manner.  ED50 values ranged from 0.2 to 10 mg kg-1, depending on model and readout.  Importantly, URB937 was significantly more effective than two global FAAH inhibitors, URB597 and PF-04457845, in the complete Freund's adjuvant model.  The effects of a combination of URB937 with the non-steroidal anti-inflammatory agent, indomethacin, were examd. in the carrageenan and chronic sciatic nerve ligation models.  Isobolog. analyses showed that the two compds. interacted synergistically to attenuate pain-related behaviors.  Furthermore, URB937 reduced the no. and severity of gastric lesions produced by indomethacin, while exerting no ulcerogenic effect when administered alone.  The results indicate that the peripheral FAAH inhibitor URB937 is more effective than globally active FAAH inhibitors at inhibiting inflammatory pain.  Our findings further suggest that FAAH and cyclooxygenase inhibitors interact functionally in peripheral tissues, to either enhance or hinder each other's actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWqynrGrr-LbVg90H21EOLACvtfcHk0lieGox1XY-KGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFGhsrs%253D&md5=67ef363a1635b950933650059e8379ee</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2012.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2012.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DColombano%26aufirst%3DG.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DPeripheral%2520FAAH%2520inhibition%2520causes%2520profound%2520antinociception%2520and%2520protects%2520against%2520indomethacin-induced%2520gastric%2520lesions%26jtitle%3DPharmacol.%2520Res.%26date%3D2012%26volume%3D65%26spage%3D553%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0lieGox1XY-KGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0lieGox1XY-KGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Csermely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoston, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongor, S.</span><span> </span><span class="NLM_article-title">The efficiency of multi-target drugs: the network approach might help drug design</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1016%2Fj.tips.2005.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=15808341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivV2ht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=178-182&author=P.+Csermelyauthor=V.+Agostonauthor=S.+Pongor&title=The+efficiency+of+multi-target+drugs%3A+the+network+approach+might+help+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The efficiency of multi-target drugs: the network approach might help drug design</span></div><div class="casAuthors">Csermely, Peter; Agoston, Vilmos; Pongor, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">178-182</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite considerable progress in genome- and proteome-based high-throughput screening methods and rational drug design, the no. of successful single-target drugs did not increase appreciably during the past decade.  Network models suggest that partial inhibition of a surprisingly small no. of targets can be more efficient than the complete inhibition of a single target.  This and the success stories of multi-target drugs and combinatorial therapies led us to suggest that systematic drug-design strategies should be directed against multiple targets.  The authors propose that the final effect of partial, but multiple, drug actions might often surpass that of complete drug action at a single target.  The future success of this novel drug-design paradigm will depend not only on a new generation of computer models to identify the correct multiple targets and their multi-fitting, low-affinity drug candidates but also on more-efficient in vivo testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQRoFMVKb5m7Vg90H21EOLACvtfcHk0lieGox1XY-KGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivV2ht70%253D&md5=4f1383f4699221ef99041dffafe03e8c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2005.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2005.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DCsermely%26aufirst%3DP.%26aulast%3DAgoston%26aufirst%3DV.%26aulast%3DPongor%26aufirst%3DS.%26atitle%3DThe%2520efficiency%2520of%2520multi-target%2520drugs%253A%2520the%2520network%2520approach%2520might%2520help%2520drug%2520design%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D178%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Zimmermann, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, C. T.</span><span> </span><span class="NLM_article-title">Multi-target therapeutics: when the whole is greater than the sum of the parts</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1016%2Fj.drudis.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=17198971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=34-42&author=G.+R.+Zimmermannauthor=J.+Leharauthor=C.+T.+Keith&title=Multi-target+therapeutics%3A+when+the+whole+is+greater+than+the+sum+of+the+parts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target therapeutics: when the whole is greater than the sum of the parts</span></div><div class="casAuthors">Zimmermann Grant R; Lehar Joseph; Keith Curtis T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">34-42</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">Drugs designed to act against individual molecular targets cannot usually combat multigenic diseases such as cancer, or diseases that affect multiple tissues or cell types such as diabetes and immunoinflammatory disorders.  Combination drugs that impact multiple targets simultaneously are better at controlling complex disease systems, are less prone to drug resistance and are the standard of care in many important therapeutic areas.  The combination drugs currently employed are primarily of rational design, but the increased efficacy they provide justifies in vitro discovery efforts for identifying novel multi-target mechanisms.  In this review, we discuss the biological rationale for combination therapeutics, review some existing combination drugs and present a systematic approach to identify interactions between molecular pathways that could be leveraged for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI14vYK2Q1LENHe_gFldTbfW6udTcc2ebRBu0BTXckkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D&md5=66715499ce21c2855dc6c477aa87f161</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%2BR.%26aulast%3DLehar%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DC.%2BT.%26atitle%3DMulti-target%2520therapeutics%253A%2520when%2520the%2520whole%2520is%2520greater%2520than%2520the%2520sum%2520of%2520the%2520parts%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D34%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Holt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paylor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldrup, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alajakku, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandevoorde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocco, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onnis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span> </span><span class="NLM_article-title">Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">565</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1016%2Fj.ejphar.2007.02.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=17397826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvFantrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=565&publication_year=2007&pages=26-36&author=S.+Holtauthor=B.+Paylorauthor=L.+Boldrupauthor=K.+Alajakkuauthor=S.+Vandevoordeauthor=A.+Sundstromauthor=M.+T.+Coccoauthor=V.+Onnisauthor=C.+J.+Fowler&title=Inhibition+of+fatty+acid+amide+hydrolase%2C+a+key+endocannabinoid+metabolizing+enzyme%2C+by+analogues+of+ibuprofen+and+indomethacin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin</span></div><div class="casAuthors">Holt, Sandra; Paylor, Ben; Boldrup, Linda; Alajakku, Kirsi; Vandevoorde, Severine; Sundstroem, Anna; Cocco, Maria Teresa; Onnis, Valentina; Fowler, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">565</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">26-36</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is evidence in the literature that the nonsteroidal anti-inflammatory drugs indomethacin and ibuprofen can interact with the cannabinoid system both in vitro and in vivo.  In the present study, a series of analogs of ibuprofen and indomethacin have been investigated with respect to their ability to inhibit fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endogenous cannabinoid anandamide.  Of the compds. tested, the 6-methyl-pyridin-2-yl analog of ibuprofen ("ibu-am5") was selected for further study.  This compd. inhibited rat brain anandamide hydrolysis in a non-competitive manner, with IC50 values of 4.7 and 2.5 μM being found at pH 6 and 8, resp.  By comparison, the IC50 values for ibuprofen were 130 and 750 μM at pH 6 and 8, resp.  There was no measurable N-acylethanolamine hydrolyzing acid amidase activity in rat brain membrane prepns.  In intact C6 glioma cells, ibu-am5 inhibited the hydrolysis of anandamide with an IC50 value of 1.2 μM.  There was little difference in the potencies of ibu-am5 and ibuprofen towards cyclooxygenase-1 and -2 enzymes, and neither compd. inhibited the activity of monoacylglycerol lipase.  Ibu-am5 inhibited the binding of [3H]-CP55,940 to rat brain CB1 and human CB2 cannabinoid receptors more potently than ibuprofen, but the increase in potency was less than the corresponding increase in potency seen for inhibition of FAAH activity.  It is concluded that ibu-am5 is an analog of ibuprofen with a greater potency towards fatty acid amide hydrolase but with a similar cyclooxygenase inhibitory profile, and may be useful for the study of the therapeutic potential of combined fatty acid amide hydrolase-cyclooxygenase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUI2qOGuDCIbVg90H21EOLACvtfcHk0lgzsfdmWZc1bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvFantrs%253D&md5=a78d189e8a84fc86c528cc5bf350c180</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.02.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.02.051%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DS.%26aulast%3DPaylor%26aufirst%3DB.%26aulast%3DBoldrup%26aufirst%3DL.%26aulast%3DAlajakku%26aufirst%3DK.%26aulast%3DVandevoorde%26aufirst%3DS.%26aulast%3DSundstrom%26aufirst%3DA.%26aulast%3DCocco%26aufirst%3DM.%2BT.%26aulast%3DOnnis%26aufirst%3DV.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DInhibition%2520of%2520fatty%2520acid%2520amide%2520hydrolase%252C%2520a%2520key%2520endocannabinoid%2520metabolizing%2520enzyme%252C%2520by%2520analogues%2520of%2520ibuprofen%2520and%2520indomethacin%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D565%26spage%3D26%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Knox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolkis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banco, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neveu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djoumbou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, D. S.</span><span> </span><span class="NLM_article-title">DrugBank 3.0: a comprehensive resource for 'omics' research on drugs</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">D1041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=D1035-D1041&author=C.+Knoxauthor=V.+Lawauthor=T.+Jewisonauthor=P.+Liuauthor=S.+Lyauthor=A.+Frolkisauthor=A.+Ponauthor=K.+Bancoauthor=C.+Makauthor=V.+Neveuauthor=Y.+Djoumbouauthor=R.+Eisnerauthor=A.+C.+Guoauthor=D.+S.+Wishart&title=DrugBank+3.0%3A+a+comprehensive+resource+for+%27omics%27+research+on+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DLaw%26aufirst%3DV.%26aulast%3DJewison%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLy%26aufirst%3DS.%26aulast%3DFrolkis%26aufirst%3DA.%26aulast%3DPon%26aufirst%3DA.%26aulast%3DBanco%26aufirst%3DK.%26aulast%3DMak%26aufirst%3DC.%26aulast%3DNeveu%26aufirst%3DV.%26aulast%3DDjoumbou%26aufirst%3DY.%26aulast%3DEisner%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DWishart%26aufirst%3DD.%2BS.%26atitle%3DDrugBank%25203.0%253A%2520a%2520comprehensive%2520resource%2520for%2520%2527omics%2527%2520research%2520on%2520drugs%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26spage%3DD1035%26epage%3DD1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Huang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irwin, J. J.</span><span> </span><span class="NLM_article-title">Benchmarking sets for molecular docking</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6789</span><span class="NLM_x">–</span> <span class="NLM_lpage">6801</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFehurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6789-6801&author=N.+Huangauthor=B.+K.+Shoichetauthor=J.+J.+Irwin&title=Benchmarking+sets+for+molecular+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Benchmarking Sets for Molecular Docking</span></div><div class="casAuthors">Huang, Niu; Shoichet, Brian K.; Irwin, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6789-6801</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand enrichment among top-ranking hits is a key metric of mol. docking.  To avoid bias, decoys should resemble ligands phys., so that enrichment is not simply a sepn. of gross features, yet be chem. distinct from them, so that they are unlikely to be binders.  We have assembled a directory of useful decoys (DUD), with 2950 ligands for 40 different targets.  Every ligand has 36 decoy mols. that are phys. similar but topol. distinct, leading to a database of 98 266 compds.  For most targets, enrichment was at least half a log better with uncorrected databases such as the MDDR than with DUD, evidence of bias in the former.  These calcns. also allowed 40×40 cross-docking, where the enrichments of each ligand set could be compared for all 40 targets, enabling a specificity metric for the docking screens.  DUD is freely available online as a benchmarking set for docking at http://blaster.docking.org/dud/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-8FVhVSsBm7Vg90H21EOLACvtfcHk0lgzsfdmWZc1bA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFehurzI&md5=43af46968c2a6d66334922bf0caedbe1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm0608356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608356%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26atitle%3DBenchmarking%2520sets%2520for%2520molecular%2520docking%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6789%26epage%3D6801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Berger, L.; Corraz, A. J.</span> Carbazoles. US 3869145.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berger%2C+L.%3B+Corraz%2C+A.+J.+Carbazoles.+US+3869145."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DL." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Narlawar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez Revuelta, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span> </span><span class="NLM_article-title">Scaffold of the cyclooxygenase-2 (COX-2) inhibitor carprofen provides Alzheimer γ-secretase modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7588</span><span class="NLM_x">–</span> <span class="NLM_lpage">7591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0610200" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7588-7591&author=R.+Narlawarauthor=B.+I.+Perez+Revueltaauthor=C.+Haassauthor=H.+Steinerauthor=B.+Schmidtauthor=K.+Baumann&title=Scaffold+of+the+cyclooxygenase-2+%28COX-2%29+inhibitor+carprofen+provides+Alzheimer+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0610200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610200%26sid%3Dliteratum%253Aachs%26aulast%3DNarlawar%26aufirst%3DR.%26aulast%3DPerez%2BRevuelta%26aufirst%3DB.%2BI.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DBaumann%26aufirst%3DK.%26atitle%3DScaffold%2520of%2520the%2520cyclooxygenase-2%2520%2528COX-2%2529%2520inhibitor%2520carprofen%2520provides%2520Alzheimer%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7588%26epage%3D7591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Bishay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haussler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijnvoord, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziebell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myrczek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costigan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehghani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tegeder, I.</span><span> </span><span class="NLM_article-title">R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e10628</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e10628&author=P.+Bishayauthor=H.+Schmidtauthor=C.+Marianauthor=A.+Hausslerauthor=N.+Wijnvoordauthor=S.+Ziebellauthor=J.+Metznerauthor=M.+Kochauthor=T.+Myrczekauthor=I.+Bechmannauthor=R.+Kunerauthor=M.+Costiganauthor=F.+Dehghaniauthor=G.+Geisslingerauthor=I.+Tegeder&title=R-flurbiprofen+reduces+neuropathic+pain+in+rodents+by+restoring+endogenous+cannabinoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBishay%26aufirst%3DP.%26aulast%3DSchmidt%26aufirst%3DH.%26aulast%3DMarian%26aufirst%3DC.%26aulast%3DHaussler%26aufirst%3DA.%26aulast%3DWijnvoord%26aufirst%3DN.%26aulast%3DZiebell%26aufirst%3DS.%26aulast%3DMetzner%26aufirst%3DJ.%26aulast%3DKoch%26aufirst%3DM.%26aulast%3DMyrczek%26aufirst%3DT.%26aulast%3DBechmann%26aufirst%3DI.%26aulast%3DKuner%26aufirst%3DR.%26aulast%3DCostigan%26aufirst%3DM.%26aulast%3DDehghani%26aufirst%3DF.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DTegeder%26aufirst%3DI.%26atitle%3DR-flurbiprofen%2520reduces%2520neuropathic%2520pain%2520in%2520rodents%2520by%2520restoring%2520endogenous%2520cannabinoids%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De10628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borjesson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiger, G.</span><span> </span><span class="NLM_article-title">Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2Fsj.bjp.0703569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=11015300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVygtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2000&pages=498-504&author=C.+J.+Fowlerauthor=M.+Borjessonauthor=G.+Tiger&title=Differences+in+the+pharmacological+properties+of+rat+and+chicken+brain+fatty+acid+amidohydrolase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase</span></div><div class="casAuthors">Fowler, Christopher J.; Borjesson, Magnus; Tiger, Gunnar</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">498-504</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 The pharmacol. properties of fatty acid amidohydrolase (FAAH) were investigated in brains of 35-day-old chickens, since nothing is known about the enzyme in avian species.  2 FAAH activity towards both [3H]-palmitoylethanolamide (PEA) [KM = 1.5 μM] and [3H]-anandamide (AEA) [KM = 5.4 μM] was demonstrated in the chicken brains.  The chicken FAAH was inhibited by the substrate analogs oleyl trifluoromethylketone (OTMK) and diazomethylarachidonyl ketone (DAK) with similar potencies to the rat FAAH.  However, in contrast to the rat brain, phenylmethylsulfonyl fluoride (PMSF) and the enantiomers of had very weak effects on chicken brain FAAH.  3 Indomethacin and niflumic acid were found to inhibit rat brain AEA hydrolysis.  The inhibition by indomethacin was reversible and competitive, with a Ki value of 120 μM.  Chicken FAAH was less sensitive to indomethacin than its rodent counterpart, but the inhibition was also competitive (Ki).  4 It is concluded that chicken FAAH activity has different pharmacol. properties to its rodent counterpart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7-86DiIYaa7Vg90H21EOLACvtfcHk0liguZQkuCVvFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVygtL0%253D&md5=374eaab658be63b35c5cb52cd4a9c833</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703569%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DBorjesson%26aufirst%3DM.%26aulast%3DTiger%26aufirst%3DG.%26atitle%3DDifferences%2520in%2520the%2520pharmacological%2520properties%2520of%2520rat%2520and%2520chicken%2520brain%2520fatty%2520acid%2520amidohydrolase%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D131%26spage%3D498%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Duggan, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harp, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">34950</span><span class="NLM_x">–</span> <span class="NLM_lpage">34959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=34950-34959&author=K.+C.+Dugganauthor=M.+J.+Waltersauthor=J.+Museeauthor=J.+M.+Harpauthor=J.+R.+Kieferauthor=J.+A.+Oatesauthor=L.+J.+Marnett&title=Molecular+basis+for+cyclooxygenase+inhibition+by+the+non-steroidal+anti-inflammatory+drug+naproxen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuggan%26aufirst%3DK.%2BC.%26aulast%3DWalters%26aufirst%3DM.%2BJ.%26aulast%3DMusee%26aufirst%3DJ.%26aulast%3DHarp%26aufirst%3DJ.%2BM.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DOates%26aufirst%3DJ.%2BA.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DMolecular%2520basis%2520for%2520cyclooxygenase%2520inhibition%2520by%2520the%2520non-steroidal%2520anti-inflammatory%2520drug%2520naproxen%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D34950%26epage%3D34959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenstrom, A.</span><span> </span><span class="NLM_article-title">Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">729</span><span class="NLM_x">–</span> <span class="NLM_lpage">734</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=9353392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADyaK2sXnsV2msLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=729-734&author=C.+J.+Fowlerauthor=G.+Tigerauthor=A.+Stenstrom&title=Ibuprofen+inhibits+rat+brain+deamidation+of+anandamide+at+pharmacologically+relevant+concentrations.+Mode+of+inhibition+and+structure-activity+relationship"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship</span></div><div class="casAuthors">Fowler, Christopher J.; Tiger, Gunnar; Stenstrom, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">729-734</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The ability of rat brain (minus cerebellum) homogenates to deamidate arachidonyl ethanolamide (anandamide) was detd. with a custom-synthesized substrate ([3H]anandamide).  Conditions whereby initial velocities were measured were established.  The homogenates deamidated anandamide with a Km value of 0.8 μM and a Vmax value of 1.73 nmol · (mg protein)-1 · min-1.  The deamidation of 2 μM [3H]anandamide was inhibited by phenylmethylsulfonyl fluoride and arachidonyl trifluoromethyl ketone with IC50 values of 3.7 and 0.23 μM, resp.  Ibuprofen inhibited anandamide deamidation in a mixed fashion, with Ki and K'i values of 82 and 1420 μM.  At an anandamide concn. of 2 μM, the IC50 values (in μM) of a series of compds. related in structure to ibuprofen were as follows: suprofen, 170; ibuprofen, 270; fenoprofen, 480; naproxen, 550; ketoprofen, 650; diclofenac, ∼1000.  Sulindac produced 27% inhibition at a concn. of 1000 μM, whereas isobutyric acid, hydrocinnamic acid, acetylsalicylic acid and acetaminophen were essentially inactive at concns. ≤ 1 mM.  We conclude that ibuprofen inhibits anandamide deamidation at pharmacol. relevant concns. and that there is some specificity to the inhibition produced by ibuprofen and suprofen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZXrS_j9s3sLVg90H21EOLACvtfcHk0liguZQkuCVvFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnsV2msLo%253D&md5=cd0e866f9513e895072cae4414a3db6e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DTiger%26aufirst%3DG.%26aulast%3DStenstrom%26aufirst%3DA.%26atitle%3DIbuprofen%2520inhibits%2520rat%2520brain%2520deamidation%2520of%2520anandamide%2520at%2520pharmacologically%2520relevant%2520concentrations.%2520Mode%2520of%2520inhibition%2520and%2520structure-activity%2520relationship%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D729%26epage%3D734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahlstrom, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenstrom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiger, G.</span><span> </span><span class="NLM_article-title">Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=1999&pages=191-196&author=C.+J.+Fowlerauthor=U.+Jansonauthor=R.+M.+Johnsonauthor=G.+Wahlstromauthor=A.+Stenstromauthor=K.+Norstromauthor=G.+Tiger&title=Inhibition+of+anandamide+hydrolysis+by+the+enantiomers+of+ibuprofen%2C+ketorolac%2C+and+flurbiprofen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DJanson%26aufirst%3DU.%26aulast%3DJohnson%26aufirst%3DR.%2BM.%26aulast%3DWahlstrom%26aufirst%3DG.%26aulast%3DStenstrom%26aufirst%3DA.%26aulast%3DNorstrom%26aufirst%3DK.%26aulast%3DTiger%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520anandamide%2520hydrolysis%2520by%2520the%2520enantiomers%2520of%2520ibuprofen%252C%2520ketorolac%252C%2520and%2520flurbiprofen%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1999%26volume%3D362%26spage%3D191%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naidu, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onnis, V.</span><span> </span><span class="NLM_article-title">The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1111%2Fj.1476-5381.2008.00029.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=19226258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1WlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=412-419&author=C.+J.+Fowlerauthor=P.+S.+Naiduauthor=A.+Lichtmanauthor=V.+Onnis&title=The+case+for+the+development+of+novel+analgesic+agents+targeting+both+fatty+acid+amide+hydrolase+and+either+cyclooxygenase+or+TRPV1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1</span></div><div class="casAuthors">Fowler, C. J.; Naidu, P. S.; Lichtman, A.; Onnis, V.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">412-419</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Although the dominant approach to drug development is the design of compds. selective for a given target, compds. targeting more than one biol. process may have superior efficacy, or alternatively a better safety profile than std. selective compds.  Here, this possibility has been explored with respect to the endocannabinoid system and pain.  Compds. inhibiting the enzyme fatty acid amide hydrolase (FAAH), by increasing local endocannabinoid tone, produce potentially useful effects in models of inflammatory and possibly neuropathic pain.  Local increases in levels of the endocannabinoid anandamide potentiate the actions of cyclooxygenase inhibitors, raising the possibility that compds. inhibiting both FAAH and cyclooxygenase can be as effective as non-steroidal anti-inflammatory drugs but with a reduced cyclooxygenase inhibitory 'load'.  An ibuprofen analog active in models of visceral pain and with FAAH and cyclooxygenase inhibitory properties has been identified.  Another approach, built in to the exptl. analgesic compd. N-arachidonoylserotonin, is the combination of FAAH inhibitory and transient receptor potential vanilloid type 1 antagonist properties.  Although finding the right balance of actions upon the two targets is a key to success, it is hoped that dual-action compds. of the types illustrated in this review will prove to be useful analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprysPLCW6j8LVg90H21EOLACvtfcHk0liGU5yswccZbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1WlsrY%253D&md5=096546b0081d52c65f928bd2e7790936</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2008.00029.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2008.00029.x%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DNaidu%26aufirst%3DP.%2BS.%26aulast%3DLichtman%26aufirst%3DA.%26aulast%3DOnnis%26aufirst%3DV.%26atitle%3DThe%2520case%2520for%2520the%2520development%2520of%2520novel%2520analgesic%2520agents%2520targeting%2520both%2520fatty%2520acid%2520amide%2520hydrolase%2520and%2520either%2520cyclooxygenase%2520or%2520TRPV1%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D156%26spage%3D412%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiger, G.</span><span> </span><span class="NLM_article-title">Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1080%2F1475636021000049726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=12751821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD3sXoslKrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=55-58&author=C.+J.+Fowlerauthor=S.+Holtauthor=G.+Tiger&title=Acidic+nonsteroidal+anti-inflammatory+drugs+inhibit+rat+brain+fatty+acid+amide+hydrolase+in+a+pH-dependent+manner"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Acidic Nonsteroidal Anti-inflammatory Drugs Inhibit Rat Brain Fatty Acid Amide Hydrolase in a pH-dependent Manner</span></div><div class="casAuthors">Fowler, Christopher J.; Holt, Sandra; Tiger, Gunnar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-58</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Previous studies have demonstrated that fatty acid amide hydrolase, the enzyme responsible for the metab. of anandamide, is inhibited by the acidic non-steroidal anti-inflammatory drug (NSAID) ibuprofen with a potency that increases as the assay pH is reduced.  Here we show that (R)-, (S)- and (R,S)-flurbiprofen, indomethacin and niflumic acid show similar pH-dependent shifts in potency to that seen with ibuprofen.  Thus, (S)-flurbiprofen inhibited 2 μM [3H]anandamide metab. with IC50 values of 13 and 50 μM at assay pH values of 6 and 8, resp.  In contrast, the neutral compd. celecoxib was a weak fatty acid amide hydrolase inhibitor and showed no pH dependency (IC50 values ∼300 μM at both assay pH).  The cyclooxygenase-2-selective inhibitors nimesulide and SC-58125 did not inhibit fatty acid amide hydrolase activity at either pH.  The data are consistent with the conclusion that the non-ionized forms of the acidic NSAIDs are responsible for the inhibition of fatty acid amide hydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-HdjxEzRsl7Vg90H21EOLACvtfcHk0liGU5yswccZbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXoslKrsw%253D%253D&md5=e3b2b69c8b4e6be41962b374156e8973</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1080%2F1475636021000049726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1475636021000049726%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DHolt%26aufirst%3DS.%26aulast%3DTiger%26aufirst%3DG.%26atitle%3DAcidic%2520nonsteroidal%2520anti-inflammatory%2520drugs%2520inhibit%2520rat%2520brain%2520fatty%2520acid%2520amide%2520hydrolase%2520in%2520a%2520pH-dependent%2520manner%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2003%26volume%3D18%26spage%3D55%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Hermanson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Cannabinoids, endocannabinoids, and cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1007%2Fs10555-011-9318-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=22038019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1emt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=599-612&author=D.+J.+Hermansonauthor=L.+J.+Marnett&title=Cannabinoids%2C+endocannabinoids%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids, endocannabinoids, and cancer</span></div><div class="casAuthors">Hermanson, Daniel J.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">599-612</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid system consists of an array of endogenously produced bioactive lipids that activate cannabinoid receptors.  Although the primary focus of endocannabinoid biol. has been on neurol. and psychiatric effects, recent work has revealed several important interactions between the endocannabinoid system and cancer.  Several different types of cancer have abnormal regulation of the endocannabinoid system that contributes to cancer progression and correlates to clin. outcomes.  Modulation of the endocannabinoid system by pharmacol. agents in various cancer types reveals that it can mediate antiproliferative and apoptotic effects by both cannabinoid receptor-dependent and -independent pathways.  Selective agonists and antagonists of the cannabinoid receptors, inhibitors of endocannabinoid hydrolysis, and cannabinoid analogs have been utilized to probe the pathways involved in the effects of the endocannabinoid system on cancer cell apoptosis, proliferation, migration, adhesion, and invasion.  The antiproliferative and apoptotic effects produced by some of these pharmacol. probes reveal that the endocannabinoid system is a promising new target for the development of novel chemotherapeutics to treat cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWWMIHHXmIYbVg90H21EOLACvtfcHk0liGU5yswccZbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1emt7nE&md5=b13c75506f28c6824853f3747f9038c8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs10555-011-9318-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-011-9318-8%26sid%3Dliteratum%253Aachs%26aulast%3DHermanson%26aufirst%3DD.%2BJ.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DCannabinoids%252C%2520endocannabinoids%252C%2520and%2520cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2011%26volume%3D30%26spage%3D599%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Inflammation and cancer: chemical approaches to mechanisms, imaging, and treatment</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">5224</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo300214d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=5224-38&author=L.+J.+Marnett&title=Inflammation+and+cancer%3A+chemical+approaches+to+mechanisms%2C+imaging%2C+and+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjo300214d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo300214d%26sid%3Dliteratum%253Aachs%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DInflammation%2520and%2520cancer%253A%2520chemical%2520approaches%2520to%2520mechanisms%252C%2520imaging%252C%2520and%2520treatment%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2012%26volume%3D77%26spage%3D5224%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Nobeli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, J. M.</span><span> </span><span class="NLM_article-title">Protein promiscuity and its implications for biotechnology</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2Fnbt1519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=19204698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Cktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=157-167&author=I.+Nobeliauthor=A.+D.+Faviaauthor=J.+M.+Thornton&title=Protein+promiscuity+and+its+implications+for+biotechnology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Protein promiscuity and its implications for biotechnology</span></div><div class="casAuthors">Nobeli, Irene; Favia, Angelo D.; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-167</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mol. recognition between proteins and their interacting partners underlies the biochem. of living organisms.  Specificity in this recognition is thought to be essential, whereas promiscuity is often assocd. with unwanted side-effects, poor catalytic properties, and errors in biol. function.  Recent exptl. evidence suggests that promiscuity, not only in interactions but also in the actual function of proteins, is not as rare as was previously thought.  This has implications not only for the fundamental understanding of mol. recognition and how protein function has evolved over time, but also in the realm of biotechnol.  Understanding protein promiscuity is becoming increasingly important not only to optimize protein engineering applications in areas as diverse as synthetic biol. and metagenomics, but also to lower attrition rates in drug discovery programs, identify drug interaction surfaces less susceptible to escape mutations, and potentiate the power of polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdzkMBuUqOqLVg90H21EOLACvtfcHk0lgX-3wpFmuH3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Cktrc%253D&md5=1e72967accb88b6183ec882a4cba2571</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnbt1519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1519%26sid%3Dliteratum%253Aachs%26aulast%3DNobeli%26aufirst%3DI.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DProtein%2520promiscuity%2520and%2520its%2520implications%2520for%2520biotechnology%26jtitle%3DNat.%2520Biotechnol.%26date%3D2009%26volume%3D27%26spage%3D157%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">A 'rule of three' for fragment-based lead discovery?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">877</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=876-877&author=M.+Congreveauthor=R.+Carrauthor=C.+Murrayauthor=H.+Jhoti&title=A+%27rule+of+three%27+for+fragment-based+lead+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DA%2520%2527rule%2520of%2520three%2527%2520for%2520fragment-based%2520lead%2520discovery%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D876%26epage%3D877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Czarnobilski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarnobilski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konturek, S. J.</span><span> </span><span class="NLM_article-title">Carprofen and the therapy of gastroduodenal ulcerations by ranitidine</span> <span class="citation_source-journal">Hepatogastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=3872836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADyaL2M7otV2ktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1985&pages=20-23&author=Z.+Czarnobilskiauthor=S.+Bemauthor=K.+Czarnobilskiauthor=S.+J.+Konturek&title=Carprofen+and+the+therapy+of+gastroduodenal+ulcerations+by+ranitidine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Carprofen and the therapy of gastroduodenal ulcerations by ranitidine</span></div><div class="casAuthors">Czarnobilski Z; Bem S; Czarnobilski K; Konturek S J</div><div class="citationInfo"><span class="NLM_cas:title">Hepato-gastroenterology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-3</span>
        ISSN:<span class="NLM_cas:issn">0172-6390</span>.
    </div><div class="casAbstract">The effects of the addition of carprofen (Roche), a new nonsteroidal antiinflammatory agent, to regular 4-5 week ranitidine (300 mg/day) therapy on gastric secretion, serum gastrin level and ulcer healing, have been examined in 15 gastric ulcer (GU) and 60 duodenal ulcer (DU) patients.  Carprofen at a therapeutic dose (300 mg/day) was well tolerated by both GU and DU patients and did not give rise to any major adverse effects.  In an open trial on 15 GU (all receiving carprofen), complete endoscopic ulcer healing was found in 9 patients after 3 weeks and in 6 others after 5 weeks of treatment.  In a double blind, placebo controlled trial on 60 DU (30 receiving carprofen and 30 receiving placebo), complete ulcer healing was seen after 2 weeks in 23 on carprofen and 22 on placebo, and after 4 weeks in all tested patients.  Pentagastrin-induced maximal acid secretion examined 24 h after the last dose of treatment was significantly reduced in DU, but not in GU, patients, and was accompanied by a significant rise in plasma gastrin levels.  No change in gastric histology was observed in any patient tested.  This study provides evidence that carprofen added to antiulcer ranitidine therapy shows excellent gastrointestinal tolerance, and does not interfere with ulcer healing; it is, therefore, recommended in the treatment of arthritic patients with peptic ulcer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAk80g0dszd8uCWE5mhx1RfW6udTcc2ebLgV5V2nc3BLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M7otV2ktw%253D%253D&md5=e11d5ecd1b39fc9591f61265902cd889</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCzarnobilski%26aufirst%3DZ.%26aulast%3DBem%26aufirst%3DS.%26aulast%3DCzarnobilski%26aufirst%3DK.%26aulast%3DKonturek%26aufirst%3DS.%2BJ.%26atitle%3DCarprofen%2520and%2520the%2520therapy%2520of%2520gastroduodenal%2520ulcerations%2520by%2520ranitidine%26jtitle%3DHepatogastroenterology%26date%3D1985%26volume%3D32%26spage%3D20%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Duggan, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermanson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusakiewicz, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheib, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2Fnchembio.663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=22053353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADC%252BC3MbmsFSjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=803-809&author=K.+C.+Dugganauthor=D.+J.+Hermansonauthor=J.+Museeauthor=J.+J.+Prusakiewiczauthor=J.+L.+Scheibauthor=B.+D.+Carterauthor=S.+Banerjeeauthor=J.+A.+Oatesauthor=L.+J.+Marnett&title=%28R%29-Profens+are+substrate-selective+inhibitors+of+endocannabinoid+oxygenation+by+COX-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2</span></div><div class="casAuthors">Duggan Kelsey C; Hermanson Daniel J; Musee Joel; Prusakiewicz Jeffery J; Scheib Jami L; Carter Bruce D; Banerjee Surajit; Oates J A; Marnett Lawrence J</div><div class="citationInfo"><span class="NLM_cas:title">Nature chemical biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">803-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cyclooxygenase-2 (COX-2) catalyzes the oxygenation of arachidonic acid and the endocannabinoids 2-arachidonoylglycerol and arachidonoylethanolamide.  Evaluation of a series of COX-2 inhibitors revealed that many weak competitive inhibitors of arachidonic acid oxygenation are potent inhibitors of endocannabinoid oxygenation. (R) enantiomers of ibuprofen, naproxen and flurbiprofen, which are considered to be inactive as COX-2 inhibitors, are potent 'substrate-selective inhibitors' of endocannabinoid oxygenation.  Crystal structures of the COX-2-(R)-naproxen and COX-2-(R)-flurbiprofen complexes verified this unexpected binding and defined the orientation of the (R) enantiomers relative to (S) enantiomers. (R)-Profens selectively inhibited endocannabinoid oxygenation by lipopolysaccharide-stimulated dorsal root ganglion (DRG) cells.  Substrate-selective inhibition provides new tools for investigating the role of COX-2 in endocannabinoid oxygenation and a possible explanation for the ability of (R)-profens to maintain endocannabinoid tone in models of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCVl07yxZ4YMvLc4ARHEmzfW6udTcc2eYShSF_J452E7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbmsFSjtA%253D%253D&md5=306005e871b9c51de475800b5375732d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.663%26sid%3Dliteratum%253Aachs%26aulast%3DDuggan%26aufirst%3DK.%2BC.%26aulast%3DHermanson%26aufirst%3DD.%2BJ.%26aulast%3DMusee%26aufirst%3DJ.%26aulast%3DPrusakiewicz%26aufirst%3DJ.%2BJ.%26aulast%3DScheib%26aufirst%3DJ.%2BL.%26aulast%3DCarter%26aufirst%3DB.%2BD.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DOates%26aufirst%3DJ.%2BA.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3D%2528R%2529-Profens%2520are%2520substrate-selective%2520inhibitors%2520of%2520endocannabinoid%2520oxygenation%2520by%2520COX-2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D803%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Bracey, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1126%2Fscience.1076535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=12459591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1793-1796&author=M.+H.+Braceyauthor=M.+A.+Hansonauthor=K.+R.+Masudaauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Structural+adaptations+in+a+membrane+enzyme+that+terminates+endocannabinoid+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling</span></div><div class="casAuthors">Bracey, Michael H.; Hanson, Michael A.; Masuda, Kim R.; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5599</span>),
    <span class="NLM_cas:pages">1793-1796</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cellular communication in the nervous system is mediated by chem. messengers that include amino acids, monoamines, peptide hormones, and lipids.  An interesting question is how neurons regulate signals that are transmitted by membrane-embedded lipids.  Here, we report the 2.8 angstrom crystal structure of the integral membrane protein fatty acid amide hydrolase (FAAH), an enzyme that degrades members of the endocannabinoid class of signaling lipids and terminates their activity.  The structure of FAAH complexed with an arachidonyl inhibitor reveals how a set of discrete structural alterations allows this enzyme, in contrast to sol. hydrolases of the same family, to integrate into cell membranes and establish direct access to the bilayer from its active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTj6G-8THMiLVg90H21EOLACvtfcHk0ljype-xGo3_sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKmsLs%253D&md5=01545bfbd00f31af713db259f41cb0ba</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1126%2Fscience.1076535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1076535%26sid%3Dliteratum%253Aachs%26aulast%3DBracey%26aufirst%3DM.%2BH.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DMasuda%26aufirst%3DK.%2BR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStructural%2520adaptations%2520in%2520a%2520membrane%2520enzyme%2520that%2520terminates%2520endocannabinoid%2520signaling%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1793%26epage%3D1796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gierse, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gildehaus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashiro, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penning, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stallings, W. C.</span><span> </span><span class="NLM_article-title">Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">644</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2F384644a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=8967954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADyaK2sXlsVKl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=644-648&author=R.+G.+Kurumbailauthor=A.+M.+Stevensauthor=J.+K.+Gierseauthor=J.+J.+McDonaldauthor=R.+A.+Stegemanauthor=J.+Y.+Pakauthor=D.+Gildehausauthor=J.+M.+Miyashiroauthor=T.+D.+Penningauthor=K.+Seibertauthor=P.+C.+Isaksonauthor=W.+C.+Stallings&title=Structural+basis+for+selective+inhibition+of+cyclooxygenase-2+by+anti-inflammatory+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents</span></div><div class="casAuthors">Kurumbail, Ravi G.; Stevens, Anna M.; Gierse, James K.; McDonald, Joseph J.; Stegeman, Roderick A.; Pak, Jina Y.; Gildehaus, Daniel; Miyashiro, Julie M.; Penning, Thomas D.; Seibert, Karen; Isakson, Peter C.; Stallings, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">6610</span>),
    <span class="NLM_cas:pages">644-648</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Prostaglandins and glucocorticoids are potent mediators of inflammation.  Non-steroidal anti-inflammatory drugs (NSAIDs) exert their effects by inhibition of prostaglandin prodn.  The pharmacol. target of NSAIDs is cyclooxygenase (COX, also known as PGH synthase), which catalyzes the first committed step in arachidonic-acid metab.  Two isoforms of the membrane protein COX are known : COX-1, which is constitutively expressed in most tissues, is responsible for the physiol. prodn. of prostaglandins; and COX-2, which is induced by cytokines, mitogens and endotoxins in inflammatory cells, is responsible for the elevated prodn. of prostaglandins during inflammation.  The structure of ovine COX-1 complexed with several NSAIDs has been detd.  Here we report the structures of unliganded murine COX-2 and complexes with flurbiprofen, indomethacin and SC-558, a selective COX-2 inhibitor, detd. at 3.0 to 2.5 Å resoln.  These structures explain the structural basis for the selective inhibition of COX-2, and demonstrate some of the conformational changes assocd. with time-dependent inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0KKKDKWXK3LVg90H21EOLACvtfcHk0ljype-xGo3_sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsVKl&md5=3f3695232f30769a9dc5006c3cc24d55</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2F384644a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F384644a0%26sid%3Dliteratum%253Aachs%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DStevens%26aufirst%3DA.%2BM.%26aulast%3DGierse%26aufirst%3DJ.%2BK.%26aulast%3DMcDonald%26aufirst%3DJ.%2BJ.%26aulast%3DStegeman%26aufirst%3DR.%2BA.%26aulast%3DPak%26aufirst%3DJ.%2BY.%26aulast%3DGildehaus%26aufirst%3DD.%26aulast%3DMiyashiro%26aufirst%3DJ.%2BM.%26aulast%3DPenning%26aufirst%3DT.%2BD.%26aulast%3DSeibert%26aufirst%3DK.%26aulast%3DIsakson%26aufirst%3DP.%2BC.%26aulast%3DStallings%26aufirst%3DW.%2BC.%26atitle%3DStructural%2520basis%2520for%2520selective%2520inhibition%2520of%2520cyclooxygenase-2%2520by%2520anti-inflammatory%2520agents%26jtitle%3DNature%26date%3D1996%26volume%3D384%26spage%3D644%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Krivov, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapovalov, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbrack, R. L.,  Jr.</span><span> </span><span class="NLM_article-title">Improved prediction of protein side-chain conformations with SCWRL4</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1002%2Fprot.22488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=19603484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSru7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=778-795&author=G.+G.+Krivovauthor=M.+V.+Shapovalovauthor=R.+L.+Dunbrack&title=Improved+prediction+of+protein+side-chain+conformations+with+SCWRL4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Improved prediction of protein side-chain conformations with SCWRL4</span></div><div class="casAuthors">Krivov, Georgii G.; Shapovalov, Maxim V.; Dunbrack, Roland L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">778-795</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Detn. of side-chain conformations is an important step in protein structure prediction and protein design.  Many such methods have been presented, although only a small no. are in widespread use.  SCWRL is one such method, and the SCWRL3 program (2003) has remained popular because of its speed, accuracy, and ease-of-use for the purpose of homol. modeling.  However, higher accuracy at comparable speed is desirable.  This has been achieved in a new program SCWRL4 through: (1) a new backbone-dependent rotamer library based on kernel d. ests.; (2) averaging over samples of conformations about the positions in the rotamer library; (3) a fast anisotropic hydrogen bonding function; (4) a short-range, soft van der Waals atom-atom interaction potential; (5) fast collision detection using k-discrete oriented polytopes; (6) a tree decompn. algorithm to solve the combinatorial problem; and (7) optimization of all parameters by detg. the interaction graph within the crystal environment using symmetry operators of the crystallog. space group.  Accuracies as a function of electron d. of the side chains demonstrate that side chains with higher electron d. are easier to predict than those with low-electron d. and presumed conformational disorder.  For a testing set of 379 proteins, 86% of χ1 angles and 75% of χ1+2 angles are predicted correctly within 40° of the X-ray positions.  Among side chains with higher electron d. (25-100th percentile), these nos. rise to 89 and 80%.  The new program maintains its simple command-line interface, designed for homol. modeling, and is now available as a dynamic-linked library for incorporation into other software programs.  Proteins 2009. © 2009 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH9elI7_b5prVg90H21EOLACvtfcHk0ljype-xGo3_sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSru7nN&md5=515b93d349447312958d8d7ebfe784c7</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fprot.22488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.22488%26sid%3Dliteratum%253Aachs%26aulast%3DKrivov%26aufirst%3DG.%2BG.%26aulast%3DShapovalov%26aufirst%3DM.%2BV.%26aulast%3DDunbrack%26aufirst%3DR.%2BL.%26atitle%3DImproved%2520prediction%2520of%2520protein%2520side-chain%2520conformations%2520with%2520SCWRL4%26jtitle%3DProteins%26date%3D2009%26volume%3D77%26spage%3D778%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Phillips, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gumbart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajkhorshid, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chipot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skeel, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kale, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulten, K.</span><span> </span><span class="NLM_article-title">Scalable molecular dynamics with NAMD</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1802</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1002%2Fjcc.20289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=16222654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1781-1802&author=J.+C.+Phillipsauthor=R.+Braunauthor=W.+Wangauthor=J.+Gumbartauthor=E.+Tajkhorshidauthor=E.+Villaauthor=C.+Chipotauthor=R.+D.+Skeelauthor=L.+Kaleauthor=K.+Schulten&title=Scalable+molecular+dynamics+with+NAMD"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Scalable molecular dynamics with NAMD</span></div><div class="casAuthors">Phillips, James C.; Braun, Rosemary; Wang, Wei; Gumbart, James; Tajkhorshid, Emad; Villa, Elizabeth; Chipot, Christophe; Skeel, Robert D.; Kale, Laxmikant; Schulten, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1781-1802</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">NAMD is a parallel mol. dynamics code designed for high-performance simulation of large biomol. systems.  NAMD scales to hundreds of processors on high-end parallel platforms, as well as tens of processors on low-cost commodity clusters, and also runs on individual desktop and laptop computers.  NAMD works with AMBER and CHARMM potential functions, parameters, and file formats.  This article, directed to novices as well as experts, first introduces concepts and methods used in the NAMD program, describing the classical mol. dynamics force field, equations of motion, and integration methods along with the efficient electrostatics evaluation algorithms employed and temp. and pressure controls used.  Features for steering the simulation across barriers and for calcg. both alchem. and conformational free energy differences are presented.  The motivations for and a roadmap to the internal design of NAMD, implemented in C++ and based on Charm++ parallel objects, are outlined.  The factors affecting the serial and parallel performance of a simulation are discussed.  Finally, typical NAMD use is illustrated with representative applications to a small, a medium, and a large biomol. system, highlighting particular features of NAMD, for example, the Tcl scripting language.  The article also provides a list of the key features of NAMD and discusses the benefits of combining NAMD with the mol. graphics/sequence anal. software VMD and the grid computing/collab. software BioCoRE.  NAMD is distributed free of charge with source code at www.ks.uiuc.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7fq_yG00T1rVg90H21EOLACvtfcHk0lhbzMaXepqqsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbJ&md5=189051128443b547f4300a1b8fb0e034</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20289%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DJ.%2BC.%26aulast%3DBraun%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DGumbart%26aufirst%3DJ.%26aulast%3DTajkhorshid%26aufirst%3DE.%26aulast%3DVilla%26aufirst%3DE.%26aulast%3DChipot%26aufirst%3DC.%26aulast%3DSkeel%26aufirst%3DR.%2BD.%26aulast%3DKale%26aufirst%3DL.%26aulast%3DSchulten%26aufirst%3DK.%26atitle%3DScalable%2520molecular%2520dynamics%2520with%2520NAMD%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D1781%26epage%3D1802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Hornak, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strockbine, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roitberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmerling, C.</span><span> </span><span class="NLM_article-title">Comparison of multiple Amber force fields and development of improved protein backbone parameters</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1002%2Fprot.21123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=16981200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWqt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2006&pages=712-725&author=V.+Hornakauthor=R.+Abelauthor=A.+Okurauthor=B.+Strockbineauthor=A.+Roitbergauthor=C.+Simmerling&title=Comparison+of+multiple+Amber+force+fields+and+development+of+improved+protein+backbone+parameters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of multiple Amber force fields and development of improved protein backbone parameters</span></div><div class="casAuthors">Hornak, Viktor; Abel, Robert; Okur, Asim; Strockbine, Bentley; Roitberg, Adrian; Simmerling, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">712-725</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The ff94 force field that is commonly assocd. with the Amber simulation package is one of the most widely used parameter sets for biomol. simulation.  After a decade of extensive use and testing, limitations in this force field, such as over-stabilization of α-helixes, were reported by the authors and other researchers.  This led to a no. of attempts to improve these parameters, resulting in a variety of "Amber" force fields and significant difficulty in detg. which should be used for a particular application.  The authors show that several of these continue to suffer from inadequate balance between different secondary structure elements.  In addn., the approach used in most of these studies neglected to account for the existence in Amber of two sets of backbone .vphi./ψ dihedral terms.  This led to parameter sets that provide unreasonable conformational preferences for glycine.  The authors report here an effort to improve the .vphi./ψ dihedral terms in the ff99 energy function.  Dihedral term parameters are based on fitting the energies of multiple conformations of glycine and alanine tetrapeptides from high level ab initio quantum mech. calcns.  The new parameters for backbone dihedrals replace those in the existing ff99 force field.  This parameter set, which the authors denote ff99SB, achieves a better balance of secondary structure elements as judged by improved distribution of backbone dihedrals for glycine and alanine with respect to PDB survey data.  It also accomplishes improved agreement with published exptl. data for conformational preferences of short alanine peptides and better accord with exptl. NMR relaxation data of test protein systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoASzza-Gd7Vg90H21EOLACvtfcHk0lhbzMaXepqqsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWqt7fM&md5=de683a26eca9e83ae524726e97ac22fa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fprot.21123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.21123%26sid%3Dliteratum%253Aachs%26aulast%3DHornak%26aufirst%3DV.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DOkur%26aufirst%3DA.%26aulast%3DStrockbine%26aufirst%3DB.%26aulast%3DRoitberg%26aufirst%3DA.%26aulast%3DSimmerling%26aufirst%3DC.%26atitle%3DComparison%2520of%2520multiple%2520Amber%2520force%2520fields%2520and%2520development%2520of%2520improved%2520protein%2520backbone%2520parameters%26jtitle%3DProteins%26date%3D2006%26volume%3D65%26spage%3D712%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Sanner, M. F.</span><span> </span><span class="NLM_article-title">Python: a programming language for software integration and development</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=10660911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=57-61&author=M.+F.+Sanner&title=Python%3A+a+programming+language+for+software+integration+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Python: a programming language for software integration and development</span></div><div class="casAuthors">Sanner, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-61</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The use of interpreted languages in biocomputing has been investigated to create a programmable, dynamic environment in which components can be tied together at a high level.  This work has demonstrated the benefits of such an approach and the features of the interpreted language that are key to successful component integration.  This involved Python, an interpreted, interactive, object-oriented programming language.  It provides high-level data structures such as list and associative arrays, dynamic typing and dynamic binding, modules, classes, exceptions, automatic memory management and others.  Python has been found to be instrumental in the mol. modeling research environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaCFXA1JC8X7Vg90H21EOLACvtfcHk0lhbzMaXepqqsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D&md5=3bf94934548080055dda54f68468c656</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanner%26aufirst%3DM.%2BF.%26atitle%3DPython%253A%2520a%2520programming%2520language%2520for%2520software%2520integration%2520and%2520development%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D1999%26volume%3D17%26spage%3D57%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-61&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0lgZ6eNzijrNdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 51 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zijian Qin, Yao Xi, Shengde Zhang, Guiping Tu, <span class="NLM_string-name hlFld-ContribAuthor">Aixia Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Classification of Cyclooxygenase-2 Inhibitors Using Support Vector Machine and Random Forest Methods. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (5)
                                     , 1988-2008. <a href="https://doi.org/10.1021/acs.jcim.8b00876" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00876</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00876%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DClassification%252Bof%252BCyclooxygenase-2%252BInhibitors%252BUsing%252BSupport%252BVector%252BMachine%252Band%252BRandom%252BForest%252BMethods%26aulast%3DQin%26aufirst%3DZijian%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D29112018%26date%3D26022019%26date%3D14022019%26volume%3D59%26issue%3D5%26spage%3D1988%26epage%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jose Antonio  Ortega</span>, <span class="hlFld-ContribAuthor ">Laura  Riccardi</span>, <span class="hlFld-ContribAuthor ">Elirosa  Minniti</span>, <span class="hlFld-ContribAuthor ">Marco  Borgogno</span>, <span class="hlFld-ContribAuthor ">Jose M.  Arencibia</span>, <span class="hlFld-ContribAuthor ">Maria L.  Greco</span>, <span class="hlFld-ContribAuthor ">Anna  Minarini</span>, <span class="hlFld-ContribAuthor ">Claudia  Sissi</span>, and <span class="hlFld-ContribAuthor ">Marco  De Vivo</span>  . </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Hybridization To Discover Novel Topoisomerase II Poisons with Promising Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1375-1379. <a href="https://doi.org/10.1021/acs.jmedchem.7b01388" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01388%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPharmacophore%252BHybridization%252BTo%252BDiscover%252BNovel%252BTopoisomerase%252BII%252BPoisons%252Bwith%252BPromising%252BAntiproliferative%252BActivity%26aulast%3DOrtega%26aufirst%3DJose%2BAntonio%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D19092017%26date%3D09112017%26date%3D08022018%26date%3D27102017%26volume%3D61%26issue%3D3%26spage%3D1375%26epage%3D1379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jose Antonio  Ortega</span>, <span class="hlFld-ContribAuthor ">Jose M.  Arencibia</span>, <span class="hlFld-ContribAuthor ">Giuseppina  La Sala</span>, <span class="hlFld-ContribAuthor ">Marco  Borgogno</span>, <span class="hlFld-ContribAuthor ">Inga  Bauer</span>, <span class="hlFld-ContribAuthor ">Luca  Bono</span>, <span class="hlFld-ContribAuthor ">Clarissa  Braccia</span>, <span class="hlFld-ContribAuthor ">Andrea  Armirotti</span>, <span class="hlFld-ContribAuthor ">Stefania  Girotto</span>, <span class="hlFld-ContribAuthor ">Anand  Ganesan</span>, and <span class="hlFld-ContribAuthor ">Marco  De Vivo</span>  . </span><span class="cited-content_cbyCitation_article-title">Pharmacophore Identification and Scaffold Exploration to Discover Novel, Potent, and Chemically Stable Inhibitors of Acid Ceramidase in Melanoma Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5800-5815. <a href="https://doi.org/10.1021/acs.jmedchem.7b00472" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPharmacophore%252BIdentification%252Band%252BScaffold%252BExploration%252Bto%252BDiscover%252BNovel%25252C%252BPotent%25252C%252Band%252BChemically%252BStable%252BInhibitors%252Bof%252BAcid%252BCeramidase%252Bin%252BMelanoma%252BCells%26aulast%3DOrtega%26aufirst%3DJose%2BAntonio%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D31032017%26date%3D27062017%26date%3D13072017%26date%3D12062017%26volume%3D60%26issue%3D13%26spage%3D5800%26epage%3D5815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Palermo</span>, <span class="hlFld-ContribAuthor ">Pablo  Campomanes</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>, <span class="hlFld-ContribAuthor ">Ursula  Rothlisberger</span>, and <span class="hlFld-ContribAuthor ">Marco  De Vivo</span>  . </span><span class="cited-content_cbyCitation_article-title">Anandamide Hydrolysis in FAAH Reveals a Dual Strategy for Efficient Enzyme-Assisted Amide Bond Cleavage via Nitrogen Inversion. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2015,</strong> <em>119 </em>
                                    (3)
                                     , 789-801. <a href="https://doi.org/10.1021/jp5052276" title="DOI URL">https://doi.org/10.1021/jp5052276</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jp5052276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjp5052276%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DAnandamide%252BHydrolysis%252Bin%252BFAAH%252BReveals%252Ba%252BDual%252BStrategy%252Bfor%252BEfficient%252BEnzyme-Assisted%252BAmide%252BBond%252BCleavage%252Bvia%252BNitrogen%252BInversion%26aulast%3DPalermo%26aufirst%3DGiulia%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D28052014%26date%3D08082014%26date%3D03102014%26date%3D22012015%26date%3D10092014%26volume%3D119%26issue%3D3%26spage%3D789%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoine  Caron</span>, <span class="hlFld-ContribAuthor ">Augusto C.  Hernandez-Perez</span>, and <span class="hlFld-ContribAuthor ">Shawn K.  Collins</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of a Carprofen Analogue Using a Continuous Flow UV-Reactor. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2014,</strong> <em>18 </em>
                                    (11)
                                     , 1571-1574. <a href="https://doi.org/10.1021/op5002148" title="DOI URL">https://doi.org/10.1021/op5002148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op5002148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop5002148%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DSynthesis%252Bof%252Ba%252BCarprofen%252BAnalogue%252BUsing%252Ba%252BContinuous%252BFlow%252BUV-Reactor%26aulast%3DCaron%26aufirst%3DAntoine%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D02072014%26date%3D28082014%26date%3D21112014%26date%3D26082014%26volume%3D18%26issue%3D11%26spage%3D1571%26epage%3D1574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayendra Z.  Patel</span>, <span class="hlFld-ContribAuthor ">Teija  Parkkari</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>, <span class="hlFld-ContribAuthor ">Agnieszka A.  Kaczor</span>, <span class="hlFld-ContribAuthor ">Susanna M.  Saario</span>, <span class="hlFld-ContribAuthor ">Juha R.  Savinainen</span>, <span class="hlFld-ContribAuthor ">Dina  Navia-Paldanius</span>, <span class="hlFld-ContribAuthor ">Mariateresa  Cipriano</span>, <span class="hlFld-ContribAuthor ">Jukka  Leppänen</span>, <span class="hlFld-ContribAuthor ">Igor O.  Koshevoy</span>, <span class="hlFld-ContribAuthor ">Antti  Poso</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Fowler</span>, <span class="hlFld-ContribAuthor ">Jarmo T.  Laitinen</span>, and <span class="hlFld-ContribAuthor ">Tapio  Nevalainen</span>  . </span><span class="cited-content_cbyCitation_article-title">Chiral 1,3,4-Oxadiazol-2-ones as Highly Selective FAAH Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (21)
                                     , 8484-8496. <a href="https://doi.org/10.1021/jm400923s" title="DOI URL">https://doi.org/10.1021/jm400923s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400923s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400923s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChiral%252B1%25252C3%25252C4-Oxadiazol-2-ones%252Bas%252BHighly%252BSelective%252BFAAH%252BInhibitors%26aulast%3DPatel%26aufirst%3DJayendra%2BZ.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D20062013%26date%3D22102013%26date%3D14112013%26date%3D01102013%26volume%3D56%26issue%3D21%26spage%3D8484%26epage%3D8496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samir  Bondock</span>, <span class="hlFld-ContribAuthor ">Salwa  Alqahtani</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  Fouda</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer evaluation of some new pyrazolo[3,4‐
              d
              ][1,2,3]triazin‐4‐ones, pyrazolo[1,5‐
              a
              ]pyrimidines, and imidazo[1,2‐
              b
              ]pyrazoles clubbed with carbazole. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2021,</strong> <em>58 </em>
                                    (1)
                                     , 56-73. <a href="https://doi.org/10.1002/jhet.4148" title="DOI URL">https://doi.org/10.1002/jhet.4148</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.4148&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.4148%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bevaluation%252Bof%252Bsome%252Bnew%252Bpyrazolo%25255B3%25252C4%2525E2%252580%252590%252Bd%252B%25255D%25255B1%25252C2%25252C3%25255Dtriazin%2525E2%252580%2525904%2525E2%252580%252590ones%25252C%252Bpyrazolo%25255B1%25252C5%2525E2%252580%252590%252Ba%252B%25255Dpyrimidines%25252C%252Band%252Bimidazo%25255B1%25252C2%2525E2%252580%252590%252Bb%252B%25255Dpyrazoles%252Bclubbed%252Bwith%252Bcarbazole%26aulast%3DBondock%26aufirst%3DSamir%26date%3D2021%26date%3D2020%26volume%3D58%26issue%3D1%26spage%3D56%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Deplano</span>, <span class="hlFld-ContribAuthor ">Jessica  Karlsson</span>, <span class="hlFld-ContribAuthor ">Federica  Moraca</span>, <span class="hlFld-ContribAuthor ">Mona  Svensson</span>, <span class="hlFld-ContribAuthor ">Claudia  Cristiano</span>, <span class="hlFld-ContribAuthor ">Carmine Marco  Morgillo</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Fowler</span>, <span class="hlFld-ContribAuthor ">Roberto  Russo</span>, <span class="hlFld-ContribAuthor ">Bruno  Catalanotti</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and
              in vitro
              and
              in vivo
              biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential analgesic agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 940-953. <a href="https://doi.org/10.1080/14756366.2021.1875459" title="DOI URL">https://doi.org/10.1080/14756366.2021.1875459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2021.1875459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2021.1875459%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin%2525C2%2525A0vitro%252Band%252Bin%2525C2%2525A0vivo%252Bbiological%252Bevaluation%252Bof%252Bflurbiprofen%252Bamides%252Bas%252Bnew%252Bfatty%252Bacid%252Bamide%252Bhydrolase%25252Fcyclooxygenase-2%252Bdual%252Binhibitory%252Bpotential%252Banalgesic%252Bagents%26aulast%3DDeplano%26aufirst%3DAlessandro%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D940%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samir  Bondock</span>, <span class="hlFld-ContribAuthor ">Tamer  Nasr</span>, <span class="hlFld-ContribAuthor ">Salwa  Alqahtanti</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and In Vitro Antitumor Evaluation of Some Carbazole‐Based Thiazole, Thiophene, and 1,3,4‐Thiadiazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2020,</strong> <em>5 </em>
                                    (39)
                                     , 12087-12097. <a href="https://doi.org/10.1002/slct.202002912" title="DOI URL">https://doi.org/10.1002/slct.202002912</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202002912&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202002912%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Band%252BIn%252BVitro%252BAntitumor%252BEvaluation%252Bof%252BSome%252BCarbazole%2525E2%252580%252590Based%252BThiazole%25252C%252BThiophene%25252C%252Band%252B1%25252C3%25252C4%2525E2%252580%252590Thiadiazole%252BDerivatives%26aulast%3DBondock%26aufirst%3DSamir%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D39%26spage%3D12087%26epage%3D12097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonardo  Brunetti</span>, <span class="hlFld-ContribAuthor ">Antonio  Carrieri</span>, <span class="hlFld-ContribAuthor ">Luca  Piemontese</span>, <span class="hlFld-ContribAuthor ">Paolo  Tortorella</span>, <span class="hlFld-ContribAuthor ">Fulvio  Loiodice</span>, <span class="hlFld-ContribAuthor ">Antonio  Laghezza</span>. </span><span class="cited-content_cbyCitation_article-title">Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (19)
                                     , 7026. <a href="https://doi.org/10.3390/ijms21197026" title="DOI URL">https://doi.org/10.3390/ijms21197026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21197026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21197026%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DBeyond%252Bthe%252BCanonical%252BEndocannabinoid%252BSystem.%252BA%252BScreening%252Bof%252BPPAR%252BLigands%252Bas%252BFAAH%252BInhibitors%26aulast%3DBrunetti%26aufirst%3DLeonardo%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D19%26spage%3D7026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Deplano</span>, <span class="hlFld-ContribAuthor ">Jessica  Karlsson</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Fowler</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>. </span><span class="cited-content_cbyCitation_article-title">The fatty acid amide hydrolase and cyclooxygenase-inhibitory properties of novel amide derivatives of carprofen. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>101 </em>, 104034. <a href="https://doi.org/10.1016/j.bioorg.2020.104034" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104034</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104034%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DThe%252Bfatty%252Bacid%252Bamide%252Bhydrolase%252Band%252Bcyclooxygenase-inhibitory%252Bproperties%252Bof%252Bnovel%252Bamide%252Bderivatives%252Bof%252Bcarprofen%26aulast%3DDeplano%26aufirst%3DAlessandro%26date%3D2020%26volume%3D101%26spage%3D104034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Deplano</span>, <span class="hlFld-ContribAuthor ">Jessica  Karlsson</span>, <span class="hlFld-ContribAuthor ">Mona  Svensson</span>, <span class="hlFld-ContribAuthor ">Federica  Moraca</span>, <span class="hlFld-ContribAuthor ">Bruno  Catalanotti</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Fowler</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 815-823. <a href="https://doi.org/10.1080/14756366.2020.1743283" title="DOI URL">https://doi.org/10.1080/14756366.2020.1743283</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1743283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1743283%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DExploring%252Bthe%252Bfatty%252Bacid%252Bamide%252Bhydrolase%252Band%252Bcyclooxygenase%252Binhibitory%252Bproperties%252Bof%252Bnovel%252Bamide%252Bderivatives%252Bof%252Bibuprofen%26aulast%3DDeplano%26aufirst%3DAlessandro%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D815%26epage%3D823" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Richa  Mishra</span>, <span class="hlFld-ContribAuthor ">Soumendra  Rana</span>. </span><span class="cited-content_cbyCitation_article-title">A rational search for discovering potential neutraligands of human complement fragment 5a (hC5a). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (19)
                                     , 115052. <a href="https://doi.org/10.1016/j.bmc.2019.115052" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115052%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DA%252Brational%252Bsearch%252Bfor%252Bdiscovering%252Bpotential%252Bneutraligands%252Bof%252Bhuman%252Bcomplement%252Bfragment%252B5a%252B%252528hC5a%252529%26aulast%3DMishra%26aufirst%3DRicha%26date%3D2019%26volume%3D27%26issue%3D19%26spage%3D115052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kangni  Wu</span>, <span class="hlFld-ContribAuthor ">Yanghui  Xiu</span>, <span class="hlFld-ContribAuthor ">Pan  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan  Qiu</span>, <span class="hlFld-ContribAuthor ">Yuhang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">A New Use for an Old Drug: Carmofur Attenuates Lipopolysaccharide (LPS)-Induced Acute Lung Injury via Inhibition of FAAH and NAAA Activities. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fphar.2019.00818" title="DOI URL">https://doi.org/10.3389/fphar.2019.00818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2019.00818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2019.00818%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DA%252BNew%252BUse%252Bfor%252Ban%252BOld%252BDrug%25253A%252BCarmofur%252BAttenuates%252BLipopolysaccharide%252B%252528LPS%252529-Induced%252BAcute%252BLung%252BInjury%252Bvia%252BInhibition%252Bof%252BFAAH%252Band%252BNAAA%252BActivities%26aulast%3DWu%26aufirst%3DKangni%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Le  Guo</span>, <span class="hlFld-ContribAuthor ">Junjie  Mao</span>, <span class="hlFld-ContribAuthor ">Shuangxi  Guo</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Shuangfei  Cai</span>, <span class="hlFld-ContribAuthor ">Wei  He</span>. </span><span class="cited-content_cbyCitation_article-title">PtAu bimetallic nanocatalyst for selective hydrogenation of alkenes over aryl halides. </span><span class="cited-content_cbyCitation_journal-name">Nano Research</span><span> <strong>2019,</strong> <em>12 </em>
                                    (7)
                                     , 1659-1662. <a href="https://doi.org/10.1007/s12274-019-2416-6" title="DOI URL">https://doi.org/10.1007/s12274-019-2416-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12274-019-2416-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12274-019-2416-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNano%2520Research%26atitle%3DPtAu%252Bbimetallic%252Bnanocatalyst%252Bfor%252Bselective%252Bhydrogenation%252Bof%252Balkenes%252Bover%252Baryl%252Bhalides%26aulast%3DGuo%26aufirst%3DLe%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D7%26spage%3D1659%26epage%3D1662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adimulam  Yesu Babu</span>, <span class="hlFld-ContribAuthor ">Deepak  Nedunuri</span>, <span class="hlFld-ContribAuthor ">Ch  Madhava Rao</span>. </span><span class="cited-content_cbyCitation_article-title">Computational prediction and validation studies on a diverse dataset of cox-2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Physics: Conference Series</span><span> <strong>2019,</strong> <em>1228 </em>, 012011. <a href="https://doi.org/10.1088/1742-6596/1228/1/012011" title="DOI URL">https://doi.org/10.1088/1742-6596/1228/1/012011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1088/1742-6596/1228/1/012011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1088%2F1742-6596%2F1228%2F1%2F012011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Physics%253A%2520Conference%2520Series%26atitle%3DComputational%252Bprediction%252Band%252Bvalidation%252Bstudies%252Bon%252Ba%252Bdiverse%252Bdataset%252Bof%252Bcox-2%252Binhibitors%26aulast%3DYesu%2BBabu%26aufirst%3DAdimulam%26date%3D2019%26date%3D2019%26volume%3D1228%26spage%3D012011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed M.  Gouda</span>, <span class="hlFld-ContribAuthor ">Faisal A.  Almalki</span>. </span><span class="cited-content_cbyCitation_article-title">Carprofen: a theoretical mechanistic study to investigate the impact of hydrophobic interactions of alkyl groups on modulation of COX-1/2 binding selectivity. </span><span class="cited-content_cbyCitation_journal-name">SN Applied Sciences</span><span> <strong>2019,</strong> <em>1 </em>
                                    (4)
                                     <a href="https://doi.org/10.1007/s42452-019-0335-5" title="DOI URL">https://doi.org/10.1007/s42452-019-0335-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s42452-019-0335-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs42452-019-0335-5%26sid%3Dliteratum%253Aachs%26jtitle%3DSN%2520Applied%2520Sciences%26atitle%3DCarprofen%25253A%252Ba%252Btheoretical%252Bmechanistic%252Bstudy%252Bto%252Binvestigate%252Bthe%252Bimpact%252Bof%252Bhydrophobic%252Binteractions%252Bof%252Balkyl%252Bgroups%252Bon%252Bmodulation%252Bof%252BCOX-1%25252F2%252Bbinding%252Bselectivity%26aulast%3DGouda%26aufirst%3DAhmed%2BM.%26date%3D2019%26date%3D2019%26volume%3D1%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Deplano</span>, <span class="hlFld-ContribAuthor ">Mariateresa  Cipriano</span>, <span class="hlFld-ContribAuthor ">Federica  Moraca</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Bruno  Catalanotti</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Fowler</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>. </span><span class="cited-content_cbyCitation_article-title">Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 562-576. <a href="https://doi.org/10.1080/14756366.2018.1532418" title="DOI URL">https://doi.org/10.1080/14756366.2018.1532418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1532418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1532418%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DBenzylamides%252Band%252Bpiperazinoarylamides%252Bof%252Bibuprofen%252Bas%252Bfatty%252Bacid%252Bamide%252Bhydrolase%252Binhibitors%26aulast%3DDeplano%26aufirst%3DAlessandro%26date%3D2019%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D562%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhuo  Chen</span>, <span class="hlFld-ContribAuthor ">Tingyuan  Yang</span>, <span class="hlFld-ContribAuthor ">Weisi  Wang</span>, <span class="hlFld-ContribAuthor ">Junmin  Yao</span>, <span class="hlFld-ContribAuthor ">Shaomin  Han</span>, <span class="hlFld-ContribAuthor ">Yi  Tao</span>, <span class="hlFld-ContribAuthor ">Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Liping  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Carbazole Aminoalcohols as Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (44)
                                     , 12630-12638. <a href="https://doi.org/10.1002/slct.201803029" title="DOI URL">https://doi.org/10.1002/slct.201803029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201803029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201803029%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BCarbazole%252BAminoalcohols%252Bas%252BAntitumor%252BAgents%26aulast%3DChen%26aufirst%3DZhuo%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D44%26spage%3D12630%26epage%3D12638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shivarudrappa H.  Pattanashetty</span>, <span class="hlFld-ContribAuthor ">K. M.  Hosamani</span>, <span class="hlFld-ContribAuthor ">Arun Kashivishwanath  Shettar</span>, <span class="hlFld-ContribAuthor ">R.  Mohammed Shafeeulla</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Computational Studies of Novel Carbazole N-phenylacetamide Hybrids as Potent Antibacterial, Anti-inflammatory, and Antioxidant Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2018,</strong> <em>55 </em>
                                    (7)
                                     , 1765-1774. <a href="https://doi.org/10.1002/jhet.3214" title="DOI URL">https://doi.org/10.1002/jhet.3214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.3214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.3214%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BComputational%252BStudies%252Bof%252BNovel%252BCarbazole%252BN-phenylacetamide%252BHybrids%252Bas%252BPotent%252BAntibacterial%25252C%252BAnti-inflammatory%25252C%252Band%252BAntioxidant%252BAgents%26aulast%3DPattanashetty%26aufirst%3DShivarudrappa%2BH.%26date%3D2018%26date%3D2018%26volume%3D55%26issue%3D7%26spage%3D1765%26epage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marek  Toczek</span>, <span class="hlFld-ContribAuthor ">Barbara  Malinowska</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced endocannabinoid tone as a potential target of pharmacotherapy. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2018,</strong> <em>204 </em>, 20-45. <a href="https://doi.org/10.1016/j.lfs.2018.04.054" title="DOI URL">https://doi.org/10.1016/j.lfs.2018.04.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2018.04.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2018.04.054%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DEnhanced%252Bendocannabinoid%252Btone%252Bas%252Ba%252Bpotential%252Btarget%252Bof%252Bpharmacotherapy%26aulast%3DToczek%26aufirst%3DMarek%26date%3D2018%26volume%3D204%26spage%3D20%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Chicca</span>, <span class="hlFld-ContribAuthor ">Chiara  Arena</span>, <span class="hlFld-ContribAuthor ">Simone  Bertini</span>, <span class="hlFld-ContribAuthor ">Francesca  Gado</span>, <span class="hlFld-ContribAuthor ">Elena  Ciaglia</span>, <span class="hlFld-ContribAuthor ">Mario  Abate</span>, <span class="hlFld-ContribAuthor ">Maria  Digiacomo</span>, <span class="hlFld-ContribAuthor ">Margherita  Lapillo</span>, <span class="hlFld-ContribAuthor ">Giulio  Poli</span>, <span class="hlFld-ContribAuthor ">Maurizio  Bifulco</span>, <span class="hlFld-ContribAuthor ">Marco  Macchia</span>, <span class="hlFld-ContribAuthor ">Tiziano  Tuccinardi</span>, <span class="hlFld-ContribAuthor ">Jürg  Gertsch</span>, <span class="hlFld-ContribAuthor ">Clementina  Manera</span>. </span><span class="cited-content_cbyCitation_article-title">Polypharmacological profile of 1,2-dihydro-2-oxo-pyridine-3-carboxamides in the endocannabinoid system. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>154 </em>, 155-171. <a href="https://doi.org/10.1016/j.ejmech.2018.05.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.05.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.05.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPolypharmacological%252Bprofile%252Bof%252B1%25252C2-dihydro-2-oxo-pyridine-3-carboxamides%252Bin%252Bthe%252Bendocannabinoid%252Bsystem%26aulast%3DChicca%26aufirst%3DAndrea%26date%3D2018%26volume%3D154%26spage%3D155%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael C.  Goodman</span>, <span class="hlFld-ContribAuthor ">Shu  Xu</span>, <span class="hlFld-ContribAuthor ">Carol A.  Rouzer</span>, <span class="hlFld-ContribAuthor ">Surajit  Banerjee</span>, <span class="hlFld-ContribAuthor ">Kebreab  Ghebreselasie</span>, <span class="hlFld-ContribAuthor ">Marco  Migliore</span>, <span class="hlFld-ContribAuthor ">Daniele  Piomelli</span>, <span class="hlFld-ContribAuthor ">Lawrence J.  Marnett</span>. </span><span class="cited-content_cbyCitation_article-title">Dual cyclooxygenase–fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2018,</strong> <em>293 </em>
                                    (9)
                                     , 3028-3038. <a href="https://doi.org/10.1074/jbc.M117.802058" title="DOI URL">https://doi.org/10.1074/jbc.M117.802058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M117.802058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M117.802058%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DDual%252Bcyclooxygenase%2525E2%252580%252593fatty%252Bacid%252Bamide%252Bhydrolase%252Binhibitor%252Bexploits%252Bnovel%252Bbinding%252Binteractions%252Bin%252Bthe%252Bcyclooxygenase%252Bactive%252Bsite%26aulast%3DGoodman%26aufirst%3DMichael%2BC.%26date%3D2018%26volume%3D293%26issue%3D9%26spage%3D3028%26epage%3D3038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  You</span>, <span class="hlFld-ContribAuthor ">Daqian  Zhu</span>, <span class="hlFld-ContribAuthor ">Wenhua  Lu</span>, <span class="hlFld-ContribAuthor ">Yichen  Sun</span>, <span class="hlFld-ContribAuthor ">Shuang  Qiao</span>, <span class="hlFld-ContribAuthor ">Bingling  Luo</span>, <span class="hlFld-ContribAuthor ">Yongliang  Du</span>, <span class="hlFld-ContribAuthor ">Rongbiao  Pi</span>, <span class="hlFld-ContribAuthor ">Yumin  Hu</span>, <span class="hlFld-ContribAuthor ">Peng  Huang</span>, <span class="hlFld-ContribAuthor ">Shijun  Wen</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of
              N
              -arylsulfonyl carbazoles as novel anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (31)
                                     , 17183-17190. <a href="https://doi.org/10.1039/C8RA02939C" title="DOI URL">https://doi.org/10.1039/C8RA02939C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8RA02939C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8RA02939C%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN%252B-arylsulfonyl%252Bcarbazoles%252Bas%252Bnovel%252Banticancer%252Bagents%26aulast%3DYou%26aufirst%3DXin%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D31%26spage%3D17183%26epage%3D17190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Costantino</span>, <span class="hlFld-ContribAuthor ">Daniela  Barlocco</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Approaches to Multitarget Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 161-205. <a href="https://doi.org/10.1002/9783527674381.ch7" title="DOI URL">https://doi.org/10.1002/9783527674381.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DDesigning%252BApproaches%252Bto%252BMultitarget%252BDrugs%26aulast%3DCostantino%26aufirst%3DLuca%26date%3D2017%26date%3D2017%26spage%3D161%26epage%3D205%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Deplano</span>, <span class="hlFld-ContribAuthor ">Carmine Marco  Morgillo</span>, <span class="hlFld-ContribAuthor ">Monica  Demurtas</span>, <span class="hlFld-ContribAuthor ">Emmelie  Björklund</span>, <span class="hlFld-ContribAuthor ">Mariateresa  Cipriano</span>, <span class="hlFld-ContribAuthor ">Mona  Svensson</span>, <span class="hlFld-ContribAuthor ">Sanaz  Hashemian</span>, <span class="hlFld-ContribAuthor ">Giovanni  Smaldone</span>, <span class="hlFld-ContribAuthor ">Emilia  Pedone</span>, <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>, <span class="hlFld-ContribAuthor ">Maria G.  Cabiddu</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Fowler</span>, <span class="hlFld-ContribAuthor ">Bruno  Catalanotti</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>. </span><span class="cited-content_cbyCitation_article-title">Novel propanamides as fatty acid amide hydrolase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>136 </em>, 523-542. <a href="https://doi.org/10.1016/j.ejmech.2017.05.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.05.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.05.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.05.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252Bpropanamides%252Bas%252Bfatty%252Bacid%252Bamide%252Bhydrolase%252Binhibitors%26aulast%3DDeplano%26aufirst%3DAlessandro%26date%3D2017%26volume%3D136%26spage%3D523%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Riccardi</span>, <span class="hlFld-ContribAuthor ">Jose M.  Arencibia</span>, <span class="hlFld-ContribAuthor ">Luca  Bono</span>, <span class="hlFld-ContribAuthor ">Andrea  Armirotti</span>, <span class="hlFld-ContribAuthor ">Stefania  Girotto</span>, <span class="hlFld-ContribAuthor ">Marco  De Vivo</span>. </span><span class="cited-content_cbyCitation_article-title">Lid domain plasticity and lipid flexibility modulate enzyme specificity in human monoacylglycerol lipase. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</span><span> <strong>2017,</strong> <em>1862 </em>
                                    (5)
                                     , 441-451. <a href="https://doi.org/10.1016/j.bbalip.2017.01.002" title="DOI URL">https://doi.org/10.1016/j.bbalip.2017.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbalip.2017.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbalip.2017.01.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520and%2520Cell%2520Biology%2520of%2520Lipids%26atitle%3DLid%252Bdomain%252Bplasticity%252Band%252Blipid%252Bflexibility%252Bmodulate%252Benzyme%252Bspecificity%252Bin%252Bhuman%252Bmonoacylglycerol%252Blipase%26aulast%3DRiccardi%26aufirst%3DLaura%26date%3D2017%26volume%3D1862%26issue%3D5%26spage%3D441%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Methods in Multitarget Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 239-258. <a href="https://doi.org/10.1016/B978-0-08-101011-2.00009-X" title="DOI URL">https://doi.org/10.1016/B978-0-08-101011-2.00009-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-101011-2.00009-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-101011-2.00009-X%26sid%3Dliteratum%253Aachs%26atitle%3DComputational%252BMethods%252Bin%252BMultitarget%252BDrug%252BDiscovery%26aulast%3DBottegoni%26aufirst%3DGiovanni%26date%3D2017%26spage%3D239%26epage%3D258%26pub%3DElsevier%26atitle%3DDesign%252Bof%252BHybrid%252BMolecules%252Bfor%252BDrug%252BDevelopment%26date%3D2017%26volume%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Qiu</span>, <span class="hlFld-ContribAuthor ">Jie  Ren</span>, <span class="hlFld-ContribAuthor ">Hongwei  Ke</span>, <span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Longhe  Yang</span>, <span class="hlFld-ContribAuthor ">Canzhong  Lu</span>, <span class="hlFld-ContribAuthor ">Yuhang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of uracil urea derivatives as potent and selective fatty acid amide hydrolase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (37)
                                     , 22699-22705. <a href="https://doi.org/10.1039/C7RA02237A" title="DOI URL">https://doi.org/10.1039/C7RA02237A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA02237A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA02237A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Buracil%252Burea%252Bderivatives%252Bas%252Bpotent%252Band%252Bselective%252Bfatty%252Bacid%252Bamide%252Bhydrolase%252Binhibitors%26aulast%3DQiu%26aufirst%3DYan%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D37%26spage%3D22699%26epage%3D22705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarah M.  Thomas</span>, <span class="hlFld-ContribAuthor ">Andrei  Purmal</span>, <span class="hlFld-ContribAuthor ">Michael  Pollastri</span>, <span class="hlFld-ContribAuthor ">Kojo  Mensa-Wilmot</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Carbazole-Derived Lead Drug for Human African Trypanosomiasis. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep32083" title="DOI URL">https://doi.org/10.1038/srep32083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep32083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep32083%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Bof%252Ba%252BCarbazole-Derived%252BLead%252BDrug%252Bfor%252BHuman%252BAfrican%252BTrypanosomiasis%26aulast%3DThomas%26aufirst%3DSarah%2BM.%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Aiello</span>, <span class="hlFld-ContribAuthor ">Gabriele  Carullo</span>, <span class="hlFld-ContribAuthor ">Mariateresa  Badolato</span>, <span class="hlFld-ContribAuthor ">Antonella  Brizzi</span>. </span><span class="cited-content_cbyCitation_article-title">TRPV1-FAAH-COX: The
              Couples Game
              in Pain Treatment. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (16)
                                     , 1686-1694. <a href="https://doi.org/10.1002/cmdc.201600111" title="DOI URL">https://doi.org/10.1002/cmdc.201600111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600111%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTRPV1-FAAH-COX%25253A%252BThe%252BCouples%252BGame%252Bin%252BPain%252BTreatment%26aulast%3DAiello%26aufirst%3DFrancesca%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D16%26spage%3D1686%26epage%3D1694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rita  Scarpelli</span>, <span class="hlFld-ContribAuthor ">Oscar  Sasso</span>, <span class="hlFld-ContribAuthor ">Daniele  Piomelli</span>. </span><span class="cited-content_cbyCitation_article-title">A
              Double Whammy
              : Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (12)
                                     , 1242-1251. <a href="https://doi.org/10.1002/cmdc.201500395" title="DOI URL">https://doi.org/10.1002/cmdc.201500395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500395%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DA%252BDouble%252BWhammy%252B%25253A%252BTargeting%252BBoth%252BFatty%252BAcid%252BAmide%252BHydrolase%252B%252528FAAH%252529%252Band%252BCyclooxygenase%252B%252528COX%252529%252BTo%252BTreat%252BPain%252Band%252BInflammation%26aulast%3DScarpelli%26aufirst%3DRita%26date%3D2016%26date%3D2015%26volume%3D11%26issue%3D12%26spage%3D1242%26epage%3D1251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Palermo</span>, <span class="hlFld-ContribAuthor ">Angelo D.  Favia</span>, <span class="hlFld-ContribAuthor ">Marino  Convertino</span>, <span class="hlFld-ContribAuthor ">Marco  De Vivo</span>. </span><span class="cited-content_cbyCitation_article-title">The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (12)
                                     , 1252-1258. <a href="https://doi.org/10.1002/cmdc.201500507" title="DOI URL">https://doi.org/10.1002/cmdc.201500507</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500507&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500507%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DThe%252BMolecular%252BBasis%252Bfor%252BDual%252BFatty%252BAcid%252BAmide%252BHydrolase%252B%252528FAAH%252529%25252FCyclooxygenase%252B%252528COX%252529%252BInhibition%26aulast%3DPalermo%26aufirst%3DGiulia%26date%3D2016%26date%3D2015%26volume%3D11%26issue%3D12%26spage%3D1252%26epage%3D1258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Marina  Veronesi</span>, <span class="hlFld-ContribAuthor ">Paola  Bisignano</span>, <span class="hlFld-ContribAuthor ">Puneet  Kacker</span>, <span class="hlFld-ContribAuthor ">Angelo D.  Favia</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>. </span><span class="cited-content_cbyCitation_article-title">Development and Application of a Virtual Screening Protocol for the Identification of Multitarget Fragments. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (12)
                                     , 1259-1263. <a href="https://doi.org/10.1002/cmdc.201500521" title="DOI URL">https://doi.org/10.1002/cmdc.201500521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500521%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDevelopment%252Band%252BApplication%252Bof%252Ba%252BVirtual%252BScreening%252BProtocol%252Bfor%252Bthe%252BIdentification%252Bof%252BMultitarget%252BFragments%26aulast%3DBottegoni%26aufirst%3DGiovanni%26date%3D2016%26date%3D2015%26volume%3D11%26issue%3D12%26spage%3D1259%26epage%3D1263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Introduction. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 1-38. <a href="https://doi.org/10.1002/9781118695692.ch1" title="DOI URL">https://doi.org/10.1002/9781118695692.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118695692.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118695692.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DIntroduction%26date%3D2016%26date%3D2016%26spage%3D1%26epage%3D38%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DIndole%252BRing%252BSynthesis%26aulast%3DGribble%26aufirst%3DGordon%2BW.%26date%3D2016%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Yan</span>, <span class="hlFld-ContribAuthor ">Miaobo  Pan</span>, <span class="hlFld-ContribAuthor ">Mian  Fu</span>, <span class="hlFld-ContribAuthor ">Jingjie  Wang</span>, <span class="hlFld-ContribAuthor ">Wenlong  Huang</span>, <span class="hlFld-ContribAuthor ">Hai  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel analgesic agents targeting both cyclooxygenase and TRPV1. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (4)
                                     , 849-857. <a href="https://doi.org/10.1016/j.bmc.2016.01.009" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.01.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.01.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Banalgesic%252Bagents%252Btargeting%252Bboth%252Bcyclooxygenase%252Band%252BTRPV1%26aulast%3DYan%26aufirst%3DLin%26date%3D2016%26volume%3D24%26issue%3D4%26spage%3D849%26epage%3D857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marco  Migliore</span>, <span class="hlFld-ContribAuthor ">Damien  Habrant</span>, <span class="hlFld-ContribAuthor ">Oscar  Sasso</span>, <span class="hlFld-ContribAuthor ">Clara  Albani</span>, <span class="hlFld-ContribAuthor ">Sine Mandrup  Bertozzi</span>, <span class="hlFld-ContribAuthor ">Andrea  Armirotti</span>, <span class="hlFld-ContribAuthor ">Daniele  Piomelli</span>, <span class="hlFld-ContribAuthor ">Rita  Scarpelli</span>. </span><span class="cited-content_cbyCitation_article-title">Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>109 </em>, 216-237. <a href="https://doi.org/10.1016/j.ejmech.2015.12.036" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.12.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.12.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.12.036%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%252Bmultitarget%252BFAAH-COX%252Binhibitors%25253A%252BDesign%252Band%252Bstructure-activity%252Brelationship%252Bstudies%26aulast%3DMigliore%26aufirst%3DMarco%26date%3D2016%26volume%3D109%26spage%3D216%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-Yuan  Lu</span>, <span class="hlFld-ContribAuthor ">Zhong-Chang  Wang</span>, <span class="hlFld-ContribAuthor ">Ting  Wei</span>, <span class="hlFld-ContribAuthor ">Xiao-Qiang  Yan</span>, <span class="hlFld-ContribAuthor ">Peng-Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of benzenesulfonamide-substituted 1,5-diarylpyrazoles containing phenylacetohydrazide derivatives as COX-1/COX-2 agents against solid tumors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (27)
                                     , 22917-22935. <a href="https://doi.org/10.1039/C6RA02168A" title="DOI URL">https://doi.org/10.1039/C6RA02168A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA02168A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA02168A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bbenzenesulfonamide-substituted%252B1%25252C5-diarylpyrazoles%252Bcontaining%252Bphenylacetohydrazide%252Bderivatives%252Bas%252BCOX-1%25252FCOX-2%252Bagents%252Bagainst%252Bsolid%252Btumors%26aulast%3DLu%26aufirst%3DXiao-Yuan%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D27%26spage%3D22917%26epage%3D22935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Consalvi</span>, <span class="hlFld-ContribAuthor ">Mariangela  Biava</span>, <span class="hlFld-ContribAuthor ">Giovanna  Poce</span>. </span><span class="cited-content_cbyCitation_article-title">COX inhibitors: a patent review (2011 – 2014). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (12)
                                     , 1357-1371. <a href="https://doi.org/10.1517/13543776.2015.1090973" title="DOI URL">https://doi.org/10.1517/13543776.2015.1090973</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2015.1090973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2015.1090973%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DCOX%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282011%252B%2525E2%252580%252593%252B2014%252529%26aulast%3DConsalvi%26aufirst%3DSara%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D12%26spage%3D1357%26epage%3D1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Karlsson</span>, <span class="hlFld-ContribAuthor ">Carmine M.  Morgillo</span>, <span class="hlFld-ContribAuthor ">Alessandro  Deplano</span>, <span class="hlFld-ContribAuthor ">Giovanni  Smaldone</span>, <span class="hlFld-ContribAuthor ">Emilia  Pedone</span>, <span class="hlFld-ContribAuthor ">F. Javier  Luque</span>, <span class="hlFld-ContribAuthor ">Mona  Svensson</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Cenzo  Congiu</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>, <span class="hlFld-ContribAuthor ">Bruno  Catalanotti</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Fowler</span>, . </span><span class="cited-content_cbyCitation_article-title">Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (11)
                                     , e0142711. <a href="https://doi.org/10.1371/journal.pone.0142711" title="DOI URL">https://doi.org/10.1371/journal.pone.0142711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0142711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0142711%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DInteraction%252Bof%252Bthe%252BN-%2525283-Methylpyridin-2-yl%252529amide%252BDerivatives%252Bof%252BFlurbiprofen%252Band%252BIbuprofen%252Bwith%252BFAAH%25253A%252BEnantiomeric%252BSelectivity%252Band%252BBinding%252BMode%26aulast%3DKarlsson%26aufirst%3DJessica%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D11%26spage%3De0142711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra  Gouveia-Figueira</span>, <span class="hlFld-ContribAuthor ">Jessica  Karlsson</span>, <span class="hlFld-ContribAuthor ">Alessandro  Deplano</span>, <span class="hlFld-ContribAuthor ">Sanaz  Hashemian</span>, <span class="hlFld-ContribAuthor ">Mona  Svensson</span>, <span class="hlFld-ContribAuthor ">Marcus  Fredriksson Sundbom</span>, <span class="hlFld-ContribAuthor ">Cenzo  Congiu</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Fowler</span>, . </span><span class="cited-content_cbyCitation_article-title">Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2015,</strong> <em>10 </em>
                                    (9)
                                     , e0139212. <a href="https://doi.org/10.1371/journal.pone.0139212" title="DOI URL">https://doi.org/10.1371/journal.pone.0139212</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0139212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0139212%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DCharacterisation%252Bof%252B%252528R%252529-2-%2525282-Fluorobiphenyl-4-yl%252529-N-%2525283-Methylpyridin-2-yl%252529Propanamide%252Bas%252Ba%252BDual%252BFatty%252BAcid%252BAmide%252BHydrolase%25253A%252BCyclooxygenase%252BInhibitor%26aulast%3DGouveia-Figueira%26aufirst%3DSandra%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D9%26spage%3De0139212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Palermo</span>, <span class="hlFld-ContribAuthor ">Inga  Bauer</span>, <span class="hlFld-ContribAuthor ">Pablo  Campomanes</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>, <span class="hlFld-ContribAuthor ">Andrea  Armirotti</span>, <span class="hlFld-ContribAuthor ">Stefania  Girotto</span>, <span class="hlFld-ContribAuthor ">Ursula  Rothlisberger</span>, <span class="hlFld-ContribAuthor ">Marco  De Vivo</span>, . </span><span class="cited-content_cbyCitation_article-title">Keys to Lipid Selection in Fatty Acid Amide Hydrolase Catalysis: Structural Flexibility, Gating Residues and Multiple Binding Pockets. </span><span class="cited-content_cbyCitation_journal-name">PLOS Computational Biology</span><span> <strong>2015,</strong> <em>11 </em>
                                    (6)
                                     , e1004231. <a href="https://doi.org/10.1371/journal.pcbi.1004231" title="DOI URL">https://doi.org/10.1371/journal.pcbi.1004231</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pcbi.1004231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pcbi.1004231%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Computational%2520Biology%26atitle%3DKeys%252Bto%252BLipid%252BSelection%252Bin%252BFatty%252BAcid%252BAmide%252BHydrolase%252BCatalysis%25253A%252BStructural%252BFlexibility%25252C%252BGating%252BResidues%252Band%252BMultiple%252BBinding%252BPockets%26aulast%3DPalermo%26aufirst%3DGiulia%26date%3D2015%26date%3D2015%26volume%3D11%26issue%3D6%26spage%3De1004231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar  Sasso</span>, <span class="hlFld-ContribAuthor ">Marco  Migliore</span>, <span class="hlFld-ContribAuthor ">Damien  Habrant</span>, <span class="hlFld-ContribAuthor ">Andrea  Armirotti</span>, <span class="hlFld-ContribAuthor ">Clara  Albani</span>, <span class="hlFld-ContribAuthor ">Maria  Summa</span>, <span class="hlFld-ContribAuthor ">Guillermo  Moreno‐Sanz</span>, <span class="hlFld-ContribAuthor ">Rita  Scarpelli</span>, <span class="hlFld-ContribAuthor ">Daniele  Piomelli</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti‐inflammatory drug‐dependent gastrointestinal damage. </span><span class="cited-content_cbyCitation_journal-name">The FASEB Journal</span><span> <strong>2015,</strong> <em>29 </em>
                                    (6)
                                     , 2616-2627. <a href="https://doi.org/10.1096/fj.15-270637" title="DOI URL">https://doi.org/10.1096/fj.15-270637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1096/fj.15-270637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1096%2Ffj.15-270637%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FASEB%2520Journal%26atitle%3DMultitarget%252Bfatty%252Bacid%252Bamide%252Bhydrolase%25252Fcyclooxygenase%252Bblockade%252Bsuppresses%252Bintestinal%252Binflammation%252Band%252Bprotects%252Bagainst%252Bnonsteroidal%252Banti%2525E2%252580%252590inflammatory%252Bdrug%2525E2%252580%252590dependent%252Bgastrointestinal%252Bdamage%26aulast%3DSasso%26aufirst%3DOscar%26date%3D2015%26date%3D2015%26volume%3D29%26issue%3D6%26spage%3D2616%26epage%3D2627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhong  Chen</span>, <span class="hlFld-ContribAuthor ">Zhong-Chang  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Qiang  Yan</span>, <span class="hlFld-ContribAuthor ">Peng-Fei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Yuan  Lu</span>, <span class="hlFld-ContribAuthor ">Long-Wang  Chen</span>, <span class="hlFld-ContribAuthor ">Hai-Liang  Zhu</span>, <span class="hlFld-ContribAuthor ">Hong-Wei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (9)
                                     , 1947-1951. <a href="https://doi.org/10.1016/j.bmcl.2015.03.022" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.03.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.03.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.03.022%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodeling%252Bof%252Bdihydropyrazole%252Bsulfonamide%252Bderivatives%252Bas%252Bpotential%252BCOX-1%25252FCOX-2%252Binhibitors%26aulast%3DChen%26aufirst%3DZhong%26date%3D2015%26volume%3D25%26issue%3D9%26spage%3D1947%26epage%3D1951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giulia  Palermo</span>, <span class="hlFld-ContribAuthor ">Ursula  Rothlisberger</span>, <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>, <span class="hlFld-ContribAuthor ">Marco  De Vivo</span>. </span><span class="cited-content_cbyCitation_article-title">Computational insights into function and inhibition of fatty acid amide hydrolase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>91 </em>, 15-26. <a href="https://doi.org/10.1016/j.ejmech.2014.09.037" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.09.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.09.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.09.037%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DComputational%252Binsights%252Binto%252Bfunction%252Band%252Binhibition%252Bof%252Bfatty%252Bacid%252Bamide%252Bhydrolase%26aulast%3DPalermo%26aufirst%3DGiulia%26date%3D2015%26volume%3D91%26spage%3D15%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabiana  Piscitelli</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Di Marzo</span>. </span><span class="cited-content_cbyCitation_article-title">The ever-expanding world of the endocannabinoids: A concise introduction. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, xxv-xlv. <a href="https://doi.org/10.1016/B978-0-12-417041-4.00024-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-417041-4.00024-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417041-4.00024-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417041-4.00024-2%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bever-expanding%252Bworld%252Bof%252Bthe%252Bendocannabinoids%25253A%252BA%252Bconcise%252Bintroduction%26aulast%3DPiscitelli%26aufirst%3DFabiana%26date%3D2015%26spage%3Dxxv%26epage%3Dxlv%26pub%3DElsevier%26atitle%3DCannabinoids%252Bin%252BNeurologic%252Band%252BMental%252BDisease%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Travis W.  Grim</span>, <span class="hlFld-ContribAuthor ">Sudeshna  Ghosh</span>, <span class="hlFld-ContribAuthor ">Ku-Lung  Hsu</span>, <span class="hlFld-ContribAuthor ">Benjamin F.  Cravatt</span>, <span class="hlFld-ContribAuthor ">Steven G.  Kinsey</span>, <span class="hlFld-ContribAuthor ">Aron H.  Lichtman</span>. </span><span class="cited-content_cbyCitation_article-title">Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Biochemistry and Behavior</span><span> <strong>2014,</strong> <em>124 </em>, 405-411. <a href="https://doi.org/10.1016/j.pbb.2014.07.008" title="DOI URL">https://doi.org/10.1016/j.pbb.2014.07.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pbb.2014.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pbb.2014.07.008%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Biochemistry%2520and%2520Behavior%26atitle%3DCombined%252Binhibition%252Bof%252BFAAH%252Band%252BCOX%252Bproduces%252Benhanced%252Banti-allodynic%252Beffects%252Bin%252Bmouse%252Bneuropathic%252Band%252Binflammatory%252Bpain%252Bmodels%26aulast%3DGrim%26aufirst%3DTravis%2BW.%26date%3D2014%26volume%3D124%26spage%3D405%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica  Karlsson</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Fowler</span>, . </span><span class="cited-content_cbyCitation_article-title">Inhibition of Endocannabinoid Metabolism by the Metabolites of Ibuprofen and Flurbiprofen. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2014,</strong> <em>9 </em>
                                    (7)
                                     , e103589. <a href="https://doi.org/10.1371/journal.pone.0103589" title="DOI URL">https://doi.org/10.1371/journal.pone.0103589</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0103589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0103589%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DInhibition%252Bof%252BEndocannabinoid%252BMetabolism%252Bby%252Bthe%252BMetabolites%252Bof%252BIbuprofen%252Band%252BFlurbiprofen%26aulast%3DKarlsson%26aufirst%3DJessica%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D7%26spage%3De103589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincenzo Di  Marzo</span>, <span class="hlFld-ContribAuthor ">Luciano De  Petrocellis</span>. </span><span class="cited-content_cbyCitation_article-title">Fifty years of ‘cannabinoid research’ and the need for a new nomenclature. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 261-289. <a href="https://doi.org/10.1002/9781118451281.ch8" title="DOI URL">https://doi.org/10.1002/9781118451281.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118451281.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118451281.ch8%26sid%3Dliteratum%253Aachs%26atitle%3DFifty%252Byears%252Bof%252B%2525E2%252580%252598cannabinoid%252Bresearch%2525E2%252580%252599%252Band%252Bthe%252Bneed%252Bfor%252Ba%252Bnew%252Bnomenclature%26aulast%3DMarzo%26aufirst%3DVincenzo%2BDi%26date%3D2014%26date%3D2014%26spage%3D261%26epage%3D289%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DCannabinoids%26aulast%3DDi%2BMarzo%26aufirst%3DVincenzo%26date%3D2014%26volume%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger G.  Pertwee</span>. </span><span class="cited-content_cbyCitation_article-title">Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the Nutrition Society</span><span> <strong>2014,</strong> <em>73 </em>
                                    (1)
                                     , 96-105. <a href="https://doi.org/10.1017/S0029665113003649" title="DOI URL">https://doi.org/10.1017/S0029665113003649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1017/S0029665113003649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1017%2FS0029665113003649%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520Nutrition%2520Society%26atitle%3DElevating%252Bendocannabinoid%252Blevels%25253A%252Bpharmacological%252Bstrategies%252Band%252Bpotential%252Btherapeutic%252Bapplications%26aulast%3DPertwee%26aufirst%3DRoger%2BG.%26date%3D2014%26date%3D2013%26volume%3D73%26issue%3D1%26spage%3D96%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariateresa  Cipriano</span>, <span class="hlFld-ContribAuthor ">Emmelie  Björklund</span>, <span class="hlFld-ContribAuthor ">Alan A.  Wilson</span>, <span class="hlFld-ContribAuthor ">Cenzo  Congiu</span>, <span class="hlFld-ContribAuthor ">Valentina  Onnis</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Fowler</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of fatty acid amide hydrolase and cyclooxygenase by the N-(3-methylpyridin-2-yl)amide derivatives of flurbiprofen and naproxen. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2013,</strong> <em>720 </em>
                                    (1-3)
                                     , 383-390. <a href="https://doi.org/10.1016/j.ejphar.2013.09.065" title="DOI URL">https://doi.org/10.1016/j.ejphar.2013.09.065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2013.09.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2013.09.065%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DInhibition%252Bof%252Bfatty%252Bacid%252Bamide%252Bhydrolase%252Band%252Bcyclooxygenase%252Bby%252Bthe%252BN-%2525283-methylpyridin-2-yl%252529amide%252Bderivatives%252Bof%252Bflurbiprofen%252Band%252Bnaproxen%26aulast%3DCipriano%26aufirst%3DMariateresa%26date%3D2013%26volume%3D720%26issue%3D1-3%26spage%3D383%26epage%3D390" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Circular tree based on pairwise Tanimoto distances between Daylight fingerprints of 382 diverse known COX inhibitors. To help in the interpretation, only selected molecules, belonging to different clusters, are depicted in proximity of their positions in the tree to highlight the structural diversity of the set. Carprofen is shown in the upper left corner.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Tree based on the pairwise Tanimoto fingerprint distances between the 25 COX inhibitors tested in the present study. The heat map highlights the distances calculated in the first 5 principal components space (variance explained >90%) originating from 10 physicochemical descriptors (i.e., net charge, MW, log <i>P</i>, log <i>S</i>, number of hydrogen bond donors, number of hydrogen bond acceptors, polar surface area, number of atoms, number of rings, and number of rotatable bonds).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Planned Chemical Variations of Carprofen, <b>1</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Deschlorinated Compound <b>2,</b> Ester <b>3</b>, and Amides <b>4</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H-Cube, H<sub>2</sub>, 10% Pd/C, EtOH, EtOAc, 60 °C, 40%; (b) MeOH, H<sub>2</sub>SO<sub>4</sub>, rt, 12 h, quantitative; (c) CDI, pyridine, 60 °C, 12 h, 85–86%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>6</b>, <b>8</b>, <b>10</b>, and <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>X, Cs<sub>2</sub>CO<sub>3</sub>, MeCN, reflux, 12 h, 32–99%; (b) R<sub>2</sub>SO<sub>2</sub>Cl, Et<sub>3</sub>N, DMAP, THF, reflux, 5 h, or 100 °C, 3 h, microwave, 35–78%; (c) R<sub>3</sub>NCO, Et<sub>3</sub>N, DMAP, THF, 100 °C, microwave, 10 h, 51–81%; (d) LiOH, MeOH, THF, H<sub>2</sub>O, 12 h, 21–85%; (e) 6 M HCl, THF, rt, 5 days, 80%; (f) hexyl chloroformate, Et<sub>3</sub>N, DMAP, THF, 100 °C, 3 h, microwave, 85%; (g) 6 M HCl, THF, rt, 3 days, 55%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>15</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, rt, 3 h, 84%; (b) acyl chloride, DMAP, Et<sub>3</sub>N, MeCN, rt, 2 h, 76–97% ; (c) H-Cube, H<sub>2</sub>, 1% or 5% Pd/C, rt, THF, 15–42%.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/medium/jm-2012-011146_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hydrophilic (light blue) and hydrophobic (orange) isocontour surfaces of FAAH-1 (A) and COX-2 (B). For the sake of clarity, relevant residues are highlighted as stick models with C atoms colored in cyan. The protein is shown as a transparent cyan tube. Substrates are methyl arachidonyl fluorophosphonate in FAAH and arachidonic acid in COX-2.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-20/jm3011146/production/images/large/jm-2012-011146_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3011146&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i96">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20301" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20301" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 63 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Wilson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Eon, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikail, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emery, P. C.</span><span> </span><span class="NLM_article-title">Major depression and insomnia in chronic pain</span> <span class="citation_source-journal">Clin. J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">77</span><span class="NLM_x">–</span> <span class="NLM_lpage">83</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1097%2F00002508-200203000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=11882770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADC%252BD387ltVSjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2002&pages=77-83&author=K.+G.+Wilsonauthor=M.+Y.+Erikssonauthor=J.+L.+D%E2%80%99Eonauthor=S.+F.+Mikailauthor=P.+C.+Emery&title=Major+depression+and+insomnia+in+chronic+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Major depression and insomnia in chronic pain</span></div><div class="casAuthors">Wilson Keith G; Eriksson Mariane Y; D'Eon Joyce L; Mikail Samuel F; Emery Patricia C</div><div class="citationInfo"><span class="NLM_cas:title">The Clinical journal of pain</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">77-83</span>
        ISSN:<span class="NLM_cas:issn">0749-8047</span>.
    </div><div class="casAbstract">OBJECTIVES:  Insomnia and depression are common problems for people with chronic pain, and previous research has found that each is correlated with measures of pain and disability.  The goal of this study was to examine the combined impact of major depression and insomnia on individuals with chronic pain.  METHODS:  The participants were patients with chronic musculoskeletal pain who underwent evaluation at an interdisciplinary treatment center.  On the basis of semistructured interviews, participants were classified in three groups depending on whether they: (1) met criteria for major depression with insomnia (n = 38); (2) had insomnia without major depression (n = 58); or (3) had neither insomnia nor major depression (n = 47).  The groups were then compared on self-report measures that included the McGill Pain Questionnaire, the Beck Depression Inventory, and the Multidimensional Pain Inventory.  RESULTS:  Participants with major depression and insomnia reported the most difficulty on measures of affective distress, life control, interference, and pain severity, although the insomniac patients without major depression also had elevated scores on some measures.  In regression analyses, insomnia severity ratings did not contribute uniquely to the prediction of psychosocial problems when depression was controlled, but they did contribute to the prediction of pain severity.  CONCLUSIONS:  These results suggest that patients with chronic pain and concurrent major depression and insomnia report the highest levels of pain-related impairment, but insomnia in the absence of major depression is also associated with increased pain and distress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4HhFGdCqV6oMcDoIzZtNkfW6udTcc2ebhYrLwthNapbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ltVSjtQ%253D%253D&md5=6a1d8b301e9d78ff65ebaa791febff2d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1097%2F00002508-200203000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002508-200203000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DK.%2BG.%26aulast%3DEriksson%26aufirst%3DM.%2BY.%26aulast%3DD%25E2%2580%2599Eon%26aufirst%3DJ.%2BL.%26aulast%3DMikail%26aufirst%3DS.%2BF.%26aulast%3DEmery%26aufirst%3DP.%2BC.%26atitle%3DMajor%2520depression%2520and%2520insomnia%2520in%2520chronic%2520pain%26jtitle%3DClin.%2520J.%2520Pain%26date%3D2002%26volume%3D18%26spage%3D77%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Morin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade, J.</span><span> </span><span class="NLM_article-title">Self-reported sleep and mood disturbance in chronic pain patients</span> <span class="citation_source-journal">Clin. J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">314</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1097%2F00002508-199812000-00007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=9874009" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADyaK1M%252FovFCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1998&pages=311-314&author=C.+M.+Morinauthor=D.+Gibsonauthor=J.+Wade&title=Self-reported+sleep+and+mood+disturbance+in+chronic+pain+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Self-reported sleep and mood disturbance in chronic pain patients</span></div><div class="casAuthors">Morin C M; Gibson D; Wade J</div><div class="citationInfo"><span class="NLM_cas:title">The Clinical journal of pain</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-4</span>
        ISSN:<span class="NLM_cas:issn">0749-8047</span>.
    </div><div class="casAbstract">OBJECTIVE:  To evaluate the prevalence of self-reported sleep disturbance and its relationship to mood disturbance in chronic pain patients.  DESIGN AND SETTING:  Survey of patients referred to a multidisciplinary outpatient pain clinic.  PATIENTS:  The sample consisted of 105 consecutive patients (59 men and 46 women), with an average age of 41.5 (SD +/-13.4) years.  MEASURES:  Self-report measures of sleep disturbance and visual analog scales of mood disturbance (anxiety and depression) and pain experience (intensity and unpleasantness).  RESULTS:  Patients were grouped according to whether they considered themselves "poor" (n = 68) or "good" (n = 37) sleepers.  Poor sleepers reported more difficulties initiating and maintaining sleep and greater pain intensity and pain unpleasantness than did good sleepers.  The two groups did not differ on measures of depressive or anxious mood.  CONCLUSION:  The results suggest that sleep disturbance is a prevalent complaint in chronic pain patients, but it is not always associated with an underlying mood disturbance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTul9RQ18hrcj0SWnHPWbmmfW6udTcc2ebhYrLwthNapbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252FovFCjtw%253D%253D&md5=ad5ca8e28454004a077a2df8a021ca1a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1097%2F00002508-199812000-00007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002508-199812000-00007%26sid%3Dliteratum%253Aachs%26aulast%3DMorin%26aufirst%3DC.%2BM.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DWade%26aufirst%3DJ.%26atitle%3DSelf-reported%2520sleep%2520and%2520mood%2520disturbance%2520in%2520chronic%2520pain%2520patients%26jtitle%3DClin.%2520J.%2520Pain%26date%3D1998%26volume%3D14%26spage%3D311%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Menefee, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doghramji, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picarello, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Schwartz, L.</span><span> </span><span class="NLM_article-title">Self-reported sleep quality and quality of life for individuals with chronic pain conditions</span> <span class="citation_source-journal">Clin. J. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1097%2F00002508-200012000-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=11153783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADC%252BD3M7jvVKhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2000&pages=290-297&author=L.+A.+Menefeeauthor=E.+D.+Frankauthor=K.+Doghramjiauthor=K.+Picarelloauthor=J.+J.+Parkauthor=S.+Jalaliauthor=L.+Perez-Schwartz&title=Self-reported+sleep+quality+and+quality+of+life+for+individuals+with+chronic+pain+conditions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Self-reported sleep quality and quality of life for individuals with chronic pain conditions</span></div><div class="casAuthors">Menefee L A; Frank E D; Doghramji K; Picarello K; Park J J; Jalali S; Perez-Schwartz L</div><div class="citationInfo"><span class="NLM_cas:title">The Clinical journal of pain</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">290-7</span>
        ISSN:<span class="NLM_cas:issn">0749-8047</span>.
    </div><div class="casAbstract">OBJECTIVE:  To determine the sleep quality and quality of life for individuals with degenerative spinal disease or failed back surgery syndrome.  DESIGN:  Cross-sectional survey design utilizing standardized instruments.  Data were analyzed with use of hierarchical stepwise multiple regression analyses.  PATIENTS:  One hundred sixty-seven individuals with degenerative spinal disease or postlaminectomy syndrome who presented to a tertiary care outpatient patient pain center.  OUTCOME MEASURES:  The Center for Epidemiological Studies Depression Index measured depressive symptomatology.  A modified Pittsburgh Sleep Quality Index (PSQI) measured sleep quality.  The arithmetic average of least and usual VAS ratings of pain measured everyday pain.  A visual analog scale rating of highest pain during the past 2 weeks measured highest pain.  The Epworth Sleepiness Scale measured daytime sleepiness.  The Medical Outcome Study-Short Form-Health Survey (SF-36) measured the mental health and general health components of quality of life.  RESULTS:  Higher overall sleep quality and lower sleep latency primarily were related to higher ratings of physical functioning and shorter duration of pain.  Ratings of the highest pain, but not everyday pain, were independent predictors of overall sleep quality and sleep latency.  Daytime sleepiness was associated with younger age and depressed mood.  Pain was not associated independently with daytime sleepiness.  The quality of life related to mental functioning was associated positively with depressed mood and with the interaction of pain and depressed mood.  None of the variables in the model (i.e., pain intensity, sleep quality, depression, and demographic variables) predicted quality of life related to overall general health.  CONCLUSIONS:  These data suggest that physical functioning, duration of pain, and age may be more important than pain intensity and depressed mood in contributing to decreased overall sleep quality and sleep latency.  The contribution of physical functioning was particularly strong and should be included in subsequent studies of sleep, pain, and mood.  The SF-36 should be compared to pain-specific quality-of-life measures to further evaluate the usefulness of this instrument with outpatients with chronic nonmalignant pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5pi1zkEdpnVw2ofyr07jXfW6udTcc2ebhYrLwthNapbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M7jvVKhuw%253D%253D&md5=7dc0ba7c02b2e4bb3686e3757c57dfa7</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1097%2F00002508-200012000-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002508-200012000-00003%26sid%3Dliteratum%253Aachs%26aulast%3DMenefee%26aufirst%3DL.%2BA.%26aulast%3DFrank%26aufirst%3DE.%2BD.%26aulast%3DDoghramji%26aufirst%3DK.%26aulast%3DPicarello%26aufirst%3DK.%26aulast%3DPark%26aufirst%3DJ.%2BJ.%26aulast%3DJalali%26aufirst%3DS.%26aulast%3DPerez-Schwartz%26aufirst%3DL.%26atitle%3DSelf-reported%2520sleep%2520quality%2520and%2520quality%2520of%2520life%2520for%2520individuals%2520with%2520chronic%2520pain%2520conditions%26jtitle%3DClin.%2520J.%2520Pain%26date%3D2000%26volume%3D16%26spage%3D290%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Stahl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briley, M.</span><span> </span><span class="NLM_article-title">Understanding pain in depression</span> <span class="citation_source-journal">Hum. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">S9</span><span class="NLM_x">–</span> <span class="NLM_lpage">S13</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2004&pages=S9-S13&issue=Suppl.+1&author=S.+Stahlauthor=M.+Briley&title=Understanding+pain+in+depression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStahl%26aufirst%3DS.%26aulast%3DBriley%26aufirst%3DM.%26atitle%3DUnderstanding%2520pain%2520in%2520depression%26jtitle%3DHum.%2520Psychopharmacol.%26date%3D2004%26volume%3D19%26issue%3DSuppl.%25201%26spage%3DS9%26epage%3DS13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Linton, S. J.</span><span> </span><span class="NLM_article-title">A review of psychological risk factors in back and neck pain</span> <span class="citation_source-journal">Spine (Philadelphia)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1148</span><span class="NLM_x">–</span> <span class="NLM_lpage">1156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1097%2F00007632-200005010-00017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=10788861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADC%252BD3c3ltFansw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2000&pages=1148-1156&author=S.+J.+Linton&title=A+review+of+psychological+risk+factors+in+back+and+neck+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A review of psychological risk factors in back and neck pain</span></div><div class="casAuthors">Linton S J</div><div class="citationInfo"><span class="NLM_cas:title">Spine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1148-56</span>
        ISSN:<span class="NLM_cas:issn">0362-2436</span>.
    </div><div class="casAbstract">STUDY DESIGN:  The literature on psychological factors in neck and back pain was systematically searched and reviewed.  OBJECTIVES:  To summarize current knowledge concerning the role of psychological variables in the etiology and development of neck and back pain.  SUMMARY OF BACKGROUND DATA:  Recent conceptions of spinal pain, especially chronic back pain, have highlighted the role of psychological factors.  Numerous studies subsequently have examined the effects of various psychological factors in neck and back pain.  There is a need to review this material to ascertain what conclusions may be drawn.  METHODS:  Medical and psychological databases and cross-referencing were used to locate 913 potentially relevant articles.  A table of 37 studies was constructed, consisting only of studies with prospective designs to ensure quality.  Each study was reviewed for the population studied, the psychological predictor variables, and the outcome.  RESULTS:  The available literature indicated a clear link between psychological variables and neck and back pain.  The prospective studies indicated that psychological variables were related to the onset of pain, and to acute, subacute, and chronic pain.  Stress, distress, or anxiety as well as mood and emotions, cognitive functioning, and pain behavior all were found to be significant factors.  Personality factors produced mixed results.  Although the level of evidence was low, abuse also was found to be a potentially significant factor.  CONCLUSIONS:  Psychological factors play a significant role not only in chronic pain, but also in the etiology of acute pain, particularly in the transition to chronic problems.  Specific types of psychological variables emerge and may be important in distinct developmental time frames, also implying that assessment and intervention need to reflect these variables.  Still, psychological factors account for only a portion of the variance, thereby highlighting the multidimensional view.  Because the methodologic quality of the studies varied considerably, future research should focus on improving quality and addressing new questions such as the mechanism, the developmental time factor, and the relevance that these risk factors have for intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTJFerIqvxa370AGQpJZWpJfW6udTcc2ebjQLDR4nRW-bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3ltFansw%253D%253D&md5=95777065afec0e30d1737f6c9bf4076f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1097%2F00007632-200005010-00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00007632-200005010-00017%26sid%3Dliteratum%253Aachs%26aulast%3DLinton%26aufirst%3DS.%2BJ.%26atitle%3DA%2520review%2520of%2520psychological%2520risk%2520factors%2520in%2520back%2520and%2520neck%2520pain%26jtitle%3DSpine%2520%2528Philadelphia%2529%26date%3D2000%26volume%3D25%26spage%3D1148%26epage%3D1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Fishbain, D. A.</span><span> </span><span class="NLM_article-title">The association of chronic pain and suicide</span> <span class="citation_source-journal">Semin. Clin. Neuropsychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=10498789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADyaK1Mvjt1Cgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=221-227&author=D.+A.+Fishbain&title=The+association+of+chronic+pain+and+suicide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The association of chronic pain and suicide</span></div><div class="casAuthors">Fishbain D A</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in clinical neuropsychiatry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-7</span>
        ISSN:<span class="NLM_cas:issn">1084-3612</span>.
    </div><div class="casAbstract">Chronic pain patients (CPPs) are at greater risk for depression than the general population.  As such, one would expect suicidal ideation, suicide attempts, and suicide completions to be commonly found within chronic pain (CP) populations.  To explore these issues, 18 studies relating to the association of CP and suicide were subjected to a structured review.  These studies indicated that suicide ideation, suicide attempts, and suicide completions are commonly found in CPP populations.  In addition, a number of controlled studies and suicide completion rate studies indicated that CP may be a suicide risk factor.  Finally, a review of known suicide risk factors from other populations indicated that CP populations commonly exhibit other suicide risk factors.  Psychiatric examiners should consider CP to be a potential suicide risk factor.  In addition, in all CPPs exhibiting suicidal behavior, a careful search for associated comorbid suicide risk factors should be initiated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfx2FlAHQi55ggzHGM8X5CfW6udTcc2ebjQLDR4nRW-bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1Mvjt1Cgsg%253D%253D&md5=1012d3f6872f4a396211712a8484c9ad</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFishbain%26aufirst%3DD.%2BA.%26atitle%3DThe%2520association%2520of%2520chronic%2520pain%2520and%2520suicide%26jtitle%3DSemin.%2520Clin.%2520Neuropsychiatry%26date%3D1999%26volume%3D4%26spage%3D221%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Tang, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, C.</span><span> </span><span class="NLM_article-title">Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links</span> <span class="citation_source-journal">Psychol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">575</span><span class="NLM_x">–</span> <span class="NLM_lpage">586</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1017%2FS0033291705006859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=16420727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADC%252BD283gtlantg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2006&pages=575-586&author=N.+K.+Tangauthor=C.+Crane&title=Suicidality+in+chronic+pain%3A+a+review+of+the+prevalence%2C+risk+factors+and+psychological+links"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Suicidality in chronic pain: a review of the prevalence, risk factors and psychological links</span></div><div class="casAuthors">Tang Nicole K Y; Crane Catherine</div><div class="citationInfo"><span class="NLM_cas:title">Psychological medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">575-86</span>
        ISSN:<span class="NLM_cas:issn">0033-2917</span>.
    </div><div class="casAbstract">BACKGROUND:  This paper reviews and integrates the growing literature concerning the prevalence of and risk factors for suicidality in chronic pain.  METHOD:  A series of systematic searches in MEDLINE and PsychINFO identified 12 relevant articles examining suicide, suicide attempts, and suicidal ideation in chronic pain.  A selection of theoretical and empirical work identifying psychological processes that have been implicated in both the pain and suicide literature and which may be related to increased suicidality was also reviewed.  RESULTS:  Relative to controls, risk of death by suicide appeared to be at least doubled in chronic pain patients.  The lifetime prevalence of suicide attempts was between 5% and 14% in individuals with chronic pain, with the prevalence of suicidal ideation being approximately 20%.  Eight risk factors for suicidality in chronic pain were identified, including the type, intensity and duration of pain and sleep-onset insomnia co-occurring with pain, which appeared to be pain-specific.  Helplessness and hopelessness about pain, the desire for escape from pain, pain catastrophizing and avoidance, and problem-solving deficits were highlighted as psychological processes relevant to the understanding of suicidality in chronic pain.  CONCLUSIONS:  Programmatic research is urgently required to investigate the role of both general and pain-specific risk factors for suicidality, to examine how the psychological processes mentioned above mediate or exacerbate suicidality, and to develop enhanced interventions for pain patients at risk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQJ66IkVJUyeDToTC3aBaesfW6udTcc2ebjQLDR4nRW-bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283gtlantg%253D%253D&md5=8068a07781b5368d4969209643da13be</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1017%2FS0033291705006859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0033291705006859%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DN.%2BK.%26aulast%3DCrane%26aufirst%3DC.%26atitle%3DSuicidality%2520in%2520chronic%2520pain%253A%2520a%2520review%2520of%2520the%2520prevalence%252C%2520risk%2520factors%2520and%2520psychological%2520links%26jtitle%3DPsychol.%2520Med.%26date%3D2006%26volume%3D36%26spage%3D575%26epage%3D586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Cyclooxygenase enzymes: catalysis and inhibition</span> <span class="citation_source-journal">Curr. Opin. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">752</span><span class="NLM_x">–</span> <span class="NLM_lpage">760</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1016%2FS0959-440X%2801%2900277-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=11751058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD3MXpt1aqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=752-760&author=R.+G.+Kurumbailauthor=J.+R.+Kieferauthor=L.+J.+Marnett&title=Cyclooxygenase+enzymes%3A+catalysis+and+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclooxygenase enzymes: catalysis and inhibition</span></div><div class="casAuthors">Kurumbail, Ravi G.; Kiefer, James R.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Structural Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">752-760</span>CODEN:
                <span class="NLM_cas:coden">COSBEF</span>;
        ISSN:<span class="NLM_cas:issn">0959-440X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review and discussion with 54 refs.  Scientists working in the field of cyclooxygenases have witnessed several major advances in the past 2 yr.  Crystal structures of fatty acid substrate and prostaglandin product complexes have been elucidated.  Elegant site-directed mutagenesis studies have pinpointed the roles of key amino acids within the active site.  Together, these results have provided key insights into the overall reaction mechanism.  Detailed kinetic, spectroscopic, and crystallog. studies have shed new light on the complex mechanism of inhibition of these fascinating enzymes.  Finally, novel substrates of cyclooxygenase-2 have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj4ySdndSyBLVg90H21EOLACvtfcHk0lhHTYxFUq1NOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXpt1aqsLs%253D&md5=5224cfc047b710642e6a1c1de5c5affe</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0959-440X%2801%2900277-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-440X%252801%252900277-9%26sid%3Dliteratum%253Aachs%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DCyclooxygenase%2520enzymes%253A%2520catalysis%2520and%2520inhibition%26jtitle%3DCurr.%2520Opin.%2520Struct.%2520Biol.%26date%3D2001%26volume%3D11%26spage%3D752%26epage%3D760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Blobaum, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Structural and functional basis of cyclooxygenase inhibition</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1425</span><span class="NLM_x">–</span> <span class="NLM_lpage">1441</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0613166" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFeisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1425-1441&author=A.+L.+Blobaumauthor=L.+J.+Marnett&title=Structural+and+functional+basis+of+cyclooxygenase+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Functional Basis of Cyclooxygenase Inhibition</span></div><div class="casAuthors">Blobaum, Anna L.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1425-1441</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  This review will focus on the structural and functional basis of the inhibition of cyclooxygenase (COX) enzymes by nonselective and COX-2 selective inhibitors.  It will integrate kinetic, mechanistic, and structural information to illustrate not only the range of mols. with COX inhibitory activity but also the diversity of mechanisms by which they act.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8SMg_SRasDLVg90H21EOLACvtfcHk0lgfBXRrBSxcOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFeisL8%253D&md5=b9de2eafa7d2b510c866245b09fba546</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm0613166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0613166%26sid%3Dliteratum%253Aachs%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DStructural%2520and%2520functional%2520basis%2520of%2520cyclooxygenase%2520inhibition%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1425%26epage%3D1441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Rouzer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Cyclooxygenases: structural and functional insights</span> <span class="citation_source-journal">J. Lipid Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl.</span><span class="NLM_x">) </span> <span class="NLM_fpage">S29</span><span class="NLM_x">–</span> <span class="NLM_lpage">S34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=S29-S34&issue=Suppl.&author=C.+A.+Rouzerauthor=L.+J.+Marnett&title=Cyclooxygenases%3A+structural+and+functional+insights"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRouzer%26aufirst%3DC.%2BA.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DCyclooxygenases%253A%2520structural%2520and%2520functional%2520insights%26jtitle%3DJ.%2520Lipid%2520Res.%26date%3D2009%26volume%3D50%26issue%3DSuppl%26spage%3DS29%26epage%3DS34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">The COXIB experience: a look in the rearview mirror</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1146%2Fannurev.pharmtox.011008.145638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=18851701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisV2jsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=265-290&author=L.+J.+Marnett&title=The+COXIB+experience%3A+a+look+in+the+rearview+mirror"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The COXIB experience: a look in the rearview mirror</span></div><div class="casAuthors">Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">265-290</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used prescription and nonprescription drugs in the world.  The discovery of cyclooxygenase (COX) as the target of NSAIDs, the subsequent identification of two isoforms of COX (COX-1 and COX-2), and studies of their regulation and sites of expression led to the hypothesis that COX-2 is the mol. target for the anti-inflammatory and analgesic effects of NSAIDs.  A corollary was that COX-2-selective inhibitors (COXIBs) would retain the desirable effects of NSAIDs without some of their liabilities (e.g., gastrointestinal toxicity, which was ascribed to COX-1 inhibition).  The first marketed COXIBs exhibited reduced gastrointestinal side effects relative to traditional NSAIDs and were enormous com. successes.  However, clin. trials testing the hypothesis that COXIBs prevent recurrence of premalignant colon polyps uncovered adverse cardiovascular effects that are mechanism based.  This review provides an overview of the discovery, development, and difficulties of the COXIBs, a perspective on what has been learned, and speculation on the way forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAJBE0T9Iu_7Vg90H21EOLACvtfcHk0lgfBXRrBSxcOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisV2jsb4%253D&md5=5147f02bf6314c86f1f707609a9d2fa5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.011008.145638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.011008.145638%26sid%3Dliteratum%253Aachs%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DThe%2520COXIB%2520experience%253A%2520a%2520look%2520in%2520the%2520rearview%2520mirror%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2009%26volume%3D49%26spage%3D265%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Naesdal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K.</span><span> </span><span class="NLM_article-title">NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options</span> <span class="citation_source-journal">Drug Saf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.2165%2F00002018-200629020-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=16454539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtlWrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=119-132&author=J.+Naesdalauthor=K.+Brown&title=NSAID-associated+adverse+effects+and+acid+control+aids+to+prevent+them%3A+a+review+of+current+treatment+options"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">NSAID-associated adverse effects and acid control aids to prevent them: a review of current treatment options</span></div><div class="casAuthors">Naesdal, Joergen; Brown, Kurt</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-132</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  NSAIDs are central to the clin. management of a wide range of conditions.  However, NSAIDs in combination with gastric acid, which has been shown to play a central role in upper gastrointestinal (GI) events, can damage the gastroduodenal mucosa and result in dyspeptic symptoms and peptic lesions such as ulceration.  NSAID-assocd. GI mucosal injury is an important clin. problem.  Gastroduodenal ulcers or ulcer complications occur in up to 25% of patients receiving NSAIDs.  However, these toxicities are often not preceded by indicative symptoms.  Data obtained from the Arthritis, Rheumatism, and Aging Medical Information System have shown that 50-60% of NSAID-assocd. peptic ulcer cases can remain clin. silent and do not present until complications occur.  Therefore, prophylactic treatment to prevent GI complications may be necessary in a substantial proportion of NSAID users, esp. those in groups assocd. with a high risk of developing these complications.  Use of cyclooxygenase (COX)-2 selective NSAIDs, also known as 'coxibs', substantially reduces the incidence of upper GI toxicities seen with non-selective NSAIDs.  However, there are concerns regarding the cardiovascular safety of coxibs.  For this reason, the US FDA recommends minimal use of coxibs and only when strictly necessary.  Addnl., rofecoxib has been removed from the US market and sales of valdecoxib have been suspended.  Furthermore, upper GI toxicities still occur in patients receiving coxibs.  Therefore, cotherapies are required to prevent and/or heal upper GI effects assocd. with NSAID use.  Effective prophylactic and treatment strategies include misoprostol, histamine H2 receptor antagonists and proton pump inhibitors (PPIs).  The key role that gastric acid plays in upper GI adverse events among NSAID users suggests that it is important to choose the most effective agent for acid control to alleviate symptoms, heal mucosal erosions and improve the reduced quality of life in this patient population.  PPIs provide effective acid suppression, which is essential to avoid GI mucosal injury, and they are, therefore, capable of dramatically decreasing the morbidity and mortality assocd. with this disorder.  Since many serious GI complications are not heralded by any previous symptoms, physicians need to be aware of risk factor profiles that predispose patients to serious GI problems.  Physicians also need to initiate the appropriate preventative acid suppressive therapy to minimize the burden of NSAID-assocd. GI adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLBdsUZ85VTbVg90H21EOLACvtfcHk0lgfBXRrBSxcOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtlWrsLc%253D&md5=d2c625dceeb0ce084a129a554dc77e7c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2165%2F00002018-200629020-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-200629020-00002%26sid%3Dliteratum%253Aachs%26aulast%3DNaesdal%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DK.%26atitle%3DNSAID-associated%2520adverse%2520effects%2520and%2520acid%2520control%2520aids%2520to%2520prevent%2520them%253A%2520a%2520review%2520of%2520current%2520treatment%2520options%26jtitle%3DDrug%2520Saf.%26date%3D2006%26volume%3D29%26spage%3D119%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Topol, E. J.</span><span> </span><span class="NLM_article-title">Failing the public health—rofecoxib, Merck, and the FDA</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">1707</span><span class="NLM_x">–</span> <span class="NLM_lpage">1709</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1056%2FNEJMp048286" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=15470193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovFSks7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2004&pages=1707-1709&author=E.+J.+Topol&title=Failing+the+public+health%E2%80%94rofecoxib%2C+Merck%2C+and+the+FDA"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Failing the public health - Rofecoxib, Merck, and the FDA</span></div><div class="casAuthors">Topol, Eric J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1707-1709</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvqA9LswLQxrVg90H21EOLACvtfcHk0lgfBXRrBSxcOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovFSks7g%253D&md5=2e9bc3805e6c50dcce0eaf737d6309c5</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1056%2FNEJMp048286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMp048286%26sid%3Dliteratum%253Aachs%26aulast%3DTopol%26aufirst%3DE.%2BJ.%26atitle%3DFailing%2520the%2520public%2520health%25E2%2580%2594rofecoxib%252C%2520Merck%252C%2520and%2520the%2520FDA%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2004%26volume%3D351%26spage%3D1707%26epage%3D1709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brideau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charleson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford-Hutchinson, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gresser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrier, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodger, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thérien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupniak, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visco, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patrick, D.</span><span> </span><span class="NLM_article-title">The discovery of rofecoxib, [MK 966, Vioxx, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1773</span><span class="NLM_x">–</span> <span class="NLM_lpage">1778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1773-1778&author=P.+Prasitauthor=Z.+Wangauthor=C.+Brideauauthor=C.-C.+Chanauthor=S.+Charlesonauthor=W.+Cromlishauthor=D.+Ethierauthor=J.+F.+Evansauthor=A.+W.+Ford-Hutchinsonauthor=J.+Y.+Gauthierauthor=R.+Gordonauthor=J.+Guayauthor=M.+Gresserauthor=S.+Kargmanauthor=B.+Kennedyauthor=Y.+Leblancauthor=S.+L%C3%A9gerauthor=J.+Manciniauthor=G.+P.+O%E2%80%99Neillauthor=M.+Ouelletauthor=M.+D.+Percivalauthor=H.+Perrierauthor=D.+Riendeauauthor=I.+Rodgerauthor=P.+Tagariauthor=M.+Th%C3%A9rienauthor=P.+Vickersauthor=E.+Wongauthor=L.-J.+Xuauthor=R.+N.+Youngauthor=R.+Zamboniauthor=S.+Boyceauthor=N.+Rupniakauthor=M.+Forrestauthor=D.+Viscoauthor=D.+Patrick&title=The+discovery+of+rofecoxib%2C+%5BMK+966%2C+Vioxx%2C+4-%284%E2%80%B2-methylsulfonylphenyl%29-3-phenyl-2%285H%29-furanone%5D%2C+an+orally+active+cyclooxygenase-2-inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DBrideau%26aufirst%3DC.%26aulast%3DChan%26aufirst%3DC.-C.%26aulast%3DCharleson%26aufirst%3DS.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DEthier%26aufirst%3DD.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DFord-Hutchinson%26aufirst%3DA.%2BW.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DGuay%26aufirst%3DJ.%26aulast%3DGresser%26aufirst%3DM.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DKennedy%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DL%25C3%25A9ger%26aufirst%3DS.%26aulast%3DMancini%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DG.%2BP.%26aulast%3DOuellet%26aufirst%3DM.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DPerrier%26aufirst%3DH.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRodger%26aufirst%3DI.%26aulast%3DTagari%26aufirst%3DP.%26aulast%3DTh%25C3%25A9rien%26aufirst%3DM.%26aulast%3DVickers%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DE.%26aulast%3DXu%26aufirst%3DL.-J.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBoyce%26aufirst%3DS.%26aulast%3DRupniak%26aufirst%3DN.%26aulast%3DForrest%26aufirst%3DM.%26aulast%3DVisco%26aufirst%3DD.%26aulast%3DPatrick%26aufirst%3DD.%26atitle%3DThe%2520discovery%2520of%2520rofecoxib%252C%2520%255BMK%2520966%252C%2520Vioxx%252C%25204-%25284%25E2%2580%25B2-methylsulfonylphenyl%2529-3-phenyl-2%25285H%2529-furanone%255D%252C%2520an%2520orally%2520active%2520cyclooxygenase-2-inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D1773%26epage%3D1778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">The endocannabinoid system: a drug discovery perspective</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs (BioMed Cent.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=16044662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2MXms1ejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=672-679&author=D.+Piomelli&title=The+endocannabinoid+system%3A+a+drug+discovery+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid system: A drug discovery perspective</span></div><div class="casAuthors">Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Investigational Drugs (Thomson Scientific)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">672-679</span>CODEN:
                <span class="NLM_cas:coden">COIDAZ</span>;
        ISSN:<span class="NLM_cas:issn">1472-4472</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  The endocannabinoids are lipid messengers that engage the same cell surface receptors targeted by Δ9-tetrahydrocannabinol, the active component of marijuana.  They are produced by cells in the brain and other tissues and combine with two subtypes of G protein-coupled cannabinoid receptors, CB1 and CB2.  Their ability to modulate a variety of pathophysiol. processes, including appetite, pain and mood, provides unique opportunities for drug discovery.  Three such opportunities are discussed here: redn. of body wt. through blockade of CB1 receptors, alleviation of pain through activation of extracerebral cannabinoid receptors, and modulation of pain and anxiety through inhibition of endocannabinoid degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonb_fUBDB5xLVg90H21EOLACvtfcHk0lhs5nybCpkBqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXms1ejsL8%253D&md5=dc723ac3c3739a94b7f9858c8affac94</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520endocannabinoid%2520system%253A%2520a%2520drug%2520discovery%2520perspective%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%2520%2528BioMed%2520Cent.%2529%26date%3D2005%26volume%3D6%26spage%3D672%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Gaetani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dipasquale, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Righetti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuomo, V.</span><span> </span><span class="NLM_article-title">The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs</span> <span class="citation_source-journal">Int. Rev. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1016%2FS0074-7742%2809%2985005-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=19607961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1Wis7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2009&pages=57-72&author=S.+Gaetaniauthor=P.+Dipasqualeauthor=A.+Romanoauthor=L.+Righettiauthor=T.+Cassanoauthor=D.+Piomelliauthor=V.+Cuomo&title=The+endocannabinoid+system+as+a+target+for+novel+anxiolytic+and+antidepressant+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs</span></div><div class="casAuthors">Gaetani, Silvana; Dipasquale, Pasqua; Romano, Adele; Righetti, Laura; Cassano, Tommaso; Piomelli, Daniele; Cuomo, Vincenzo</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">Advances in Neuropharmacology</span>),
    <span class="NLM_cas:pages">57-72</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Observational studies in humans suggest that exposure to marijuana and other cannabis-derived drugs produces a wide range of subjective effects on mood tone and emotionality.  These observations have their counterpart in animal studies, showing that cannabinoid agonists strongly affect emotional reactivity in directions that vary depending on dose and context.  Based on these evidence, the activation of central CB1 receptor has emerged as potential target for the development of antianxiety and antidepressant therapies.  However, the variable effects of exogenous cannabinoid agonists have gradually shifted the interest to the alternative approach of amplifying the effects of endogenous cannabinoids (EC), namely anandamide (AEA) and 2-arachidonoylglycerol (2-AG), by preventing their deactivation.  The enzyme fatty acid amide hydrolase (FAAH) has been the target of intense research efforts aimed at developing potent and selective inhibitors that might prolong AEA actions in vivo.  Among the inhibitors developed, the compd. URB597 was found to potently inhibit FAAH activity in vivo and cause brain AEA levels to increase.  Interestingly, the enhanced AEA tone produced by URB597 does not result in the behavioral effects typical of a direct-acting cannabinoid agonist.  Though URB597 does not elicit a full-fledged cannabinoid profile of behavioral responses, it does elicit marked anxiolytic-like and antidepressant-like effects in rats and mice.  Such effects involve the downstream activation of CB1 receptors, since they are attenuated by the CB1 antagonist SR141716 (rimonabant).  Parallel to FAAH inhibition, similar results can also be obsd. by pharmacol. blocking the AEA transport system, which is responsible of the intracellular uptake of AEA from the synaptic cleft.  The reason why FAAH inhibition approach produces a smaller set of cannabimimetic effects might depend on the mechanism of EC synthesis and release upon neuronal activation and on the target selectivity of the drug.  The mechanism of EC release is commonly referred to as "on request", since they are not synthesized and stored in synaptic vesicles, such as classical neurotransmitters, but are synthesized from membrane precursors and immediately released in the synaptic cleft following neuronal activation.  The neural stimulation in specific brain areas, for example, those involved in the regulation of mood tone and/or emotional reactivity, would result in an increased EC tone in these same areas, but not necessarily in others.  Therefore, inhibition of AEA metab. activity could amplify CB1 activation mainly where AEA release is higher.  Furthermore, the inhibition of FAAH causes an accumulation of AEA but not 2-AG, which, being 200-fold more abundant than AEA in the brain, might differently modulate CB1-mediated behavioral responses.  The evidence outlined above supports the hypothesis that the EC system plays an important role in anxiety and mood disorders and suggests that modulation of FAAH activity might be a pharmacol. target for novel anxiolytic and antidepressant therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoikIKJ9JJfGLVg90H21EOLACvtfcHk0lhs5nybCpkBqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1Wis7rL&md5=159980712c246a32cd127e61a98df686</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2809%2985005-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252809%252985005-8%26sid%3Dliteratum%253Aachs%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DDipasquale%26aufirst%3DP.%26aulast%3DRomano%26aufirst%3DA.%26aulast%3DRighetti%26aufirst%3DL.%26aulast%3DCassano%26aufirst%3DT.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DCuomo%26aufirst%3DV.%26atitle%3DThe%2520endocannabinoid%2520system%2520as%2520a%2520target%2520for%2520novel%2520anxiolytic%2520and%2520antidepressant%2520drugs%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2009%26volume%3D85%26spage%3D57%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Gobbi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bambico, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangieri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campolongo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solinas, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgese, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debonnel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trezza, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuomo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">18620</span><span class="NLM_x">–</span> <span class="NLM_lpage">18625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=18620-18625&author=G.+Gobbiauthor=F.+R.+Bambicoauthor=R.+Mangieriauthor=M.+Bortolatoauthor=P.+Campolongoauthor=M.+Solinasauthor=T.+Cassanoauthor=M.+G.+Morgeseauthor=G.+Debonnelauthor=A.+Durantiauthor=A.+Tontiniauthor=G.+Tarziaauthor=M.+Morauthor=V.+Trezzaauthor=S.+R.+Goldbergauthor=V.+Cuomoauthor=D.+Piomelli&title=Antidepressant-like+activity+and+modulation+of+brain+monoaminergic+transmission+by+blockade+of+anandamide+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGobbi%26aufirst%3DG.%26aulast%3DBambico%26aufirst%3DF.%2BR.%26aulast%3DMangieri%26aufirst%3DR.%26aulast%3DBortolato%26aufirst%3DM.%26aulast%3DCampolongo%26aufirst%3DP.%26aulast%3DSolinas%26aufirst%3DM.%26aulast%3DCassano%26aufirst%3DT.%26aulast%3DMorgese%26aufirst%3DM.%2BG.%26aulast%3DDebonnel%26aufirst%3DG.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTrezza%26aufirst%3DV.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DCuomo%26aufirst%3DV.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAntidepressant-like%2520activity%2520and%2520modulation%2520of%2520brain%2520monoaminergic%2520transmission%2520by%2520blockade%2520of%2520anandamide%2520hydrolysis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D18620%26epage%3D18625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sciolino, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spradley, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohmann, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2Fnn.2632" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=20852626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=1265-1270&author=J.+R.+Clapperauthor=G.+Moreno-Sanzauthor=R.+Russoauthor=A.+Guijarroauthor=F.+Vacondioauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Sanchiniauthor=N.+R.+Sciolinoauthor=J.+M.+Spradleyauthor=A.+G.+Hohmannauthor=A.+Calignanoauthor=M.+Morauthor=G.+Tarziaauthor=D.+Piomelli&title=Anandamide+suppresses+pain+initiation+through+a+peripheral+endocannabinoid+mechanism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism</span></div><div class="casAuthors">Clapper, Jason R.; Moreno-Sanz, Guillermo; Russo, Roberto; Guijarro, Ana; Vacondio, Federica; Duranti, Andrea; Tontini, Andrea; Sanchini, Silvano; Sciolino, Natale R.; Spradley, Jessica M.; Hohmann, Andrea G.; Calignano, Antonio; Mor, Marco; Tarzia, Giorgio; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1265-1270</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Peripheral cannabinoid receptors exert a powerful inhibitory control over pain initiation, but the endocannabinoid signal that normally engages this intrinsic analgesic mechanism is unknown.  To address this question, we developed a peripherally restricted inhibitor (URB937) of fatty acid amide hydrolase (FAAH), the enzyme responsible for the degrdn. of the endocannabinoid anandamide.  URB937 suppressed FAAH activity and increased anandamide levels outside the rodent CNS.  Despite its inability to access brain and spinal cord, URB937 attenuated behavioral responses indicative of persistent pain in rodent models of peripheral nerve injury and inflammation and prevented noxious stimulus-evoked neuronal activation in spinal cord regions implicated in nociceptive processing.  CB1 cannabinoid receptor blockade prevented these effects.  These results suggest that anandamide-mediated signaling at peripheral CB1 receptors controls the access of pain-related inputs to the CNS.  Brain-impenetrant FAAH inhibitors, which strengthen this gating mechanism, might offer a new approach to pain therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2AxNb5bVlE7Vg90H21EOLACvtfcHk0lgqvi9gVnyxGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOht73O&md5=f75c13a37e3524ab4130b2ebd67d6348</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnn.2632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.2632%26sid%3Dliteratum%253Aachs%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DRusso%26aufirst%3DR.%26aulast%3DGuijarro%26aufirst%3DA.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DSciolino%26aufirst%3DN.%2BR.%26aulast%3DSpradley%26aufirst%3DJ.%2BM.%26aulast%3DHohmann%26aufirst%3DA.%2BG.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DAnandamide%2520suppresses%2520pain%2520initiation%2520through%2520a%2520peripheral%2520endocannabinoid%2520mechanism%26jtitle%3DNat.%2520Neurosci.%26date%3D2010%26volume%3D13%26spage%3D1265%26epage%3D1270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kathuria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaetani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fegley, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Rana, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calignano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giustino, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tattoli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmery, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuomo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Modulation of anxiety through blockade of anandamide hydrolysis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">76</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2Fnm803" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=12461523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivF2l" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=76-81&author=S.+Kathuriaauthor=S.+Gaetaniauthor=D.+Fegleyauthor=F.+Valinoauthor=A.+Durantiauthor=A.+Tontiniauthor=M.+Morauthor=G.+Tarziaauthor=G.+La+Ranaauthor=A.+Calignanoauthor=A.+Giustinoauthor=M.+Tattoliauthor=M.+Palmeryauthor=V.+Cuomoauthor=D.+Piomelli&title=Modulation+of+anxiety+through+blockade+of+anandamide+hydrolysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of anxiety through blockade of anandamide hydrolysis</span></div><div class="casAuthors">Kathuria, Satish; Gaetani, Silvana; Fegley, Darren; Valino, Fernando; Duranti, Andrea; Tontini, Andrea; Mor, Marco; Tarzia, Giorgio; La Rana, Giovanna; Calignano, Antonio; Giustino, Arcangela; Tattoli, Maria; Palmery, Maura; Cuomo, Vincenzo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">76-81</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The psychoactive constituent of cannabis, Δ9-tetrahydrocannabinol, produces in humans subjective responses mediated by CB1 cannabinoid receptors, indicating that endogenous cannabinoids may contribute to the control of emotion.  But the variable effects of Δ9-tetrahydrocannabinol obscure the interpretation of these results and limit the therapeutic potential of direct cannabinoid agonists.  An alternative approach may be to develop drugs that amplify the effects of endogenous cannabinoids by preventing their inactivation.  Here, the authors describe a class of potent, selective, and systemically active inhibitors of fatty acid amide hydrolase, the enzyme responsible for the degrdn. of the endogenous cannabinoid anandamide.  Like clin. used anti-anxiety drugs, in rats the inhibitors exhibit benzodiazepine-like properties in the elevated zero-maze test and suppress isolation-induced vocalizations.  These effects are accompanied by augmented brain levels of anandamide and are prevented by CB1 receptor blockade.  Apparently, anandamide participates in the modulation of emotional states and fatty acid amide hydrolase inhibition is an innovative approach to anti-anxiety therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbjKypjqxPcrVg90H21EOLACvtfcHk0lgqvi9gVnyxGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivF2l&md5=350c8a5af97b6ea4e41e9f0c821231e4</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnm803&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm803%26sid%3Dliteratum%253Aachs%26aulast%3DKathuria%26aufirst%3DS.%26aulast%3DGaetani%26aufirst%3DS.%26aulast%3DFegley%26aufirst%3DD.%26aulast%3DValino%26aufirst%3DF.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DLa%2BRana%26aufirst%3DG.%26aulast%3DCalignano%26aufirst%3DA.%26aulast%3DGiustino%26aufirst%3DA.%26aulast%3DTattoli%26aufirst%3DM.%26aulast%3DPalmery%26aufirst%3DM.%26aulast%3DCuomo%26aufirst%3DV.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DModulation%2520of%2520anxiety%2520through%2520blockade%2520of%2520anandamide%2520hydrolysis%26jtitle%3DNat.%2520Med.%26date%3D2003%26volume%3D9%26spage%3D76%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Devane, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevenson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelbaum, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Etinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span> </span><span class="NLM_article-title">Isolation and structure of a brain constituent that binds to the cannabinoid receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">258</span><span class="NLM_x">, </span> <span class="NLM_fpage">1946</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1126%2Fscience.1470919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=1470919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADyaK3sXpvVKntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=258&publication_year=1992&pages=1946-1949&author=W.+A.+Devaneauthor=L.+Hanusauthor=A.+Breuerauthor=R.+G.+Pertweeauthor=L.+A.+Stevensonauthor=G.+Griffinauthor=D.+Gibsonauthor=A.+Mandelbaumauthor=A.+Etingerauthor=R.+Mechoulam&title=Isolation+and+structure+of+a+brain+constituent+that+binds+to+the+cannabinoid+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structure of a brain constituent that binds to the cannabinoid receptor</span></div><div class="casAuthors">Devane, William A.; Hanus, Lumir; Breuer, Aviva; Pertwee, Roger G.; Stevenson, Lesley A.; Griffin, Graeme; Gibson, Dan; Mandelbaum, Asher; Etinger, Alexander; Mechoulam, Raphael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">258</span>
        (<span class="NLM_cas:issue">5090</span>),
    <span class="NLM_cas:pages">1946-9</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Arachidonylethanolamide, an arachidonic acid deriv. in the porcine brain, was identified as an endogenous ligand for the cannabinoid receptor.  The structure of this compd., anandamide, was detd. by mass spectrometry and NMR spectroscopy and was confirmed by synthesis.  Anandamide inhibited the specific binding of a radiolabeled cannabinoid probe to synaptosomal membranes in a manner typical of competitive ligands and produced a concn.-dependent inhibition of the elec. evoked twitch responses of the mouse vas deferens, a characteristic effect of psychotropic cannabinoids.  Anandamide may function as a natural ligand for the cannabinoid receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXqh5E4vHczbVg90H21EOLACvtfcHk0lgqvi9gVnyxGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXpvVKntg%253D%253D&md5=13c7aa7316cd687240779f7f192d086b</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1126%2Fscience.1470919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1470919%26sid%3Dliteratum%253Aachs%26aulast%3DDevane%26aufirst%3DW.%2BA.%26aulast%3DHanus%26aufirst%3DL.%26aulast%3DBreuer%26aufirst%3DA.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DStevenson%26aufirst%3DL.%2BA.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DGibson%26aufirst%3DD.%26aulast%3DMandelbaum%26aufirst%3DA.%26aulast%3DEtinger%26aufirst%3DA.%26aulast%3DMechoulam%26aufirst%3DR.%26atitle%3DIsolation%2520and%2520structure%2520of%2520a%2520brain%2520constituent%2520that%2520binds%2520to%2520the%2520cannabinoid%2520receptor%26jtitle%3DScience%26date%3D1992%26volume%3D258%26spage%3D1946%26epage%3D1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">The molecular logic of endocannabinoid signalling</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">873</span><span class="NLM_x">–</span> <span class="NLM_lpage">884</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2Fnrn1247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=14595399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosFOktrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=873-884&author=D.+Piomelli&title=The+molecular+logic+of+endocannabinoid+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular logic of endocannabinoid signalling</span></div><div class="casAuthors">Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">873-884</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The endocannabinoids are a family of lipid messengers that engage the cell surface receptors that are targeted by Δ9-tetrahydrocannabinol, the active principle in marijuana (Cannabis).  They are made on demand through cleavage of membrane precursors and are involved in various short-range signaling processes.  In the brain, they combine with CB1 cannabinoid receptors on axon terminals to regulate ion channel activity and neurotransmitter release.  Their ability to modulate synaptic efficacy has a wide range of functional consequences and provides unique therapeutic possibilities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUrtdaKTjDoLVg90H21EOLACvtfcHk0liXIxmf54DjNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosFOktrY%253D&md5=d4af135f5309e6551bdb1f8ade45b565</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrn1247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1247%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DThe%2520molecular%2520logic%2520of%2520endocannabinoid%2520signalling%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2003%26volume%3D4%26spage%3D873%26epage%3D884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">A thickening network of lipids</span> <span class="citation_source-journal">Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">4</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2012&pages=3-4&author=D.+Piomelli&title=A+thickening+network+of+lipids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520thickening%2520network%2520of%2520lipids%26jtitle%3DPain%26date%3D2012%26volume%3D153%26spage%3D3%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span> </span><span class="NLM_article-title">NSAIDs: eNdocannabinoid stimulating anti-inflammatory drugs?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">468</span><span class="NLM_x">–</span> <span class="NLM_lpage">473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=468-473&issue=9&author=C.+J.+Fowler&title=NSAIDs%3A+eNdocannabinoid+stimulating+anti-inflammatory+drugs%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DNSAIDs%253A%2520eNdocannabinoid%2520stimulating%2520anti-inflammatory%2520drugs%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2012%26volume%3D33%26issue%3D9%26spage%3D468%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Fowler, C. J.; Bjorklund, E.; Lichtman, A. H.; Naidu, P. S.; Congiu, C.; Onnis, V.</span><span> </span><span class="NLM_article-title">Inhibitory properties of ibuprofen and its amide analogues towards the hydrolysis and cyclooxygenation of the endocannabinoid anandamide</span>. J. Enzyme Inhib. Med. Chem.<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">, </span>in press. </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=22225576" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=C.+J.+Fowler&author=E.+Bjorklund&author=A.+H.+Lichtman&author=P.+S.+Naidu&author=C.+Congiu&author=V.+Onnis&title=Inhibitory+properties+of+ibuprofen+and+its+amide+analogues+towards+the+hydrolysis+and+cyclooxygenation+of+the+endocannabinoid+anandamide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DInhibitory%2520properties%2520of%2520ibuprofen%2520and%2520its%2520amide%2520analogues%2520towards%2520the%2520hydrolysis%2520and%2520cyclooxygenation%2520of%2520the%2520endocannabinoid%2520anandamide%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Seierstad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitenbucher, J. G.</span><span> </span><span class="NLM_article-title">Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7327</span><span class="NLM_x">–</span> <span class="NLM_lpage">7343</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800311k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7327-7343&author=M.+Seierstadauthor=J.+G.+Breitenbucher&title=Discovery+and+development+of+fatty+acid+amide+hydrolase+%28FAAH%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm800311k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800311k%26sid%3Dliteratum%253Aachs%26aulast%3DSeierstad%26aufirst%3DM.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DDiscovery%2520and%2520development%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7327%26epage%3D7343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Otrubova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ezzili, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boger, D. L.</span><span> </span><span class="NLM_article-title">The discovery and development of inhibitors of fatty acid amide hydrolase (FAAH)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4674</span><span class="NLM_x">–</span> <span class="NLM_lpage">4685</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4674-4685&author=K.+Otrubovaauthor=C.+Ezziliauthor=D.+L.+Boger&title=The+discovery+and+development+of+inhibitors+of+fatty+acid+amide+hydrolase+%28FAAH%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOtrubova%26aufirst%3DK.%26aulast%3DEzzili%26aufirst%3DC.%26aulast%3DBoger%26aufirst%3DD.%2BL.%26atitle%3DThe%2520discovery%2520and%2520development%2520of%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4674%26epage%3D4685" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Palermo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branduardi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vivo, M.</span><span> </span><span class="NLM_article-title">Covalent inhibitors of fatty acid amide hydrolase: a rationale for the activity of piperidine and piperazine aryl ureas</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6612</span><span class="NLM_x">–</span> <span class="NLM_lpage">6623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2004283" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFCgsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6612-6623&author=G.+Palermoauthor=D.+Branduardiauthor=M.+Masettiauthor=A.+Lodolaauthor=M.+Morauthor=D.+Piomelliauthor=A.+Cavalliauthor=M.+De+Vivo&title=Covalent+inhibitors+of+fatty+acid+amide+hydrolase%3A+a+rationale+for+the+activity+of+piperidine+and+piperazine+aryl+ureas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Covalent Inhibitors of Fatty Acid Amide Hydrolase: A Rationale for the Activity of Piperidine and Piperazine Aryl Ureas</span></div><div class="casAuthors">Palermo, Giulia; Branduardi, Davide; Masetti, Matteo; Lodola, Alessio; Mor, Marco; Piomelli, Daniele; Cavalli, Andrea; De Vivo, Marco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6612-6623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, covalent drugs have attracted great interest in the drug discovery community, with successful examples that have demonstrated their therapeutic effects.  Here, we focus on the covalent inhibition of the fatty acid amide hydrolase (FAAH), which is a promising strategy in the treatment of pain and inflammation.  Among the most recent and potent FAAH inhibitors (FAAHi), there are the cyclic piperidine and piperazine aryl ureas.  FAAH hydrolyzes efficiently the amide bond of these compds., forming a covalent enzyme-inhibitor adduct.  To rationalize this exptl. evidence, we performed an extensive computational anal. centered on piperidine-based PF750 (1) and piperazine-based JNJ1661010 (2), two potent lead compds. used to generate covalent inhibitors as clin. candidates.  We found that FAAH induces a distortion of the amide bond of the piperidine and piperazine aryl ureas.  Quantum mechanics/mol. mechanics ΔELUMO-HOMO energies indicate that the obsd. enzyme-induced distortion of the amide bond favors the formation of a covalent FAAH-inhibitor adduct.  These findings could help in the rational structure-based design of novel covalent FAAHi.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXM0Vnrifb87Vg90H21EOLACvtfcHk0liXIxmf54DjNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFCgsb3O&md5=3130e9ef929a52cc0900ad77b38a7453</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm2004283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2004283%26sid%3Dliteratum%253Aachs%26aulast%3DPalermo%26aufirst%3DG.%26aulast%3DBranduardi%26aufirst%3DD.%26aulast%3DMasetti%26aufirst%3DM.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DDe%2BVivo%26aufirst%3DM.%26atitle%3DCovalent%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%253A%2520a%2520rationale%2520for%2520the%2520activity%2520of%2520piperidine%2520and%2520piperazine%2520aryl%2520ureas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6612%26epage%3D6623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Boger, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyauchi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardouin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fecik, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedrick, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acevedo, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guimaraes, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jorgensen, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Discovery of a potent, selective, and efficacious class of reversible α-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1849</span><span class="NLM_x">–</span> <span class="NLM_lpage">1856</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049614v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1849-1856&author=D.+L.+Bogerauthor=H.+Miyauchiauthor=W.+Duauthor=C.+Hardouinauthor=R.+A.+Fecikauthor=H.+Chengauthor=I.+Hwangauthor=M.+P.+Hedrickauthor=D.+Leungauthor=O.+Acevedoauthor=C.+R.+Guimaraesauthor=W.+L.+Jorgensenauthor=B.+F.+Cravatt&title=Discovery+of+a+potent%2C+selective%2C+and+efficacious+class+of+reversible+%CE%B1-ketoheterocycle+inhibitors+of+fatty+acid+amide+hydrolase+effective+as+analgesics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm049614v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049614v%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DMiyauchi%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DW.%26aulast%3DHardouin%26aufirst%3DC.%26aulast%3DFecik%26aufirst%3DR.%2BA.%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHwang%26aufirst%3DI.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26aulast%3DLeung%26aufirst%3DD.%26aulast%3DAcevedo%26aufirst%3DO.%26aulast%3DGuimaraes%26aufirst%3DC.%2BR.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520efficacious%2520class%2520of%2520reversible%2520%25CE%25B1-ketoheterocycle%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520effective%2520as%2520analgesics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1849%26epage%3D1856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivo</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1505</span><span class="NLM_x">–</span> <span class="NLM_lpage">1513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1505-1513&author=J.+R.+Clapperauthor=F.+Vacondioauthor=A.+R.+Kingauthor=A.+Durantiauthor=A.+Tontiniauthor=C.+Silvaauthor=S.+Sanchiniauthor=G.+Tarziaauthor=M.+Morauthor=D.+Piomelli&title=A+second+generation+of+carbamate-based+fatty+acid+amide+hydrolase+inhibitors+with+improved+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DKing%26aufirst%3DA.%2BR.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DA%2520second%2520generation%2520of%2520carbamate-based%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%2520with%2520improved%2520activity%2520in%2520vivo%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1505%26epage%3D1513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Vacondio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clapper, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span> </span><span class="NLM_article-title">Structure-property relationships of a class of carbamate-based fatty acid amide hydrolase (FAAH) inhibitors: chemical and biological stability</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1495</span><span class="NLM_x">–</span> <span class="NLM_lpage">1504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=1495-1504&author=F.+Vacondioauthor=C.+Silvaauthor=A.+Lodolaauthor=A.+Fioniauthor=S.+Rivaraauthor=A.+Durantiauthor=A.+Tontiniauthor=S.+Sanchiniauthor=J.+R.+Clapperauthor=D.+Piomelliauthor=M.+Morauthor=G.+Tarzia&title=Structure-property+relationships+of+a+class+of+carbamate-based+fatty+acid+amide+hydrolase+%28FAAH%29+inhibitors%3A+chemical+and+biological+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVacondio%26aufirst%3DF.%26aulast%3DSilva%26aufirst%3DC.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DFioni%26aufirst%3DA.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DSanchini%26aufirst%3DS.%26aulast%3DClapper%26aufirst%3DJ.%2BR.%26aulast%3DPiomelli%26aufirst%3DD.%26aulast%3DMor%26aufirst%3DM.%26aulast%3DTarzia%26aufirst%3DG.%26atitle%3DStructure-property%2520relationships%2520of%2520a%2520class%2520of%2520carbamate-based%2520fatty%2520acid%2520amide%2520hydrolase%2520%2528FAAH%2529%2520inhibitors%253A%2520chemical%2520and%2520biological%2520stability%26jtitle%3DChemMedChem%26date%3D2009%26volume%3D4%26spage%3D1495%26epage%3D1504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stiff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazerwith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fay, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beidler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudley, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadagopan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattachar, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesten, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomanbhoy, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, K.</span><span> </span><span class="NLM_article-title">Discovery of PF-04457845: a highly potent, orally bioavailable, and selective urea FAAH inhibitor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml100190t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=91-96&author=D.+S.+Johnsonauthor=C.+Stiffauthor=S.+E.+Lazerwithauthor=S.+R.+Kestenauthor=L.+K.+Fayauthor=M.+Morrisauthor=D.+Beidlerauthor=M.+B.+Liimattaauthor=S.+E.+Smithauthor=D.+T.+Dudleyauthor=N.+Sadagopanauthor=S.+N.+Bhattacharauthor=S.+J.+Kestenauthor=T.+K.+Nomanbhoyauthor=B.+F.+Cravattauthor=K.+Ahn&title=Discovery+of+PF-04457845%3A+a+highly+potent%2C+orally+bioavailable%2C+and+selective+urea+FAAH+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor</span></div><div class="casAuthors">Johnson, Douglas S.; Stiff, Cory; Lazerwith, Scott E.; Kesten, Suzanne R.; Fay, Lorraine K.; Morris, Mark; Beidler, David; Liimatta, Marya B.; Smith, Sarah E.; Dudley, David T.; Sadagopan, Nalini; Bhattachar, Shobha N.; Kesten, Stephen J.; Nomanbhoy, Tyzoon K.; Cravatt, Benjamin F.; Ahn, Kay</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">91-96</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fatty acid amide hydrolase (FAAH) is an integral membrane serine hydrolase that degrades the fatty acid amide family of signaling lipids, including the endocannabinoid anandamide.  Genetic or pharmacol. inactivation of FAAH leads to analgesic and anti-inflammatory phenotypes in rodents without showing the undesirable side effects obsd. with direct cannabinoid receptor agonists, indicating that FAAH may represent an attractive therapeutic target for the treatment of inflammatory pain and other nervous system disorders.  Herein, the discovery and characterization of a highly efficacious and selective FAAH inhibitor PF-04457845, N-(3-pyridazinyl)-4-(3-[5-trifluoromethyl-2-pyridinyloxy]benzylidene)piperidine-1-carboxamide (I), are reported.  This compd. inhibited FAAH by a covalent, irreversible mechanism involving carbamylation of the active-site serine nucleophile of FAAH with high in vitro potency (kinact/Ki and IC50 values of 40300 M-1 s-1 and 7.2 nM, resp., for human FAAH).  The compd. I had exquisite selectivity for FAAH relative to other members of the serine hydrolase superfamily as demonstrated by competitive activity-based protein profiling.  Oral administration of I at 0.1 mg/kg results in efficacy comparable to that of naproxen at 10 mg/kg in a rat model of inflammatory pain.  Compd. I is being evaluated in human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoINP05KK-SNLVg90H21EOLACvtfcHk0lhuSYfehkXMVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVaisrfO&md5=c7ba2900e3abeda46f885d23bf1f76b8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fml100190t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100190t%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DStiff%26aufirst%3DC.%26aulast%3DLazerwith%26aufirst%3DS.%2BE.%26aulast%3DKesten%26aufirst%3DS.%2BR.%26aulast%3DFay%26aufirst%3DL.%2BK.%26aulast%3DMorris%26aufirst%3DM.%26aulast%3DBeidler%26aufirst%3DD.%26aulast%3DLiimatta%26aufirst%3DM.%2BB.%26aulast%3DSmith%26aufirst%3DS.%2BE.%26aulast%3DDudley%26aufirst%3DD.%2BT.%26aulast%3DSadagopan%26aufirst%3DN.%26aulast%3DBhattachar%26aufirst%3DS.%2BN.%26aulast%3DKesten%26aufirst%3DS.%2BJ.%26aulast%3DNomanbhoy%26aufirst%3DT.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DAhn%26aufirst%3DK.%26atitle%3DDiscovery%2520of%2520PF-04457845%253A%2520a%2520highly%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520urea%2520FAAH%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D91%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Mor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plazzi, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duranti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tontini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piersanti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kathuria, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4998</span><span class="NLM_x">–</span> <span class="NLM_lpage">5008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031140x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4998-5008&author=M.+Morauthor=S.+Rivaraauthor=A.+Lodolaauthor=P.+V.+Plazziauthor=G.+Tarziaauthor=A.+Durantiauthor=A.+Tontiniauthor=G.+Piersantiauthor=S.+Kathuriaauthor=D.+Piomelli&title=Cyclohexylcarbamic+acid+3%E2%80%B2-+or+4%E2%80%B2-substituted+biphenyl-3-yl+esters+as+fatty+acid+amide+hydrolase+inhibitors%3A+synthesis%2C+quantitative+structure-activity+relationships%2C+and+molecular+modeling+studies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm031140x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031140x%26sid%3Dliteratum%253Aachs%26aulast%3DMor%26aufirst%3DM.%26aulast%3DRivara%26aufirst%3DS.%26aulast%3DLodola%26aufirst%3DA.%26aulast%3DPlazzi%26aufirst%3DP.%2BV.%26aulast%3DTarzia%26aufirst%3DG.%26aulast%3DDuranti%26aufirst%3DA.%26aulast%3DTontini%26aufirst%3DA.%26aulast%3DPiersanti%26aufirst%3DG.%26aulast%3DKathuria%26aufirst%3DS.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DCyclohexylcarbamic%2520acid%25203%25E2%2580%25B2-%2520or%25204%25E2%2580%25B2-substituted%2520biphenyl-3-yl%2520esters%2520as%2520fatty%2520acid%2520amide%2520hydrolase%2520inhibitors%253A%2520synthesis%252C%2520quantitative%2520structure-activity%2520relationships%252C%2520and%2520molecular%2520modeling%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4998%26epage%3D5008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Naidu, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A. H.</span><span> </span><span class="NLM_article-title">Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">56</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1124%2Fjpet.108.143487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=19118134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVKntb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2009&pages=48-56&author=P.+S.+Naiduauthor=L.+Bookerauthor=B.+F.+Cravattauthor=A.+H.+Lichtman&title=Synergy+between+enzyme+inhibitors+of+fatty+acid+amide+hydrolase+and+cyclooxygenase+in+visceral+nociception"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception</span></div><div class="casAuthors">Naidu, Pattipati S.; Booker, Lamont; Cravatt, Benjamin F.; Lichtman, Aron H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-56</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present study investigated whether inhibition of fatty acid amide hydrolase (FAAH), the enzyme responsible for anandamide catabolism, produces antinociception in the acetic acid-induced abdominal stretching model of visceral nociception.  Genetic deletion or pharmacol. inhibition of FAAH reduced acetic acid-induced abdominal stretching.  Transgenic mice that express FAAH exclusively in the nervous system displayed the antinociceptive phenotype, indicating the involvement of peripheral fatty acid amides.  The cannabinoid receptor 1 (CB1) receptor antagonist, rimonabant, but not the cannabinoid receptor 2 (CB2) receptor antagonist, SR144528, blocked the antinociceptive phenotype of FAAH(-/-) mice and the analgesic effects of URB597 (3'-carbamoyl-biphenyl-3-yl-cyclohexylcarbamate) or OL-135 (1-oxo-1[5-(2-pyridyl)-2-yl]-7-Ph heptane), resp. irreversible and reversible FAAH inhibitors, administered to C57BL/6 mice.  The opioid receptor antagonist, naltrexone, did not block the analgesic effects of either FAAH inhibitor.  URB597, ED50 [95% confidence interval (CI) = 2.1 (1.5-2.9) mg/kg], and the non-selective cyclooxygenase inhibitor, diclofenac sodium [ED50 (95% CI) = 9.8 (8.2-11.7) mg/kg], dose-dependently inhibited acetic acid-induced abdominal stretching.  Combinations of URB597 and diclofenac yielded synergistic analgesic interactions according to isobolog. anal.  It is important that FAAH(-/-) mice and URB597-treated mice displayed significant redns. in the severity of gastric irritation caused by diclofenac.  URB597 lost its gastroprotective effects in CB1(-/-) mice, whereas it maintained its efficacy in CB2(-/-) mice, indicating a CB1 mechanism of action.  Taken together, the results of the present study suggest that FAAH represents a promising target for the treatment of visceral pain, and a combination of FAAH inhibitors and NSAIDs may have great utility to treat visceral pain, with reduced gastric toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg5twrLEI_mbVg90H21EOLACvtfcHk0ljLzCBuSeyNnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVKntb0%253D&md5=8efa156c1a389d8510fb62af14d2cd8b</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.143487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.143487%26sid%3Dliteratum%253Aachs%26aulast%3DNaidu%26aufirst%3DP.%2BS.%26aulast%3DBooker%26aufirst%3DL.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DLichtman%26aufirst%3DA.%2BH.%26atitle%3DSynergy%2520between%2520enzyme%2520inhibitors%2520of%2520fatty%2520acid%2520amide%2520hydrolase%2520and%2520cyclooxygenase%2520in%2520visceral%2520nociception%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D329%26spage%3D48%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Sasso, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarpelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armirotti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Sanz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piomelli, D.</span><span> </span><span class="NLM_article-title">Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">553</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1016%2Fj.phrs.2012.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=22420940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFGhsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2012&pages=553-563&author=O.+Sassoauthor=R.+Bertorelliauthor=T.+Bandieraauthor=R.+Scarpelliauthor=G.+Colombanoauthor=A.+Armirottiauthor=G.+Moreno-Sanzauthor=A.+Reggianiauthor=D.+Piomelli&title=Peripheral+FAAH+inhibition+causes+profound+antinociception+and+protects+against+indomethacin-induced+gastric+lesions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions</span></div><div class="casAuthors">Sasso, Oscar; Bertorelli, Rosalia; Bandiera, Tiziano; Scarpelli, Rita; Colombano, Giampiero; Armirotti, Andrea; Moreno-Sanz, Guillermo; Reggiani, Angelo; Piomelli, Daniele</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">553-563</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Fatty-acid amide hydrolase (FAAH) catalyzes the intracellular hydrolysis of the endocannabinoid anandamide and other bioactive lipid amides.  In the present study, we conducted a comparative characterization of the effects of the newly identified brain-impermeant FAAH inhibitor, URB937 ([3-(3-carbamoylphenyl)-4-hydroxy-phenyl] N-cyclohexylcarbamate), in various rodent models of acute and persistent pain.  When administered by the oral route in mice, URB937 was highly active (median ED, ED50, to inhibit liver FAAH activity: 0.3 mg kg-1) and had a bioavailability of 5.3%.  The antinociceptive effects of oral URB937 were investigated in mouse models of acute inflammation (carrageenan), peripheral nerve injury (chronic sciatic nerve ligation) and arthritis (complete Freund's adjuvant).  In all models, URB937 was as effective or more effective than std. analgesic and anti-inflammatory drugs (indomethacin, gabapentin, dexamethasone) and reversed pain-related responses (mech. hyperalgesia, thermal hyperalgesia, and mech. allodynia) in a dose-dependent manner.  ED50 values ranged from 0.2 to 10 mg kg-1, depending on model and readout.  Importantly, URB937 was significantly more effective than two global FAAH inhibitors, URB597 and PF-04457845, in the complete Freund's adjuvant model.  The effects of a combination of URB937 with the non-steroidal anti-inflammatory agent, indomethacin, were examd. in the carrageenan and chronic sciatic nerve ligation models.  Isobolog. analyses showed that the two compds. interacted synergistically to attenuate pain-related behaviors.  Furthermore, URB937 reduced the no. and severity of gastric lesions produced by indomethacin, while exerting no ulcerogenic effect when administered alone.  The results indicate that the peripheral FAAH inhibitor URB937 is more effective than globally active FAAH inhibitors at inhibiting inflammatory pain.  Our findings further suggest that FAAH and cyclooxygenase inhibitors interact functionally in peripheral tissues, to either enhance or hinder each other's actions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWqynrGrr-LbVg90H21EOLACvtfcHk0ljLzCBuSeyNnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFGhsrs%253D&md5=67ef363a1635b950933650059e8379ee</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2012.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2012.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DSasso%26aufirst%3DO.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DScarpelli%26aufirst%3DR.%26aulast%3DColombano%26aufirst%3DG.%26aulast%3DArmirotti%26aufirst%3DA.%26aulast%3DMoreno-Sanz%26aufirst%3DG.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DPiomelli%26aufirst%3DD.%26atitle%3DPeripheral%2520FAAH%2520inhibition%2520causes%2520profound%2520antinociception%2520and%2520protects%2520against%2520indomethacin-induced%2520gastric%2520lesions%26jtitle%3DPharmacol.%2520Res.%26date%3D2012%26volume%3D65%26spage%3D553%26epage%3D563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Cavalli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minarini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tumiatti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recanatini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melchiorre, C.</span><span> </span><span class="NLM_article-title">Multi-target-directed ligands to combat neurodegenerative diseases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">372</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009364" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=347-372&author=A.+Cavalliauthor=M.+L.+Bolognesiauthor=A.+Minariniauthor=M.+Rosiniauthor=V.+Tumiattiauthor=M.+Recanatiniauthor=C.+Melchiorre&title=Multi-target-directed+ligands+to+combat+neurodegenerative+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target-Directed Ligands to Combat Neurodegenerative Diseases</span></div><div class="casAuthors">Cavalli, Andrea; Bolognesi, Maria Laura; Minarini, Anna; Rosini, Michela; Tumiatti, Vincenzo; Recanatini, Maurizio; Melchiorre, Carlo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">347-372</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The authors review the investigations reported in the past decade that illustrate the ability of medicinal chemists to design multi-target-directed ligands (MTDLs) to confront neurodegenerative diseases.  The authors briefly illustrate the multifactorial nature of these diseases before discussing the possible development of MTDLs in light of the known mol. bases of the main neurodegenerative pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYY0I0UHEir7Vg90H21EOLACvtfcHk0ljLzCBuSeyNnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsl2qsbk%253D&md5=c682235151489316d043cf97f78e56f3</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm7009364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009364%26sid%3Dliteratum%253Aachs%26aulast%3DCavalli%26aufirst%3DA.%26aulast%3DBolognesi%26aufirst%3DM.%2BL.%26aulast%3DMinarini%26aufirst%3DA.%26aulast%3DRosini%26aufirst%3DM.%26aulast%3DTumiatti%26aufirst%3DV.%26aulast%3DRecanatini%26aufirst%3DM.%26aulast%3DMelchiorre%26aufirst%3DC.%26atitle%3DMulti-target-directed%2520ligands%2520to%2520combat%2520neurodegenerative%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D347%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Morphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Designed multiple ligands. An emerging drug discovery paradigm</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6523</span><span class="NLM_x">–</span> <span class="NLM_lpage">6543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058225d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6523-6543&author=R.+Morphyauthor=Z.+Rankovic&title=Designed+multiple+ligands.+An+emerging+drug+discovery+paradigm"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Designed Multiple Ligands.</span></div><div class="casAuthors">Morphy, Richard; Rankovic, Zoran</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6523-6543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The review discusses main areas in designed multiple ligands (DMLs) discovery that include 5HT transporter-based DMLs for depression, dopamine D2-receptor based DMLs for schizophrenia, histamine H1 receptor-based DMLs for allergies, DMLs targeting the angiotensin system for hypertension, nonsteroidal anti-inflammatory drugs, and PPAR-based DMLs for metabolic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgouWcjsiKgbVg90H21EOLACvtfcHk0lh8Ej8ZcmOCLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVeisr%252FL&md5=00e3bf5a521fc91996ce95bb379a0b5c</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm058225d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058225d%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DDesigned%2520multiple%2520ligands.%2520An%2520emerging%2520drug%2520discovery%2520paradigm%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6523%26epage%3D6543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Csermely, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agoston, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongor, S.</span><span> </span><span class="NLM_article-title">The efficiency of multi-target drugs: the network approach might help drug design</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">178</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1016%2Fj.tips.2005.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=15808341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivV2ht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=178-182&author=P.+Csermelyauthor=V.+Agostonauthor=S.+Pongor&title=The+efficiency+of+multi-target+drugs%3A+the+network+approach+might+help+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">The efficiency of multi-target drugs: the network approach might help drug design</span></div><div class="casAuthors">Csermely, Peter; Agoston, Vilmos; Pongor, Sandor</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">178-182</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite considerable progress in genome- and proteome-based high-throughput screening methods and rational drug design, the no. of successful single-target drugs did not increase appreciably during the past decade.  Network models suggest that partial inhibition of a surprisingly small no. of targets can be more efficient than the complete inhibition of a single target.  This and the success stories of multi-target drugs and combinatorial therapies led us to suggest that systematic drug-design strategies should be directed against multiple targets.  The authors propose that the final effect of partial, but multiple, drug actions might often surpass that of complete drug action at a single target.  The future success of this novel drug-design paradigm will depend not only on a new generation of computer models to identify the correct multiple targets and their multi-fitting, low-affinity drug candidates but also on more-efficient in vivo testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQRoFMVKb5m7Vg90H21EOLACvtfcHk0lh8Ej8ZcmOCLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivV2ht70%253D&md5=4f1383f4699221ef99041dffafe03e8c</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2005.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2005.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DCsermely%26aufirst%3DP.%26aulast%3DAgoston%26aufirst%3DV.%26aulast%3DPongor%26aufirst%3DS.%26atitle%3DThe%2520efficiency%2520of%2520multi-target%2520drugs%253A%2520the%2520network%2520approach%2520might%2520help%2520drug%2520design%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2005%26volume%3D26%26spage%3D178%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Zimmermann, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, C. T.</span><span> </span><span class="NLM_article-title">Multi-target therapeutics: when the whole is greater than the sum of the parts</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1016%2Fj.drudis.2006.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=17198971" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=34-42&author=G.+R.+Zimmermannauthor=J.+Leharauthor=C.+T.+Keith&title=Multi-target+therapeutics%3A+when+the+whole+is+greater+than+the+sum+of+the+parts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Multi-target therapeutics: when the whole is greater than the sum of the parts</span></div><div class="casAuthors">Zimmermann Grant R; Lehar Joseph; Keith Curtis T</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">34-42</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">Drugs designed to act against individual molecular targets cannot usually combat multigenic diseases such as cancer, or diseases that affect multiple tissues or cell types such as diabetes and immunoinflammatory disorders.  Combination drugs that impact multiple targets simultaneously are better at controlling complex disease systems, are less prone to drug resistance and are the standard of care in many important therapeutic areas.  The combination drugs currently employed are primarily of rational design, but the increased efficacy they provide justifies in vitro discovery efforts for identifying novel multi-target mechanisms.  In this review, we discuss the biological rationale for combination therapeutics, review some existing combination drugs and present a systematic approach to identify interactions between molecular pathways that could be leveraged for therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTI14vYK2Q1LENHe_gFldTbfW6udTcc2eakX9PqzjAW3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s%252Fgt1ygtQ%253D%253D&md5=66715499ce21c2855dc6c477aa87f161</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2006.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2006.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DZimmermann%26aufirst%3DG.%2BR.%26aulast%3DLehar%26aufirst%3DJ.%26aulast%3DKeith%26aufirst%3DC.%2BT.%26atitle%3DMulti-target%2520therapeutics%253A%2520when%2520the%2520whole%2520is%2520greater%2520than%2520the%2520sum%2520of%2520the%2520parts%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D34%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Holt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paylor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boldrup, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alajakku, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandevoorde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundstrom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocco, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onnis, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, C. J.</span><span> </span><span class="NLM_article-title">Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">565</span><span class="NLM_x">, </span> <span class="NLM_fpage">26</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1016%2Fj.ejphar.2007.02.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=17397826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlvFantrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=565&publication_year=2007&pages=26-36&author=S.+Holtauthor=B.+Paylorauthor=L.+Boldrupauthor=K.+Alajakkuauthor=S.+Vandevoordeauthor=A.+Sundstromauthor=M.+T.+Coccoauthor=V.+Onnisauthor=C.+J.+Fowler&title=Inhibition+of+fatty+acid+amide+hydrolase%2C+a+key+endocannabinoid+metabolizing+enzyme%2C+by+analogues+of+ibuprofen+and+indomethacin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin</span></div><div class="casAuthors">Holt, Sandra; Paylor, Ben; Boldrup, Linda; Alajakku, Kirsi; Vandevoorde, Severine; Sundstroem, Anna; Cocco, Maria Teresa; Onnis, Valentina; Fowler, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">565</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">26-36</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">There is evidence in the literature that the nonsteroidal anti-inflammatory drugs indomethacin and ibuprofen can interact with the cannabinoid system both in vitro and in vivo.  In the present study, a series of analogs of ibuprofen and indomethacin have been investigated with respect to their ability to inhibit fatty acid amide hydrolase, the enzyme responsible for the hydrolysis of the endogenous cannabinoid anandamide.  Of the compds. tested, the 6-methyl-pyridin-2-yl analog of ibuprofen ("ibu-am5") was selected for further study.  This compd. inhibited rat brain anandamide hydrolysis in a non-competitive manner, with IC50 values of 4.7 and 2.5 μM being found at pH 6 and 8, resp.  By comparison, the IC50 values for ibuprofen were 130 and 750 μM at pH 6 and 8, resp.  There was no measurable N-acylethanolamine hydrolyzing acid amidase activity in rat brain membrane prepns.  In intact C6 glioma cells, ibu-am5 inhibited the hydrolysis of anandamide with an IC50 value of 1.2 μM.  There was little difference in the potencies of ibu-am5 and ibuprofen towards cyclooxygenase-1 and -2 enzymes, and neither compd. inhibited the activity of monoacylglycerol lipase.  Ibu-am5 inhibited the binding of [3H]-CP55,940 to rat brain CB1 and human CB2 cannabinoid receptors more potently than ibuprofen, but the increase in potency was less than the corresponding increase in potency seen for inhibition of FAAH activity.  It is concluded that ibu-am5 is an analog of ibuprofen with a greater potency towards fatty acid amide hydrolase but with a similar cyclooxygenase inhibitory profile, and may be useful for the study of the therapeutic potential of combined fatty acid amide hydrolase-cyclooxygenase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUI2qOGuDCIbVg90H21EOLACvtfcHk0lgvlJjxSs9qGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlvFantrs%253D&md5=a78d189e8a84fc86c528cc5bf350c180</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2007.02.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2007.02.051%26sid%3Dliteratum%253Aachs%26aulast%3DHolt%26aufirst%3DS.%26aulast%3DPaylor%26aufirst%3DB.%26aulast%3DBoldrup%26aufirst%3DL.%26aulast%3DAlajakku%26aufirst%3DK.%26aulast%3DVandevoorde%26aufirst%3DS.%26aulast%3DSundstrom%26aufirst%3DA.%26aulast%3DCocco%26aufirst%3DM.%2BT.%26aulast%3DOnnis%26aufirst%3DV.%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26atitle%3DInhibition%2520of%2520fatty%2520acid%2520amide%2520hydrolase%252C%2520a%2520key%2520endocannabinoid%2520metabolizing%2520enzyme%252C%2520by%2520analogues%2520of%2520ibuprofen%2520and%2520indomethacin%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2007%26volume%3D565%26spage%3D26%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Knox, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Law, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolkis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banco, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neveu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djoumbou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wishart, D. S.</span><span> </span><span class="NLM_article-title">DrugBank 3.0: a comprehensive resource for 'omics' research on drugs</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">D1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">D1041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=D1035-D1041&author=C.+Knoxauthor=V.+Lawauthor=T.+Jewisonauthor=P.+Liuauthor=S.+Lyauthor=A.+Frolkisauthor=A.+Ponauthor=K.+Bancoauthor=C.+Makauthor=V.+Neveuauthor=Y.+Djoumbouauthor=R.+Eisnerauthor=A.+C.+Guoauthor=D.+S.+Wishart&title=DrugBank+3.0%3A+a+comprehensive+resource+for+%27omics%27+research+on+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKnox%26aufirst%3DC.%26aulast%3DLaw%26aufirst%3DV.%26aulast%3DJewison%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLy%26aufirst%3DS.%26aulast%3DFrolkis%26aufirst%3DA.%26aulast%3DPon%26aufirst%3DA.%26aulast%3DBanco%26aufirst%3DK.%26aulast%3DMak%26aufirst%3DC.%26aulast%3DNeveu%26aufirst%3DV.%26aulast%3DDjoumbou%26aufirst%3DY.%26aulast%3DEisner%26aufirst%3DR.%26aulast%3DGuo%26aufirst%3DA.%2BC.%26aulast%3DWishart%26aufirst%3DD.%2BS.%26atitle%3DDrugBank%25203.0%253A%2520a%2520comprehensive%2520resource%2520for%2520%2527omics%2527%2520research%2520on%2520drugs%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D2011%26volume%3D39%26spage%3DD1035%26epage%3DD1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Huang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoichet, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irwin, J. J.</span><span> </span><span class="NLM_article-title">Benchmarking sets for molecular docking</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6789</span><span class="NLM_x">–</span> <span class="NLM_lpage">6801</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0608356" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFehurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6789-6801&author=N.+Huangauthor=B.+K.+Shoichetauthor=J.+J.+Irwin&title=Benchmarking+sets+for+molecular+docking"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Benchmarking Sets for Molecular Docking</span></div><div class="casAuthors">Huang, Niu; Shoichet, Brian K.; Irwin, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">6789-6801</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Ligand enrichment among top-ranking hits is a key metric of mol. docking.  To avoid bias, decoys should resemble ligands phys., so that enrichment is not simply a sepn. of gross features, yet be chem. distinct from them, so that they are unlikely to be binders.  We have assembled a directory of useful decoys (DUD), with 2950 ligands for 40 different targets.  Every ligand has 36 decoy mols. that are phys. similar but topol. distinct, leading to a database of 98 266 compds.  For most targets, enrichment was at least half a log better with uncorrected databases such as the MDDR than with DUD, evidence of bias in the former.  These calcns. also allowed 40×40 cross-docking, where the enrichments of each ligand set could be compared for all 40 targets, enabling a specificity metric for the docking screens.  DUD is freely available online as a benchmarking set for docking at http://blaster.docking.org/dud/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-8FVhVSsBm7Vg90H21EOLACvtfcHk0lgvlJjxSs9qGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFehurzI&md5=43af46968c2a6d66334922bf0caedbe1</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm0608356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0608356%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DN.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DIrwin%26aufirst%3DJ.%2BJ.%26atitle%3DBenchmarking%2520sets%2520for%2520molecular%2520docking%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6789%26epage%3D6801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Berger, L.; Corraz, A. J.</span> Carbazoles. US 3869145.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Berger%2C+L.%3B+Corraz%2C+A.+J.+Carbazoles.+US+3869145."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DL." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Narlawar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez Revuelta, B. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, K.</span><span> </span><span class="NLM_article-title">Scaffold of the cyclooxygenase-2 (COX-2) inhibitor carprofen provides Alzheimer γ-secretase modulators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">7588</span><span class="NLM_x">–</span> <span class="NLM_lpage">7591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0610200" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=7588-7591&author=R.+Narlawarauthor=B.+I.+Perez+Revueltaauthor=C.+Haassauthor=H.+Steinerauthor=B.+Schmidtauthor=K.+Baumann&title=Scaffold+of+the+cyclooxygenase-2+%28COX-2%29+inhibitor+carprofen+provides+Alzheimer+%CE%B3-secretase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm0610200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0610200%26sid%3Dliteratum%253Aachs%26aulast%3DNarlawar%26aufirst%3DR.%26aulast%3DPerez%2BRevuelta%26aufirst%3DB.%2BI.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DBaumann%26aufirst%3DK.%26atitle%3DScaffold%2520of%2520the%2520cyclooxygenase-2%2520%2528COX-2%2529%2520inhibitor%2520carprofen%2520provides%2520Alzheimer%2520%25CE%25B3-secretase%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D7588%26epage%3D7591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Bishay, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marian, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haussler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wijnvoord, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziebell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myrczek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bechmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costigan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dehghani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geisslinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tegeder, I.</span><span> </span><span class="NLM_article-title">R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e10628</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e10628&author=P.+Bishayauthor=H.+Schmidtauthor=C.+Marianauthor=A.+Hausslerauthor=N.+Wijnvoordauthor=S.+Ziebellauthor=J.+Metznerauthor=M.+Kochauthor=T.+Myrczekauthor=I.+Bechmannauthor=R.+Kunerauthor=M.+Costiganauthor=F.+Dehghaniauthor=G.+Geisslingerauthor=I.+Tegeder&title=R-flurbiprofen+reduces+neuropathic+pain+in+rodents+by+restoring+endogenous+cannabinoids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBishay%26aufirst%3DP.%26aulast%3DSchmidt%26aufirst%3DH.%26aulast%3DMarian%26aufirst%3DC.%26aulast%3DHaussler%26aufirst%3DA.%26aulast%3DWijnvoord%26aufirst%3DN.%26aulast%3DZiebell%26aufirst%3DS.%26aulast%3DMetzner%26aufirst%3DJ.%26aulast%3DKoch%26aufirst%3DM.%26aulast%3DMyrczek%26aufirst%3DT.%26aulast%3DBechmann%26aufirst%3DI.%26aulast%3DKuner%26aufirst%3DR.%26aulast%3DCostigan%26aufirst%3DM.%26aulast%3DDehghani%26aufirst%3DF.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DTegeder%26aufirst%3DI.%26atitle%3DR-flurbiprofen%2520reduces%2520neuropathic%2520pain%2520in%2520rodents%2520by%2520restoring%2520endogenous%2520cannabinoids%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De10628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borjesson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiger, G.</span><span> </span><span class="NLM_article-title">Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2Fsj.bjp.0703569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=11015300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVygtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2000&pages=498-504&author=C.+J.+Fowlerauthor=M.+Borjessonauthor=G.+Tiger&title=Differences+in+the+pharmacological+properties+of+rat+and+chicken+brain+fatty+acid+amidohydrolase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Differences in the pharmacological properties of rat and chicken brain fatty acid amidohydrolase</span></div><div class="casAuthors">Fowler, Christopher J.; Borjesson, Magnus; Tiger, Gunnar</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">498-504</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">1 The pharmacol. properties of fatty acid amidohydrolase (FAAH) were investigated in brains of 35-day-old chickens, since nothing is known about the enzyme in avian species.  2 FAAH activity towards both [3H]-palmitoylethanolamide (PEA) [KM = 1.5 μM] and [3H]-anandamide (AEA) [KM = 5.4 μM] was demonstrated in the chicken brains.  The chicken FAAH was inhibited by the substrate analogs oleyl trifluoromethylketone (OTMK) and diazomethylarachidonyl ketone (DAK) with similar potencies to the rat FAAH.  However, in contrast to the rat brain, phenylmethylsulfonyl fluoride (PMSF) and the enantiomers of had very weak effects on chicken brain FAAH.  3 Indomethacin and niflumic acid were found to inhibit rat brain AEA hydrolysis.  The inhibition by indomethacin was reversible and competitive, with a Ki value of 120 μM.  Chicken FAAH was less sensitive to indomethacin than its rodent counterpart, but the inhibition was also competitive (Ki).  4 It is concluded that chicken FAAH activity has different pharmacol. properties to its rodent counterpart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7-86DiIYaa7Vg90H21EOLACvtfcHk0lgiYtIgUz79dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVygtL0%253D&md5=374eaab658be63b35c5cb52cd4a9c833</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0703569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0703569%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DBorjesson%26aufirst%3DM.%26aulast%3DTiger%26aufirst%3DG.%26atitle%3DDifferences%2520in%2520the%2520pharmacological%2520properties%2520of%2520rat%2520and%2520chicken%2520brain%2520fatty%2520acid%2520amidohydrolase%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2000%26volume%3D131%26spage%3D498%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Duggan, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walters, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harp, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">34950</span><span class="NLM_x">–</span> <span class="NLM_lpage">34959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=34950-34959&author=K.+C.+Dugganauthor=M.+J.+Waltersauthor=J.+Museeauthor=J.+M.+Harpauthor=J.+R.+Kieferauthor=J.+A.+Oatesauthor=L.+J.+Marnett&title=Molecular+basis+for+cyclooxygenase+inhibition+by+the+non-steroidal+anti-inflammatory+drug+naproxen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuggan%26aufirst%3DK.%2BC.%26aulast%3DWalters%26aufirst%3DM.%2BJ.%26aulast%3DMusee%26aufirst%3DJ.%26aulast%3DHarp%26aufirst%3DJ.%2BM.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DOates%26aufirst%3DJ.%2BA.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DMolecular%2520basis%2520for%2520cyclooxygenase%2520inhibition%2520by%2520the%2520non-steroidal%2520anti-inflammatory%2520drug%2520naproxen%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D34950%26epage%3D34959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenstrom, A.</span><span> </span><span class="NLM_article-title">Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">729</span><span class="NLM_x">–</span> <span class="NLM_lpage">734</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=9353392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADyaK2sXnsV2msLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=729-734&author=C.+J.+Fowlerauthor=G.+Tigerauthor=A.+Stenstrom&title=Ibuprofen+inhibits+rat+brain+deamidation+of+anandamide+at+pharmacologically+relevant+concentrations.+Mode+of+inhibition+and+structure-activity+relationship"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship</span></div><div class="casAuthors">Fowler, Christopher J.; Tiger, Gunnar; Stenstrom, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">729-734</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The ability of rat brain (minus cerebellum) homogenates to deamidate arachidonyl ethanolamide (anandamide) was detd. with a custom-synthesized substrate ([3H]anandamide).  Conditions whereby initial velocities were measured were established.  The homogenates deamidated anandamide with a Km value of 0.8 μM and a Vmax value of 1.73 nmol · (mg protein)-1 · min-1.  The deamidation of 2 μM [3H]anandamide was inhibited by phenylmethylsulfonyl fluoride and arachidonyl trifluoromethyl ketone with IC50 values of 3.7 and 0.23 μM, resp.  Ibuprofen inhibited anandamide deamidation in a mixed fashion, with Ki and K'i values of 82 and 1420 μM.  At an anandamide concn. of 2 μM, the IC50 values (in μM) of a series of compds. related in structure to ibuprofen were as follows: suprofen, 170; ibuprofen, 270; fenoprofen, 480; naproxen, 550; ketoprofen, 650; diclofenac, ∼1000.  Sulindac produced 27% inhibition at a concn. of 1000 μM, whereas isobutyric acid, hydrocinnamic acid, acetylsalicylic acid and acetaminophen were essentially inactive at concns. ≤ 1 mM.  We conclude that ibuprofen inhibits anandamide deamidation at pharmacol. relevant concns. and that there is some specificity to the inhibition produced by ibuprofen and suprofen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZXrS_j9s3sLVg90H21EOLACvtfcHk0lgiYtIgUz79dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXnsV2msLo%253D&md5=cd0e866f9513e895072cae4414a3db6e</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DTiger%26aufirst%3DG.%26aulast%3DStenstrom%26aufirst%3DA.%26atitle%3DIbuprofen%2520inhibits%2520rat%2520brain%2520deamidation%2520of%2520anandamide%2520at%2520pharmacologically%2520relevant%2520concentrations.%2520Mode%2520of%2520inhibition%2520and%2520structure-activity%2520relationship%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D729%26epage%3D734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahlstrom, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenstrom, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiger, G.</span><span> </span><span class="NLM_article-title">Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">191</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=1999&pages=191-196&author=C.+J.+Fowlerauthor=U.+Jansonauthor=R.+M.+Johnsonauthor=G.+Wahlstromauthor=A.+Stenstromauthor=K.+Norstromauthor=G.+Tiger&title=Inhibition+of+anandamide+hydrolysis+by+the+enantiomers+of+ibuprofen%2C+ketorolac%2C+and+flurbiprofen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DJanson%26aufirst%3DU.%26aulast%3DJohnson%26aufirst%3DR.%2BM.%26aulast%3DWahlstrom%26aufirst%3DG.%26aulast%3DStenstrom%26aufirst%3DA.%26aulast%3DNorstrom%26aufirst%3DK.%26aulast%3DTiger%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520anandamide%2520hydrolysis%2520by%2520the%2520enantiomers%2520of%2520ibuprofen%252C%2520ketorolac%252C%2520and%2520flurbiprofen%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1999%26volume%3D362%26spage%3D191%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naidu, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onnis, V.</span><span> </span><span class="NLM_article-title">The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">412</span><span class="NLM_x">–</span> <span class="NLM_lpage">419</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1111%2Fj.1476-5381.2008.00029.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=19226258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1WlsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=2009&pages=412-419&author=C.+J.+Fowlerauthor=P.+S.+Naiduauthor=A.+Lichtmanauthor=V.+Onnis&title=The+case+for+the+development+of+novel+analgesic+agents+targeting+both+fatty+acid+amide+hydrolase+and+either+cyclooxygenase+or+TRPV1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">The case for the development of novel analgesic agents targeting both fatty acid amide hydrolase and either cyclooxygenase or TRPV1</span></div><div class="casAuthors">Fowler, C. J.; Naidu, P. S.; Lichtman, A.; Onnis, V.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">412-419</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Although the dominant approach to drug development is the design of compds. selective for a given target, compds. targeting more than one biol. process may have superior efficacy, or alternatively a better safety profile than std. selective compds.  Here, this possibility has been explored with respect to the endocannabinoid system and pain.  Compds. inhibiting the enzyme fatty acid amide hydrolase (FAAH), by increasing local endocannabinoid tone, produce potentially useful effects in models of inflammatory and possibly neuropathic pain.  Local increases in levels of the endocannabinoid anandamide potentiate the actions of cyclooxygenase inhibitors, raising the possibility that compds. inhibiting both FAAH and cyclooxygenase can be as effective as non-steroidal anti-inflammatory drugs but with a reduced cyclooxygenase inhibitory 'load'.  An ibuprofen analog active in models of visceral pain and with FAAH and cyclooxygenase inhibitory properties has been identified.  Another approach, built in to the exptl. analgesic compd. N-arachidonoylserotonin, is the combination of FAAH inhibitory and transient receptor potential vanilloid type 1 antagonist properties.  Although finding the right balance of actions upon the two targets is a key to success, it is hoped that dual-action compds. of the types illustrated in this review will prove to be useful analgesic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprysPLCW6j8LVg90H21EOLACvtfcHk0lgiYtIgUz79dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1WlsrY%253D&md5=096546b0081d52c65f928bd2e7790936</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2008.00029.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2008.00029.x%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DNaidu%26aufirst%3DP.%2BS.%26aulast%3DLichtman%26aufirst%3DA.%26aulast%3DOnnis%26aufirst%3DV.%26atitle%3DThe%2520case%2520for%2520the%2520development%2520of%2520novel%2520analgesic%2520agents%2520targeting%2520both%2520fatty%2520acid%2520amide%2520hydrolase%2520and%2520either%2520cyclooxygenase%2520or%2520TRPV1%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D156%26spage%3D412%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Fowler, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiger, G.</span><span> </span><span class="NLM_article-title">Acidic nonsteroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner</span> <span class="citation_source-journal">J. Enzyme Inhib. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1080%2F1475636021000049726" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=12751821" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD3sXoslKrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=55-58&author=C.+J.+Fowlerauthor=S.+Holtauthor=G.+Tiger&title=Acidic+nonsteroidal+anti-inflammatory+drugs+inhibit+rat+brain+fatty+acid+amide+hydrolase+in+a+pH-dependent+manner"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Acidic Nonsteroidal Anti-inflammatory Drugs Inhibit Rat Brain Fatty Acid Amide Hydrolase in a pH-dependent Manner</span></div><div class="casAuthors">Fowler, Christopher J.; Holt, Sandra; Tiger, Gunnar</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-58</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Previous studies have demonstrated that fatty acid amide hydrolase, the enzyme responsible for the metab. of anandamide, is inhibited by the acidic non-steroidal anti-inflammatory drug (NSAID) ibuprofen with a potency that increases as the assay pH is reduced.  Here we show that (R)-, (S)- and (R,S)-flurbiprofen, indomethacin and niflumic acid show similar pH-dependent shifts in potency to that seen with ibuprofen.  Thus, (S)-flurbiprofen inhibited 2 μM [3H]anandamide metab. with IC50 values of 13 and 50 μM at assay pH values of 6 and 8, resp.  In contrast, the neutral compd. celecoxib was a weak fatty acid amide hydrolase inhibitor and showed no pH dependency (IC50 values ∼300 μM at both assay pH).  The cyclooxygenase-2-selective inhibitors nimesulide and SC-58125 did not inhibit fatty acid amide hydrolase activity at either pH.  The data are consistent with the conclusion that the non-ionized forms of the acidic NSAIDs are responsible for the inhibition of fatty acid amide hydrolase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-HdjxEzRsl7Vg90H21EOLACvtfcHk0li-vmtzrFRfWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXoslKrsw%253D%253D&md5=e3b2b69c8b4e6be41962b374156e8973</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1080%2F1475636021000049726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F1475636021000049726%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DC.%2BJ.%26aulast%3DHolt%26aufirst%3DS.%26aulast%3DTiger%26aufirst%3DG.%26atitle%3DAcidic%2520nonsteroidal%2520anti-inflammatory%2520drugs%2520inhibit%2520rat%2520brain%2520fatty%2520acid%2520amide%2520hydrolase%2520in%2520a%2520pH-dependent%2520manner%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2003%26volume%3D18%26spage%3D55%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Hermanson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Cannabinoids, endocannabinoids, and cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">599</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1007%2Fs10555-011-9318-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=22038019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1emt7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=599-612&author=D.+J.+Hermansonauthor=L.+J.+Marnett&title=Cannabinoids%2C+endocannabinoids%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoids, endocannabinoids, and cancer</span></div><div class="casAuthors">Hermanson, Daniel J.; Marnett, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">599-612</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  The endocannabinoid system consists of an array of endogenously produced bioactive lipids that activate cannabinoid receptors.  Although the primary focus of endocannabinoid biol. has been on neurol. and psychiatric effects, recent work has revealed several important interactions between the endocannabinoid system and cancer.  Several different types of cancer have abnormal regulation of the endocannabinoid system that contributes to cancer progression and correlates to clin. outcomes.  Modulation of the endocannabinoid system by pharmacol. agents in various cancer types reveals that it can mediate antiproliferative and apoptotic effects by both cannabinoid receptor-dependent and -independent pathways.  Selective agonists and antagonists of the cannabinoid receptors, inhibitors of endocannabinoid hydrolysis, and cannabinoid analogs have been utilized to probe the pathways involved in the effects of the endocannabinoid system on cancer cell apoptosis, proliferation, migration, adhesion, and invasion.  The antiproliferative and apoptotic effects produced by some of these pharmacol. probes reveal that the endocannabinoid system is a promising new target for the development of novel chemotherapeutics to treat cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWWMIHHXmIYbVg90H21EOLACvtfcHk0li-vmtzrFRfWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1emt7nE&md5=b13c75506f28c6824853f3747f9038c8</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1007%2Fs10555-011-9318-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-011-9318-8%26sid%3Dliteratum%253Aachs%26aulast%3DHermanson%26aufirst%3DD.%2BJ.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DCannabinoids%252C%2520endocannabinoids%252C%2520and%2520cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2011%26volume%3D30%26spage%3D599%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">Inflammation and cancer: chemical approaches to mechanisms, imaging, and treatment</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">5224</span><span class="NLM_x">–</span> <span class="NLM_lpage">38</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo300214d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=5224-38&author=L.+J.+Marnett&title=Inflammation+and+cancer%3A+chemical+approaches+to+mechanisms%2C+imaging%2C+and+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjo300214d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo300214d%26sid%3Dliteratum%253Aachs%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3DInflammation%2520and%2520cancer%253A%2520chemical%2520approaches%2520to%2520mechanisms%252C%2520imaging%252C%2520and%2520treatment%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2012%26volume%3D77%26spage%3D5224%26epage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Nobeli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favia, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, J. M.</span><span> </span><span class="NLM_article-title">Protein promiscuity and its implications for biotechnology</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2Fnbt1519" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=19204698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Cktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=157-167&author=I.+Nobeliauthor=A.+D.+Faviaauthor=J.+M.+Thornton&title=Protein+promiscuity+and+its+implications+for+biotechnology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Protein promiscuity and its implications for biotechnology</span></div><div class="casAuthors">Nobeli, Irene; Favia, Angelo D.; Thornton, Janet M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-167</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mol. recognition between proteins and their interacting partners underlies the biochem. of living organisms.  Specificity in this recognition is thought to be essential, whereas promiscuity is often assocd. with unwanted side-effects, poor catalytic properties, and errors in biol. function.  Recent exptl. evidence suggests that promiscuity, not only in interactions but also in the actual function of proteins, is not as rare as was previously thought.  This has implications not only for the fundamental understanding of mol. recognition and how protein function has evolved over time, but also in the realm of biotechnol.  Understanding protein promiscuity is becoming increasingly important not only to optimize protein engineering applications in areas as diverse as synthetic biol. and metagenomics, but also to lower attrition rates in drug discovery programs, identify drug interaction surfaces less susceptible to escape mutations, and potentiate the power of polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdzkMBuUqOqLVg90H21EOLACvtfcHk0li-vmtzrFRfWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Cktrc%253D&md5=1e72967accb88b6183ec882a4cba2571</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fnbt1519&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1519%26sid%3Dliteratum%253Aachs%26aulast%3DNobeli%26aufirst%3DI.%26aulast%3DFavia%26aufirst%3DA.%2BD.%26aulast%3DThornton%26aufirst%3DJ.%2BM.%26atitle%3DProtein%2520promiscuity%2520and%2520its%2520implications%2520for%2520biotechnology%26jtitle%3DNat.%2520Biotechnol.%26date%3D2009%26volume%3D27%26spage%3D157%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhoti, H.</span><span> </span><span class="NLM_article-title">A 'rule of three' for fragment-based lead discovery?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">876</span><span class="NLM_x">–</span> <span class="NLM_lpage">877</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=876-877&author=M.+Congreveauthor=R.+Carrauthor=C.+Murrayauthor=H.+Jhoti&title=A+%27rule+of+three%27+for+fragment-based+lead+discovery%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DCarr%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DA%2520%2527rule%2520of%2520three%2527%2520for%2520fragment-based%2520lead%2520discovery%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2003%26volume%3D8%26spage%3D876%26epage%3D877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Czarnobilski, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarnobilski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konturek, S. J.</span><span> </span><span class="NLM_article-title">Carprofen and the therapy of gastroduodenal ulcerations by ranitidine</span> <span class="citation_source-journal">Hepatogastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">23</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=3872836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADyaL2M7otV2ktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1985&pages=20-23&author=Z.+Czarnobilskiauthor=S.+Bemauthor=K.+Czarnobilskiauthor=S.+J.+Konturek&title=Carprofen+and+the+therapy+of+gastroduodenal+ulcerations+by+ranitidine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Carprofen and the therapy of gastroduodenal ulcerations by ranitidine</span></div><div class="casAuthors">Czarnobilski Z; Bem S; Czarnobilski K; Konturek S J</div><div class="citationInfo"><span class="NLM_cas:title">Hepato-gastroenterology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">20-3</span>
        ISSN:<span class="NLM_cas:issn">0172-6390</span>.
    </div><div class="casAbstract">The effects of the addition of carprofen (Roche), a new nonsteroidal antiinflammatory agent, to regular 4-5 week ranitidine (300 mg/day) therapy on gastric secretion, serum gastrin level and ulcer healing, have been examined in 15 gastric ulcer (GU) and 60 duodenal ulcer (DU) patients.  Carprofen at a therapeutic dose (300 mg/day) was well tolerated by both GU and DU patients and did not give rise to any major adverse effects.  In an open trial on 15 GU (all receiving carprofen), complete endoscopic ulcer healing was found in 9 patients after 3 weeks and in 6 others after 5 weeks of treatment.  In a double blind, placebo controlled trial on 60 DU (30 receiving carprofen and 30 receiving placebo), complete ulcer healing was seen after 2 weeks in 23 on carprofen and 22 on placebo, and after 4 weeks in all tested patients.  Pentagastrin-induced maximal acid secretion examined 24 h after the last dose of treatment was significantly reduced in DU, but not in GU, patients, and was accompanied by a significant rise in plasma gastrin levels.  No change in gastric histology was observed in any patient tested.  This study provides evidence that carprofen added to antiulcer ranitidine therapy shows excellent gastrointestinal tolerance, and does not interfere with ulcer healing; it is, therefore, recommended in the treatment of arthritic patients with peptic ulcer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAk80g0dszd8uCWE5mhx1RfW6udTcc2eaz0ELklr_nqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2M7otV2ktw%253D%253D&md5=e11d5ecd1b39fc9591f61265902cd889</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCzarnobilski%26aufirst%3DZ.%26aulast%3DBem%26aufirst%3DS.%26aulast%3DCzarnobilski%26aufirst%3DK.%26aulast%3DKonturek%26aufirst%3DS.%2BJ.%26atitle%3DCarprofen%2520and%2520the%2520therapy%2520of%2520gastroduodenal%2520ulcerations%2520by%2520ranitidine%26jtitle%3DHepatogastroenterology%26date%3D1985%26volume%3D32%26spage%3D20%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Duggan, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermanson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusakiewicz, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheib, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oates, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marnett, L. J.</span><span> </span><span class="NLM_article-title">(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2Fnchembio.663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=22053353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A280%3ADC%252BC3MbmsFSjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=803-809&author=K.+C.+Dugganauthor=D.+J.+Hermansonauthor=J.+Museeauthor=J.+J.+Prusakiewiczauthor=J.+L.+Scheibauthor=B.+D.+Carterauthor=S.+Banerjeeauthor=J.+A.+Oatesauthor=L.+J.+Marnett&title=%28R%29-Profens+are+substrate-selective+inhibitors+of+endocannabinoid+oxygenation+by+COX-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2</span></div><div class="casAuthors">Duggan Kelsey C; Hermanson Daniel J; Musee Joel; Prusakiewicz Jeffery J; Scheib Jami L; Carter Bruce D; Banerjee Surajit; Oates J A; Marnett Lawrence J</div><div class="citationInfo"><span class="NLM_cas:title">Nature chemical biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">803-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cyclooxygenase-2 (COX-2) catalyzes the oxygenation of arachidonic acid and the endocannabinoids 2-arachidonoylglycerol and arachidonoylethanolamide.  Evaluation of a series of COX-2 inhibitors revealed that many weak competitive inhibitors of arachidonic acid oxygenation are potent inhibitors of endocannabinoid oxygenation. (R) enantiomers of ibuprofen, naproxen and flurbiprofen, which are considered to be inactive as COX-2 inhibitors, are potent 'substrate-selective inhibitors' of endocannabinoid oxygenation.  Crystal structures of the COX-2-(R)-naproxen and COX-2-(R)-flurbiprofen complexes verified this unexpected binding and defined the orientation of the (R) enantiomers relative to (S) enantiomers. (R)-Profens selectively inhibited endocannabinoid oxygenation by lipopolysaccharide-stimulated dorsal root ganglion (DRG) cells.  Substrate-selective inhibition provides new tools for investigating the role of COX-2 in endocannabinoid oxygenation and a possible explanation for the ability of (R)-profens to maintain endocannabinoid tone in models of neuropathic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCVl07yxZ4YMvLc4ARHEmzfW6udTcc2eaz0ELklr_nqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbmsFSjtA%253D%253D&md5=306005e871b9c51de475800b5375732d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.663%26sid%3Dliteratum%253Aachs%26aulast%3DDuggan%26aufirst%3DK.%2BC.%26aulast%3DHermanson%26aufirst%3DD.%2BJ.%26aulast%3DMusee%26aufirst%3DJ.%26aulast%3DPrusakiewicz%26aufirst%3DJ.%2BJ.%26aulast%3DScheib%26aufirst%3DJ.%2BL.%26aulast%3DCarter%26aufirst%3DB.%2BD.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DOates%26aufirst%3DJ.%2BA.%26aulast%3DMarnett%26aufirst%3DL.%2BJ.%26atitle%3D%2528R%2529-Profens%2520are%2520substrate-selective%2520inhibitors%2520of%2520endocannabinoid%2520oxygenation%2520by%2520COX-2%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2011%26volume%3D7%26spage%3D803%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Bracey, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cravatt, B. F.</span><span> </span><span class="NLM_article-title">Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1793</span><span class="NLM_x">–</span> <span class="NLM_lpage">1796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1126%2Fscience.1076535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=12459591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFKmsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1793-1796&author=M.+H.+Braceyauthor=M.+A.+Hansonauthor=K.+R.+Masudaauthor=R.+C.+Stevensauthor=B.+F.+Cravatt&title=Structural+adaptations+in+a+membrane+enzyme+that+terminates+endocannabinoid+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling</span></div><div class="casAuthors">Bracey, Michael H.; Hanson, Michael A.; Masuda, Kim R.; Stevens, Raymond C.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5599</span>),
    <span class="NLM_cas:pages">1793-1796</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Cellular communication in the nervous system is mediated by chem. messengers that include amino acids, monoamines, peptide hormones, and lipids.  An interesting question is how neurons regulate signals that are transmitted by membrane-embedded lipids.  Here, we report the 2.8 angstrom crystal structure of the integral membrane protein fatty acid amide hydrolase (FAAH), an enzyme that degrades members of the endocannabinoid class of signaling lipids and terminates their activity.  The structure of FAAH complexed with an arachidonyl inhibitor reveals how a set of discrete structural alterations allows this enzyme, in contrast to sol. hydrolases of the same family, to integrate into cell membranes and establish direct access to the bilayer from its active site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTj6G-8THMiLVg90H21EOLACvtfcHk0lggwUqfypObiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFKmsLs%253D&md5=01545bfbd00f31af713db259f41cb0ba</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1126%2Fscience.1076535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1076535%26sid%3Dliteratum%253Aachs%26aulast%3DBracey%26aufirst%3DM.%2BH.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DMasuda%26aufirst%3DK.%2BR.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DStructural%2520adaptations%2520in%2520a%2520membrane%2520enzyme%2520that%2520terminates%2520endocannabinoid%2520signaling%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1793%26epage%3D1796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Kurumbail, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gierse, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stegeman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gildehaus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyashiro, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penning, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isakson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stallings, W. C.</span><span> </span><span class="NLM_article-title">Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">644</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1038%2F384644a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=8967954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADyaK2sXlsVKl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=1996&pages=644-648&author=R.+G.+Kurumbailauthor=A.+M.+Stevensauthor=J.+K.+Gierseauthor=J.+J.+McDonaldauthor=R.+A.+Stegemanauthor=J.+Y.+Pakauthor=D.+Gildehausauthor=J.+M.+Miyashiroauthor=T.+D.+Penningauthor=K.+Seibertauthor=P.+C.+Isaksonauthor=W.+C.+Stallings&title=Structural+basis+for+selective+inhibition+of+cyclooxygenase-2+by+anti-inflammatory+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents</span></div><div class="casAuthors">Kurumbail, Ravi G.; Stevens, Anna M.; Gierse, James K.; McDonald, Joseph J.; Stegeman, Roderick A.; Pak, Jina Y.; Gildehaus, Daniel; Miyashiro, Julie M.; Penning, Thomas D.; Seibert, Karen; Isakson, Peter C.; Stallings, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">384</span>
        (<span class="NLM_cas:issue">6610</span>),
    <span class="NLM_cas:pages">644-648</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Prostaglandins and glucocorticoids are potent mediators of inflammation.  Non-steroidal anti-inflammatory drugs (NSAIDs) exert their effects by inhibition of prostaglandin prodn.  The pharmacol. target of NSAIDs is cyclooxygenase (COX, also known as PGH synthase), which catalyzes the first committed step in arachidonic-acid metab.  Two isoforms of the membrane protein COX are known : COX-1, which is constitutively expressed in most tissues, is responsible for the physiol. prodn. of prostaglandins; and COX-2, which is induced by cytokines, mitogens and endotoxins in inflammatory cells, is responsible for the elevated prodn. of prostaglandins during inflammation.  The structure of ovine COX-1 complexed with several NSAIDs has been detd.  Here we report the structures of unliganded murine COX-2 and complexes with flurbiprofen, indomethacin and SC-558, a selective COX-2 inhibitor, detd. at 3.0 to 2.5 Å resoln.  These structures explain the structural basis for the selective inhibition of COX-2, and demonstrate some of the conformational changes assocd. with time-dependent inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0KKKDKWXK3LVg90H21EOLACvtfcHk0ljXT97-bwaV7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlsVKl&md5=3f3695232f30769a9dc5006c3cc24d55</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2F384644a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F384644a0%26sid%3Dliteratum%253Aachs%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DStevens%26aufirst%3DA.%2BM.%26aulast%3DGierse%26aufirst%3DJ.%2BK.%26aulast%3DMcDonald%26aufirst%3DJ.%2BJ.%26aulast%3DStegeman%26aufirst%3DR.%2BA.%26aulast%3DPak%26aufirst%3DJ.%2BY.%26aulast%3DGildehaus%26aufirst%3DD.%26aulast%3DMiyashiro%26aufirst%3DJ.%2BM.%26aulast%3DPenning%26aufirst%3DT.%2BD.%26aulast%3DSeibert%26aufirst%3DK.%26aulast%3DIsakson%26aufirst%3DP.%2BC.%26aulast%3DStallings%26aufirst%3DW.%2BC.%26atitle%3DStructural%2520basis%2520for%2520selective%2520inhibition%2520of%2520cyclooxygenase-2%2520by%2520anti-inflammatory%2520agents%26jtitle%3DNature%26date%3D1996%26volume%3D384%26spage%3D644%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Krivov, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapovalov, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunbrack, R. L.,  Jr.</span><span> </span><span class="NLM_article-title">Improved prediction of protein side-chain conformations with SCWRL4</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">–</span> <span class="NLM_lpage">795</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1002%2Fprot.22488" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=19603484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSru7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=778-795&author=G.+G.+Krivovauthor=M.+V.+Shapovalovauthor=R.+L.+Dunbrack&title=Improved+prediction+of+protein+side-chain+conformations+with+SCWRL4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Improved prediction of protein side-chain conformations with SCWRL4</span></div><div class="casAuthors">Krivov, Georgii G.; Shapovalov, Maxim V.; Dunbrack, Roland L., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">778-795</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Detn. of side-chain conformations is an important step in protein structure prediction and protein design.  Many such methods have been presented, although only a small no. are in widespread use.  SCWRL is one such method, and the SCWRL3 program (2003) has remained popular because of its speed, accuracy, and ease-of-use for the purpose of homol. modeling.  However, higher accuracy at comparable speed is desirable.  This has been achieved in a new program SCWRL4 through: (1) a new backbone-dependent rotamer library based on kernel d. ests.; (2) averaging over samples of conformations about the positions in the rotamer library; (3) a fast anisotropic hydrogen bonding function; (4) a short-range, soft van der Waals atom-atom interaction potential; (5) fast collision detection using k-discrete oriented polytopes; (6) a tree decompn. algorithm to solve the combinatorial problem; and (7) optimization of all parameters by detg. the interaction graph within the crystal environment using symmetry operators of the crystallog. space group.  Accuracies as a function of electron d. of the side chains demonstrate that side chains with higher electron d. are easier to predict than those with low-electron d. and presumed conformational disorder.  For a testing set of 379 proteins, 86% of χ1 angles and 75% of χ1+2 angles are predicted correctly within 40° of the X-ray positions.  Among side chains with higher electron d. (25-100th percentile), these nos. rise to 89 and 80%.  The new program maintains its simple command-line interface, designed for homol. modeling, and is now available as a dynamic-linked library for incorporation into other software programs.  Proteins 2009. © 2009 Wiley-Liss, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH9elI7_b5prVg90H21EOLACvtfcHk0ljXT97-bwaV7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSru7nN&md5=515b93d349447312958d8d7ebfe784c7</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Fprot.22488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.22488%26sid%3Dliteratum%253Aachs%26aulast%3DKrivov%26aufirst%3DG.%2BG.%26aulast%3DShapovalov%26aufirst%3DM.%2BV.%26aulast%3DDunbrack%26aufirst%3DR.%2BL.%26atitle%3DImproved%2520prediction%2520of%2520protein%2520side-chain%2520conformations%2520with%2520SCWRL4%26jtitle%3DProteins%26date%3D2009%26volume%3D77%26spage%3D778%26epage%3D795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Phillips, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braun, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gumbart, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tajkhorshid, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chipot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skeel, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kale, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulten, K.</span><span> </span><span class="NLM_article-title">Scalable molecular dynamics with NAMD</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1781</span><span class="NLM_x">–</span> <span class="NLM_lpage">1802</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1002%2Fjcc.20289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=16222654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1781-1802&author=J.+C.+Phillipsauthor=R.+Braunauthor=W.+Wangauthor=J.+Gumbartauthor=E.+Tajkhorshidauthor=E.+Villaauthor=C.+Chipotauthor=R.+D.+Skeelauthor=L.+Kaleauthor=K.+Schulten&title=Scalable+molecular+dynamics+with+NAMD"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Scalable molecular dynamics with NAMD</span></div><div class="casAuthors">Phillips, James C.; Braun, Rosemary; Wang, Wei; Gumbart, James; Tajkhorshid, Emad; Villa, Elizabeth; Chipot, Christophe; Skeel, Robert D.; Kale, Laxmikant; Schulten, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1781-1802</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">NAMD is a parallel mol. dynamics code designed for high-performance simulation of large biomol. systems.  NAMD scales to hundreds of processors on high-end parallel platforms, as well as tens of processors on low-cost commodity clusters, and also runs on individual desktop and laptop computers.  NAMD works with AMBER and CHARMM potential functions, parameters, and file formats.  This article, directed to novices as well as experts, first introduces concepts and methods used in the NAMD program, describing the classical mol. dynamics force field, equations of motion, and integration methods along with the efficient electrostatics evaluation algorithms employed and temp. and pressure controls used.  Features for steering the simulation across barriers and for calcg. both alchem. and conformational free energy differences are presented.  The motivations for and a roadmap to the internal design of NAMD, implemented in C++ and based on Charm++ parallel objects, are outlined.  The factors affecting the serial and parallel performance of a simulation are discussed.  Finally, typical NAMD use is illustrated with representative applications to a small, a medium, and a large biomol. system, highlighting particular features of NAMD, for example, the Tcl scripting language.  The article also provides a list of the key features of NAMD and discusses the benefits of combining NAMD with the mol. graphics/sequence anal. software VMD and the grid computing/collab. software BioCoRE.  NAMD is distributed free of charge with source code at www.ks.uiuc.edu.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7fq_yG00T1rVg90H21EOLACvtfcHk0ljXT97-bwaV7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbJ&md5=189051128443b547f4300a1b8fb0e034</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20289%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DJ.%2BC.%26aulast%3DBraun%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DGumbart%26aufirst%3DJ.%26aulast%3DTajkhorshid%26aufirst%3DE.%26aulast%3DVilla%26aufirst%3DE.%26aulast%3DChipot%26aufirst%3DC.%26aulast%3DSkeel%26aufirst%3DR.%2BD.%26aulast%3DKale%26aufirst%3DL.%26aulast%3DSchulten%26aufirst%3DK.%26atitle%3DScalable%2520molecular%2520dynamics%2520with%2520NAMD%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D1781%26epage%3D1802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Hornak, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strockbine, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roitberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmerling, C.</span><span> </span><span class="NLM_article-title">Comparison of multiple Amber force fields and development of improved protein backbone parameters</span> <span class="citation_source-journal">Proteins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">725</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1002%2Fprot.21123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=16981200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWqt7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2006&pages=712-725&author=V.+Hornakauthor=R.+Abelauthor=A.+Okurauthor=B.+Strockbineauthor=A.+Roitbergauthor=C.+Simmerling&title=Comparison+of+multiple+Amber+force+fields+and+development+of+improved+protein+backbone+parameters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of multiple Amber force fields and development of improved protein backbone parameters</span></div><div class="casAuthors">Hornak, Viktor; Abel, Robert; Okur, Asim; Strockbine, Bentley; Roitberg, Adrian; Simmerling, Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Proteins: Structure, Function, and Bioinformatics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">712-725</span>CODEN:
                <span class="NLM_cas:coden">PSFBAF</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">The ff94 force field that is commonly assocd. with the Amber simulation package is one of the most widely used parameter sets for biomol. simulation.  After a decade of extensive use and testing, limitations in this force field, such as over-stabilization of α-helixes, were reported by the authors and other researchers.  This led to a no. of attempts to improve these parameters, resulting in a variety of "Amber" force fields and significant difficulty in detg. which should be used for a particular application.  The authors show that several of these continue to suffer from inadequate balance between different secondary structure elements.  In addn., the approach used in most of these studies neglected to account for the existence in Amber of two sets of backbone .vphi./ψ dihedral terms.  This led to parameter sets that provide unreasonable conformational preferences for glycine.  The authors report here an effort to improve the .vphi./ψ dihedral terms in the ff99 energy function.  Dihedral term parameters are based on fitting the energies of multiple conformations of glycine and alanine tetrapeptides from high level ab initio quantum mech. calcns.  The new parameters for backbone dihedrals replace those in the existing ff99 force field.  This parameter set, which the authors denote ff99SB, achieves a better balance of secondary structure elements as judged by improved distribution of backbone dihedrals for glycine and alanine with respect to PDB survey data.  It also accomplishes improved agreement with published exptl. data for conformational preferences of short alanine peptides and better accord with exptl. NMR relaxation data of test protein systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoASzza-Gd7Vg90H21EOLACvtfcHk0ljXT97-bwaV7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWqt7fM&md5=de683a26eca9e83ae524726e97ac22fa</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1002%2Fprot.21123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprot.21123%26sid%3Dliteratum%253Aachs%26aulast%3DHornak%26aufirst%3DV.%26aulast%3DAbel%26aufirst%3DR.%26aulast%3DOkur%26aufirst%3DA.%26aulast%3DStrockbine%26aufirst%3DB.%26aulast%3DRoitberg%26aufirst%3DA.%26aulast%3DSimmerling%26aufirst%3DC.%26atitle%3DComparison%2520of%2520multiple%2520Amber%2520force%2520fields%2520and%2520development%2520of%2520improved%2520protein%2520backbone%2520parameters%26jtitle%3DProteins%26date%3D2006%26volume%3D65%26spage%3D712%26epage%3D725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Sanner, M. F.</span><span> </span><span class="NLM_article-title">Python: a programming language for software integration and development</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=10660911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=57-61&author=M.+F.+Sanner&title=Python%3A+a+programming+language+for+software+integration+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Python: a programming language for software integration and development</span></div><div class="casAuthors">Sanner, M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-61</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The use of interpreted languages in biocomputing has been investigated to create a programmable, dynamic environment in which components can be tied together at a high level.  This work has demonstrated the benefits of such an approach and the features of the interpreted language that are key to successful component integration.  This involved Python, an interpreted, interactive, object-oriented programming language.  It provides high-level data structures such as list and associative arrays, dynamic typing and dynamic binding, modules, classes, exceptions, automatic memory management and others.  Python has been found to be instrumental in the mol. modeling research environment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaCFXA1JC8X7Vg90H21EOLACvtfcHk0lgAs1UcIaCBsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhtV2rsA%253D%253D&md5=3bf94934548080055dda54f68468c656</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanner%26aufirst%3DM.%2BF.%26atitle%3DPython%253A%2520a%2520programming%2520language%2520for%2520software%2520integration%2520and%2520development%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D1999%26volume%3D17%26spage%3D57%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Trott, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, A. J.</span><span> </span><span class="NLM_article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm3011146&amp;key=10.1002%2Fjcc.21334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm3011146&amp;key=19499576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm3011146&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2010&pages=455-61&author=O.+Trottauthor=A.+J.+Olson&title=AutoDock+Vina%3A+improving+the+speed+and+accuracy+of+docking+with+a+new+scoring+function%2C+efficient+optimization%2C+and+multithreading"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span></div><div class="casAuthors">Trott, Oleg; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">455-461</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">AutoDock Vina, a new program for mol. docking and virtual screening, is presented.  AutoDock Vina achieves an approx. 2 orders of magnitude speed-up compared with the mol. docking software previously developed in the authors' lab (AutoDock 4), while also significantly improving the accuracy of the binding mode predictions, judging by the authors' tests on the training set used in AutoDock 4 development.  Further speed-up is achieved from parallelism, by using multithreading on multicore machines.  AutoDock Vina automatically calcs. the grid maps and clusters the results in a way transparent to the user.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLecOIkUxIlrVg90H21EOLACvtfcHk0lgAs1UcIaCBsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGnur3O&md5=c6974af8a1235f7aa09918d3e6f70dc4</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21334%26sid%3Dliteratum%253Aachs%26aulast%3DTrott%26aufirst%3DO.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock%2520Vina%253A%2520improving%2520the%2520speed%2520and%2520accuracy%2520of%2520docking%2520with%2520a%2520new%2520scoring%2520function%252C%2520efficient%2520optimization%252C%2520and%2520multithreading%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2010%26volume%3D31%26spage%3D455%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1mt5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1mt5','PDB','1mt5'); return false;">PDB: 1mt5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pgh" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3pgh','PDB','3pgh'); return false;">PDB: 3pgh</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i92"><a href="/doi/suppl/10.1021/jm3011146">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62466"></div></div></div></div></div><hr /></hr><p class="last">Percentage distribution of some molecular properties of the 382 COX inhibitors and putative binding mode to FAAH of some known COX inhibitors, including carprofen and some of its derivatives. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3011146/suppl_file/jm3011146_si_001.pdf">jm3011146_si_001.pdf (1.1 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3011146&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-20%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm3011146%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3011146" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799557a9e4ad203","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
